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Summary 
The investigations carried out during the course of this research are concerned 
with the short-term physiological mechanisms modulating protein and amino acid- 
induced satiety in human beings, an area which has recently received little attention in 
the field of appetite regulation. 
Research into the effect of the essential amino acid, phenylalanine, on satiety 
demonstrated that 5g phenylalanine reduced food intake by 13 % (p<0.05). 
Phenylalanine (5 g) increased plasma cholecystokinin (CCK) concentrations (basal 
1.6 pmol/L ± SEM 0.4; t+35 min 4.6 pmol/L ± SEM 1.1, p<0.05) whereas there was 
no significant increase following the cornflour control. Aspartame (L-aspartyl-L- 
phenylalanine methyl ester), previously shown to reduce food intake, was 
hypothesised to increase CCK secretion. This was not shown in the current research. 
Both aspartame and its constituent amino acids shortened gastric emptying times (by 
8 and 27 % respectively, p<0.005) and suppressed glucagon-like peptide-1 (GLP-1) 
secretion (by 74 and 59 %, p<0.05) following a test meal. The amino acids also 
reduced subjective desire to eat following the test meal (p<0.05), and this was 
associated with a rapid increase in post-prandial plasma phenylalanine levels 
(p<0.005). 
The hormonal and metabolic responses to different protein types and their 
effect on satiety was investigated using test meals containing casein or whey protein. 
Previous work had shown that food intake is reduced following a meal containing 
whey compared to casein. The current work demonstrated that whey test meals led to 
a 28 % increase in post-prandial plasma amino acid concentrations over 3 hours 
compared to casein (incremental AUC (iAUC) p<0.05). There was also a statistically 
significant increase in plasma CCK by 60 % (iAUC p<0.005), GLP-1 by 65 % (iAUC 
p<0.05) and glucose-dependent insulinotropic polypeptide (GIP) by 36 % (iAUC 
p<0.01) following the whey meal compared to casein. The two meals also resulted in 
different time courses for plasma paracetamol concentrations, an indicator of gastric 
emptying rate. Greater subjective satiety followed the whey test meal (p<0.05). 
Electrical impedance epigastrography (EIE), used in the current research for 
the measurement of gastric emptying, was compared to other methods, firstly with the 
"gold standard" method scintigraphy, and secondly, with paracetamol absorption and 
II 
the 13C-octanoic acid breath test. EIE distinguished between low and high fat test 
meals adequately, but half-emptying times were short and correlated poorly with 
scintigraphy, the breath test, and also paracetamol absorption parameters. 
The investigations into protein- and amino acid-induced satiety show that 
large doses of phenylalanine affect satiety and plasma CCK levels, but smaller doses 
of phenylalanine, while still enhancing satiety, do not involve these hormonal 
changes. Studies with whole proteins emphasise the importance of considering the 
impact of protein type on the appetitive responses to fat and carbohydrate. 
Contents 
Acknowledgements i 
Summary ii 
List of figures xi 
List of tables xviii 
List of abbreviations xxi 
Chapter 1- Introduction 1 
1.1 Theories for the control of appetite 3 
1.1.1 Energostatic theory 3 
1.1.2 Glucostatic theory 4 
1.1.3 Lipostatic theory 5 
1.1.4 Aminostatic theory 6 
1.1.4.1 The original theory 6 
1.1.4.2 Why is the regulation of protein and amino acid intake 7 
important? 
1.1.4.3 Recent modifications to the aminostatic theory 8 
1.1.4.4 Adaptive changes in protein metabolism and protein-related 9 
satiety 
1.2 Peripheral Mechanisms 11 
1.2.1 Pre-absorptive mechanisms for protein and amino acid induced 11 
satiety 
1.2.1.1 Neuronal responses 12 
1.2.1.2 Hormonal responses 13 
1.2.1.2.1 Cholecystokinin (CCK) 13 
1.2.1.2.2 Glucagon-like peptide-1 (GLP-1) 16 
1.2.1.3 Gastric emptying and gastric distension 18 
1.2.1.3.1 The stomach 18 
1.2.1.3.2 Why measure gastric emptying? 20 
1.2.1.3.3 Methods of measuring gastric emptying 20 
1.2.1.3.4 The physical state of a meal 21 
1.2.1.3.5 Viscosity, osmolality, pH and temperature 22 
1.2.1.3.6 Volume versus energy content 22 
1.2.1.3.7 Carbohydrate 23 
1.2.1.3.8 Fat 23 
1.2.1.3.9 Protein 24 
1.2.1.3.10 Other influences on gastric emptying 24 
1.2.1.3.11 Gastric emptying and distension in relation to appetite 24 
1.2.1.4 Summary 26 
1.2.2 Post-absorptive mechanisms for protein- and amino acid-induced 26 
satiety 
1.2.2.1 Signals from hepatic amino acid sensors 27 
1.2.2.2 Amino acid flux into skeletal muscle as a hypothetical locus for 28 
appetite regulation 
iv 
1.3 Central Mechanisms 29 
1.3.1 Evidence that circulating and central nervous system amino acid 29 
concentrations influence food intake 
1.3.1.1 Animal studies 29 
1.3.1.2 Human studies 31 
1.3.2 Phenylalanine. tyrosine and dopamine 31 
1.3.2.1 Phenylalanine 32 
1.3.2.2 Dopamine influences eating behaviour 33 
1.3.2.3 Plasma tyrosine and dopamine synthesis 34 
1.3.2.4 The effect of meals on brain tyrosine and dopamine synthesis 35 
1.3.2.5 Conclusions 36 
1.3.3 Tryptophan and serotonin 36 
1.3.3.1 Effects of diet or tryptophan on serotonin synthesis 36 
1.3.3.2 Effects of diet or tryptophan on food intake 37 
1.3.3.3 Other pathways for serotonergic effects on food intake 39 
1.3.3.4 Conclusions 39 
1.3.4 y-aminobutyric acid (GABA) and glutamate 39 
1.4 Psychological and social aspects of appetite control 41 
1.4.1 Introduction 41 
1.4.2 The food 41 
1.4.3 External influences 42 
1.4.4 Psychological influences 43 
1.5 Conclusions 44 
1.6 Aims and objectives of the current research 46 
Chapter 2- Materials and Methods 48 
2.1 Materials 49 
2.1.1 Equipment 49 
2.1.2 Reagents 50 
2.1.3 Peptides and amino acids 50 
2.1.4 Antisera 51 
2.1.5 Sera 51 
2.1.6 Buffers 51 
2.1.7 Miscellaneous 53 
2.2 Methods 53 
2.2.1 Measurement of appetite 53 
2.2.1.1 Recruitment of subjects 54 
2.2.1.2 Measurement of food intake 54 
2.2.1.3 Measurement of motivation to eat 56 
2.2.2 Measurement of gastric emptying 58 
2.2.2.1 Scintigraphy 58 
2.2.2.2 Electrical impedance epigastrography 59 
2.2.2.3 13C-octanoic acid breath test 60 
V 
2.2.3 Measurement of circulating metabolites and hormones 
2.2.3.1 Blood sampling 
2.2.3.2 Analysis of glucose 
2.2.3.3 Analysis of amino acids 
2.2.3.3.1 Standard preparation 
2.2.3.3.2 Deproteinisation 
2.2.3.3.3 Derivatisation 
2.2.3.3.4 Eluents 
2.2.3.3.5 Processing of chromatograms and analysis of peak areas 
2.2.3.3.6 Quality controls 
2.2.3.4 Analysis of paracetamol 
2.2.3.5 Analysis of plasma gut and pancreatic hormones by 
radioimmunoassay 
2.2.3.5.1 Analysis of insulin 
2.2.3.5.2 Analysis of GIP 
2.2.3.5.3 Analysis of GLP-1 
2.2.3.5.4 Analysis of CCK 
2.2.3.5.5 Preparation of charcoal stripped serum 
2.2.3.5.6 Quality controls 
2.2.3.5.7 Iodination 
2.2.3.5.8 Affinity purification of GIP and GLP-1 
2.2.4 Statistical analysis 
2.3 
2.3.1 
2.3.2 
Reproducibility of satiety methodology: the 
measurement of food intake using ad libitum test meals 
and visual analogue scales for the subjective assessment 
of appetite 
Aims 
Subjects 
2.3.3 Study Protocol 
2.3.4 Test meals 
2.3.5 Statistical analysis 
2.3.6 Results 
2.3.6.1 Energy and food intake 
2.3.6.2 Subjective appetite ratings 
2.3.7 Discussion 
2.3.7.1 Food intake 
2.3.7.2 Visual analogue scales 
62 
62 
63 
63 
63 
64 
65 
65 
66 
66 
68 
68 
68 
70 
72 
74 
76 
77 
77 
79 
79 
80 
80 
80 
80 
81 
82 
82 
82 
84 
87 
87 
88 
V1 
Chapter 3- The effect of phenylalanine on 92 
appetite and possible physiological 
mechanisms 
3.1 General introduction 93 
3.2 The effect of phenylalanine supplementation on food 97 
intake 
3.2.1 Aims and hypotheses 97 
3.2.2 Subjects 97 
3.2.3 General procedure 97 
3.2.4 Subjective measures of appetite 99 
3.2.5 Treatment doses and meals 99 
3.2.6 Results 100 
3.2.6.1 Energy and food intake 100 
3.2.6.2 Subjective ratings of appetite 102 
3.2.6.3 Food preference checklist 105 
3.2.7 Discussion 105 
3.2.7.1 Food intake 105 
3.2.7.2 Macronutrient selection 106 
3.2.7.3 Subjective appetite 107 
3.2.7.4 Food preference checklists 108 
3.3 The effect of phenylalanine supplementation on 108 
circulating metabolite and hormone status, gastric 
emptying and satiety 
3.3.1 Aims and hypotheses 108 
3.3.2 Subjects 109 
3.3.3 General procedure 109 
3.3.4 Treatments and meals 111 
3.3.5 Subjective measures of appetite 111 
3.3.6 Results 111 
3.3.6.1 Gastric emptying 111 
3.3.6.2 Blood metabolites and hormone profiles 112 
3.3.6.2.1 Plasma glucose 112 
3.3.6.2.2 Plasma Phenylalanine 112 
3.3.6.2.3 Plasma tyrosine 113 
3.3.6.2.4 Plasma leucine 114 
3.3.6.2.5 Plasma GIP 115 
3.3.6.2.6 Plasma GLP-1 116 
3.3.6.2.7 Plasma insulin 116 
3.3.6.2.8 Plasma CCK 117 
3.3.6.3 Energy and food intake 118 
3.3.6.4 Subjective ratings for appetite 119 
3.3.7 Discussion 120 
vii 
3.4 The effect of alanine supplementation on food intake and 124 
subjective appetite ratings 
3.4.1 Aims and hypotheses 124 
3.4.2 Subjects 124 
3.4.3 General procedure 125 
3.4.4 Subjective measures of appetite 126 
3.4.5 Treatments and meals 126 
3.4.6 Results 127 
3.4.6.1 Energy and food intake 127 
3.4.6.2 Subjective ratings of appetite 127 
3.4.6.3 Food preference checklist 130 
3.4.7 Discussion 133 
3.5 The effect of aspartame and aspartame constituents on 134 
gastric emptying, plasma cholecystokinin and glucagon- 
like peptide-1 response 
3.5.1 Aims and hypotheses 134 
3.5.2 Subjects 134 
3.5.3 General procedure 135 
3.5.4 Treatments and meals 136 
3.5.5 Subjective measures of appetite 137 
3.5.6 Results 137 
3.5.6.1 Gastric emptying 137 
3.5.6.1.1 Electrical impedance epigastrography 137 
3.5.6.1.2 Paracetamol absorption 139 
3.5.6.2 Blood metabolites and hormones 140 
3.5.6.2.1 Plasma lug cose 140 
3.5.6.2.2 Plasma phenylalanine 141 
3.5.6.2.3 Plasma aspartic acid 143 
3.5.6.2.4 Plasma tyrosine 144 
3.5.6.2.5 Plasma CCK 144 
3.5.6.2.6 Plasma insulin 145 
3.5.6.2.7 Plasma GIP 145 
3.5.6.2.8 Plasma GLP-1 146 
3.5.6.3 Subjective ratings of appetite 147 
3.5.6.3.1 Correlations between desire to eat and plasma 151 
phenylalanine/gastric emptying times following the liquid test meal 
3.5.7 Discussion 152 
viii 
Chapter 4-A comparison of electrical 163 
impedance epigastrography with other 
techniques for the measurement of gastric 
emptying 
4.1 General introduction 164 
4.2 Comparison of electrical impedance epigastrography 166 
with the "gold standard" method, scintigraphy, using 
liquid test meals of differing energy content 
4.2.1 Aims and hypotheses 166 
4.2.2 Subjects 166 
4.2.3 General procedure 166 
4.2.4 Meals 168 
4.2.5 Statistical analysis 169 
4.2.6 Results 169 
4.2.6.1 Gastric emptying times 169 
4.2.6.1.1 Electrical impedance a ip gastrography (EIE) 169 
4.2.6.1.2 Scintigraphy 170 
4.2.6.1.3 Comparison of the two methods 171 
4.2.6.2 Plasma glucose and insulin 172 
4.2.6.2.1 Plasma glucose 172 
4.2.6.2.2 Plasma insulin 173 
4.2.7 Discussion 174 
4.3 Comparison of electrical impedance epigastrography 178 
with paracetamol absorption and the 13C-octanoic acid 
breath test, using low and high fat liquid test meals 
4.3.1 Aims and hypotheses 178 
4.3.2 Subjects 178 
4.3.3 General procedure 178 
4.3.4 Meals 180 
4.3.5 Statistical analysis 183 
4.3.6 Results 183 
4.3.6.1 Gastric emptying times 183 
4.3.6.1.1 Electrical impedance epigastrograph (EIE) 183 
4.3.6.1.2 13C-octanoic acid breath test 184 
4.3.6.1.3 Paracetamol absorption test 186 
4.3.6.1.4 Comparison of the three methods 188 
4.3.6.1.4.1 EIE and ? aracetamol absorption test 188 
4.3.6.1.4.2 EIE and 3C-octanoic acid breath test 189 
4.3.6.1.4.3 Paracetamol absorption and 13C-octanoic acid breath test 190 
4.3.6.1.4.4 Discriminatory power of the gastric emptying parameters between 191 
the low and high fat liquid test meals 
ix 
4.3.6.2 
4.3.6.2.1 
4.3.6.2.2 
4.3.6.2.3 
4.3.6.2.4 
4.3.6.2.5 
Plasma metabolites and hormones 
Plasma lud cose 
Plasma insulin 
Plasma GIP 
Plasma GLP-1 
Plasma CCK 
4.3.7 Discussion 
192 
192 
193 
194 
195 
196 
197 
Chapter 5- The effect of casein and whey 204 
protein on appetite and physiological 
mechanisms 
5.1 Introduction 205 
5.2 Investigation into the effect of casein and whey protein 207 
on circulating metabolite and hormone status, gastric 
emptying and subjective appetite ratings 
5.2.1 Aims and hypothesis 207 
5.2.2 Subjects 207 
5.2.3 General procedure 208 
5.2.4 Meals 209 
5.2.5 Subjective measures of appetite 210 
5.2.6 Results 210 
5.2.6.1 Gastric emptying 210 
5.2.6.2 Blood metabolites and hormone profiles 211 
5.2.6.2.1 Plasma lug 211 
5.2.6.2.2 Plasma amino acids 212 
5.2.6.2.3 Plasma GIP 216 
5.2.6.2.4 Plasma GLP-1 216 
5.2.6.2.5 Plasma insulin 217 
5.2.6.2.6 Plasma CCK 217 
5.2.6.3 Subjective ratings of appetite 219 
5.2.7 Discussion 221 
Chapter 6- General discussion 225 
6.1 Methodolo2v 
6.1.1 The measurement of appetite 
6.1.2 The measurement of gastric emptying 
6.2 Phenylalanine and appetite 
6.3 Physiological mechanisms behind the differing satiating 
effects of two proteins, casein and whey 
6.4 Concluding remarks 
6.5 Recommendations for future work 
Publications 
References 
Appendices 
226 
226 
230 
231 
235 
236 
237 
239 
241 
290 
X 
List of figures 
Chapter 1- Introduction 
1.1 Mechanisms of food intake regulation 2 
1.2 Comparison of satiety responses following a 13 day period of dietary 11 
intervention (which increased the protein intake of the habitual high 
protein group (HP) and decreased the protein intake of the habitual low 
protein group (LP)) between the LP and HP diet groups in response to 
three high protein test meals. 
1.3 The anatomy of the stomach showing the three gastric regions: fundus, 19 
body and antrum. From Vander (1994). 
1.4 Mechanisms whereby protein and amino acids may influence hunger 45 
and satiety 
Chapter 2- Materials and Methods 
2.1 Example of an electrical impedance epigastrography (EIE) impedance 60 
trace and the calculation of gastric half-emptying time (T50) following 
a non-conductive test meal (water) from the raw data. 
2.2 Example of a single subject's fitted curves for cumulative percentage of 62 
13C dose recovered over time following low fat (11314 kJ) and high fat 
(2820 kJ) liquid test meals. 
2.3 Calibration curve for relative peak area of phenylalanine (x/NLE) at 64 
four different concentrations (0.5,0.25,0.125 and 0.0625 mM) 
2.4 Elution profile of a GLP-1 iodination (counts per minute in 10 µl of 78 
fraction). 
2.5 Energy intake following repeated identical 1992 kJ liquid meal 83 
preloads on three separate test occasions 
2.6 Macronutrient intake following repeated identical 1992 kJ liquid meal 84 
preloads on three separate test occasions 
2.7 VAS ratings (cm) for hunger following repeated identical 1992 kJ 85 
liquid meal preloads on three separate test occasions 
2.8 VAS ratings (cm) for desire to eat following repeated identical 1992 kJ 86 
liquid meal preloads on three separate test occasions 
2.9 VAS ratings (cm) for fullness following repeated identical 1992 kJ 86 
R1 
liquid meal preloads on three separate test occasions 
2.10 Mean within-subject CVs (%) on VAS ratings following repeated 87 
identical 1992 kJ liquid preloads (baseline, post-preload, and post-ad 
libitum test meal) for hunger, desire to eat (DTE) and fullness VAS 
ratings 
Chapter 3- The effect of phenylalanine on 
appetite and possible physiological 
mechanisms 
3.1 The molecular structure of a) phenylalanine and b) L-aspartyl-L- 93 
phenylalanine methyl ester (aspartame) 
3.2 The effect of phenylalanine dose (400 mg, 2g or 5 g) on food intake 101 
(weight ingested (g) per kg body weight) 
3.3 Hunger VAS ratings (cm) following consumption of encapsulated 103 
phenylalanine at doses of 400 mg, 2 g, or 5g compared to control 
3.4 Desire to eat VAS ratings (cm) following consumption of encapsulated 104 
phenylalanine at doses of 400 mg, 2 g, or 5g compared to control. 
3.5 Fullness VAS ratings (cm) following consumption of encapsulated 104 
phenylalanine at doses of 400 mg, 2 g, or 5g compared to control 
3.6 Number of food items selected from the food preference checklist 105 
following consumption of encapsulated phenylalanine at doses of 400 
mg, 2 g, or 5g compared to control 
3.7 Plasma glucose concentrations following either 5g phenylalanine or 5 112 
g cornflour (control) 
3.8 Plasma phenylalanine concentrations following either 5g 113 
phenylalanine or 5g cornflour (control) 
3.9 Plasma tyrosine concentrations following either 5g phenylalanine or 5 114 
g cornflour (control) 
3.10 Plasma leucine concentrations following either 5g phenylalanine or 5g 115 
cornflour (control) 
3.11 Plasma GIP concentrations following an encapsulated treatment of 116 
either 5g phenylalanine or 5g cornflour (control) 
3.12 Plasma GLP-1 concentrations following an encapsulated treatment of 116 
either 5g phenylalanine or 5g cornflour (control) 
xii 
3.13 Plasma insulin concentrations following an encapsulated treatment of 117 
either 5g phenylalanine or 5g cornflour (control) 
3.14 Plasma CCK concentrations following an encapsulated treatment of 118 
either 5g phenylalanine or 5g cornflour (control) 
3.15 Hunger VAS ratings following consumption of 5g encapsulated 119 
phenylalanine or cornflour (control) 
3.16 Desire to eat VAS ratings following consumption of 5g encapsulated 119 
phenylalanine or cornflour (control) 
3.17 Fullness VAS ratings following consumption of 5g encapsulated 120 
phenylalanine or cornflour (control) 
3.18 Hunger VAS ratings following consumption of 5g encapsulated 128 
alanine or cornflour (control) 
3.19 Desire to eat VAS ratings following consumption of 5g encapsulated 129 
alanine or cornflour (control) 
3.20 Fullness VAS ratings following consumption of 5g encapsulated 129 
alanine or cornflour (control) 
3.21 Change in number of food items selected from the food preference 131 
checklist following consumption of encapsulated alanine compared to 
control 
3.22 Change in number of high-protein food items selected from the food 131 
preference checklist following consumption of encapsulated alanine 
compared to control 
3.23 Change in number of high-carbohydrate food items selected from the 132 
food preference checklist following consumption of encapsulated 
alanine compared to control 
3.24 Change in number of high-fat food items selected from the food 132 
preference checklist following consumption of encapsulated alanine 
compared to control 
3.25 Mean gastric emptying T50s following aspartame or its amino acid 138 
constituents compared to the control treatment 
3.26 Percentage volume of liquid test meal remaining in the stomach 139 
consumed one hour after ingestion of aspartame, constituent amino 
acids of aspartame or the control 
3.27 Plasma paracetamol concentrations following consumption of 140 
X111 
aspartame or constituent amino acids compared to control 
3.28 Plasma glucose concentrations following consumption of aspartame or 141 
constituent amino acids compared to control 
3.29 Plasma phenylalanine concentrations (x-b) following consumption of 142 
aspartame or constituent amino acids compared to control 
3.30 Plasma aspartic acid concentrations (x-b) following consumption of 143 
aspartame or constituent amino acids compared to control 
3.31 Plasma tyrosine concentrations (x-b) following consumption of 144 
aspartame or constituent amino acids compared to control 
3.32 Plasma CCK concentrations following consumption of aspartame or 145 
constituent amino acids compared to control 
3.33 Plasma insulin concentrations following consumption of aspartame or 146 
constituent amino acids compared to control 
3.34 Plasma GIP concentrations following consumption of aspartame or 146 
constituent amino acids compared to control 
3.35 Plasma GLP-1 concentrations following consumption of aspartame or 147 
constituent amino acids compared to control 
3.36 Hunger VAS ratings following consumption of aspartame or 148 
constituent amino acids compared to control 
3.37 Desire to eat VAS ratings following consumption of aspartame or 149 
constituent amino acids compared to control 
3.38 Fullness VAS ratings following consumption of aspartame or 150 
constituent amino acids compared to control 
3.39 The association between individual ratings of change in desire to eat 151 
(cm) following ingestion of the liquid test meal (t +70 -t +60 min) and 
change in plasma phenylalanine concentrations at t+ 75 min (mmol/L) 
Chapter 4-A comparison of electrical 
impedance epigastrography with other 
techniques for the measurement of gastric 
emptying 
4.1 Gastric half emptying times (T50s) obtained by the electrical 170 
impedance epigastrography method 
4.2 Gastric half emptying times (T50s) obtained by the scintigraphy 170 
xiv 
method 
4.3 Scatterplot showing the association between gastric half emptying 171 
times (T50s) from the two methods, EIE and scintigraphy, following 
each of the liquid test meals (glucose 753 kJ, low fat 1314 kJ, and high 
fat 2820 kJ) 
4.4 Plasma glucose concentrations (mean ± SEM, n= 6) following each of 173 
the liquid test meals (glucose 753 kJ, low fat 1314 kJ, and high fat 2820 
kJ) 
4.5 Plasma insulin concentrations (mean ± SEM, n= 6) following each of 174 
the liquid test meals (glucose 753 kJ, low fat 1314 kJ, and high fat 2820 
kJ) 
4.6 Gastric half emptying times (T50s) obtained by the electrical 184 
impedance epigastrography method 
4.7 Gastric half emptying times (T50s) obtained by the 13C-octanoic acid 185 
breath test method 
4.8 Cumulative 13C(CO2) recovery as a percentage of dose administered 186 
following low (1314 kJ) and high fat (2820 kJ) liquid test meals 
4.9 Plasma paracetamol concentrations (mmol/L) following low fat (1314 187 
kJ) and high fat (2820 kJ) liquid test meals 
4.10 Plasma paracetamol gastric emptying parameters, tmax (min) and 188 
incremental AUC, 0-120 min (mmol/L by time (min)), following low 
fat (1314 kJ) and high fat (2820 kJ) liquid test meals 
4.11 Plasma paracetamol gastric emptying parameters, tmax (min), IAUC 0- 189 
120 min (mmol/L by time) and IAUC 0-60 min (mmol/L by time), 
plotted against EIE T50s (min) following low fat (1314 kJ) and high fat 
(2820 kJ) liquid test meals 
4.12 13C-octanoic acid breath test T50s (min) plotted against EIE T50s (min) 190 
following low fat (1314 kJ) and high fat (2820 kJ) liquid test meals 
4.13 Plasma paracetamol gastric emptying parameters, tmax (min), IAUC 0- 191 
120 min (mmol/L by time) and IAUC 0-60 min (mmol/L by time), 
plotted against 13C-octanoic acid breath test T50s (min) following low 
fat (1314 kJ) and high fat (2820 kJ) liquid test meals 
4.14 The magnitude of the differences in gastric emptying times between the 192 
low and high fat test meals by each of the three different methods, BE 
xv 
T50,13C-octanoic acid breath test T50 and paracetamol tmax (min) 
4.15 Plasma glucose concentrations following differing liquid test meals 193 
(low fat 1314 kJ and high fat 2820 kJ) 
4.16 Plasma insulin concentrations following differing liquid test meals (low 194 
fat 1314 kJ and high fat 2820 kJ) 
4.17 Plasma GIP concentrations following differing liquid test meals (low 195 
fat 1314 kJ and high fat 2820 kJ) 
4.18 Plasma GLP-1 concentrations following differing liquid test meals (low 196 
fat 1314 kJ and high fat 2820 kJ) 
4.19 Plasma CCK concentrations following differing liquid test meals (low 197 
fat 1314 kJ and high fat 2820 kJ) 
Chapter 5- The effect of casein and whey 
protein on appetite and physiological 
mechanisms 
5.1 Ad libitum test meal energy intakes 90 min after isoenergetic liquid 206 
preloads containing 48 g casein or whey protein (1674 and 1695 kJ 
respectively) 
5.2 Plasma paracetamol concentrations following isoenergetic -1700 kJ 211 
liquid test meals containing either casein or whey protein (50 % 
energy) 
5.3 Plasma glucose concentrations following isoenergetic -1700 kJ liquid 212 
test meals containing either casein or whey protein (50 % energy) 
5.4 Change in mean total plasma amino acids following isoenergetic --1700 213 
kJ liquid test meals containing either casein or whey protein (50 % 
energy) 
5.5 Change in mean total plasma branched chain amino acids following 215 
isoenergetic ~ 1700 kJ liquid test meals containing either casein or 
whey protein (50 % energy) 
5.6 Plasma GIP concentrations following isoenergetic -1700 kJ liquid test 216 
meals containing either casein or whey protein (50 % energy) 
5.7 Plasma GLP-1 concentrations following isoenergetic --1700 kJ liquid 217 
test meals containing either casein or whey protein (50 % energy) 
5.8 Plasma insulin concentrations following isoenergetic -1700 kJ liquid 218 
xvi 
test meals containing either casein or whey protein (50 % energy) 
5.9 Plasma CCK concentrations following isoenergetic -1700 kJ liquid test 218 
meals containing either casein or whey protein (50 % energy) 
5.10 VAS ratings (cm) for hunger following isoenergetic 1700 kJ liquid 219 
test meals containing either casein or whey protein (50 % energy) 
5.11 VAS ratings (cm) for desire to eat following isoenergetic -1700 kJ 220 
liquid test meals containing either casein or whey protein (50 % 
energy) 
5.12 VAS ratings (cm) for fullness following isoenergetic -1700 kJ liquid 220 
test meals containing either casein or whey protein (50 % energy) 
xvii 
List of tables 
Chapter 2- Materials and Methods 
2.1 Reversed phase HPLC gradient used for Waters PICO-TAGTM Amino 66 
Acid Analysis System 
2.2 Mean inter-run and intra-run coefficients of variance (%) for HPLC 67 
quality control samples using both deproteinisation methods, 
ultrafiltration and sulphosalicylic acid precipitation 
2.3 Insulin radioimmunoassay protocol 70 
2.4 GIP radioimmunoassay protocol 72 
2.5 GLP-1 radioimmunoassay protocol 74 
2.6 CCK radioimmunoassay protocol 76 
2.7 Composition of liquid preload used to test the reproducibility of satiety 82 
methodology 
Chapter 3- The effect of phenylalanine on 
appetite and possible physiological 
mechanisms 
3.1 Study protocol for the investigation of the effect of phenylalanine 99 
supplementation on food intake and subjective appetite ratings 
3.2 Approximate energy, carbohydrate and phenylalanine content of each 100 
treatment 
3.3 Food intake by energy (kJ) and weight (g) per kg body weight (per 102 
kg/bw), and macronutrient intake by weight (g) per kg/bw following 
the control condition and increasing doses of phenylalanine (400 mg, 2 
g, and 5 g) 
3.4 Gastric half-emptying times (T50s) following 5g of encapsulated 112 
phenylalanine or cornflour (control) 
3.5 Food intake by energy (kJ) and weight (g), and macronutrient intake by 118 
weight (g) following an encapsulated treatment of either 5g 
phenylalanine or 5g cornflour (control) 
3.6 Study protocol for the effect of alanine on food intake and subjective 126 
appetite ratings 
xviii 
3.7 Food intake by energy (kJ) and weight (g), and macronutrient intake by 127 
weight (g) following consumption of 5g encapsulated alanine or 
cornflour (control) 
3.8 Study protocol for the effect of aspartame and constituent amino acids 136 
on gastric emptying, plasma metabolite and hormone response and 
subjective appetite ratings 
3.9 Composition of liquid test meal used to test the physiological effects of 137 
ingesting aspartame or aspartame constituents (400 mg) 
3.10 Gastric emptying parameters for paracetamol absorption following 140 
consumption of aspartame or constituent amino acids compared to 
control 
Chapter 4-A comparison of electrical 
impedance epigastrography with other 
techniques for the measurement of gastric 
emptying 
4.1 Outline of protocol for comparison of scintigraphy and EIE in the 167 
measurement of gastric emptying 
4.2 Composition of glucose, low and high fat liquid test meals used for the 169 
comparison of scintigraphy and EIE in the measurement of gastric 
emptying 
4.3 Mean gastric half-emptying times and descriptive statistics following 172 
each of the liquid test meals (glucose 753 kJ, low fat 1314 kJ, and high 
fat 2820 kJ) 
4.4 Outline of protocol for comparison of EIE, paracetamol absorption and 180 
13C-octanoic acid breath test in the measurement of gastric emptying 
4.5 Composition of low and high fat liquid test meals used for the 181 
comparison of EIE, paracetamol absorption and 13C-octanoic acid 
breath test in the measurement of gastric emptying 
4.6 Plasma paracetamol gastric emptying parameter, cmax (mmol/L), 188 
following low fat (1314 kJ) and high fat (2820 kJ) liquid test meals 
xix 
Chapter 5- The effect of casein and whey 
protein on appetite and physiological 
mechanisms 
5.1 Study protocol for the effect of casein and whey liquid test meals on 209 
plasma metabolite and hormone response, gastric emptying and 
subjective appetite ratings 
5.2 Composition of liquid test meals used to test the effect of different 209 
protein types, casein and whey, on plasma metabolite and hormonal 
response 
5.3 Mean gastric emptying parameters for paracetamol absorption 211 
following isoenergetic -1700 kJ liquid test meals containing 50 % 
energy either casein or whey protein, t +0 -t +90 min (before the 
standard lunch) 
5.4 Mean plasma amino acid values (mmol/L) overt +0 to t +180 min 214 
expressed as change from baseline (x-b), derived from two-way 
repeated measures ANOVA, following isoenergetic -1700 kJ liquid 
test meals containing 50 % energy either casein or whey protein 
xx 
Abbreviations 
2-DG 
5-HT 
AMPA 
ANCOVA 
ANOVA 
APE 
ATP 
AUC 
BMI 
BSA 
CCK 
CHO 
CNS 
C02 
CR 
CSS 
CV 
DA 
DAGP 
DAR 
DEBQ 
DMN 
DOPA 
DOPAC 
DPP-IV 
DTE 
DTPA 
EDTA 
EIE 
GABA 
GET 
GIP 
GLP- I 
HPLC 
HSA 
IAUC 
KA 
KJ 
LH 
LNAA 
NA 
NGPS 
NLE 
NMDA 
NPY 
NSB 
NTS 
2-deoxy-D-glucose 
Serotonin, 5-hydroxytryptamine, 
a-amino-3-hydroxy-5-methyl-i soxazole 
Analysis of covariance 
Analysis of variance 
Atom percent excess 
Adenosine triphosphate 
Area under the curve 
Body mass index 
Bovine serum albumin 
Cholecystokinin 
Carbohydrate 
Central nervous system 
Carbon dioxide 
Coefficient of repeatability 
Charcoal stripped serum 
Coefficient of variation 
Dopamine 
Donkey anti-guinea pig 
Donkey anti-rabbit 
Dutch eating behaviour questionnaire 
Dorsal medial nucleus of the hypothalamus 
Dihydroxyphenylalanine 
3,4-dihydroxyphenylacetic acid 
Dipeptidyl peptidase-IV 
Desire to eat 
Diethylenediaminepentaacetic acid 
Ethylenediaminetetraacetic acid 
Electrical impedance epigastrography 
y-aminobutyric acid 
Gastric emptying parameter 
Glucose-dependent insulinotropic polypeptide 
Glucagon-like peptide-1 
High performance liquid chromatography 
Human serum albumin 
Incremental area under the curve 
Kainic acid 
Kilojoule 
Lateral hypothalamus 
Large neutral amino acids 
Noradrenaline 
Normal guinea pig serum 
Norleucine 
N-methyl-D-aspartate 
Neuropeptide Y 
Non-specific binding 
Nucleus of the solitary tract 
xxi 
Polyethylene glycol 
Phenylisothiocyanate 
Paraventricular nucleus 
Royal Surrey County Hospital 
Quality control 
Standard deviation 
Standard error of the mean 
Gastric half emptying time 
Triethylamine 
Three factor eating questionnaire 
Ultraviolet 
Visual analogue scale 
Ventromedial hypothalamus 
xxii 
Chapter One 
Chapter 1 
INTRODUCTION 
The regulation of appetite is an area of research that has preoccupied scientists 
for decades. Recently it has become increasingly important to understand the 
regulation of appetite in the light of accelerating levels of overweight and obesity in 
the UK, and alarming predictions for the next few decades. It is also an area that has 
caught the attention of the public and media, with more and more newspaper space 
and broadcasting time devoted to the problem of overweight and obesity. 
The two main concepts within the field of appetite research are "hunger" and 
"satiety". "Hunger" and "satiety" are distinct terms and should not be regarded as 
simply the two extremes of a continuum. "Hunger" describes a biological drive to eat 
and in evolutionary terms is arguably the primary eating drive. Humans evolved in an 
environment where obtaining enough food was a primary force for natural selection: 
hunger was dominant and biological systems developed to protect from deprivation. 
In affluent societies, such systems are increasingly redundant, and may only be 
irregularly experienced by the well-nourished. For these individuals, the hunger drive 
may only become dominant in specific physiological states such as rapid growth, or 
recovery from starvation or illness. The initiation of an eating episode, or meal, does 
not wholly rely on hunger sensations, since the palatability and sensory properties of 
the food can stimulate food intake when the hunger drive is not necessarily present. 
This is often termed the desire to eat, and although it is definitively distinct from 
hunger, these two terms are frequently used interchangeably. Thus control of food 
intake in industrialised societies requires systems to minimise excess by inhibiting 
food intake. "Satiety" describes the inhibition of the hunger drive and desire to eat; 
this involves metabolic and systemic signals, a sensation of gastric distension 
(fullness) and the sensory and cognitive suppression of the pleasantness of food. 
These events, initiated and intensified during a meal, can be collectively termed as the 
satiation process. 
Appetite regulation is a complex function of behavioural factors influencing 
eating behaviour, and physiological and metabolic factors regulating energy balance 
and body composition. Figure 1.1 illustrates the complexity behind the term "appetite 
regulation" and indicates the multitude of psychological and physiological processes 
involved. 
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Central nervous system 
Neuropeptides - neurotensin, PYY, NPY, substance 
P, galanin, MCH, CRI, GLP-1, CART, aMSH 
Neurotransmitters - dopamine, serotonin, GABA, 
glutamate 
Eating behaviour 
Food cues - mouthfeel palatability 
Environmental cues - cultural, social, 
economic, stress, time of day, smoking 
The individual - attitudes to food, 
psychological factors (emotional, externaL 
restraint), eating disorders, obesity, gender 
Gastrointestinal 
Factors 
CCK, secretin, gasten, 
notilin, GI. P-I, GIP, 
glucagon, sonntostatm, 
pancreatic polypeptide. 
Figure 1.1. Mechanisms of food intake regulation. "Appetite regulation" is a complex interaction 
between a multitude of psychological and physiological processes involved in the regulation of meal 
initiation through hunger, and meal termination through satiety. The powerful physiological processes 
that mediate hunger and satiety are modified by a wide range of non-physiological factors which 
determine eating behaviour. For instance, cultural-environmental influences, e. g. differences in body 
shape preference or religious taboos; external stimuli, such as the sight of food; and internal emotions 
may all influence food intake. Food itself can influence appetite through sensory properties and 
palatability. Sensory specific satiety, the decrease in perceived pleasantness of a food that occurs 
during the course of a meal, eventually inhibits eating. The perceived sensory qualities of food can 
increase desire to eat, and this is linked to the cephalic phase response (where the sight, smell or 
thought of food is known to trigger physiological responses in the body in preparation for a meal). 
Hunger or a desire to eat leads to meal initiation and ingestion of food, and involve signals that derive 
from tissue macronutrient stores monitoring. Food macronutrients enter the stomach and cause gastric 
distension, generating immediate satiety signals sent via neural pathways to the brain. Macronutrients 
(apart from alcohol) in the intestine produce short-term satiety signals via the enteric and sympathetic 
nervous system, and by inducing the secretion of gastrointestinal hormones and insulin. Absorbed 
nutrients are transported in the circulation to be taken up into the liver and other tissues for storage or 
metabolic consumption via oxidation. Hepatic metabolic consumption appears to be specifically 
important for monitoring fuel balance and signalling to the CNS to control food intake. Body pools of 
carbohydrate, fat and protein each appear to influence appetite. Depletion of glycogen may trigger an 
increase in food intake to replenish carbohydrate stores (Flatt, 1996). Adipose tissue secretes the 
hormone leptin, which is responsible for long-term regulation of body fat. Signalling by the 
concentration and pattern of circulating amino acids to the CNS may acutely control food intake. 
Changes in the net flux between circulating and tissue protein-bound amino acids especially skeletal 
muscle, as determined by overall nutritional state and stage of growth and development, may also 
signal longer-term food intake possibly via changes in the circulating free amino acid pool. 
Neuropeptides and neurotransmitters within the brain participate in the conversion of these peripheral 
neural and hormonal monitoring signals to feelings of hunger or satiety. 
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The following introduction will briefly summarise present knowledge of the 
control of appetite, particularly in regard to the role of protein/amino acids. Peripheral 
and central factors involved in protein/amino acid-induced appetite control such as 
gastric emptying, gut hormones and neuronal stimulation will be discussed. In 
addition to the physiological mechanisms, psychological aspects of satiety will also 
be briefly addressed - both areas that are pertinent to current research in this report. 
1.1 Theories for the control of appetite 
Metabolic control mechanisms have been previously discussed under four 
main headings. These relate to body stores of the three principal macronutrients (or 
their precursors) and to energy balance regulation. Some of the major hypotheses are 
outlined below. 
1.1.1 Energostatic theory 
The energostatic hypothesis is based on the theory that the energy content of a 
meal is the key factor that regulates food intake. The macronutrients - protein, 
carbohydrate, and fat - would each be expected to exert equal amounts of negative 
feedback to suppress further food intake if a positive energy balance was reached. 
Evidence from a few studies suggested that individual macronutrients were having no 
differential effect on satiety where the fat and carbohydrate intake ratio were 
manipulated in human beings (Van Stratum et al., 1978; Goldberg et al., 1998). 
Many researchers dispute the idea of an energostatic control of food intake. It 
has been suggested that habituation to eating a constant weight or volume of food 
may lead to passive overconsumption if energy density is increased (Poppitt & 
Prentice, 1996). Much work has been done to show that each macronutrient has a 
different effect on food intake. A high fat, and therefore energy dense diet leads to 
passive overconsumption in animals and human subjects (De Castro, 1987; Lissner et 
al., 1987; Tremblay et al., 1989; Tremblay et al., 1991; Thomas et al., 1992; Rolls et 
al., 1994). Protein and carbohydrate seem to suppress subsequent energy intake to a 
greater extent than fat (Lissner et al., 1987; Tremblay et al., 1989; van Amelsvoort et 
al., 1990; Thomas et al., 1992; Blundell et al., 1993; Rolls et al., 1994; Stubbs et al., 
1996). In the light of these findings, most investigations have been directed at the 
macronutrient composition of a diet rather than energy content when looking at the 
control of food intake. 
3 
1.1.2 Glucostatic Theory 
The original glucostatic theory proposed by Jean Mayer (Mayer, 1955) was 
that an increase in peripheral glucose utilisation would suppress subsequent food 
intake, and a decrease in peripheral glucose utilisation would stimulate feeding. These 
changes would be detected by gluco-sensitive receptors in the brain and the liver, and 
were perhaps complementary to a longer-term lipostatic mechanism for the control of 
energy intake (Van Itallie, 1990). The glucostatic model was modified into a 
glycogenostatic model by Russek (Russek, 1963), who proposed that hepatic gluco- 
sensors are involved in the control of feeding. Flatt (Flatt, 1987; Flatt, 1996) 
developed a two-compartment model for a glycogenostatic mechanism using the idea 
that the respiratory quotient must match the food quotient for fuel mix in order to 
maintain energy balance. A high fat, low carbohydrate diet would be predicted to 
deplete glycogen stores, which would trigger an increase in food intake to replenish 
carbohydrate reserves. Thus it would be predicted that hunger would be driven by 
carbohydrate reserves. 
There is much human and animal experimental evidence in support of the 
glucostatic theories. Peripheral administration of glucose in rats suppresses food 
intake (Booth & Jarman, 1976; Novin & Vanderweele, 1977; Tordoff et al., 1989) 
and central injections of glucose anti-metabolites like 2-deoxy-D-glucose (2-DG) 
stimulates glucoprivic feeding (Oomura, 1983). Experiments with 2-DG in the liver 
have also provided evidence for hepatic gluco-sensitive receptors in the control of 
feeding in animals (Langhans, 1996). Transient declines in blood glucose in rats 
precede a meal, with a transient spike in insulin just before the glucose decline 
(Campfield & Smith, 1990). It was proposed that CNS glucose receptors are triggered 
by these transient declines, to initiate feeding, based on the observation that 
vagotomised rats are not as sensitive to transient declines in blood glucose in their 
feeding behaviour. Similar transient declines in blood glucose in human beings were 
then observed just before a meal request or a change in hunger (Campfield, 1997). 2- 
DG infusions in healthy men increased hunger and decreased sensations of fullness 
(Thompson & Campbell, 1977). In the 1950s, arteriovenous glucose differences were 
measured to represent the rate of tissue removal of glucose (Van Itallie, 1990). Good 
correlations between sustained elevations of peripheral arteriovenous differences and 
satiety, and between sustained negligible peripheral arteriovenous differences 
("metabolic hypoglycaemia") and hunger were reported. However, later studies found 
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that these differences didn't consistently correlate with hunger and satiety (Stunkard 
& Wolff, 1954; Bernstein & Grossman, 1956). 
Insulin may be important in the control of food intake. Its reduction of satiety 
in rats (Woods & Porte Jr., 1983), and the relationship between fasting insulin and 
adiposity (Jen et at., 1985), provoked a specific insulinostatic theory of feeding 
behaviour. Woods and Porte (1983) proposed that increased circulating insulin 
following a meal entered the brain via the cerebrospinal fluid, modulated by the 
amount of adipose tissue. The discovery of insulin-responsive neurons in the 
paraventricular nucleus (PVN) of the medial hypothalamus supported this hypothesis 
(Oomura, 1983). It was later suggested that insulin may be transported into the brain 
by insulin receptors present in the endothelial cells (Woods et al., 1990). However, as 
regards the idea of insulin regulating appetite via a role as an adiposity signal, as 
suggested by Woods and Porte (Woods & Porte Jr., 1983), there seems to be little 
evidence to support this. A new adipose tissue-linked factor has now been 
discovered- the ob gene and its protein product leptin - and this has recently been the 
subject of many insights in the field of appetite regulation (Campfield et al., 1995; 
Halaas et al., 1995, Pellymounter et al., 1995). 
1.1.3 Lipostatic theory 
When reviewing the evidence for a glucostatic regulation of food intake 
(particularly the investigations that addressed the relative satiating properties of the 
macronutrients) there is little to support a lipostatic theory, since fat is a poor 
regulator of energy balance. The original hypothesis (Kennedy, 1953) proposed that 
there might be a centre in the brain that monitored plasma levels of fat metabolites, 
which were directly proportional to fat stores. However, Welch and colleagues 
(Welch et al., 1985) found that intravenous administration of lipid in human subjects 
failed to produce any satiety effects. 
The most convincing evidence for a body fat-derived signalling pathway for 
the control of appetite, in accordance with Kennedy's original hypothesis, comes 
from the study of hormones. Insulin was regarded as an important signaller of 
adiposity, since it is secreted in proportion to body fat and insulin receptors are 
expressed in various regions of the brain (Jen et al., 1985; Woods & Seeley, 2000). In 
support of this, insulin has been shown to reduce food intake under some 
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circumstances (Woods & Porte Jr., 1983; Woods & Seeley, 2000). Amylin is another 
suggested candidate, as this pancreactic ß-cell polypeptide is also secreted in 
proportion to body fat and is transported into the brain (Woods & Seeley, 2000). 
Amylin strongly inhibits gastric emptying (Young et al., 1996), and peripheral and 
central administration decreases food intake in rats (Young, 1997). The discovery of 
leptin, a hormone that is actually secreted by adipose tissue, is transported into the 
brain, and decreases food intake when centrally administered, heralded the strongest 
candidate for a circulating adiposity signal yet (Campfield et al., 1995; Halaas et al., 
1995, Pellymounter et al., 1995). Leptin is also distinct in that it is a chronic regulator 
of body weight, rather than signalling short-term satiety signals as insulin and amylin 
are postulated to do. 
1.1.4 Aminostatic Theory 
There is abundant animal and human evidence that varying dietary 
concentrations of either protein or amino acids can determine short and long-term 
appetite regulation. 
1.1.4.1 The original theory 
The animal literature on food selection and intake regulation is extensive in 
relation to both amino acid imbalance (e. g. Harper et al., 1970; Harper & Peters, 
1989; Gietzen, 1993), and variation in protein concentration (reviewed in Millward, 
1995). Early studies revealed that feeding behaviour was suppressed by dietary amino 
acid imbalance (Leung et al., 1968a; Leung et al., 1968b; Leung et al., 1968c), and 
very high protein diets (Harper et al., 1970; Rogers & Leung, 1973; Gurr et al., 1980) 
with self-selection of an optimum protein intake over lower or high protein 
concentrations (Peng et al., 1975). 
It was Mellinkoff who originally suggested that there might be an aminostatic 
mechanism controlling appetite and food intake. In a series of experiments on human 
volunteers (Mellinkoff et al., 1956), feelings of hunger increased after ingestion of a 
protein-rich breakfast as serum amino acid levels declined. Intravenous infusion of 
amino acids and glucose produced similar relationships, and although appetite 
decreased with increasing blood glucose the correlation was weaker than that for 
amino acids. Administration of casein hydrolysate intravenously or by mouth also led 
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to diminished feelings of hunger as plasma amino acid concentrations rose, and even 
as blood glucose levels decreased. 
Several subsequent studies, although not all, have confirmed these initial 
findings. Thus with protein, a reduced short-term food intake and/or increased 
subjective satiety ratings, has been shown following a protein preload or during a 
high protein meal compared to fat or carbohydrate, (Booth et al., 1970; De Castro, 
1987; Barkeling et al., 1990; Hill & Blundell, 1990; Johnstone et al., 1996; 
Vandewater & Vickers, 1996; Stubbs et al., 1996; Porrini et al., 1997; Latner & 
Schwartz, 1999). The minority of reports that do not show such effects, (Sunkin & 
Garrow, 1982; Geliebter, 1979; De Graaf et al., 1992), are characterised by differing 
experimental designs and type, size and timing of preload in relation to test meal. 
Individual amino acids also suppress food intake in the case of tryptophan (Hrboticky 
et al., 1985; Hill & Blundell, 1988; Muurahainen et al., 1988) and phenylalanine 
(Muurahainen et al., 1988; Ballinger & Clark, 1994). Subjects also reduced their food 
intake half an hour after an oral load of mixed amino acids (phenylalanine, valine, 
methionine, and tryptophan) compared to the placebo (magnesium trisilicate) in a 
study by Butler and colleagues (Butler et al., 1981). 
1.1.4.2 Why is the regulation of protein and amino acid intake important? 
An aminostatic-mediated inhibition of food intake by dietary protein is to be 
expected as part of amino acid and protein homeostasis. The accumulation of certain 
free amino acids has to be avoided as the aromatic, branched chain and sulphur- 
containing amino acids are toxic at high concentrations (Millward & Rivers, 1988). 
The capacity for disposal of protein through storage is limited with a fixed upper limit 
of the skeletal muscle mass as a function of height (Millward, 1995). While disposal 
of excess dietary protein as fat can occur biochemically, the lipogenic pathway is 
energetically expensive so that energy storage of dietary protein as fat is inefficient 
(Millward et al., 1974). Furthermore, simple use of dietary protein as a metabolic fuel 
is disadvantageous compared with glucose and fat since amino acid oxidation 
includes a number of oxidative steps not linked to ATP production. Thus complete 
oxidation of amino acids is inherently less efficient than glucose or fat and would be 
associated with greater levels of thermogenesis. Even without the need for amino acid 
disposal to avoid toxicity, the energy cost of the ureagenesis, gluconeogenesis and 
lipogenesis required to dispose of surplus amino acids, or the increased 
7 
thermogenesis associated with their complete oxidation, is such that the evolution of a 
regulatory system to limit protein intake rather than glucose and especially fat, would 
be expected. 
With bodily function dependent on adequate cellular protein, a hunger drive in 
growing animals which varies with the rate of protein deposition in lean tissue might 
also be expected, and is indeed found (Webster, 1993). This has been reviewed 
previously (Millward, 1995), where it was stated that the nutrient requirements of a 
growing animal are determined principally by its impetus for lean tissue growth, with 
appetite and meal size dependent upon the dietary protein level, when this is below 
the optimal requirement level. It is thought that a similar process occurs in human 
beings during recovery from malnutrition, thereby allowing catch-up growth 
(Ashworth & Millward, 1985). However, these increases in hunger drive associated 
with net protein accretion relate to nutritional circumstances that may never be 
experienced in the life of an adult human being. 
1.1.4.3 Recent modifications to the aminostatic theory 
Many of the original theories of appetite, including Mellinkoffs (Mellinkoff 
et al., 1956), had the concept of central monitoring of circulating substrate levels as 
their central premise. There is now growing evidence for appetite signalling pathways 
originating from all macronutrients at the level of terminal fuel oxidation (Friedman, 
1998), i. e. by hepatic ATP availability. It has been shown that metabolic blockers 
used with glucose and fatty acids in animal models lead to an increase in hunger and 
food intake (Novin & Vanderweele, 1977; Friedman et al., 1990). Some evidence for 
a satiety effect of hepatic fatty acid oxidation exists in human beings, with medium 
chain triglycerides, which are more readily oxidised, suppressing food intake in non- 
dieting humans (Stubbs & Harbron, 1996), and the stimulation of eating in men 
(especially those that have a high baseline level of fatty acid oxidation) by the use of 
a fatty acid oxidation inhibitor (Kahler et al., 1999). Stubbs developed this approach 
(Stubbs, 1995; Stubbs, 1998), so that the extent to which the three macronutrients are 
able to act as precursors for oxidative metabolism, as opposed to being stored, 
determines their satiating power through some cellular energy balance-sensing 
mechanisms. Regulation of food intake (usually inhibition) in relation to dietary 
macronutrient composition is described in terms of a protein>carbohydrate>fat 
hierarchy of macronutrient satiating efficiency reflecting the extent to which their 
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metabolic pools are more tightly autoregulated by oxidation, i. e. oxidation increases 
with intake. Fat, the least satiating nutrient, is primarily stored when ingested with 
other macronutrients, and an increase in fat oxidation does not necessarily follow a 
fat-rich eating episode (Friedman, 1990; Himaya et al., 1997; Stubbs, 1998) unless 
the fat is easily oxidised as with dietary medium chain triglycerides. Thus protein, the 
macronutrient with the least flexible autoregulation in the body, is also the most 
satiating macronutrient in this "hierarchical oxidation hypothesis". 
There are a number of problems with this theory in terms of protein-related 
food intake regulation. This model is focused on fuel oxidation as the key regulatory 
metabolic process, but the supporting experimental studies concentrate entirely on 
glucose and fat oxidation (Ritter & Calingasan, 1994; Friedman, 1998). It has not 
been demonstrated experimentally that the inhibition of amino acid oxidation 
increases food intake. The physiological relevance of inhibiting fuel oxidation is 
questionable in any case, since oxidation rates are linked to fuel availability, i. e. a 
decrease in food intake would lead to reduced fuel oxidation, not a complete 
cessation of oxidation. Increased food intake, associated with a greater rate of fuel 
oxidation, would be expected to increase satiety, but it is not yet clear whether 
increased levels of fuel oxidation are directly responsible for satiety. In fact, it can be 
shown that an increase in amino acid oxidation does not always cause a decrease in 
food intake. A study in malnourished children showed that when two levels of protein 
were fed during catch-up growth, similar intakes of energy intake occurred with quite 
different levels of oxidation (Badaloo et al., 1999). The relative ease with which 
amino acids can be disposed of either as protein deposition or oxidation may be the 
important factor in aminostatic appetite regulation. In this way, the key metabolic 
responses sensed by the body relate to the changes in free amino acid pool sizes 
subsequent to feeding, similar to Mellinkoff s original theory. 
1.1.4.4 Adaptive changes in protein metabolism and protein-related satiety 
There is a small amount of evidence that variation in long-term protein intake 
in healthy adults influences food intake. Protein: energy ratio was weakly negatively 
correlated with total energy intake (r = -0.45) in free-living post-menopausal women; 
in contrast, the carbohydrate: energy ratio was unrelated (r = 0.00) while the 
fat: energy ratio was very weakly positively correlated with energy intake (r = 0.18) 
(Bingham et al., 1994). Protein intakes vary within society (mainly a function of 
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levels of meat intake) and the weak relationship between protein: energy ratio and 
energy intake in this sub-group is surprising in view of the fact that protein is the 
most satiating macronutrient. The adaptive changes in amino acid metabolism that 
occur in response to changes in habitual protein intake ought to be taken into 
consideration when attempting to unravel aminostatic mechanisms. 
One adaptive response to a habitually high dietary protein intake is an 
increasing capacity to dispose of dietary amino acids (Price et al., 1994; Millward, 
1998). This includes a greater capacity for amino acid oxidation as a result of 
adaptive changes in key enzymes in catabolic pathways for amino acids occurs 
(Millward & Rivers, 1988), not only after feeding (as would be expected from 
subjects in overall nitrogen balance) but also increasing postabsorptive oxidation 
rates. This in turn results in an increasing capacity for postprandial protein gain. Thus 
the amplitude of the diurnal changes in body protein (Garlick et al., 1973; Millward 
et al., 1974; Clugston & Garlick, 1982; Rennie et al., 1982; Hoffer et al., 1985) 
increases with protein intake (Price et al., 1994). Therefore, with greater dietary 
protein intakes, the increasing ease of its disposal through transient deposition and 
oxidation via adaptation may equalise the relative satiating power of a wide range of 
different dietary protein concentrations. Given this adaptive variation in amino acid 
disposal, the satiating effect of a fixed protein intake is therefore likely to vary 
inversely with habitual protein intake. Protein-related appetite mechanisms in the 
longer term are thus more likely to be observed when habitual protein intakes change. 
There is evidence to support this prediction from measurements of the effect of 
habitual dietary protein intake on subjective ratings of appetite (Long et al., 2000a). 
As shown in figure 1.2, a high protein meal was more satiating to subjects habituated 
to a low compared with a high protein diet especially after their dietary intake was 
manipulated to further increase the differences in protein intakes. 
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Figure 1.2. Comparison of satiety responses following a 13 day period of dietary intervention 
(which increased the protein intake of the habitual high protein group (HP) and decreased the 
protein intake of the habitual low protein group (LP)) between the LP and HP diet groups in 
response to three high protein test meals (a mixed meal consisting of boiled chicken breast, 
mashed potato and broccoli, and chocolate digestive biscuits designed to provide 2.2 g protein 
per kg body weight). Values are means with their standard errors represented by vertical bars (n 14). 
LP group (n = 7, A) and HP group (n = 7, A), significant ANCOVA main effect of treatment (p = 
0.025). (From Long et al., 2000a). 
Adaptive changes in amino acid oxidation and diurnal protein gains and losses 
are not the only possible explanation of the findings of Long et al. (2000a). The 
protein-induced delay in gastric emptying was attenuated over time in rats following 
a habitual high-protein diet (Shi et al., 1997). Thus subjects who habitually consumed 
a high protein diet could exhibit faster gastric emptying rates for the protein meal 
with less gastric distension. 
1.2 Peripheral Mechanisms 
1.2.1 Pre-absorptive mechanisms for protein and amino acid induced satiety 
Of the many potential mechanisms by which satiety signals may be generated 
in response to protein ingestion and amino acid absorption, it is useful to separate 
those that may originate pre- or post-absorptively. There is much to indicate that 
protein-induced satiety includes a gut-mediated component, through an intestinal 
neuronal response, hormonal/neuropeptide responses (specifically cholecystokinin 
11 
(CCK)), and via gastric emptying which is in turn controlled by both neural and 
hormonal/neuropeptide pathways. This arrangement of pre-absorptive signalling 
pathways from the gastrointestinal tract has been conceptualised by Smith (Smith, 
2000) into a model for the direct control of meal size (the effect of nutrients on vagal 
mechano- and chemo-receptors and various hormones/neuropeptides/ 
neurotransmitters that are triggered by nutrients contacting with mucosal receptors in 
the gastrointestinal tract), requiring only the hindbrain; this is modulated by indirect 
controls, e. g. metabolic, cognitive. 
1.2.1.1 Neuronal responses 
Nutrients entering the gastrointestinal tract trigger a sequence of neural 
pathways that signal elsewhere in the gut or to the brain. Starting in the stomach, 
there are vagal afferent nerve endings in the circular and longitudinal muscle, the 
myenteric plexus, the submucosa and mucosa, indicating that these neurons send 
messages to the nucleus of the solitary tract (NTS) in response to gastric distension 
and contraction, enteric neural transmissions (from elsewhere in the gastrointestinal 
tract) and direct nutrient-chemical stimulation from the lumen. There is a dense 
distribution of vagal afferent nerve fibres around the pylorus and upper duodenum, 
with the density gradient lessening in the distal duodenum. As in the stomach, these 
fibres innervate several regions including the muscle layers, the myenteric plexus and 
submucosal plexus, mucosal crypts, the submucosa, the lamina propria - even as far 
as the basal lamina of the lumenal epithelial cells (Schwartz, 2000). These vagal 
afferent terminations also innervate the intestine down to the jejunum and ileum. 
Duodenal afferent responses can be mechanical and chemical, with nutrient-specific 
chemoreceptors on vagal afferent fibres to intestinal infusions of carbohydrates (Mei, 
1978), amino acids (Jeanningros, 1982) and lipids (Randich et al., 2000). It was also 
shown that there are low affinity CCK-A receptors (see section 1.2.1.2.1) on vagal 
afferent terminations situated near to CCK-secreting cells, an important pathway 
whereby nutrient- and distension-induced satiety is enhanced by endogenous 
production of paracrine CCK in response to a meal (Moran et al., 1992; Weatherford 
et al., 1993; Schwartz, 2000). 
With regard to aminostatic mechanisms of appetite control, phenylalanine and 
tryptophan appear to be particularly potent in the suppression of food intake in either 
sham or naturally feeding rats when the intestine is infused with amino acids (Meyer 
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et al., 1998). There is evidence that this is a preabsorptive effect. Intestinal infusion 
of amino acid mixtures or individual amino acids in anaesthetised cats increases the 
firing rate of many vagal neurons as a very early response (Jeanningros, 1982), with 
37% of lateral hypothalamus neurons responding with a short latency (Jeanningros, 
1983). In comparison, neurons of the ventromedial hypothalamus (VMH) took much 
longer to respond and far fewer responded, suggesting this to be a postabsorptive 
effect of the intestinal infusion. This experiment provides good evidence that amino 
acids can be monitored in the intestine before absorption, and that the exact 
mechanism involves vagal afferent neurons that relay signals to the lateral 
hypothalamus. 
1.2.1.2 Hormonal responses 
The regulation of food intake by circulating physiological factors can be 
roughly grouped into gastrointestinal hormones, neuropeptides, neurotransmitters and 
other circulatory central and peripheral factors (see figure 1.1). None of these 
categories are exclusive, and many of these factors are interdependent. Two important 
satiety gut peptides will be described here. 
1.2.1.2.1 Cholecystokinin (CCK) 
CCK is a hormone and neuropeptide released following a mixed meal, and it 
is considered to be a major satiety factor. Many different forms of CCK have been 
identified, with CCK-8 being the most potent, and CCK-33 and -58 the most 
prominent in human plasma (Liddle, 1997). Apart from the satiety action of CCK, 
this peptide also stimulates gallbladder contraction (Liddle et al., 1989), the secretion 
of pancreatic enzymes (Schmidt et al., 1991), delays gastric emptying (Jin et al., 
1994) and inhibits gastric acid secretion (Konturek et al., 1993). 
CCK is produced by endocrine cells in the duodenum and proximal jejunum, 
with a graded increase in concentration towards the top of the small intestine, and 
also by some pituitary and adrenal medullary cells. CCK is one of a group of peptides 
termed "brain-gut peptides" and is distributed throughout the brain (Moran & 
Schwartz, 1994). CCK is also distributed throughout the peripheral autonomic 
nervous system, specifically the vagus nerve, coeliac plexus, submucous plexus, 
myenteric plexus, and neurons around the islets of Langerhans in the pancreas (which 
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may reflect the ability of CCK to stimulate insulin and glucose release) and in the 
circular muscle of the distal small intestine and colon. 
CCK release is stimulated by the entry of fat and protein into the duodenum. 
Perfusion of the duodenum with amino acids increased CCK secretion, especially 
following phenylalanine, methionine and valine (Go et al., 1970). The potent effect of 
intraduodenal phenylalanine on CCK release in human beings was later confirmed 
(Owyang et al., 1986), and was associated with a reduction in food intake (Ballinger 
& Clark, 1994). A recent study has provided evidence that phenylalanine stimulates 
CCK secretion via a calcium-dependent mechanism in the CCK-secreting cells 
(Mangel et al., 1995). Intraduodenal perfusion of trypsin has been shown to suppress 
the secretion of CCK in human subjects (Kanarek et al., 1995). It was proposed that 
there is a trypsin-sensitive releasing factor for CCK, secreted into the lumen of the 
small intestine by the pancreas - this would be degraded by trypsin but protected by 
the entry of protein into the gut (Calam et al., 1987). Since CCK stimulates pancreatic 
secretion and trypsin would block the release of CCK, this proposal provides a 
possible mechanism for the negative feedback regulation of CCK. 
Evidence in animals for a satiety effect of CCK is strong (Gibbs et al., 1973) 
but the importance of CCK as an endogenous mediator of hunger and satiety in 
human beings is less clear. It was shown that peripheral CCK administration reduced 
appetite in some human studies (Stacher et at., 1979; Kissileff et at., 1981; Pi-Sunyer 
et al., 1982), but other researchers challenged their findings. Exogenous CCK 
administration may have produced a pharmacological response rather than a physical 
one in these experiments (Schick et al., 1991), and effects on food intake or appetite 
ratings may have been mostly due to the aversive and sedative effects produced. 
Evidence that CCK administration produced conditioned taste aversions was 
presented, but subsequent studies failed to replicate this effect with doses that could 
suppress food intake by up to 50% (Kulkosky, 1985). 
The stimulation of endogenous CCK secretion by intraduodenal 
administration of phenylalanine strongly reduced food intake and increased subjective 
sensations of fullness (Ballinger & Clark, 1994); and peripheral administration of 
physiological levels of CCK also decreased food intake (Ballinger et al., 1995) and 
increased satiety sensations in human subjects (Lieverse et al., 1994; Lieverse et al., 
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1995). Any further doubts over the importance of endogenous CCK in mediating 
satiety were dismissed using a different methodological tool - CCK antagonists. 
There are two types of CCK receptor: CCK-A receptors (peripheral receptors 
responsive to the sulphated tyrosine moiety of CCK-8 and CCK-33, found in the 
pancreas and on vagal afferent and enteric neurons in the small intestine and stomach, 
and also in some brain sites) and CCK-B receptors (predominantly central receptors, 
binding gastrin, desulphated CCK and CCK fragments, found in brain, afferent vagus 
nerve and within stomach). Studies with loxiglumide in human subjects, an antagonist 
that inhibits CCK-A receptors, found that it accelerated gastric emptying (GE) 
(Meyer et at., 1989), and increased food intake (Lieverse et at., 1994). However, a 
similar effect on food-stimulated GE and satiety was not observed in all studies 
(Corazziari et at., 1990; Konturek et al., 1990; Drewe et al., 1992; Lieverse et at., 
1995). CCK-A receptors exist in low and high affinity forms and antagonist studies 
that differentiate between these types have shed light on the inconsistencies 
previously found for type A receptors. The antagonist effects of CCK-JMV-180 to 
endogenous CCK (an antagonist at the low affinity CCK-A receptors and an agonist 
at high affinity CCK-A receptors) implied that endogenous CCK acts on low affinity 
CCK-A receptors. Since the physiological concentrations of CCK normally present in 
blood plasma are only sufficient to stimulate high affinity CCK-A receptors, it is 
thought that endogenous CCK acts to decrease food intake via paracrine and 
neurocrine pathways rather than endocrine pathways (Moran, 2000). 
Overall, there is good experimental evidence for a CCK-mediated satiety 
mechanism, but presenting a clear picture of how CCK can exert its effects is 
problematical. CCK acts peripherally on satiety, gastric emptying and gastric 
secretion via CCK-A receptors on afferent vagal fibres and circular muscle cells in 
the pylorus (French et al., 1993; Schwartz & Moran, 1994; Moran, 2000). Total 
vagotomy has been shown to block the satiety effect of CCK in the rat (Lorenz & 
Goldman, 1982), although if vagal transection was limited to the gastric branches the 
CCK action was still blocked effectively (Smith et al., 1981). The vagal afferent 
satiety response to CCK is further potentiated by gastric loads, which became more 
effective in increasing activity in vagal afferent fibres when different doses of CCK 
were administered locally (Moran & Schwartz, 1994). Moran and colleagues found 
that pylorectomised rats still reduced their food intake at low doses of CCK but the 
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dose response effect was curtailed at a higher CCK dose (Moran et al., 1988). In 
contrast, rats with afferent vagotomies reduced the potency of low and high doses of 
CCK, with low doses leaving food intake unaffected (Moran et al., 1997). This led 
Moran to postulate that low doses of CCK activate CCK-A receptors on vagal 
afferent fibres to reduce food intake, and that higher doses of CCK only reduce food 
intake indirectly via pyloric CCK-A receptors, and the consequent inhibition of 
gastric emptying (Moran, 2000). In this way, it is hypothesised that CCK can 
influence appetite directly and via inhibition of gastric emptying. 
The role of central CCK systems in satiety has been the subject of some 
attention, especially as the brain contains sites where CCK-A receptors have been 
detected (nucleus accumbens, the dorsal medial nucleus of the hypothalamus (DMN), 
and NTS) (Hill et al., 1992). However, although studies on farm and experimental 
animals indicate central CCK-mediated satiety (Crawley & Corwin, 1994; Baldwin et 
al., 1998), a study by Corp and colleagues found no evidence for this in rats using 
CCK-A and CCK-B receptor antagonists (Corp et al., 1997). 
In conclusion, the importance of CCK in the regulation of food intake cannot 
be disputed, and it is increasingly apparent that there is a large amount of interaction 
with other hormones and neuromodulators, a huge area of research that is still rapidly 
expanding. 
1.2.1.2.2 Gluca own-like peptide-1 (GLP- 1) 
GLP-1 (7-36 amide) is a relatively recently discovered gastrointestinal 
hormone, now agreed to be the major incretin factor in human beings, i. e. it 
potentiates glucose-induced insulin secretion (Nauck et al., 1993; Wang et al., 1995; 
Scrocchi et al., 1996). It is released from L-cells in the distal small intestine and 
colon into the circulation in response to mixed meals, especially if high in fat content, 
or oral carbohydrate loads (Orskov et al., 1991; Elliott et al., 1993). The mechanism 
of GLP-1 release from ileal L cells is under debate since the peptide is rapidly 
secreted following ingestion of a meal, long before the digesta has reached the distal 
small intestine. Evidence for similar GLP-1 levels in ileostomy patients and normal 
subjects further diminishes the likelihood of direct nutrient stimulation of the L cell 
being a primary mechanism for GLP-1 release (D'Alessio et al., 1993). GLP-l may 
be released in response to stimulation by GIP (Damholt et al., 1998), especially as 
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immunocytochemical research (Damholt et al., 1999) has shown that the GIP K cells 
and GLP-1 L cells overlap in the jejunum (30 % of the L cells in the middle intestine 
are adjacent to K cells), suggesting the existence of a paracrine action. Researchers 
have recently hypothesised that a neuroendocrine loop stimulates the L cells when 
nutrients enter the duodenum, involving the stimulation of GIP secretion, which acts 
on vagal afferents to send a signal to the brain in rats (Rocca & Brubaker, 1999). A 
vagal efferent signal is then postulated to act via gastrin-releasing peptide (GRP) 
neurons in the myenteric plexus to stimulate the L cell in the distal small intestine 
(Rocca & Brubaker, 1999). 
GLP-1 exerts a number of other effects in addition to stimulation of insulin 
secretion, including inhibition of gastric acid secretion (Wettergren et al., 1993; 
Layer et at., 1995; Fung et al., 1998), inhibition of food intake (Schick et al., 1992), 
and delaying of gastric emptying (Wettergren et al., 1993; Schirra et al., 1996; Young 
et at., 1996; Imeryuz et al., 1997). Specifically, GLP-1 delays gastric emptying by 
inhibiting antro-duodenal contractility, which reduces emptying rate, and stimulating 
pyloric contractions to reduce the volume emptied (Schirra et al., 2000). 
Plasma concentrations of intact GLP-1 are very low due to rapid metabolism 
by dipeptidyl peptidase-IV (DPP-IV), which cleaves off the two N-terminal amino 
acids (Mentlein et al., 1993). It is thought that this rapid degradation of active GLP-1 
occurs within 1 to 1.5 min of entering the circulation, so that the majority of GLP-1- 
induced effects on gastrointestinal motility and secretion occur before the molecule 
has left the gut, i. e. by interacting with sensory nerve endings in the lamina propria 
before entering the capillaries (Holst, 2000). In support of this, vagal afferent 
denervation in rats abolished the gastric inhibitory effects of GLP-1 (Imeryuz et al., 
1997). The GLP-1 receptor is expressed in areas of the brain that theoretically could 
be accessed by peripheral GLP-1 through leaks in the blood brain barrier (the 
subfornical organ and area postrema) (Orskov et al., 1996), and also areas of the brain 
that can only be stimulated by centrally-secreted GLP-1, including the hypothalamus 
( Kanse et al., 1988; Kreymann et al., 1989; Larsen et al., 1997) and the PVN and the 
antral nucleus of the amygdala (Turton et al., 1996). The importance of central GLP- 
I is further supported by a study on rats where central GLP-1 reduced food intake but 
intraperitoneal GLP-1 did not have any effect on feeding (Oomura, 1983). When 
exendin was used to block the central inhibitory effect of GLP-1, food intake was 
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more than doubled in satiated rats, although there was little effect in fasted rats. This, 
and other studies on central GLP-1 in rats, suggests that GLP-1 may be an important 
satiety factor (Gunn et al., 1996; Tang-Christensen et al., 1996). 
However, Thiele and colleagues (Thiele et al., 1997) showed that 
intraventricular GLP-1 but not leptin produced a conditioned taste aversion in rats. 
This means that it is possible that the reduced food intake observed in these animals 
after the central infusion of exogenous GLP-1 may reflect aversive effects rather than 
a biological satiety response. It can also be said that the demonstration of a 
conditioned taste aversion at high doses of central GLP-1 does not rule out the 
possibility that GLP-1 can independently induce satiety at lower doses, and that 
central and peripheral mechanisms for a GLP-1-induced suppression of food intake 
may co-exist. Other researchers have shown a reduction in food intake and subjective 
appetite ratings in human beings following peripheral administration of GLP-1 (Flint 
et al., 1998; Naslund et al., 1998; Gutzwiller et al., 1999). It is impossible to say from 
the literature available whether the satiety effect is independent of gastric inhibitory 
effects. 
1.2.1.3 Gastric emptying and gastric distension 
1.2.1.3.1 The stomach 
The stomach is a J-shaped, sac-like organ, and is located between the 
oesophagus and small intestine in the upper abdomen. Its functions are to act as a 
reservoir for ingested food, to break down the food into small particles, and to deliver 
to the small intestine in a form of a solution called chyme. The stomach can be 
divided into anatomical parts (see figure 1.3). 
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Figure 1.3. The anatomy of the stomach showing the three gastric regions: fundus, body and 
antrum. Reproduced from Vander, A. J. (1994), Human physiology: the mechanisms of body function, 
6th cd. NewYork, London: McGraw-Hill. 
The surface of the gastric mucosa is covered by columnar epithelial cells, and 
the epithelial layer turns in on itself into the mucosa to form tubular glands, or gastric 
pits. Mucous, alkaline fluid, hydrochloric acid, intrinsic factor, pepsinogen and 
gastrin are all secreted from the stomach. The stomach is innervated by sympathetic 
and parasympathetic nerve fibres which relay long reflexes via the CNS, and the 
enteric nervous system (consisting of the myenteric and submucosal plexuses) which 
relay short reflexes located wholly within the gastrointestinal tract wall. Afferent 
nerves carry signals to the brain from cherno-receptors and mechano-receptors in the 
stomach wall and efferent nerves lead to motor, endocrine, secretory and vascular 
responses in the stomach. 
The peristaltic waves that originate in the body of the stomach produce 
powerful contractions in the antral area, which mixes the stomach contents and closes 
the pyloric sphincter. This forces the liquid chyme to be expelled into the duodenum 
and also forces the larger particles of digesta back into the body of the stomach for 
further dissolution. The basic electrical rhythm generated by the pacemaker cells in 
the longitudinal smooth muscle layer determines gastric peristaltic wave frequency 
(three peristaltic waves per minute). Contraction strength depends on the frequency of 
action potentials triggered by the slow waves, which are influenced by excitatory 
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neurotransmitters and hormones acting on the antral area. Distension of the stomach 
also increases the force of antral contractions through long and short reflexes, i. e. a 
larger volume of food will increase gastric emptying rate. However, this is 
counteracted by the presence of nutrients, acid and sheer volume in the duodenum, 
triggering mechano-, osmo-, pH- and chemoreceptors to activate long vagal and short 
local reflexes to inhibit gastric emptying (McHugh et al., 1982; Greenberg et al., 
1990; Schwartz & Moran, 1998). The sieving action of the pylorus means that the 
antrum will only pass digestible particles less than lmm in size into the duodenum 
(Meyer et al., 1981). 
1.2.1.3.2 Why measure gastric emptying? 
Methods that have been developed to measure gastric emptying have many 
clinical and research applications. Disorders of the gastrointestinal tract, e. g. 
following surgery for duodenal ulcer, leading to symptoms such as gastric stasis, 
dumping or diarrhoea, require clinical evaluation of emptying. From a research point 
of view, the rate or duration of gastric emptying can be measured to evaluate the 
effects of different nutrients, whole foods (i. e. their physical properties or 
biochemical consequences) or drugs on absorption, postprandial parameters and 
satiety. 
1.2.1.3.3 Methods of measuring gastric emptying 
Gastric emptying rates have been measured since 1833 (Beaumont, 1833, 
quoted in Pickworth, 1984), and a range of methods have been developed in order to 
do this. Intubation is a direct way of assessing how much of a meal is left in the 
stomach, by aspirating the stomach contents through a naso-gastric tube. The dye- 
dilution method is similar but involves the labelling of the test meal with phenol-red 
to monitor changes in concentration of the dye. Another method is to measure the 
appearance of iodine in saliva after the consumption of potassium iodide in a barium 
meal, which reflects the absorption of the meal from the duodenum, from which 
gastric emptying rate is extrapolated. The passage of fluids, granules, pellets or meals 
containing barium sulphate through the gut can be measured radiographically. 
Absorption of paracetamol from the duodenum can also be taken to reflect gastric 
emptying by measuring concentrations in blood samples at sequential time points. 
Another tracer method is the "C-octanoic acid breath test, where the cumulative 
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percentage of dose recovered in the breath is used to calculate gastric half emptying 
times (Ghoos et al., 1993). Ultrasound scanning, applied potential tomography, 
magnetic resonance imaging and scintigraphy are all imaging techniques used for the 
measurement of gastric emptying. Electrical impedance epigastrography (EIE) uses 
the change in impedance of an electrical current after a liquid meal to calculate gastric 
emptying parameters such as half-emptying time. Similar techniques include applied 
potential tomography and impedance gastrography. See appendix I for a summary. 
1.2.1.3.4 The physical state of a meal 
The emptying of non-nutrient liquids, nutrient-containing liquids, solid meals, 
and solid-liquid meals all follow different patterns. A non-nutrient liquid meal will 
empty mono-exponentially from the stomach if the solution is pH-neutral and iso- 
osmolar, such as physiological saline (Urbain & Charkes, 1995). The greater the 
volume of the liquid, then the faster the GE rate. A liquid that contains nutrients will 
empty linearly (Urbain & Charkes, 1995). Emptying of a solid meal, however, shows 
an initial lag phase, a long phase with a constant rate of emptying, followed by a 
slower phase of emptying, which produces a sigmoidal gastric emptying curve 
(Urbain & Charkes, 1995). 
Many researchers have looked at gastric emptying of solid-liquid meals using 
the scintigraphic dual isotope method. The solid phase is usually labelled with 
99mTechnetium-sulphur colloid incorporated into chicken liver and the liquid phase 
113mIn-DTPA (diethylenetriaminepentaacetic acid). These studies have found that the 
liquid phase is rapidly emptied, but at a rate that is directly correlated with the energy 
density of the solution (usually 10.5 - 13.0 kJ/min) (Macdonald, 1996). In another 
study, the liquid component emptied exponentially (Notivol et al., 1984) depending 
on the nutrient content, and the solid component emptied linearly (Notivol et al., 
1984) depending on particle size, viscosity etc. If the liquid phase contained 25% 
dextrose the liquid and solid emptying was delayed compared to saline due to a 
prolonged lag period and increased retention in the proximal stomach (Collins et al., 
1991). The pylorus exhibits a sieving action of the liquid phase, the emptying of 
which is mainly controlled by the distal stomach, whereas the proximal stomach 
retains the solid portion until it is in a liquid enough form to enter the antrum. Solid 
particles that are too large are propelled by antral contractions back into the proximal 
stomach until adequately "liquefied" (Urbain & Charkes, 1995). Emptying solid 
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meals made of large particles is slower than meals of small particles due to this 
liquefying process, a difference that is absent in patients who have undergone gastric 
surgery (Holt et al., 1982). The fibre content of a meal can have a strong effect on 
gastric emptying, whether due to viscosity, bulk, or digestibility of the stomach 
contents (Benini et al., 1995). 
1.2.1.3.5 Viscosity, osmolality, pH and temperature 
As the viscosity of a meal increases the rate of gastric emptying is slowed and 
stronger antral contractions are observed (Wilmshurst & Crawley, 1980; Marciani et 
al., 2000). Osmolality of a meal is an important determinant of gastric emptying rate 
- physiological saline empties faster than lower or higher concentration salt solutions, 
and isotonic sugar solutions empty faster than water (Thomas, 1957). The pH of a 
meal can affect gastric emptying, with acids prolonging gastric emptying, especially 
weak acids of high molecular weight (Hunt & Knox, 1972), weak alkalis increasing 
the rate and strong alkalis delaying gastric emptying (Thomas, 1957). However, the 
range of acids or alkalis likely to be present in food are insignificant for normal 
gastric emptying. Initial gastric emptying is faster for cooler liquid loads compared to 
liquids at body temperature, although the majority of the subsequent gastric emptying 
half-time was unaffected (Bateman, 1982). 
1.2.1.3.6 Volume versus energy content 
The duration of gastric emptying is related to the volume of the liquid meal 
(Cohnheim & Best, 1910; Bateman, 1982), or the weight of a solid meal. Moore and 
colleagues (Moore et al., 1981) found that the rate of solids transferred into the 
duodenum stayed constant for larger meals (16928 and 900g) but was slower for the 
300g meal. The rate of energy transferred to the duodenum increased with greater 
meal volume and with greater energy density, with a doubling of volume increasing 
gastric emptying rate slightly more than a doubling of energy density (+3.01 kJ/min 
and +2.59 kJ/min respectively) in a study by Hunt et al (Hunt et al., 1985). Wisen et 
al. (Wisen et al., 1993) also found that the higher the energy density of the meal, the 
slower the gastric emptying , but that this did not fully compensate 
for the increasing 
energy density in terms of energy delivered to the duodenum. Moore et al (Moore et 
al., 1984) found that a 300% increase in meal weight led to a much greater increase in 
gastric emptying rate in terms of grams of solid emptied per minute compared to a 
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300% increase in energy content (388% increase compared to a 43% increase, 
respectively). On the whole it is believed that the gastric emptying of liquids is 
controlled so that around 837 kJ per hour are delivered to the duodenum, and that the 
greater the energy density of a meal the less is the volume emptied per minute (Hunt, 
1983; Carbonnel et al., 1994). 
1.2.1.3.7 Carbohydrate 
The glucose content of a meal can also alter the rate of gastric emptying. 
Carbohydrate empties more rapidly than fat or protein (Cannon, 1911). Intravenous 
glucose administration leading to hyperglycaemia slowed gastric emptying of fat and 
protein meals, but emptying of non-nutrient saline meals were unaffected (Macgregor 
et al., 1976). However, the emptying of the saline meal is significantly slowed if 
glucose is infused into the duodenum, indicating the role of nutrient receptors in the 
duodenum in feedback control of gastric emptying (Brener et al., 1983). There is also 
some evidence that habituation to glucose in the diet can occur, with dietary glucose 
supplementation resulting in faster gastric emptying of a glucose test meal while 
emptying of a protein test meal was unaffected (Cunningham et al., 1991b). 
1.2.1.3.8 Fat 
Gastric emptying is slower when fat is added to a test meal (Cunningham & 
Read, 1989; Houghton et at., 1990). Lipid meals (instilled into the stomach) of 2.5% 
or greater concentration increased relaxation of the proximal stomach (McLaughlin et 
al., 1998), a determinant of gastric emptying, independently of energy content or 
osmolality. There is evidence for desensitisation of gastric emptying mechanisms for 
a high fat diet and a high fat test meal (as seen for glucose supplementation and high 
glucose meals) (Cunningham et al., 1991a), and this is thought to be linked to a 
reduced potency of CCK's inhibitory effects (Covasa & Ritter, 2000). Evidence has 
been reported that pancreatic lipase is needed for fat-mediated inhibition of gastric 
emptying in dogs (Meyer et at., 1994), and chylomicron formation is required for 
delayed gastric emptying (Raybould et at., 1998). Long chain fatty acids are less 
effective than short or medium chain fatty acids at delaying gastric emptying, and 
fatty acids are more effective than di-or triglycerides (Hunt & Knox, 1968; Cortot et 
al., 1982). Fat in the intestine leads to CCK secretion from endocrine cells in the 
23 
intestinal mucosa, which seems to almost entirely account for the delay in gastric 
emptying after a fatty meal (Moran et al., 1993). 
1.2.1.3.9 Protein and amino acids 
Protein and amino acid meals also liberate CCK and therefore delay gastric 
emptying. Phenylalanine and tryptophan are the most potent amino acids in slowing 
gastric emptying (Stephens et al., 1975; Byrne et al., 1977; Fisher & Hunt, 1977; 
Mangel & Koegel, 1984). Egg albumin had little effect on gastric emptying unless it 
was boiled (and therefore denatured) which led to a slowing of gastric emptying 
(Hunt, 1983). This suggests that protein has to be readily digestible in order to delay 
gastric emptying. Feeding rats with a high protein diet for three weeks led to faster 
gastric emptying rates following a protein containing meal, indicating an adaptive 
response (Shi et al., 1997), similar to that found for high fat and high glucose diets. 
It was noticed that boiled milk, which produces small, soft curds in the 
stomach, empties faster than raw milk, which produces larger, tougher curds (Hawk 
et al., 1926). The casein in the milk is responsible for curd formation in the low pH 
environment of the stomach, and so the milk is emptied in a liquid and solid phase. 
Casein is also a potent secretagogue for CCK, which would delay gastric emptying 
still further (Lewis et at., 1990, cited in Maes et at., 1995). Casein was emptied most 
slowly in human subjects compared to glucose, partially hydrolysed gelatin, and 
intact or denatured egg albumin (Low, 1990). 
1.2.1.3.10 Other influences on gastric emptying 
Other potential influences on gastric emptying include gender (Notivol et al., 
1984; Knight et al., 1997), body size (Lavigne et al., 1978; Brogna et al., 1998), and 
age (Moore et al., 1983; Maes et al., 1995). 
1.2.1.3.11 Gastric emptying and distension in relation to appetite 
An empty stomach would be expected to cause a greater feeling of hunger 
compared to a full stomach, with degrees of appetite correlating with stomach content 
in between the two extremes. However, the available evidence has not always proven 
the relationship between appetite and gastric emptying. Fructose emptied more 
rapidly than glucose or xylose in rhesus monkeys, but this had no effect on the 
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amount of food ingested subsequently (Moran & McHugh, 1981). Although 
relationships were demonstrated between plasma CCK response and subjective 
appetite scores, and between plasma CCK response and gastric emptying, there were 
no significant correlations between gastric emptying rate or half-emptying times and 
subjective appetite scores (French et al., 1993). 
Some researchers have been successful in demonstrating a link between 
gastric emptying and appetite. It has been shown that with the use of guar gum to 
increase viscosity and therefore gastric emptying time, there was a relationship 
between gastric transit time and time of self-rated maximum hunger in obese subjects 
(Wilmshurst & Crawley, 1980). Postprandial fullness was related to the retention of 
dextrose in the antrum in a study by Hveem et al. (Hveem et al., 1996). Hunger was 
decreased and gastric emptying time increased in a decubitus position following an 
oil and aqueous meal, compared to a sitting position, and hunger was significantly 
related to the retention of oil in the stomach in the decubitus position (Horowitz et al., 
1993). Bergmann et al. (Bergmann et al., 1992) showed that the use of psyllium (a 
soluble dietary fibre) could delay gastric emptying in the later stages of emptying, 
and that subjective sensations of hunger and satiety were significantly correlated with 
gastric emptying time. Rigaud et al. (1998), however, went on to show that if 
psyllium was ingested fifteen minutes before the test meal, although hunger and 
subsequent food intake was still reduced there was no delay in gastric emptying 
compared to the placebo. This finding shows that a significant correlation such as 
increased gastric emptying time with reduced hunger does not necessarily mean that 
hunger is directly affected by gastric emptying. 
Gastric distension is a state that is related to gastric emptying (since the latter 
is a function of intra-gastric pressure), and is also associated with pre-absorptive 
appetite control, especially with regard to feelings of fullness. Vagal afferent nerves 
terminate in the circular and longitudinal muscle layers of the stomach, sensitive to 
contraction or stretch in the muscle tissue. In rats, the discharge rate of vagal afferent 
fibres increases with gastric loads (Schwartz et al., 1991), and gastric loads volume- 
dependently reduce food intake independently of nutrient content when the pylorus 
was occluded (Phillips & Powley, 1996). This suggests that gastric distension-related 
signals are of primary importance in the satiation process. However, this relationship 
between gastric distension and gastric-related fullness is not straightforward, as 
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vagotomy does not block the satiating effect of food in the stomach of rats (Kraly & 
Gibbs, 1980). During the course of a meal, nutrients are emptied from the stomach 
and enter the intestine, where they also trigger satiety signals from mechanoreceptors, 
chemoreceptors and hormone/neuropeptide secretion, thereby modulating gastric 
distension sensations. It has been shown that CCK augments the sensations of gastric 
distension (subjective ratings of fullness) (Melton et al., 1992), and also stimulates 
gastric and duodenal vagal mechanosensitive afferents, sensitising and amplifying the 
afferent response to gastric loads (Davison & Clarke, 1988; Schwartz et al., 1991; 
Schwartz & Moran, 1994). Gastric distension-type feelings of fullness probably 
initiate the satiety process, especially following meals of large volume or bulk. In 
fact, it has been suggested that gastric distension dominates the fullness sensations 
experienced after a meal (Cecil et al., 1998). Distension-induced satiety signals are 
then enhanced and prolonged while the food is emptying from the stomach by 
intestinal nutrient-related signals, both direct (e. g. direct stimulation of mucosal vagal 
afferent termination fibres) and indirect (e. g. via stimulation of gastrointestinal 
hormone secretion). 
1.2.1.4 Summary 
In summary, hormonal, neurological and gastric emptying studies point to 
pre-absorptive signals arising from amino acids and protein in the gastrointestinal 
tract as important regulators of short-term food intake. These neuroendocrine signals 
appear to be key to the satiation process during the course of a meal. 
1.2.2 Post-absorptive mechanisms for protein- and amino acid-induced satiety 
Ritter & Calingasan (Ritter & Calingasan, 1994) interpreted studies based on 
metabolic drugs and brain lesions as indicating that lipoprivic signals (i. e. those 
generated through an inhibition of fat oxidation) are monitored peripherally and reach 
the brain via vagal sensory neurons, while glucoprivic signals (generated through an 
inhibition of glycolysis) act both peripherally and centrally, i. e. there are no vagal 
afferents arising from the periphery that are exclusively essential for the glucoprivic 
feeding responses. On the basis of experiments with glucose and fatty acid oxidation, 
Friedman (Friedman, 1998), postulated that metabolic signals may originate at the 
most basic cellular level - changes in intracellular ATP are sensed by the liver and 
signalled vagally to the brain. With amino acid oxidation involving a variety of 
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pathways in gastrointestinal mucosal cells, liver, skeletal muscle and kidney, there are 
many potential candidate metabolic pathways and organs but as yet no identifiable 
experimental evidence. 
1.2.2.1 Signals from hepatic amino acid sensors 
Russek (Russek, 1971) proposed that hepatic glycogen and protein reserves 
were the main factors that influenced the regulation of food intake. Following 
feeding, these reserves would be replenished and an absence of "hunger signals" 
would follow. As these hepatic glycogen and protein reserves decreased, receptors in 
the liver would start signalling to the CNS to increase feelings of hunger. Russek's 
ideas prompted a great deal of research and it is widely believed that the liver is a 
likely candidate for fuel utilisation monitoring and signalling to hunger and satiety 
centres in the CNS. 
In fact, because the liver plays a direct regulatory role in postprandial amino 
acid homeostasis, a hepatic source for an amino acid-derived satiety signal is a logical 
theory. Following a meal the inhibition of hepatic proteolysis (Garlick et al., 1973) 
allows the accumulation of hepatic protein (Millward et al., 1974) which buffers the 
large increase in blood amino acids and maintains a steady supply of amino acids to 
peripheral tissues for up to eight hours (Wahren et al., 1976). Furthermore inhibition 
of proteolysis appears to increase progressively with increasing protein intake (Pacy 
et al., 1994) and is mediated in part by amino acid supply with a specific role for 
alanine as a coregulator of proteolysis (Pösö & Mortimore, 1984) probably acting 
through a receptor-mediated mechanism (Miotto et al., 1992). With alanine the major 
end product of both skeletal muscle and intestinal amino acid oxidation, alanine 
uptake and disposal in the liver is an obvious signalling source that might 
theoretically regulate food protein intake. 
Hepatic amino acid supply can initiate a neural output with sensors in the rat 
hepato-portal system sensitive to alanine and other amino acids (Tanaka et al., 1990). 
Intraportal infusion of an amino acid mixture decreases the firing rate of hepatic vagal 
afferent neurons responsive to amino acids, in a dose-dependent way (Niijima & 
Meguid, 1994), and individual amino acids act either to excite (arginine, alanine, 
histidine, leucine, lysine, serine, tryptophan and valine) or inhibit (cysteine, glycine, 
isoleucine, methionine, phenylalanine, proline and threonine) the discharge rate 
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(Niijima & Meguid, 1995). Although, it is not understood why some amino acids are 
excitatory while others are inhibitory, it provides a theoretical mechanism by which 
amino acid supply in the periphery may be monitored centrally thereby acting as a 
sensitive regulatory system for the control of food intake. 
1.2.2.2 Amino acids flux into skeletal muscle as a hypothetical locus for appetite 
regulation 
There is as yet no identifiable evidence of amino-acid sensitive signalling 
mechanisms in muscle comparable to those identified in the liver. However control of 
skeletal muscle growth has been proposed to link the regulation of growth and body 
composition to an aminostatic mechanism of appetite control (Millward, 1995). 
Muscle protein synthesis, which is part of the postprandial responses to dietary amino 
acids observed in the whole body (Pacy et al., 1994; Gibson et al., 1996; Millward et 
al., 1996), is sensitive to amino acid supply in the leg (Gelfand et al., 1988; Bennet et 
al., 1989; Bennet et al., 1990), and in insulin-clamped pig skeletal muscle (Watt et 
al., 1992). Thus post-feeding disposal of amino acids occurs in muscle as both net 
protein deposition and amino acid oxidation (mostly branched chain amino acids, 
comprising some 25% of dietary protein). Given the size of muscle relative to body 
size, this may be a major proportion of total body net protein deposition and amino 
acid oxidation. Most importantly, within the protein-stat hypothesis proposed by 
Millward (1995), muscle is identified at a higher level than other organs within a 
hierarchy of growth regulation: i. e. the canalised linear growth of long bones 
mediates the rate of and target size for muscle growth, which in turn determines 
energy expenditure, energy requirements and food intake, the latter regulating 
splanchnic organ mass. In this sense, muscle mass determines food intake while food 
intake determines splanchnic organ mass. When major changes in food intake are 
required, e. g. during early postnatal life or during nutritional rehabilitation, much of 
the increased protein and energy requirements are for skeletal muscle growth and it is 
postulated within the protein-stat hypothesis that the signalling mechanisms for the 
required changes in intake originate from muscle. 
However, the identification of a metabolic locus in the muscle for aminostatic 
signal transduction is problematic. There are no neural pathways apart from those 
involved in pain or muscle length detection. It may be that simply through its role as 
the largest single component of the lean body mass, muscle regulates food intake 
28 
through its ability to remove or release amino acids from the circulating pool, with 
sensors elsewhere monitoring such changes and mediating aminostatic signal 
transduction. It may also be the case that such a mechanism is only operative during 
early postnatal life, growth spurts during adolescence, catch-up growth, and recovery 
from illness where muscle wasting has occurred. In the well nourished adult (with 
muscle fibres replete, minimal net fluxes of amino acids between muscle and the 
circulation, and with modest protein requirements limited to the replacement of 
postabsorptive losses), the role of muscle in appetite regulation may be of minor 
importance. In this case, with protein-related hunger mechanisms unnecessary, 
aminostatic components of appetite regulation may be managed elsewhere by gut 
mediated, hepatic, or central mechanisms. 
1.3 Central mechanisms 
1.3.1 Evidence that circulating and central nervous system amino acid 
concentrations influence food intake. 
Previously, through work on animals with hypothalamic lesions or neural 
transactions, it was established that the hypothalamus was the main brain region 
responsible for the control of food intake, especially the VMH, DMN, PVN, and LH. 
Extensive subsequent research has uncovered the extent of the complexity of the 
hypothalamic appetite circuitry and its connections to the periphery and other regions 
of the brain. 
1.3.1.1 Animal studies 
Infusion of amino acids into the circulation depresses food intake in rats 
(Walls & Koopmans, 1992), suggesting that the gastrointestinal tract is not the sole 
mediator of the satiety response. Circulating amino acid levels may be regulated by a 
central receptor, since rats with a reduced food intake, due to an amino acid- 
imbalanced diet, normalise their feeding when the limiting amino acid is infused into 
the carotid artery but not the jugular vein (Rogers & Leung, 1973). One site may be 
the hypothalamus, since feeding is inhibited by a balanced amino acid solution 
injected into this area (Panksepp & Booth, 1971). However, food intake remains 
responsive to dietary amino acid manipulations in rats with hypothalamic lesions 
(Rogers & Leung, 1973), so the hypothalamus is unlikely to be the only receptive 
region of the brain. Lesions in the prepyriform cortex and the medial amygdala 
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prevented the reduction in food intake observed when rats were fed amino acid- 
imbalanced diets but not amino acid deficient or high protein diets. Lesions in the 
septal area did not appear to be important in the regulation of amino acid intake, and 
lesions in the hippocampus did not affect the feeding response to diets containing 
amino acids in excess (Leung & Rogers, 1979). Concentrations of a limiting amino 
acid were not decreased in rats fed an imbalanced amino acid diet in the three 
hypothalamic regions studied (VMH, LH and PVN), but noradrenaline concentrations 
were shown to be increased in the VMH. (Gietzen et al., 1989). Since noradrenaline 
concentrations were also decreased in the prepyriform cortex this implicated the 
noradrenergic system in the regulation of intake of imbalanced amino acid diets 
(Leung & Rogers, 1971). 
Another approach to locate the receptive areas of the brain is to examine 
actual neuronal activity of the various likely brain centres in response to variation in 
amino acid concentrations. Examination of the discharge frequency response of 
specific neurons in the cerebral hemisphere and LH to the electrophoretic application 
of individual essential amino acids revealed that none of the cells in the cerebral 
cortex responded to any of the amino acids, but neurons in the thalamus, zona incerta 
and LH were responsive, especially to threonine, tryptophan, methionine and valine 
(Wayner et al., 1975). More recently perfusion of cerebrospinal fluid (CSF) 
containing normal physiological concentrations of all amino acids increased the 
excitability of neurons in the VMH, which was then shown to be mainly due to 
glutamine (Nishimura et al., 1995). Although the importance of excitatory amino acid 
receptors in appetite regulation could not be clarified (see section 1.3.4), a direct link 
between the excitatory amino acid, glutamate (whose precursor is glutamine), in the 
LH and the initiation of a strong immediate eating response in satiated rats was 
shown (Stanley et al., 1993). Another study of single neuron activity found that 
specific set of LH neurons were more active in response to dietary lysine in lysine- 
deficient rats whereas the neurons of normal lysine-status rats responded non- 
differentially, a phenomenon that was reflected in their preference for lysine (Torii et 
al., 1998). The authors suggested that neurons in the LH are particularly important in 
recognising nutrient deficiencies and that neural plasticity in response to deficiency or 
learned preferences may play an important role in amino acid intake regulation. 
30 
A lack of temporal associations between plasma and brain amino acid levels 
and feeding has led some investigators to question a postabsorptive aminostatic 
theory. Ng and Anderson (Ng & Anderson, 1992) did observe reductions in food 
intake following intragastric or intraperitoneal administration of tryptophan and 
tyrosine but they were unable to link this with changes in concentrations of these 
amino acids in the plasma or brain at the time of feeding. In subsequent rat studies, 
Anderson and colleagues (Anderson et al., 1994) point to a lack of temporal 
association between protein-induced satiety and plasma amino acid responses. Oral 
intake of albumin, as protein or its constituent amino acids, did reduce food intake 
during the first hour of feeding, but plasma amino acids did not change until the end 
of that hour. They also reported a lack of consistent change in brain amino acid 
concentrations in the study, further reinforcing their arguments. 
1.3.1.2 Human studies 
As far as human evidence is concerned we are still very reliant on 
Mellinkoff's original work that changing concentrations of plasma or brain amino 
acids influence feeding behaviour (Mellinkoff et al., 1956). One study, not 
specifically designed to examine aminostatic mechanisms, did show that in healthy 
males, voluntary oral intakes of a covert liquid diet were decreased to a greater extent 
by intravenous infusions of a combination of amino acids, glucose, and fat than with 
glucose or fat alone (Gil et al., 1991). However, the design does not allow resolution 
of the influence of the amino acids per se as opposed to a combined satiety effect of 
all three macronutrients. Even more straightforward studies are not entirely 
unambiguous. Gielkens et al. (Gielkens et al., 1999) reported that food intake was 
unaffected by intravenous infusion of two concentrations of amino acids but that 
subjective feelings of satiety were increased dose-dependently, with a small, short- 
lived (first half hour) increase in plasma CCK concentrations during the high dose 
infusion. 
1.3.2 Phenylalanine, tyrosine and dopamine 
This section will review the individual amino acid phenylalanine, its 
conversion to tyrosine, and the importance of the availability of this precursor to 
dopamine formation and the appetite effects of dopamine. 
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1.3.2.1 Phenylalanine 
The upper requirement for total aromatic amino acids was set at 14mg/kg 
body weight per day for adults in the 1985 FAO/WHO/UNU report. However, this 
has not been agreed upon, and subsequent studies have also disagreed on the level of 
phenylalanine intake required for phenylalanine balance (Waterlow, 1996). The main 
reason for the uncertainty surrounding the correct requirement for balance is lack of 
agreement on the proportion of phenylalanine that undergoes hydroxylation to 
tyrosine. A more recent study suggested that a mean intake of 39mg/kg/d is required 
in healthy adults (Basile-Filho et al., 1998). In practice, daily consumption of the 
average mixed diet in adults greatly exceeds this value (Harper, 1984). 
Phenylalanine is widely ingested as the sweetener, aspartame; a high intensity, 
non-nutritive sweetener, and a methyl ester of the dipeptide 1-aspartyl-l- 
phenylalanine. One 330m1 (12 oz) can of "diet" carbonated beverage contains 200mg 
of aspartame (112mg of phenylalanine) (Federal Register, Vol. 46, No 142, July 
(1981), p. 38290 (US), in Pardridge, 1986). In a child weighing 30 kg, a can of this 
drink would provide 3.7 mg/kg body weight of phenylalanine in the child and 1.6 
mg/kg body weight in an adult. These seem insignificant amounts compared to the 
projected 99th percentile of aspartame ingestion (34 mg/kg/day) set by the Food and 
Drug Administration in the USA (Pardridge, 1986). Stegink et al (Stegink et al., 
1988; Stegink et al., 1989; Marcou et al., 1987) found that repeated ingestion of an 
aspartame-sweetened beverage throughout the day does not lead to an accumulation 
of plasma phenylalanine and other aspartame metabolites beyond normal postprandial 
levels. Plasma phenylalanine is cleared relatively quickly, with a half time of 
approximately 60-90 minutes (Moller, 1991). Therefore it would be surprising if there 
were an accumulation of phenylalanine in the plasma even at the highly unlikely 
levels of consumption administered in the experiments carried out by Stegink and 
colleagues. 
Phenylalanine may influence satiety via peripheral mechanisms, e. g. 
increasing CCK secretion, or centrally by its conversion to tyrosine. Moller (1991) 
investigated the plasma phenylalanine and tyrosine response in human beings to 
ingestion of phenylalanine in the form of aspartame and found that it is quickly 
absorbed, reaching a peak at 15 minutes, and that it increased plasma tyrosine levels. 
Aspartame increased plasma phenylalanine/large neutral amino acid (LNAA) ratio at 
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15 minutes, and phenylalanine/LNAA as a% of basal was significantly increased for 
2'/2 hours. Tyrosine/LNAA ratios were also significantly increased by aspartame from 
30 minutes to 4 hours. These elevated phenylalanine/LNAA and tyrosine/LNAA 
ratios represent an increased availability of these amino acids to the brain after 
aspartame. This, potentially, could mean that there is greater synthesis of 
catecholamines such as dopamine and noradrenaline (see section 1.3.2.3). 
Other studies had also shown that aspartame loading results in some of the 
phenylalanine being converted to tyrosine (Stegink et al., 1977; Stegink et al., 1987; 
Stegink et al., 1988; Mangel et al., 1995; Maffei et al., 1996). In a recent 24 hour 
stable isotope tracer study (Basile-Filho et al., 1998), the rate of phenylalanine 
hydroxylation and tyrosine oxidation varied with the level of phenylalanine in the 
diet. The high phenylalanine diet led to a different pattern of whole-body 
phenylalanine and tyrosine metabolism during the fed and fast phases compared to 
the intermediate and low phenylalanine diet, with phenylalanine concentrations 
increasing for the former and staying the same or decreasing for the latter. 
Tyrosine is a precursor for the formation of the catecholamines dopamine 
(DA, dihydroxyphenylethyl amine), noradrenaline (NA) and adrenaline. 
Catecholamines are "organic compounds that contain a catechol nucleus (a benzene 
ring with 2 adjacent hydroxyl substituents) and an amine group" (Cooper et al., 
1996). Tyrosine is converted to 3,4-dihydroxyphenylalanine (DOPA) by the enzyme 
tyrosine hydroxylase. Then, in the brain or the peripheral neuron (in the case of NA) a 
number of enzymatic steps take place to form one or other of the catecholamines. 
Tyrosine transport into the brain involves the same large neutral amino acid carrier as 
tryptophan; and a tyrosine/LNAA supply-limited mechanism of DA synthesis is an 
obvious candidate for appetite regulation, similar to the purported tryptophan- 
serotonin link (see section 1.3.3). 
1.3.2.2 Dopamine influences eating behaviour 
Dopamine (DA) is strongly believed to be involved in the regulation of food 
intake but the evidence does not clearly indicate the direction of this effect. Depletion 
of ventrolateral striatal DA in rats (Salamone et al., 1993) and genetic DA-deficiency 
in mice (Szczypka et al., 1999) both reduce food intake. However, DA concentrations 
in the cerebrospinal fluid are depressed during food deprivation and normalised by 
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ingestion of food in rats (Bednar et al., 1991), while DA agonists (for D1 and D2 
receptors) inhibit feeding in rats (Bednar et al., 1995). DA also acts to inhibit food 
intake via CCK-mediated mechanisms (Bednar et al. 1991). 
1.3.2.3 Plasma tyrosine and dopamine synthesis 
Rat studies have shown changes in brain concentrations of DA metabolites in 
response to normal feeding or dietary manipulation of tyrosine and phenylalanine 
intake (Biggio et al., 1977; Thurmond et al., 1980; Glanville & Anderson, 1986; 
Hernandez & Hoebel, 1988; Lehnert & Wurtman, 1993; Yeomans et al., 1997; 
Greenberg et al., 1990). The plasma tyrosine to phenylalanine ratio correlated with 
long term energy intake in weanling rats (Anderson & Ashley, 1977), and some 
authors have shown that an increase in brain tyrosine can enhance NA synthesis 
(Gibson & Wurtman, 1978; Brady et al., 1980), but not DA synthesis (Spring et al., 
1987). However the inference that this represents a tyrosine-mediated control of food 
intake can be questioned by the failure to show an increase in NA levels after 
phenylalanine supplementation, despite increased concentrations of phenylalanine 
and tyrosine in the brain (Thurmond et al., 1980). Moreover, directly increasing brain 
tyrosine produced no increase in the rate of catecholamine synthesis (Sved, 1983). 
The low Km for tyrosine hydroxylase leads to its saturation with tyrosine under 
normal conditions, and therefore it is no longer thought to act as a rate-limiting step 
for catecholamine synthesis (Cooper et al., 1996). The product of tyrosine 
hydroxylase, DOPA (dihydroxyphenylalanine), is more likely to rate-limit 
catecholamine synthesis. This is present in the brain at very low concentrations, due 
to its rapid conversion to DA by aromatic amino acid decarboxylase. 
It may be that tyrosine does influence neurotransmitter synthesis when 
noradrenergic or dopaminergic pathways are physiologically stimulated, and 
peripheral sympathetic or central noradrenergic or dopaminergic neurons are rapidly 
firing (Spring et al., 1987). When this occurs in the relevant neurons, tyrosine 
hydroxylase becomes less inhibited by the end product due to a greater affinity for its 
cofactor (tetrahydrobiopterin) as a result of phosphorylation (Lehnert & Wurtman, 
1993). This relationship can be demonstrated in DA neurons in the retina, which fire 
actively in the light but are inactive in the dark. Tyrosine hydroxylase activity 
increases in retinal DA neurons in the light, a process that is enhanced when tyrosine 
is injected (Fernstrom & Fernstrom, 1994). It was also shown that there is a 
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competitive LNAA transport into the retina, and therefore the plasma tyrosine to 
LNAA ratio should influence tyrosine hydroxylation rates in the retina. Another 
example is cold stressed animals, which show increased synthesis and release of NA 
in response to increased brain tyrosine concentrations, an effect which is also 
achieved by administration of probenecid (Spring et al., 1987). However, DA release 
was not affected. 
1.3.2.4 The effect of meals on brain tyrosine and dopamine synthesis 
Feeding has been reported to increase extracellular concentrations of DA in 
the nucleus accumbens, a part of the brain that is a major target of the mesolimbic 
dopaminergic system (Radhakishun et al., 1988; Yoshida et al., 1992; Young, 1998). 
Rats fed a protein meal had increased retinal tyrosine levels and tyrosine 
hydroxylation rates, and effect that was not observed following a protein-free meal 
(Fernstrom & Fernstrom, 1994). This showed that tyrosine hydroxylation could be 
increased by feeding as well as by direct tyrosine injection. However, this 
physiological effect has not been proven in any brain DA neurons, which would need 
to be actively firing ones. Tyrosine hydroxylation rates were shown to be higher in 
the hypothalamus of rats ingesting greater amounts of protein for two weeks, but it 
was not known if this was occurring in DA or NA neurons (Fernstrom & Fernstrom, 
1994). In other rat studies, the palatability of food influenced the magnitude of the 
increase in DA and its metabolites in the nucleus accumbens (Martel & Fantino, 
1996), suggesting either that mesolimbic dopaminergic system activity is related to 
the rewarding aspects of feeding, or that the higher ingested energy density with the 
highly palatable food was responsible. Plasma DOPA has been observed to fall in 
human subjects after a mixed meal (Eldrup et al., 1997), possibly reflecting increased 
DA synthesis, since there were also large increases in plasma total DA, not all of 
which could be accounted for by the meal DA content. However, the responses could 
also reflect increased uptake of DOPA into muscle following postprandial increases 
of insulin, especially since there was no relationship between plasma DOPA and 
plasma NA. Plasma tyrosine and phenylalanine increased after the meals but 
concentrations did not correlate with plasma DOPA, DOPAC (3,4- 
dihydroxyphenylacetic acid) or DA-sulphate concentrations. Clearly meal-feeding 
studies of sympathetic nervous activity, in which DA is provided in food and could 
account for some of the responses (e. g., the observed increase in plasma DOPAC 
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concentrations), create difficulties in their interpretation. These results neither support 
nor rule out the possibility that increased tyrosine uptake in the brain after the meals 
may have contributed towards increased DA synthesis and release. 
1.3.2.5 Conclusions 
DA is involved in food intake regulation, although it appears that this 
relationship is not straightforward. The plasma tyrosine: LNAA ratio can be increased 
by high protein meals which enhances tyrosine entry into the CNS. However, the 
rate-limiting step of tyrosine hydroxylation is only effective in rapidly firing DA 
neurons, otherwise the enzyme is saturated under normal conditions. The areas of the 
brain that contain rapidly firing DA neurons are poorly understood, and whether these 
project to appetite regulation centres remains to be discovered. There is little evidence 
in animals or human beings that meals of differing composition can modulate DA 
synthesis and release, or that this influences eating behaviour. 
1.3.3 Tryotoahan and serotonin 
There is considerable literature on the relationship between tryptophan, 
serotonergic activity, and eating behaviour (Wurtman et al., 1981; Hrboticky et al., 
1985; Hill & Blundell, 1988). Serotonergic, or 5-HT neurons, (serotonin is 5- 
hydroxytryptamine, 5-HT), certainly play an important part in the regulation of 
appetite with serotonergic agents (5-HT releasers, re-uptake blockers and direct 
agonists) inducing a prompt anorexia; as a result they are used to control obesity and 
eating disorders (Blundell & Hill, 1992). This has, not surprisingly, raised the 
possibility that aminostatic regulation of appetite may be simply explained by amino 
acids acting centrally through their role as neurotransmitter precursors to influence 
eating behaviour. This popular hypothesis has in fact proved difficult to demonstrate. 
1.3.3.1 Effects of diet or tryptophan on serotonin synthesis 
Tryptophan is a precursor for 5-HT, with tryptophan uptake into the brain 
thought to regulate 5-HT synthesis, and with tryptophan competing with other large 
neutral amino acids (LNAA) (phenylalanine, tyrosine, isoleucine, leucine and valine) 
at the blood-brain barrier transporter (Wurtman et al., 1981). Tryptophan 
concentrations are low in most dietary proteins, and the plasma tryptophan to LNAA 
ratio (tryptophan/LNAA) after a meal depends on the net dynamic effect of insulin 
secretion and subsequent tissue uptake of amino acids, and the postprandial rise in 
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circulatory amino acids. In a series of rat experiments, Fernstrom & Wurtman 
(Fernstrom "& Wurtman, 1972) established that brain tryptophan and 5-HT 
concentrations could be increased by injections of tryptophan or insulin, or 
consumption of high carbohydrate diets, and that this response was abolished with 
protein consumption. It has been assumed that a high carbohydrate meal, which 
increases insulin secretion, will lower plasma LNAA concentrations through 
promotion of their uptake into tissue protein. In particular, concentrations of plasma 
branched-chain amino acids would be reduced and the tryptophan/LNAA ratio would 
increase (Wurtman et al., 1981). 
It is also argued that the insulin-mediated inhibition of release of non- 
esterified fatty acids into the plasma frees up albumin binding sites for tryptophan, 
although the importance of this has been disputed with the suggestion that most 
plasma tryptophan (70-80%) may be "free" in the brain capillaries and available for 
transport into the brain (Leathwood, 1989). Since tryptophan hydroxylase is not 
normally saturated by tryptophan, tryptophan uptake, a function of the plasma 
tryptophan: LNAA ratio becomes the rate-limiting step (Cooper et al., 1996). A raised 
brain tryptophan level will therefore increase conversion to 5-hydroxytryptophan (5- 
HTP) and then 5-HT by hydroxylation. The problem with this hypothesis is that the 
addition of even a small amount of protein to a high-carbohydrate meal is enough to 
prevent this tryptophan-mediated 5-HT increase (Teff et al., 1989), and large 
excursions in brain tryptophan concentrations are needed to produce observable 
increases in 5-HT (Ashley et al., 1985). Indeed, the majority of available evidence 
does not support the idea that protein or carbohydrate meals alter plasma amino acids 
sufficiently to cause significant changes in brain 5-HT synthesis (Ashley et al., 1982; 
Leathwood, 1989; Teff et al., 1989). In addition, the functional 5-HT pool does not 
necessarily relate to total 5-HT concentrations in the brain. Functional 5-HT may be 
inhibited in order to regulate neurotransmission rates, either by intracellular 
metabolism before synaptic release, or the adaptive slowing of raphe neuron firing 
rates if there is a large increase in 5-HT synthesis (Leathwood, 1987). 
1.3.3.2 Effects of diet or tryptophan on food intake 
The reduction in energy intake in human subjects following oral tryptophan, 
albeit as a large dose (2 g encapsulated supplement), initially provided partial support 
for this theory (Hrboticky et al., 1985). However, the hypothesis that serotonergic 
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effects on appetite are related to a feedback loop for specific macronutrients 
(Fernstrom et al., 1979; Woodger et al., 1979) was not supported since the proportion 
of carbohydrate or protein eaten was not affected. Furthermore, a tryptophan and 
carbohydrate lunch, (expected to enhance 5-HT synthesis), did not inhibit food 
intake, while high protein and high protein plus tryptophan meals did (Blundell & 
Hill, 1987), i. e. tryptophan appeared to exert its effects through its combination with 
protein rather than carbohydrate, therefore not through its capacity to increase 5-HT 
activity in the brain. Studies manipulating carbohydrate and protein intake that have 
shown associated changes in plasma tryptophan/LNAA ratios and differences in 
macronutrient selection, do not rule out other intermediary mechanisms (Pijl et al., 
1993). The elimination of this purported feedback regulation of macronutrient intake 
by treatment with fluoxetine, which suppressed food intake, suggests that this short- 
term effect was not necessarily 5-HT -mediated since it was not enhanced by a 5-HT 
re-uptake blocker. 
Studies of postprandial satiety and plasma amino acids in male subjects after 
the ingestion of beef, chicken and fish indicated that the greater satiety after a fish 
meal was correlated with differences observed in the postprandial tryptophan to large 
neutral amino acid ratio (Uhe et al., 1992). However, this merely hints at supporting 
the increasingly flimsy premise that dietary amino acids in normal meals can alter 5- 
HT release to affect appetite - it does not offer firm evidence that these changes in 
plasma LNAA profile were sufficient to alter 5-HT synthesis in amounts that could 
influence satiety and that some alternative neurochemical pathway was not involved. 
A non-serotonergic mechanism of tryptophan action was certainly indicated by 
studies of infused tryptophan metabolism and kinetics (Huether et al., 1992). 1,3 and 
5g doses of tryptophan failed to alter whole blood 5-HT concentrations but did 
change concentrations of many other neuroactive tryptophan metabolites, none of 
which were saturated by tryptophan, as well as increasing amino acid utilisation for 
protein synthesis, to the detriment of brain tyrosine availability for catecholamine 
synthesis. 
Thus the carbohydrate-tryptophan-serotonin satiety pathway suggested by 
animal studies appears difficult to demonstrate in humans, with tryptophan exerting 
its effects on appetite through its combination with protein rather than carbohydrate, 
and little evidence that serotonin is involved in this dietary paradigm. Although there 
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is no doubt that serotonin is an important regulator for appetite, the original 
carbohydrate-tryptophan-serotonin theory of behaviour and appetite is over- 
simplistic, with solutions more likely to involve other pathways of brain 
neurochemistry. 
1.3.3.3 Other pathways for serotonergic effects on food intake 
It seems that although serotonergic mechanisms can regulate food intake as 
shown by the agonist responses, whether food intake influences serotonergic activity 
is by no means clear. 5-HT has a large number of receptors, with many subtypes 
identified. Sumatriptan, a 5-HT1A receptor agonist, has been shown to inhibit motilin 
action and suppress motor activity in the stomach (Tack et al., 1998), as well as 
inhibiting gastric emptying rates (Coulie et al., 1997) and causing a post-prandial 
dilatation of the distal and proximal stomach (Vingerhagen et al., 2000). Since 5-HT 
has been identified in the myenteric plexus, this suggests that it may be acting on 
receptors in the enteric nervous system. Serotonin acting on specific receptors (5- 
HTIB/2C) in the hypothalamus may be inhibiting food intake by interacting with 
neuropeptide Y (NPY) and CCK (Cooper et al., 1992; Poeschla et al., 1993; Dryden 
et al., 1996; Voigt et al., 1998). These studies show the large degree of 
interdependence of neurotransmitters and neuropeptides in triggering satiety 
following food intake, pointing to a need for more information about the exact neural 
and systemic pathways that mediate these interactions. 
1.3.3.4 Conclusions 
There is no doubt that serotonergic neurotransmission can regulate food 
intake. It is also recognised that in certain specialised experimental conditions 
ingestion of tryptophan or pure carbohydrate can increase 5-HT synthesis in the brain. 
Whether this influences serotonergic neurotransmission is debatable. The evidence, 
however, that the tryptophan-carbohydrate-serotonin pathway is important in appetite 
regulation in free-living humans beings is unconvincing. 
1.3.4 y-aminobutvric acid (GABA) and glutamate 
Amino acids not only act as precursors for neurotransmitters - some, or 
related metabolites such as GABA, are themselves neurotransmitters in the CNS. 
GABA is classed as an "inhibitory amino acid" (Cooper et al., 1996). Only trace 
amounts occur in peripheral nerve tissue but GABA is found throughout the brain and 
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spinal cord; high concentrations are found in the nigrostriatal system of the brain, 
with lower levels in the cerebral hemispheres, pons and medulla (Rang & Dale, 1991; 
Cooper et al., 1996). Glutamate is the precursor for GABA, itself an "excitatory 
amino acid" neurotransmitter. There is a mounting body of animal evidence to 
suggest that GABA neurons are involved in the regulation of feeding behaviour. 
Low doses of inhibitors of GABA transaminase (raising brain GABA levels), 
led to the inhibition of feeding behaviour in rats (Nobrega et al., 1988); confirming 
earlier similar results in rats after ICV injections of GABA and GABA-transaminase 
inhibitor (Olgiati et al., 1980). The benzodiazepine system (benzodiazepine drugs, 
e. g. diazepam, potentiate the effects of GABA) has been investigated in relation to an 
appetite drive and taste palatability (Berridge & Pecina, 1995). The ability of 
benzodiazepine drugs to stimulate feeding is independent of their powerful sedative 
effects, and it is argued that these agonists increase feeding by enhancing pleasure 
and hedonic reactions to food (Cooper, 1980; Berridge, 1995). 
Recent evidence has come to light to suggest that glutamate has a role in the 
control of food intake. Glutamate is an "excitatory amino acid" in the CNS (Cooper et 
al., 1996). Glutamate is present, like GABA, at high concentrations throughout the 
CNS, as well as throughout the body as part of the free amino acid pool (Rang & 
Dale, 1991). Many hypothalamic nerve terminals contain glutamate in their synaptic 
vesicles, and glutamate and its receptor agonists kainic acid (KA), a-amino-3- 
hydroxy-5-methyl-isoxazole (AMPA) and N-methyl-D-aspartate (NMDA) have 
particularly pervasive excitatory effects in the hypothalamus (van den Pol et al., 
1990). Lateral hypothalamic injections of glutamate and glutamate agonists elicited 
strong, immediate feeding responses in satiated rats (Stanley et al., 1993). Strangely, 
an NMDA receptor antagonist enhanced chow intake in food-deprived rats, and 
increased liquid sucrose intake in both food-deprived and satiated rats (Burns & 
Ritter, 1997). NMDA receptor blockade thus appears to diminish satiety signals, 
although one might expect an NMDA antagonist to inhibit feeding. The limited 
evidence suggests that glutamate is indeed involved in the regulation of feeding 
behaviour, but that glutamate receptors cannot be regarded as simple on/off switches 
for satiety. Further research needs to be done into the exact behavioural effects of the 
glutamate neural system, bearing in mind the complex food reward behavioural 
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patterns observed in investigations into benzodiazepine-GABAergic and opioid 
neural systems. 
1.4 Psychological and Social Aspects of Appetite Control 
1.4.1 Introduction 
Appetite regulation in human beings is a complex combination of events. A 
theoretical satiety or hunger signal from the brain does not follow a direct pathway to 
a physical consummatory or terminating action - there are many social and 
psychological ramifications along the way. The following section is a brief summary 
of these facets of human eating behaviour. 
1.4.2 The Food 
Eating behaviour can be recorded and classified in terms of the micro- 
structure of eating, a term which refers to the pattern of biting, chewing, swallowing 
and pausing, as well as the duration of a bout of eating or meal. These parameters of 
eating behaviour may reflect attitudes to food or psychological profiles. For example, 
it has been suggested that obese people may have a different pattern of eating 
behaviour within a meal (a faster rate of chewing and swallowing, less pauses etc. ), 
increasing the amount of food consumed before the physiological satiety signals take 
effect (Mela & Rogers, 1998). The microstructure of eating is determined by the 
palatability of the meal. Palatability can mean many things but it is generally taken to 
reflect an individual's liking for a food based on its sensory (taste, flavour and 
texture) properties (Mela and Rogers, 1998). Palatability is distinct from food 
preference as the latter term can reflect other factors (economic, social, and 
psychological) in addition to palatability. Palatability alters eating behaviour. A more 
palatable meal enhances food intake in human subjects, and increases and prolongs 
subjective hunger ratings with the initiation of an eating episode (Yeomans et al., 
1997). 
Sensory-specific satiety is an expression used to describe the decrease in 
palatability that occurs during the course of a meal, which eventually inhibits eating, 
especially where only one type of food is provided as is the case in many eating 
behaviour studies. The decline in subjective ratings of pleasantness and attractiveness 
for a food may persist beyond termination of the meal (Rogers & Blundell, 1990). 
The sensory properties of a food are believed to be of great importance in short-term 
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satiety (Hetherington et al., 1989). Furthermore, the regulation of food intake may be 
more responsive to sensory-specific satiety than sensations of gastric fullness, and it 
was suggested that satiety may follow two phases, satiety to a specific food, and then 
general satiety for the meal (Hetherington, 1996). The sensory properties of a food 
have an effect on psychological and physiological appetitive processes. This 
phenomenon is illustrated particularly well when considering the process called the 
cephalic phase response. The sight and smell of food is known to trigger responses in 
the body in preparation for a meal, e. g. production of more saliva (Pavlov, 1927, cited 
in Mela and Rogers, 1998), gastric acid secretion and the release of insulin (Sjostrom 
et al., 1980). Gastrointestinal hormones are also released (Powley & Berthoud, 1985). 
There are a number of possible functions for these cephalic phase physiological 
responses: buffering the body against excess nutrient loads; providing an internal 
signal for hunger; or perhaps preparing the body for the ingestion, digestion and 
absorption of nutrients. These physiological reflex responses may be heightened by 
the increased palatability of the food (Louis-Sylvestre & Le Magnen, 1980), although 
this depends on the form of sensory stimuli in human beings (Bellisle et al., 1985; 
Teff et al., 1995; Teff & Engelman, 1996). 
Food can affect eating behaviour via learned food preferences and aversions, 
demonstrated in laboratory animals and human subjects (Holman, 1968; Booth et al., 
1982; Weingarten & Kulikovsky, 1989; Warwick & Weingarten, 1994; Sclafani, 
1997). Food can also influence emotional state, cognitive function and fatigue 
through the macronutrient content of a meal (Lloyd et al., 1996), tryptophan intake 
(Spring et al., 1987), or its pharmacological constituents such as caffeine and alcohol 
(Rogers, 1995). 
1.4.3 External influences 
Eating behaviour and food intake is strongly influenced by external influences 
on a number of levels - religious, cultural, geographical, and social. Different 
cultures attach values to specific foods, e. g. people talk about "addiction" to 
chocolate. Foods have different uses (beyond that of nutrition) in certain contexts and 
are appropriate for different moods, e. g. comfort foods, food as a treat or reward, or 
food as a gift. 
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The time of day affects meal composition, size, frequency and duration. Time 
constraints due to work or family life are important in determining human feeding 
patterns but there is some evidence that these factors are secondary to preprandial 
factors such as time interval since last eating episode in terms of energy intake (De 
Castro et al., 1986). Social setting is also an important determinant of eating 
behaviour (Kim & Kissileff, 1996). 
1.4.4 Psycholosical influences 
Psychological factors influencing eating behaviour are complex. There is a 
great risk that many experimental designs, aiming to untangle the physiological 
regulators of appetite, are inherently flawed either because they fail to take account of 
the psychological profile of an individual or because the sensitivity of design is not 
great enough to pick up physiological patterns, above the "noise" of psychological 
influences. It is common practice now for researchers into eating behaviour to employ 
questionnaires, e. g. the Dutch Eating Behaviour Questionnaire (DEBQ) (Van Strien 
et al., 1986), the Three Factor Eating Questionnaire (TFEQ) (Stunkard & Messick, 
1985), to measure a person's psychological profile and eating attitudes before a 
decision is made on whether to include them as a subject, or to target specific patterns 
of behaviour. These screening tools are based upon three main theories of eating 
behaviour - Externality theory, Psychosomatic (emotional) theory, and Restraint 
theory. The psychosomatic view stated that obesity is a result of overeating in 
response to emotional feelings (Rogers, 1993), and that excessive eating can be used 
as a way of coping with depression or stress. Another theory, the externality theory 
(Schachter, 1968) states that a person may disregard their internal state of satiety in 
response to external stimuli, especially food-related stimuli, a trait that was postulated 
to be a feature of obesity. The Restrained eating theory brings together both these 
theories of eating in response to emotions or external stimuli and disregarding 
internal signals. Pressure to diet causes unmaintainable self-restriction of food intake, 
triggering feelings of depression. A process called disinhibition, where self-imposed 
restrictions break down, frequently ensues leading to excessive eating and a 
perpetuation of the cycle (Herman & Polivy, 1984). The Dutch Eating Behaviour 
Questionnaire (DEBQ) was developed from a factor analysis of large groups of 
normal and overweight people chosen to reflect eating behaviours of interest (Van 
Strien et al., 1986). It measures three areas of eating behaviour theory - restrained 
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eating, emotional eating and external eating, with a choice of five responses: `never', 
`seldom', `sometimes', `often', `very often', and where appropriate `not relevant'. 
See appendix H. 
1.5 Conclusions 
In the light of the evidence discussed here, it appears that the notion of a 
single aminostatic model to explain the regulation of appetite is over-simplistic and 
that the physiological explanation for protein- and amino acid-induced satiety may 
embrace several different mechanisms. The phenomenology of protein/amino acids 
and human appetite is itself complex as shown in figure 1.4. 
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Figure 1.4. Mechanisms whereby protein and amino acids may influence hunger and satiety. 
Mechanisms are shown in relation to body organs and compartments represented by the outer circle, 
the circulation, middle circle, and the central nervous system, the inner circle. Macronutrients in the 
stomach pass into the small intestine with proteins hydrolysed to polypeptides, peptides and amino 
acids. There are two possible routes whereby amino acids in the intestine can influence satiety. Amino 
acids can act directly to stimulate specific vagal afferent receptors in the upper intestinal mucosa, 
which may stimulate satiety centres in the brain, activating vagal efferent neurons that delay gastric 
emptying or increase secretion of CCK, or activating fibres of the enteric nervous system to stimulate 
CCK secretion. Another pre-absorptive route involves intestinal amino acids stimulating the CCK- 
secreting I cells bordering the small intestine lumenal wall. Protein may stimulate CCK by another 
route. Trypsin, secreted by the pancreas into the small intestine, may suppress CCK secretion by 
degrading a pancreatic CCK-releasing peptide (monitor peptide) and a lumenal CCK-releasing peptide 
(Liddle, 1997). However, the entry of protein into the small intestine protects these CCK-releasing 
factors by binding trypsin (Calam et al., 1987). CCK acts peripherally to delay gastric emptying and 
amplify gastric distension via vagal afferent nerves originating from the stomach wall and intestine 
(Schwartz & Moran, 1994; French et al., 1993). CCK also acts centrally via CCK-A (peripheral) and 
CCK-B (central) receptors to increase satiety. Amino acids are eventually absorbed and enter the 
circulation. Absorbed amino acids may influence satiety by acting as neurotransmitters (GABA, 
glutamate) or precursors of neurotransmitters (DA, 5-HT) in the CNS. The intestinal carbohydrate 
stimulates insulin secretion from the pancreas (via secretagogue effects on insulinotropic factors), 
which increases uptake of circulating amino acids into the body protein mass. Hepatic amino acid 
uptake, protein accretion and amino acid oxidation are important in regulating circulating amino acid 
concentrations. Hepatic vagal afferents sensitive to individual amino acids may also be a pathway for 
an amino acid-derived satiety signal, Similar peripheral aminostatic signals monitored by the CNS 
have yet to be identified in skeletal muscle but might be expected given the large potential for 
modifying circulation amino acid concentrations during periods of rapid growth when substantial 
protein accretion occurs. 
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When metabolic demands for protein are low, as in the well nourished adult, 
hunger sensations are slight and protein acts as the most highly satiating 
macronutrient, although there can be minor adaptive changes in the degree of its 
satiating power with variation in habitual intake. In contrast the high metabolic 
demands for protein of rapid growth appear to result in a specific hunger drive for 
dietary protein and loss of its satiating power over a wide range of intakes. It is not 
known whether the changes in hunger and satiety involve separate mechanisms 
peripherally and centrally, or whether there is a simple inverse relationship between 
protein-related hunger and satiety as a function of the relationship between metabolic 
demand and dietary supply. However, an aminostatic mechanism for appetite 
regulation a) provides for biological requirements by monitoring the balance between 
dietary intake and metabolic demands for amino acids, especially in terms of net 
uptake into the body protein mass, which is then relayed to hunger centres, and b) 
protects against toxicity through strong satiety and hormonal/neuronal responses to 
specific amino acids or high protein loads involving both pre-absorptive and post- 
absorptive elements. The postprandial rise in circulating amino acids may also initiate 
signals to satiety centres in the CNS in the short term (i. e. in the hours following a 
meal) either directly or by hepatic mechanisms. In addition, the very short-term 
regulation of food intake, (i. e. during and immediately following a meal) is highly 
dependent on pre-absorptive satiety signals arising from protein/amino acids in the 
gastrointestinal tract. Protein- and amino acid-induced satiety mechanisms (as shown 
in figure 1.4) should be considered against a background of other regulatory systems 
that influence food intake, in particular the physiological and metabolic processes that 
are linked to glucostatic or lipostatic regulation. The available evidence supporting 
aminostatic control is meagre and this area of research is deserving of much more 
interest than it has received hitherto. There are some exciting leads in neurological 
science that may clarify the nature of amino acid-linked appetite signals. 
1.6 Aims and objectives of the current research 
The research projects described in this thesis originated from the desire for a 
greater understanding of the physiological mechanisms behind satiety, specifically 
with regard to appetite mechanisms arising from the ingestion of protein or individual 
amino acids. Scientific publications covering the role of protein or amino acids in 
appetite have shown that protein is the most satiating macronutrient, kilojoule for 
kilojoule, but few papers have been published on the biological importance and 
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physiological mechanisms behind these observations. The current research focuses on 
the importance of putative short-term satiety signalling pathways in relation to protein 
or amino acid ingestion, such as the release of two satiety gut hormones, CCK and 
GLP-1, and effects on gastric emptying. 
The main objectives of the research were as follows: 
a) To further investigate the effectiveness and mechanisms of an individual 
amino acid, phenylalanine, in reducing appetite. This idea was conceived within 
the context of using one single amino acid as a possible appetite suppressor that may 
prove useful in the treatment of obesity. Phenylalanine was a promising candidate for 
this due to existing research that had shown aspartame (of which phenylalanine is a 
major component) can suppress food intake in human volunteers (Rogers et al., 
1990). The effectiveness of phenylalanine in reducing appetite and the physiological 
mechanisms by which this occurred were thus investigated. 
b) To explore the physiological mechanisms underlying the differences in 
satiating properties of different protein types. Satiety and hormone and metabolite 
responses following liquid meals, containing predominantly whey or casein protein, 
were measured with the purpose of understanding the mechanisms behind the appetite 
response to high-protein meals. 
c) To assess the repeatability of the methodology used to measure food 
intake and subjective appetite. Repeated identical preloads and ad libitum buffet- 
style test meals were used on three study days to determine the reproducibility of 
methods frequently used in the current work, and by other researchers, to measure 
hunger and satiety. 
d) To compare different available methods of measuring gastric emptying 
rate. Gastric emptying was measured by electrical impedance epigastrography (EIE) 
by colleagues in the Department of Physics as part of the current work. Initial studies 
showed that gastric emptying times obtained by this method did not correspond to 
those reported in the literature, and so further studies were planned to compare EIE 
gastric emptying times with those obtained by scintigraphy and other methods. 
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Chapter Two 
Chapter 2 
MATERIALS AND METHODS 
The following chapter will describe the practical materials and methods used 
in carrying out the series of investigations. Individual protocols for each study will be 
described at the beginning of each chapter, together with any alterations to the 
methods described here. 
2.1 Materials 
2.1.1 Equipment 
Butterfly needles, 0.8 x 22.2 mm (venisystems, Sligo, Ireland) 
Cannulae, 1.1 x 28 mm (Y-Can, Simcare, Lancing) 
Capsules, opaque, gelatine, size 0 (gift from Dr P. Rogers, University of Bristol, 
Bristol) 
Chromatography columns, 35 micron filter (Evergreen Scientific, Los Angeles, USA) 
Cobas Mira automated analyser (Roche Products Ltd, Welwyn Garden City) 
Cuvettes (Roche Products Ltd, Welwyn Garden City) 
Deltatrac (Datex, Helsinki, Finland) 
Fluoride oxalate tubes, 1 ml (L. I. P. Ltd, Shipley) 
Gamma counter (Wallac Wizard 1470 with Multicalc Level 4. M software) 
HPLC Waters Pico-Tag System with Maxima 820 software, Millipore (1987) 
(Waters, Massachusetts, USA) 
Lignocaine Hydrochloride Injection B. P. 2% w/v 5m1 (Antigen Pharmaceuticals Ltd, 
Roscrea, Ireland) 
Lithium heparin tubes, 5 ml/10 ml (L. I. P. Ltd, Shipley) 
Needles, 0.5 x 16 mm, 0.8 x 40 mm (Terumo Europe N. V., Leuven, Belgium) 
Potassium EDTA tubes, 1 ml/5 ml (L. I. P. Ltd, Shipley) 
Test tubes, polystyrene, LP3 and LP4 (L. I. P. Ltd, Shipley) 
Vacutainers, K3 EDTA 4.5 ml & PST Gel and lithium heparin 6 ml, (Becton 
Dickinson Vacutainer Systems Europe, Meylan, France) 
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2.1.2 Reagents 
1251 CCK-8 sulphated, labelled with Bolton and Hunter reagent (Amersham 
Pharmacia Biotech UK Ltd, Little Chalfont, BUCKS) 
'25I-sodium iodide (3.7 GBq/ml) (ICN Biomedicals Inc., Thame, OXON) 
125I-insulin (from Dr S. M. Hampton, University of Surrey) 
5-Sulfosalicylic acid (Sigma Chemical Company Ltd, Poole) 
Agarose - type III-A (Sigma Chemical Company Ltd, Poole) 
Albumin, Bovine Serum (BSA) Fraction V powder (Sigma Chemical Company Ltd, 
Poole) 
Albumin, Human Serum (HSA) Fraction V powder (Sigma Chemical Company Ltd, 
Poole) 
Aprotinin (Sigma. Chemical Company Ltd, Poole) 
Charcoal, activated, Norit PN. 5 (BDH Ltd, Poole) 
Chloramine T, (Sigma. Chemical Company Ltd, Poole) 
Ethanol (Hayman Ltd, Witham Essex) 
Glucose assay kit (Unimate 5 GLUC HK, Roche Diagnostics Systems, Welwyn 
Garden City) 
Hydrochloric acid (HCI) (BDH Laboratory Supplies Ltd, Poole) 
Methanol, HPLC grade (Fisher Scientific UK Ltd, Loughborough) 
Paracetamol assay kit (Cambridge Life Sciences plc, Ely) 
Phenylisothiocyanate (PITC) (Sigma Chemical Company Ltd, Poole) 
Polyethylene glycol (PEG) (BDH Chemicals Ltd, Poole) 
Sephadex, G- 15 for gel filtration (Sigma Chemical Company Ltd, Poole) 
Sodium metabisulphate (Sigma Chemical Company Ltd, Poole) 
Triethylamine (TEA) (Sigma Chemical Company Ltd, Poole) 
2.1.3 Peptides and amino acids 
Amino acids for standard solution (Sigma Chemical Company Ltd, Poole) 
CCK-8 sulphated (26-33) (Bachem UK Ltd, Saffron Waldon, Essex) 
GIP, synthetic human (Sigma Chemical Company Ltd, Poole) 
GLP-1 fragment 7-36 amide, synthetic human (Sigma Chemical Company Ltd, 
Poole) 
Insulin standard (NIBSC, South Mimms, Potters Bar, Hereford) 
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2.1.4 Antisera 
Donkey anti-guinea pig (DAGP) (Guildhay Antisera Ltd, Guildford) 
Donkey anti-rabbit (DAR) (from Dr S. M. Hampton, University of Surrey) 
Donkey anti-rabbit Sac-Cel (IDS Ltd, Boldon, Tyne & Wear) 
Guinea pig anti-insulin antisera (from Dr S. M. Hampton, University of Surrey) 
Rabbit anti-CCK antisera (from Professor J. Calam, Royal Postgraduate Medical 
School, Hammersmith Hospital) 
Rabbit anti-GIP antisera, RIC 34 iii J (from Dr L. M. Morgan, University of Surrey) 
Rabbit anti-GLP-1 antisera, G2-30/6/89 (from Dr L. M. Morgan, University of 
Surrey) 
2.1.5 Sera 
Normal Guinea Pig serum (from Dr S. M. Hampton, University of Surrey) 
Normal Rabbit serum (Sigma Chemical Company Ltd, Poole) 
2.1.6 Buffers 
Reverse osmosis (RO) water was used for preparing all buffers unless 
otherwise stated. 
CCK radioimmunoassay buffer 
6.89 g NaH2PO4-H20 (sodium dihydrogen orthophosphate 1-hydrate), 0.05M 
3.72 g EDTA (ethylenediaminetetraacetic acid), 0.01M 
2.5 g Gelatine powder, 0.25% 
200 mg Sodium azide, 0.02% 
1 litre of water is added, warmed to dissolve gelatine, and pH is adjusted to 7.4 with 
NaOH. Stored at 4°C. 
GIP radioimmunoassay stock buffer 
(0.4M phosphate buffer, pH 6.5) 
0.4M KH2PO4 (potassium dihydrogen orthophosphate) A 
0.4M Na2HPO4 (di-sodium hydrogen orthophosphate anhydrous) B 
1 litre of each solution was prepared and solution A was added drop-wise to solution 
B to give required pH. Stored at 4°C. 
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GLP-1 radioimmunoassay stock buffer 
(0.4M phosphate buffer, pH 6.5) 
as above 
Insulin radioimmunoassay stock buffer 
(0.04M phosphate buffer, pH 7.4) 
23 g Na2HPO4 (di-sodium hydrogen orthophosphate anhydrous) 
5.97 g NaH2PO4-2H20 (sodium dihydrogen orthophosphate) 
Made up to 5 litres and stored at 4°C. 
Bicarbonate buffer for column affinity purification of GIP and GLP-1 
(0.1 M Na2CO3/NaHCO3 buffer, pH 9.8) 
10.6 g Na2CO3 (sodium carbonate) 
8.5 g NaHCO3 (sodium hydrogen carbonate) 
Dissolved in 1 litre water and stored at 4°C. 
Buffers for iodination of GIP and GLP-1 
0.4M phosphate buffer, pH 7.4 
(see insulin RIA stock buffer) 
0.1 M sodium acetate, pH 5.0 
13.61 g C2H3O2Na-3H2O (sodium acetate trihydrate) 
in I litre water. Titrated to pH 5.0 with IM glacial acetic acid. Stored at 4°C. 
Sodium acetate buffer added to blood collection tubes for CCK analysis 
1.02 g NaCl (sodium chloride) 
3 ml C2H402 (glacial acetic acid) 
6.3 ml IM NaOH (sodium hydroxide) 
Made up to 100 ml with water and adjust to pH 3.6 with HCI. Stored at 4°C. 
Eluent 1 for Waters Pico-Tag HPLC analysis of amino acids in plasma 
70mM sodium acetate trihydrate, pH 6.45 + 2.5% acetonitrile 
38.1 g C2H3O2Na-3H2O (sodium acetate trihydrate) 
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Dissolved in 4 litres Milli-Q water and adjust pH to 6.45 with 10% acetic acid. 
Filtered under vacuum (0.45 micron filter). Added 100 ml of acetonitrile to 3900 ml 
buffer. Stored at 4°C. 
Eluent 2 for Waters Pico-Tag HPLC analysis of amino acids in plasma 
450 ml C2H3N (MeCN) (acetonitrile HPLC grade) 
400 ml H2O (Milli-Q) 
150 ml CH3OH (MeOH) (methanol HPLC grade) 
2.1.7 Miscellaneous 
Aspartame, NutraSweet powder (donated by Forum Products Ltd, Redhill) 
Casein protein powder, strawberry flavour (Tropicana World Ltd, Birmingham) 
Cornflour (Sainsburys) 
Double cream (Tescos) 
L-alanine for consumption (Scientific Hospital Supplies, Liverpool) 
L-aspartic acid for consumption (Scientific Hospital Supplies, Liverpool) 
L-phenylalanine for consumption (Scientific Hospital Supplies, Liverpool) 
Maltodextrin (free sample from Cerestar Pur, Manchester) 
Nesquik (Nestle) 
Paracetamol, Panadol tablets (SmithKline Beecham) 
Sodium [1-13C] octanoic acid (a gift from Professor J. Mathers, University of 
Newcastle, Newcastle upon Tyne) 
Whey protein powder, vanilla flavour (Prolab Nutrition, Bloomfield, Connecticut, 
USA) 
2.2 Methods 
2.2.1 Measurement of Appetite 
Many of the investigations described in this thesis involve the measurement of 
appetite. Appetite is a difficult parameter to quantify. There are no tangible factors in 
the blood that can be assayed, nor physical characteristics that can be measured, as 
with most subject matter in the field of nutritional science. The multifaceted nature of 
the regulation of appetite, encompassing psychological as well as physiological 
influences, is reflected in the difficulty in measuring observable manifestations of 
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appetite, usually referred to as `eating behaviour'. The following sections describe the 
methodology used to measure eating behaviour. 
2.2.1.1 Recruitment of subjects 
The psychological factors that could influence eating behaviour are multiple 
and extremely complex. There is a great risk that many experimental designs, aiming 
to untangle the physiological regulators of appetite, are inherently flawed either 
because they fail to take account of the psychological profile of an individual or 
because the sensitivity of design is not great enough to pick up physiological patterns, 
above the "noise" of psychological influences. It is common practice now for 
researchers into eating behaviour to employ questionnaires, e. g. the Dutch Eating 
Behaviour Questionnaire (Van Strien et al., 1986) and the Three Factor Eating 
Questionnaire (Stunkard & Messick, 1985), to measure a person's psychological 
profile and eating attitudes before a decision is made on whether to include them as a 
subject, or to target specific patterns of behaviour. 
The Dutch Eating Behaviour Questionnaire (DEBQ) was developed from a 
factor analysis of large groups of normal and overweight people chosen to reflect 
eating behaviours of interest (van Strien et al., 1986). It measures three areas of eating 
behaviour theory - restrained eating, emotional eating and external eating, with a 
choice of five responses: `never', `seldom', `sometimes', `often', `very often', and 
where appropriate `not relevant' (see appendix II). During the recruitment process for 
practical work involving the measurement of appetite responses, every volunteer was 
required to complete the DEBQ before taking part. Only those scoring an average of 
less than 3.0 points (min 1, max 5), which would indicate eating behaviour that is 
likely to be relatively free of restrained, external or emotional influences, were asked 
to participate. 
2.2.1.2 Measurement of food intake 
There are numerous methods available to measure eating behaviour, and 
which methods are used depends on the subject of investigation, setting (laboratory, 
free-living, etc. ) and duration of study. Frequently in nutritional science, investigators 
want to investigate the effect of a food or food component on subsequent eating 
behaviour. One way to do this is to measure ad libitum food intake. 
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The most common method is the ad libitum buffet test meal, which involves 
weighing a range of different foods of known energy and macronutrient content 
before it is offered to the subject as a meal, and then re-weighing what is left when 
the meal is finished (Hill et al., 1995). The meal is often a selection of palatable 
foods, served in excess of that normally eaten at one meal, where the subject is free to 
eat as much of any type of food as they like to feel comfortably full. It is important 
that the subjects are at the same state of hunger on each occasion, that the subjects 
like the food, and that they are encouraged not to eat amounts in excess of that 
required to produce a comfortable level of fullness. This method is expensive and 
time-consuming in the purchasing and preparation of these test meals. However it is a 
more naturalistic method than many others available and macronutrient intake data 
may also be collected. 
Preloading techniques are frequently used in the measurement of eating 
behaviour and appetite. The preload is a controlled meal that is given at a set interval 
before the test meal, and the subject is usually required to consume it all. This preload 
is also commonly the manipulated meal and its effects on subsequent behaviour and 
intake at the ad libitum test meal are measured. The interval between preload and test 
meal can be from a few minutes to five or six hours. The preload can be a liquid or 
sold meal, highly artificial or normal food. 
In the current research, satiety was assessed by the measurement of energy 
and macronutrient intake 40-90 minutes (see individual methods sections) after 
consumption of a preload containing the variable of interest. The buffet-style ad 
libitum test meal consisted of a variety of palatable, cold, lunch-type foods on a tray - 
sandwiches with two types of fillings, salad items, full-fat fruit yoghurt, biscuits, and 
cake. (See appendix III for a description of the foods used). To ensure that the 
subjects liked the foods provided but did not eat excessively, they were asked to 
complete a questionnaire that rated food choices and excluded foods that they did not 
like (appendix N). The subject's second choice for each food category was provided 
in the ad libitum test meal. A glass of water was provided with the meal. All foods 
were weighed before serving and re-weighed after the subjects had eaten to obtain the 
amount consumed (g) of each food. Energy and macronutrient content of the food 
consumed was calculated using an Excel spreadsheet with food composition data 
available from the manufacturers and in McCance and Widdowson's "The 
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Composition of Foods, 5`h Edition" (McCance & Widdowson, 1991). The total 
energy available from a tray of food was approximately 12,500 kJ. Subjects were 
instructed to eat to a comfortable level of fullness on each occasion, and to prevent 
overeating they were informed that they could take the remaining food home with 
them. 
2.2.1.3 Measurement of motivation to eat 
Subjective, self-reported measures of hunger, satiety, palatability, mood, and 
physical well-being are commonly used tools for the study of eating behaviour. A 
common example of this method is the Visual Analogue Scale (VAS), where a series 
of 100mm lines appear on a page and words that describe the variable of interest are 
printed at either end of the scale. The subject is required to mark a point on the line 
that they feel best describes how they feel at that moment. The scale may be for two 
extremes of the same adjective, e. g. 
Not at As hungry as 
all hungry I've ever felt 
or two adjectives to describe the two extremes of a feeling or sensation, e. g. 
Drowsy Alert 
VAS measurements are most often employed in repeated measures, within 
subject designs and have proved to be reliable indicators in as far as they are sensitive 
to preload/test-meal manipulations. They also appear to have good validity in that 
people consistently associate the same sensations with the terms hunger or fullness 
(Hill et al., 1995). They are useful in tracking changes in appetite over time, 
(especially in conjunction with the measurement of food intake), and can be used to 
ensure that there are no other changes in mood or physical well-being that may 
confound the results. Unfortunately, investigators cannot be certain that when a 
subject reports an increase in hunger or decrease in fullness, that this does not reflect 
cognitive cues, which can occur if food is anticipated (Hill et al., 1995). One study 
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used VAS scores to test the association between subjects' predictions of how filling a 
snack food would be (after tasting) and actual intake on a separate occasion (Green & 
Blundell, 1996). They found that ratings for sweet high-fat foods were higher than 
other foods but in fact led to a greater energy intake. This could be interpreted as a 
poor ability on the part of the subjects to predict using VAS scores how filling this 
particular category of food was, and that subjective scores for hunger and satiety 
sensations may not always correspond to an actual effect. However, it is more likely a 
reflection of the fact that sweet high-fat foods are highly palatable, are poorly 
regulated by internal satiety mechanisms, leading to passive over-consumption. Each 
subject may have a slightly different interpretation of concepts such as hunger in 
relation to how they feel, but if the experiment is a within-subject design then some 
of the disadvantages of self-reported scores for appetite are out of the equation. A 
further modification to the use of VAS measurements suggested by Green et al 
(Green et al., 1997) is the satiety quotient (SQ), which uses the VAS ratings of 
hunger and fullness and food intake data to calculate a quotient that relates intake to 
the rate of return of motivation to eat in the period after the test meal. 
Another subjective measure frequently used in eating behaviour experiments 
is the food preference checklist. This is a list of different types of food, e. g. `a large 
tomato', `fruit yoghurt', `a bread roll', etc. and the subject is required to tick each 
food they feel motivated to eat at that point in time (Blundell & Rogers, 1980). These 
foods are scored in terms of total energy and macronutrient energy, or total number of 
foods and number of foods high in a type of macronutrient. Subjects are told that they 
are not being asked to construct a menu and to consider each item individually. 
Results from this method are highly correlated with total food intake (r = 0.64 to 
0.76) (Blundell & Rogers, 1980). This method is easy to use and inexpensive. 
Motivation to eat is expressed in "real food" terms and can be determined in terms of 
macronutrient choice. Disadvantages include the possibility of subjects selecting 
foods that may reflect motivators other than hunger/satiety, or that may not relate to 
actual intake ("eyes bigger than the belly" effect! ). 
In the current research, subjects rated their hunger, desire to eat, and fullness at 
intervals using VAS ratings. The subjects were asked to rate how they felt at that 
moment and to regard the ends of the scales as the most extreme feeling they had ever 
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experienced. The VAS ratings were analysed by measuring the point marked on the 
line with a ruler and entering the rating (cm) into an Excel spreadsheet (appendix V). 
Food preference checklists were also completed simultaneously as part of some of the 
current research. Each subject ticked foods that they would like to eat at that moment 
from a list of various sweet and savoury foods, categorised into high protein, high 
carbohydrate, high fat, low fat and mixed (high fat and high carbohydrate) food types 
but presented in a random uncategorised list (appendix VI). They were instructed that 
they were not expected to construct a menu from the list, but just to mark each food 
that they felt like eating at that point in time. Again, the number of each type of food, 
as well as the energy this would provide in terms of total food and food type (high 
protein, high fat etc. ) was calculated using Micosoft Excel. 
2.2.2 Measurement of Gastric Emptying 
2.2.2.1 Scintigraphy 
Gastric emptying times were measured using radioscintigraphic techniques 
carried out by Dr Rosemary Morton and Professor Patrick Horton at the Department 
of Nuclear Medicine, Royal Surrey County Hospital. The scintigraphy technique 
involves the incorporation of radiolabels into a meal and the detection of the 
reduction in counts in the stomach by a gamma camera. The gamma camera is a large 
detector comprises the collimator, which focuses the gamma rays using a scintillation 
crystal into visible light, and then converts the light signals into electronic signals. 
These electrical signals are then digitised into counts. Images are taken by the gamma 
camera every minute until the stomach has emptied. Subjects were required to 
consume a glucose or low/high fat liquid test meal through a wide bore plastic tube, 
containing 12 MBq of 99mTc-DTPA (99mTechnetium-diethylenetriaminepentaacetic 
acid) label, whilst lying almost fully supine against the camera. DTPA was the 
appropriate radiolabel carrier to use in liquid meals. The uniform distribution of the 
99mTc-DTPA throughout the test meals was confirmed by imaging the meals in 
volumetric tubes in front of the gamma camera, with and without various 
concentrations of hydrochloric acid. Immediately following ingestion, gamma camera 
imaging was begun using a dual-headed camera (anterior and posterior views) and a 
dedicated nuclear medicine computer. The stomach was positioned in the centre of 
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the field of view. From 0 to 120 minutes after the subject's meal ingestion images 
were acquired every minute. 
2.2.2.2 Electrical Impedance Epigastrography 
EIE is a method of measuring gastric emptying using the decrease in 
conductivity (and therefore increase in impedance) that occurs when a non- 
conductive liquid meal is ingested and passes through the stomach (Sutton & 
McClelland, 1983; Pickworth, 1984; Sutton et al., 1985; McClelland & Sutton, 1985). 
This technique was carried out by Dr Anastasia Giouvanoudi and Dr Behain Amaee 
from the Department of Physics at the University of Surrey. Six skin-contact 
electrodes (one pair for inputting the electrical current and two pairs for recording the 
impedance information) were placed on the upper left abdomen and lower back of the 
volunteer. The electrodes were positioned according to surface anatomical features. 
The first was placed adjacent to and below the transpyloric plane (an imaginary plane 
half-way between the xiphisternum and the uppermost part of the ileum of the pelvis, 
XP), the second was placed above the transpyloric plane (to target the end of the 
proximal stomach), and the third electrode lay below and midway between the others 
over the antral pyloric region. The posterior electrodes were placed parallel to the 
anterior electrodes. The small (4mA) AC current generated was at a frequency of 
100kHz (Sutton et al., 1985) and could not be felt by the subject. Subjects adopted a 
semi-supine position on the bed and a baseline measurement of impedance before 
ingestion of a liquid was recorded. Subjects were required to remain immobile if 
possible as the impedance profile was very sensitive to movement, creating data 
artifacts. When a satisfactory baseline had been obtained, the change in impedance 
that occurred as the liquid entered and emptied out of the stomach was measured 
(deflection). The test meals were in liquid form, non-conductive (< 2 
milliSiemens/cm) and 450 ml in volume in order to induce a significant impedance 
deflection on ingestion. The half emptying time was calculated from the peak of the 
deflection as a result of ingestion of the meal and the point at which the trace has 
returned to baseline (figure 2.1). 
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Figure 2.1 Example of an electrical impedance epigastrography (EIE) 
impedance trace and the calculation of gastric half-emptying time (T50) 
following a non-conductive test meal (water) from the raw data. 
2.2.2.3 13C-octanoic acid breath test 
This breath test uses a stable isotope for the indirect measurement of gastric 
emptying whereby the appearance of 13CO2 in breath is monitored subsequent to 
ingestion and metabolism of 13C-octanoic acid or 13C sodium octanoate. Octanoic 
acid is an eight carbon fatty acid which occurs naturally in food. Because it is a 
medium chain fatty acid it is quickly absorbed in the duodenum and rapidly 
transported to the liver bound to serum albumin where it is oxidised to C02- 
Therefore, the time it takes 13CO2 to be excreted in the breath reflects the time taken 
for the meal to empty from the stomach, be absorbed and metabolised. However, the 
digestion, absorption and metabolism of the labelled test meal is not thought to vary 
among individuals therefore any difference in this time is assumed to reflect 
differences in gastric emptying rate. 
After an overnight fast, breath samples were taken at -10 and 0 minutes 
before the labelled test meal to obtain a baseline of 13C02 excretion. CO2 production 
rate was measured using a Deltatrac (Datex, Helsinki, Finland) and ventilated hood 
with a flow rate of 40 ml/min. The Deltatrac was switched on an hour before use to 
warm up and was calibrated for atmospheric pressure and gas calibrated using a 
calibration gas (5% C029 95% 02). Measurements of CO2 production (n-/min) were 
made for 20 minutes before the labelled test meal and then a further 4 sessions for 20 
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minutes over the next four hours. 50 mg 13C sodium octanoate (donated by Professor 
J. C. Mathers, Department of Biological and Nutritional Sciences, University of 
Newcastle, Newcastle upon Tyne) was incorporated into the liquid test meal. Breath 
samples were taken in duplicate through a drinking straw into evacuated glass tubes 
with screw on/off lids with rubber septa. Subjects were counted down and then blew 
gently for 8-10 seconds through the straw into the tube, which was immediately 
sealed. Breath samples were taken at frequent intervals for 4 hours following the test 
meal (see section 4.3.3). 
13C enrichment of the breath was determined with an isotope ratio mass 
spectrometer by Dr Chris Seal of the University of Newcastle (Newcastle upon 
Tyne). 13C excretion in the breath was expressed as atom percent excess (the 
percentage of 13CO2 in total CO2 above natural background of 13CO2 concentration). 
The change from baseline of APE after the meal was multiplied by CO2 production in 
µmol/min by time (time since the last sample, e. g. 5,10 or twenty minutes), to give 
13CO2 in gmol produced in each time interval. This was summed over the four hours 
to give a cumulative curve, and then expressed as a percentage of the initial dose 
cumulatively to give a sigmoidal curve. These values were fitted mathematically 
using the model equations of Ghoos et al. (1993): y= m(1-e ")ß. y is the percentage of 
cumulative 13C excretion in breath, t is time in minutes, m is an estimate of the total 
cumulative 13C recovery when time is infinite, and k and ß are estimated constants. 
Half gastric emptying time (T50) and lag phase (Tiag) were calculated from this fitted 
curve model as: 
T50 = {-I/k} x In{1-(0.5)'i0} and Tlag = {-1/k} x In{ 1-(0.1)'lß} 
Figure 2.2 shows an example of a fitted curve. 
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Figure 2.2 Example of a single subject's fitted curves for cumulative percentage 
of 13C dose recovered over time following low fat (11314 kJ) and high fat (2820 
kJ) liquid test meals. 
2.2.3 Measurement of circulating metabolites and hormones 
2.2.3.1 Blood sampling 
Blood samples were taken at regular intervals from subjects via an 
intravenous cannula inserted into an antecubital vein under local anaesthetic by a 
qualified medical doctor. Blood samples were taken into tubes containing 
preservatives. They were kept on ice before centrifugation at 4 °C for ten minutes at 
1560 g(av) to separate the plasma. The plasma was immediately frozen at -20 °C for 
analysis at a later date. For the measurement of glucose, blood was transferred to I ml 
fluoride oxalate tubes before centrifugation. 10 ml lithium heparin tubes were used 
for collection of blood for the measurement of CCK (only one study), amino acids, 
insulin, and GIP. 5 ml lithium heparin tubes containing added aprotinin (200 KIU/ml 
blood) were used for the collection of blood for GLP-1. Chilled 5 ml EDTA tubes 
containing I ml sodium acetate buffer (pH 3.6) per 4 ml blood were used to collect 
blood for the measurement of the plasma CCK. After centrifugation, the separated 
plasma was transferred into capped LP3 tubes using plastic Pasteur pastettes and 
frozen at a temperature of -20 °C. 
For the measurement of CCK, 0.5 ml of the separated plasma was added to 1 
ml 98% (v/v) ethanol in LP4 tubes (duplicates) on the study day. The LP4 tubes were 
capped and vortexed, then centrifuged at 1560 g(av) for 15 minutes. The supernatant 
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was poured into fresh LP4 tubes and the pellet discarded. The supernatant was then 
either immediately dried for 14 hours in the Savant Speedvac on low vacuum, or 
stored at -80°C for a maximum of a week before drying. Dried samples were then 
stored at -80°C until assayed. 
2.2.3.2 Analysis of glucose 
Plasma glucose was assayed using the Unimate 5 Glucose HK kit supplied by 
Roche Diagnostic Products Ltd. (Welwyn Garden City, Hertfordshire). The samples 
were analysed automatically using the Cobas-Mira biochemical analyser (Roche 
Products Ltd., Hertfordshire), using the hexokinase method outlined below: 
hexokinase 
D-glucose + ATP D-glucose-6-phosphate + ADP 
glucose-6-phosphate dehydrogenase 
D-glucose-6-phosphate + NAD+- lo D-gluconate-6-phosphate + NADH + H+ 
The amount of glucose in any plasma sample will be proportional to the 
amount of NADH produced. The concentration of NADH was measured 
spectrophotometrically at 340nm. Quality control samples were inserted into the 
beginning and end of every assay run, and the interassay coefficient of variation (CV) 
for the assay was 1.3 %. Intra-assay variation was small, as indicated by a comparison 
of QC's run at the beginning and end of the assay. If QC values fell outside 2 
standard deviations of the mean the assay was repeated. 
2.2.3.3 Analysis of amino acids 
Plasma free amino acids were analysed using the Waters PICO-TAG TM 
Amino Acid Analysis System, which involves the pre-column derivatisation of the 
sample with phenylisothiocyanate (PITC) followed by reversed-phase HPLC (high 
performance liquid chromatography). 
2.2.3.3.1 Standard preparation 
The physiological standard was prepared from individual amino acids (Sigma) 
dissolved in 0.1 M HC1. 
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Prior to analysis of the samples four concentrations of the standard mixture 
(0.5,0.25,0.125 and 0.0625 mM) were run on the HPLC and calibration curves 
produced for each amino acid. This was in order to confirm that there was a linear 
relationship in relative peak areas (peak area of amino acid/peak area of internal 
standard) at each concentration. Norleucine (NLE) was used as the internal standard 
at a concentration of 0.25 mM in each standard mix. Fig 2.3 shows an example for 
phenylalanine. 
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Figure 2.3 Calibration curve for relative peak area of phenylalanine (x/NLE) at 
four different concentrations (0.5,0.25,0.125 and 0.0625 mM). 
2.2.3.3.2 Deproteinisation 
Plasma samples required preparation before derivatisation and analysis, 
involving the deproteinisation of plasma to obtain just free amino acids. Norleucine 
was used as an internal standard and was added to the samples before deproteinisation 
at the same concentration as that in the standard amino acid mixture (0.526 mM). 
Three methods were compared ultrafiltration, sulphosalicylic acid and acetonitrile, 
but the latter yielded very small peaks on the HPLC. The remaining two methods 
were consequently used to deproteinise the plasma samples. 
Firstly, ultrafiltration was used for deproteinising the plasma samples from the 
aspartame study (section 3.5). This involves placing 100-200 pl of plasma plus 
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internal standard in an ultrafiltration device containing a Millipore PLGC membrane 
with a 10,000 molecular weight cut-off limit, and spinning the ultrafiltration device 
for 10 min at 2122 g(QV). A small amount of filtrate is recovered (approximately 50 µl) 
which can then be frozen at -20 °C or immediately derivatised. This is the method 
recommended by Waters because it protects the column from harmful high molecular 
weight compounds, eliminates risk of contamination, and produces a filtrate which is 
"highly reproducible from sample to sample". However, this relies on using a number 
of ultrafiltration devices, which limits the number of samples that can be 
deproteinised at one time. In addition, membranes were expensive and only came in 
packs of 100, which were quickly used when running large numbers of samples. 
Millipore later discontinued production of the membranes used to fit the ultrafiltration 
devices in the laboratory. 
The alternative method of deproteinising plasma samples, sulphosalicylic acid 
(SSA) precipitation, was then adopted for the remaining studies. 190 gl of plasma 
(plus 10 gl internal standard (10 mM) to give a final concentration of 0.526 mM) was 
vortex mixed with 200 µl of SSA solution (40 gg/m1), and this was spun at 13000 
g(av) for 15 min. The supernatant was then either frozen at -20 °C or immediately 
derivatised. 
2.5.3.3.3 Derivatisation 
Standards, samples, controls and blanks were derivatised using a drying 
solution of methanol, IM sodium acetate , and triethylamine 
(TEA) (2: 1: 1), and a 
derivatising solution of methanol, TEA, water, and PITC (7: 1: 1: 1), according to 
Waters methodology. PITC is the main derivatising agent and produces 
phenylthiocarbamyl (PTC) amino acid derivatives, which are stable and easily 
separated by reversed phase HPLC. PITC is also known as Edman's reagent, and is 
used to degrade peptides in protein sequencing research. See appendix VII for the 
derivatisation protocol. 
2.2.3.3.4 Eluents 
Eluents were made in the laboratory at the University of Surrey. Eluent A 
consisted of Milli-Q water with 70 mM sodium acetate trihydrate + 2.5 % acetonitrile 
(pH 6.45) and eluent B comprised 45 % acetonitrile + 40 % Milli-Q water + 15 % 
methanol. Eluent A was filtered under vacuum before the acetonitrile was added and 
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stored at 4 °C. Both eluents were degassed by bubbling helium gas through the 
solution for 5-10 minutes prior to use. 
The standard Waters gradient used was as follows: 
Time Flow rate (ml/min) % eluent A% eluent B 
Initial 1.0 100 0 
13.5 1.0 97 3 
24.0 1.0 94 6 
30.0 1.0 91 9 
50.0 1.0 66 34 
62.0 1.0 66 34 
62.5 1.0 0 100 
66.5 1.0 0 100 
67.0 1.0 100 0 
75.0 1.0 100 0 
90.0 1.0 100 0 
Table 2.1 Reversed phase HPLC gradient used for Waters PICO-TAGTM Amino 
Acid Analysis System. 
A Nova Pak C18 (3.9 x 300 mm I. D. ), 60 A, 4 µl column was used for the 
separation of the amino acid derivatives. The UV detector operated at a wavelength of 
254 nm. 
2.2.3.3.5 Processing of chromatograms and analysis of peak areas 
Peaks were identified from relative retention times and peak areas were 
calculated using Maxima software on the PC. Further analysis, specifically the 
calculation of amino acid concentrations, was carried out using Microsoft Excel. 
Relative retention times were highly reproducible and closely followed those reported 
in the Waters manual. Typical chromatograms for a standard and a plasma sample are 
given in appendix VIII. 
2.2.3.3.6 Quality controls 
Fasting plasma samples from a volunteer were used as quality controls. Prior 
to running the study samples the reproducibility of the relative peak areas obtained 
from these quality control were tested. 7 QCs were prepared and 2 injections were 
carried out on each sample number. The mean of the 1 s1 and 2nd injection from each 
sample were used to calculate intra-run CVs. Intra-run CVs were 10 % or less for all 
amino acids except arginine. Values obtained from the relative peak areas were 
compared with those obtained in the literature and shown to be in the correct range. 
66 
Although tryptophan was included in the standard mix, it degraded quickly and could 
not always be identified in the chromatograms. 
The control samples were deproteinised (by ultrafiltration or sulphosalicylic 
acid) and derivatised at the same time as the rest of the samples in each run. These 
were analysed at the beginning and end of each HPLC run to ensure that the values 
were within range and that there was no big difference in values. The average 
coefficients of variance for each amino acid measured in the quality control sample 
within a run and between runs are listed in table 2.2 (n = 38). 
Inter-run CV (%) Intra-run CV (%) 
Ultrafiltration Sulphosalicylic 
acid 
Ultrafiltration Sulphosalicylic 
acid 
asp 25.4 15.6 10.0 10.7 
glu 17.5 13.3 3.5 4.7 
ser 18.4 14.4 3.8 4.7 
gly 15.5 15.9 8.0 8.1 
tau 18.6 16.7 8.5 8.8 
thr 21.0 14.8 5.2 5.6 
ala 19.4 13.1 3.5 4.2 
arg 33.5 12.2 5.1 7.2 
pro 20.1 15.4 8.7 8.1 
tyr 14.3 16.6 4.7 5.4 
val 15.5 14.2 3.0 10.7 
met 23.9 15.1 11.9 6.5 
He 17.2 10.4 5.3 11.0 
leu 17.8 13.1 3.4 6.0 
he he 14.9 13.0 4.2 8.7 t 
22.7 12.7 8.9 8.8 
Mean 19.7 14.2 6.1 7.5 
Table 2.2. Mean inter-run and intra-run coefficients of variance (%) for HPLC 
quality control samples using both deproteinisation methods, ultrafiltration and 
sulphosalicylic acid precipitation. 
Intra-run variation was low as most amino acids had mean CVs of less than 10 
%. However, inter-run variation in the quality control plasma samples was quite 
large, and noticeably larger when the plasma was deproteinised by ultrafiltration, 
ranging from 14.3 % for tyrosine to 33.5 % for arginine. Since intra-run variability 
was much lower, all samples from an individual subject under one treatment (i. e. all 
time points from a single study day) were prepared and run together, and data was 
transformed to change from baseline (x-baseline value) before comparing between 
conditions. 
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2.2.3.4 Analysis of paracetamol 
Blood samples for paracetamol were collected in 1 ml potassium EDTA tubes. 
The analysis was performed using a commercial paracetamol assay kit (Cambridge 
Life Sciences) with the automated Cobas Mira biochemical analyser. It utilises an 
enzyme specific for the amide bond of acylated aromatic amines, which cleaves the 
paracetamol molecule, yielding p-aminophenol. This reacts specifically with o-cresol 
in ammoniacal copper solution to produce a blue colour. The absorbance of the blue 
colour is measured at 615 nm. Quality controls (QCs) were produced at the 
University of Surrey by administering a normal paracetamol dose with water to a 
fasted volunteer and collecting blood 45 min later. The blood was centrifuged and 
plasma was frozen in 500 µl aliquots. QCs were interspersed throughout all 
paracetamol assays. The intra- and inter-assay coefficients of variation for QCs at 
0.19 mmol/L were calculated to be 4.7 and 8.4 % respectively. 
2.2.3.5 Analysis of plasma gut and pancreatic hormones by radioimmunoassay 
2.2.3.5.1 Analysis of insulin 
Plasma insulin was analysed by radioimmunoassay using iodinated label and 
polyethylene glycol-accelerated double antibody precipitation by methodology 
developed by Hampton and Whithey (Hampton & Whithey, 1993) at the University 
of Surrey. The insulin radiolabel, I125 conjugated to human insulin, was produced at 
the University of Surrey, and the insulin antiserum was raised in guinea pigs injected 
with porcine insulin conjugated to ovalbumin. Normal guinea pig serum (NGPS) and 
donkey anti-guinea pig (DAGP) serum were used to separate the free insulin from the 
bound. The non-specific binding (tubes containing assay buffer, sample, radiolabel, 
NGPS, DAGP, and polyethylene glycol (PEG)) is measured as well as the specific 
insulin binding (tubes containing all of the above plus guinea pig anti-insulin serum). 
The charcoal stripped serum (CSS) was produced at the University of Surrey using 
serum collected from fasted volunteers (see section 2.2.3.5.5). 
The insulin radioimmunoassay procedure was as follows: 
1) LP3 tubes were set up and labelled in duplicate in racks on a cold tray, 
where each stage of the assay was carried out. 
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2) Assay buffer was prepared by adding 0.5 % bovine serum albumin to 
the stock insulin RIA buffer described in the materials section. 
3) Plasma samples were defrosted and centrifuged at 1560 g(,,, ) (4 'C) to 
spin down fibrin clots. 
4) Natural human insulin standards were double diluted to give a 
standard curve of 1500,750,375,188,94,47, and 23 pmol/l. 
5) On Day 1, a positive displacement pipette was used to add standards, 
charcoal stripped serum (CSS), QCs (quality controls), and samples. Insulin 
antiserum was diluted with assay buffer (1: 15000) and added to all tubes except 
totals and NSB tubes. 
6) On Day 2, insulin radiolabel was added to all tubes at 10,000 counts 
per minute (cpm) per 100 µl (per tube). 
7) On Day 3, the bound and free antibody was separated by adding NGPS 
(1: 200 dilution), DAGP (1: 16 dilution) and 4% PEG. Following incubation and 
centrifugation, the supernatant was aspirated under vacuum and the resultant 
pellet counted on an automated gamma counter (Wizard 1470) to obtain the cpm 
of the bound insulin. Insulin concentrations were then automatically calculated 
from the standard curve using the software linked to the gamma counter. 
See table 2.3 for details of the protocol. 
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REAG- 
ENTS TUBES (µl) 
DAY 1 Totals NSB Standard 
ß 
Standard Standard NSB QC QC 
NSB 
sample 
Sample 
Assay 
buffer - 350 250 200 350 250 350 250 
Standard - - - 50 - - - - 
CSS - 50 50 50 - - - - 
QC 
plasma - - - - 
50 50 - - 
Sample - - - - - - 50 50 
Antiserum - - 100 100 - 100 - 100 
Vortex mix all tubes and incubate for 24 hours at 4 °C 
DAY 2 Totals NSB D 
Standard Standard 
Standard NSB QC QC 
NSB 
sample 
Sample 
Label 100 
-1 
100 100 100 100 100 100 100 
Vortex mix all tubes and incubate for 24 hours at 4 °C 
DAY3 Totals NSB Standard 
A 
Standard Standard NSB QC QC 
NSB 
sample 
Sample 
NGPS - 100 100 100 100 100 100 100 
DAGP - 100 100 100 100 100 100 100 
4% PEG - 700 700 700 700 700 700 700 
Vortex mix all tubes and incubate for 2 hours at 4 °C. Centrifuge at 1300 g(,,, ) for 30 
min, aspirate and count the pellet 
Table 2.3 Insulin radioimmunoassay protocol. 
Low and high QC samples were run at the beginning and end of an assay. The 
inter-assay coefficients of variation (CVs) for low, medium and high quality control 
samples at 62,230 and 410 pmol/L were calculated to be 8.8,11.4 and 13.2 % 
respectively. The laboratory intra-assay coefficients of variation (CVs) for low and 
high quality control samples were 4.2 % and 5.7 % respectively. If any QC values fell 
outside 2 standard deviations from the mean the assay was repeated. 
2.2.3.5.2 Analysis of GIP 
Plasma GIP was measured by double antibody radioimmunoassay using an 
iodinated label and double antibody precipitation by methodology established by 
Morgan and colleagues (Morgan et al., 1978) at the University of Surrey. The 
antiserum was raised in rabbits against porcine GIP conjugated to ovalbumin, and 
cross reacts 100 % with human GIP. GIP was iodinated (125I-GIP) at the University of 
Surrey and the biosynthetic GIP standard was from Sigma. The charcoal stripped 
serum (CSS) was produced at the University of Surrey using serum collected from 
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fasted volunteers (see section 2.2.3.5.5). Donkey anti-rabbit Sac-Cel, a solid phase 
second antibody suspension, was used to separate the antibody-bound GIP from the 
free. The GIP radio immunoassay procedure was as follows: 
1) LP3 tubes were set up and labelled in duplicate in racks on a cold tray, 
where each stage of the assay was carried out. 
2) Assay buffer was prepared by adding 0.5 % human serum albumin and 
50,000 KIU/100 ml aprotinin to the stock GIP RIA buffer described in the 
materials section. 
3) Plasma samples were defrosted and centrifuged at 1560 g(,,, ) (4 'C) to 
spin down fibrin clots. 
4) Synthetic human GIP standards were double diluted to give a standard 
curve of 800,400,200,100,50 and 25 pmol/1. 
5) On Day 1, a positive displacement pipette was used to add standards, 
charcoal stripped serum (CSS), QCs (quality controls), and samples. GIP 
antiserum was diluted with assay buffer (1: 9000) and added to all tubes except 
totals and NSB tubes. 
6) On Day 2, GIP label (prepared in-house, see section 2.2.3.5.7) was 
affinity purified (see section 2.2.3.5.8) and then added to all tubes at 5000 counts 
per minute (cpm) per 100 µ1 (per tube). 
7) On Day 4, the bound and free antibody was separated by adding DAR 
Sac-Cel (IDS). Following incubation and centrifugation, the supernatant was 
aspirated under vacuum and the resultant pellet counted on an automated gamma 
counter (Wizard 1470) to obtain the cpm of the bound GIP. GIP concentrations 
were then automatically calculated from the standard curve using the software 
linked to the gamma counter. 
See table 2.4 for a detailed protocol. 
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REAL- TUBES (µl) ENTS 
DAY] Totals NSB Standard 
0 
Standard Standard NSB QC QC 
NSB 
sample 
Sample 
Assay 
- 300 200 100 300 200 300 200 buffer 
Standard - - - 100 - - - - 
CSS - 100 100 100 - - - - 
QC 
- - - - 100 100 - - plasma 
Sample - - - - - - 100 100 
Antiserum - - 100 100 - 100 - 100 
Vortex mix all tubes and incubate for 24 hours at 4 °C 
DAY 2 Totals NSB Standard 
0 
Standard Standard NSB QC QC 
NSB Sample 
sample 
Label 100 100 100 100 100 100 100 100 
Vortex mix all tubes and incubate for 48 hours at 4 °C 
DAY 4 Totals NSB Standard 
0 
Standard Standard NSB QC QC 
NSB 
sample 
Sample 
Anti-rabbit 
- 100 100 100 100 100 100 100 Sac-Cel 
Vortex mix all tubes and incubate for 1/2 hour at room temperature. Add 1 ml RO 
water. Centrifuge at 1100 ov for 30 min, aspirate and count the pellet 
Table 2.4 GIP radioimmunoassay protocol. 
Low and high QC samples were run at the beginning and end of each assay. 
The inter-assay coefficient of variation for quality control samples at 383 pmol/L was 
calculated to be 11.4 %. The laboratory intra-assay coefficients of variation (CVs) for 
low and high quality control samples were 5.9 % and 4.1 % respectively. If QC's fell 
outside 2 standard deviations from the mean the assay was repeated. 
2.2.3.5.3 Analysis of GLP-1 
Plasma GLP-1 was analysed using radioimmunoassay methods already 
established at the University of Surrey (Elliott et al., 1993). The GLP-1 (7-36) amide 
radiolabel was iodinated in-house. Antisera against synthetic human GLP-1(7-36) 
amide conjugated to bovine serum albumin were raised in rabbits, specific for the C- 
terminal amidated forms of the peptide. This cross-reacts less than 0.2 % with GLP- 
1(7-37) amide or GLP- l (1-37) amide, but 100 % with GLP-1(7-36) amide. GLP-1 
standards were prepared using synthetic human GLP-1 at the University of Surrey. 
The charcoal stripped serum (CSS) was produced at the University of Surrey using 
serum collected from fasted volunteers (see section 2.2.3.5.5). Separation of antibody 
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bound and free GLP-1 is achieved by the use of Sac-Cel, as with GIP. The GLP-1 
radioimmunoassay procedure was as follows: 
1) LP3 tubes were set up and labelled in duplicate in racks on a cold tray, 
where each stage of the assay was carried out. 
2) Assay buffer was prepared by adding 0.5 % human serum albumin and 
50,000 KIU/100 ml aprotinin to the stock GLP-1 RIA buffer described in the 
materials section. 
3) Plasma samples were defrosted and centrifuged at 1560 g(,,, ) (4 'C) to 
spin down fibrin clots. 
4) Synthetic human GLP-1 standards were reconstituted in assay buffer 
and then double diluted with CSS to give a standard curve of 160,80,40,20,10 
and 5 pmol/1. 
5) On Day 1, a positive displacement pipette was used to add standards, 
charcoal stripped serum (CSS), QCs (quality controls), and samples. GLP-1 
antiserum was diluted with assay buffer (1: 6000) and added to all tubes except 
totals and NSB tubes. 
6) On Day 2, GLP-1 label (prepared in-house, see section 2.2.3.5.7) was 
affinity purified (see section 2.2.3.5.8) and then added to all tubes at 5000 counts 
per minute (epm) per 100 µl (per tube). 
7) On Day 4, the bound and free antibody was separated by adding DAR 
Sac-Cel (IDS). Following incubation and centrifugation, the supernatant was 
aspirated under vacuum and the resultant pellet counted on an automated gamma 
counter (Wizard 1470) to obtain the cpm of the bound GLP-1. GLP-1 
concentrations were then automatically calculated from the standard curve using 
the software linked to the gamma counter. 
See table 2.5 for a more detailed protocol. 
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REAL- TUBES (µl) ENTS 
DAY] Totals Standard Sta Bard Standard NSB QC QC samBe Sample 
Assay buffer - 200 100 100 200 100 200 100 
Standard - - - 200 - - - - 
CSS - 200 200 - - - - - 
QC 
- - - - 200 200 - - plasma 
Sample - - - - - - 200 200 
Antiserum - - 100 100 - 100 - 100 
Vortex mix all tubes and incubate for 24 hours at 4 °C 
DAY 2 Totals 0 Sta Bard Stn Bard Standard NSB QC QC sam 
Be Sample 
Label 100 100 100 100 100 100 100 100 
Vortex mix all tubes and incubate for 48 hours at 4 °C 
DAY 4 Totals Stn dard Sta Bard Standard NSB QC QC samBe Sample 
Anti-rabbit 
- 100 100 100 100 100 100 100 Sac-Cel 
Vortex mix all tubes and incubate for 1/2 hour at room temperature. Add 1 ml RO 
water for 30 min aspirate and count the pellet Centrifu e at 1100 . , g , Table 2.5 GLP-1 radioimmunoassay protocol. 
Low and high QC samples were run at the beginning and end of each assay. 
The inter-assay coefficient of variation for low and high quality control samples at 13 
and 39 pmol/L was calculated to be 18.9 and 16.2 % respectively. The laboratory 
intra-assay coefficients of variation (CVs) for low and high quality control samples 
were 2.9 % and 8.0 % respectively. If QC's fell outside 2 standard deviations from 
the mean the assay was repeated. 
2.2.3.5.4 Analysis of CCK 
Plasma CCK was analysed using radioimmunoassay methods originally 
established by Professor John Calam (Department of Gastroenterology, Royal 
Postgraduate Medical School, Hammersmith Hospital, London) (Beardshall et al., 
1992) and further developed at the University of Surrey by Samantha Long and Linda 
Morgan. Plasma was collected into lithium heparin tubes or EDTA tubes containing 
sodium acetate buffer as described earlier (section 2.2.3.1). Ethanol extraction of the 
plasma samples was either completed immediately following the separation of the 
blood (i. e. during the study), or following a period of freezing at -20 °C (details in the 
methods sections for each chapter). The supernatant obtained from ethanol extraction 
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was stored at -80 °C for a short time before drying under vacuum (Savant Speedvac 
SC21OA, Lifesciences International). The dried samples were stored at -80 °C until 
the assay. 
An antibody raised in rabbits (Dino-7 antisera) was obtained from John Calam 
and Mark Jordinson (Royal Postgraduate Medical School, Hammersmith Hospital). 
This antibody cross-reacts 100% with human sulphated CCK-8 and larger forms of 
CCK to a similar extent. Cross-reactivity to synthetic and natural gastrin is less than I 
% (Beardshall et al., 1992). Synthetic sulphated CCK-8 (Bachem) was used as 
standard and sulphated CCK-8 125I-labelled with Bolton and Hunter reagent 
(Amersham Pharmacia Biotech UK Ltd, Amersham, Bucks) was used as the tracer. 
Incubation was performed at 4 °C for two further days and separation of free and 
bound tracer was carried out on day 4 by using anti-rabbit Sac-cel. The assay 
procedure was as follows: 
On Day 1, duplicate LP4 tubes containing the dried supernatant from plasma 
ethanol extraction process were set up along with labelled tubes for the standard 
curve in racks on a cold tray, where each stage of the assay was carried out. CCK 
assay buffer was prepared according the recipe (see materials section). 
2. Freeze-dried CCK standards (1.6 pmol/ml) were reconstituted in assay buffer 
and then diluted with buffer to give three dilutions of 1 (1 pmol/ml), 1: 10 and 
1: 100. The three dilutions were added to the standard curve at three different 
volumes to give 100,50,20,10,5,2,1,0.5 and 0.1 pmol/1. 
3. CCK antiserum was diluted with assay buffer (1: 100) and added to all tubes 
except totals and NSB tubes. CCK radiolabel (Amersham) was diluted to 1000 
cpm/400 µl and then added to all tubes. 
4. On Day 4, the bound and free antibody was separated by adding DAR Sac-Cel 
(IDS). Following incubation and centrifugation, the supernatant was aspirated 
under vacuum and the resultant pellet counted on an automated gamma counter 
(Wizard 1470) to obtain the cpm of the bound CCK. CCK concentrations were 
then automatically calculated from the standard curve using the software linked to 
the gamma counter. Values obtained were subsequently multiplied by 2, since 
standard curve values were per ml whereas samples contained only 0.5 ml of 
plasma. 
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See table 2.6 for the detailed protocol. 
REAL TUBES (µl) 
-ENTS 
1: 100 dilution 1: 10 dilution Stock solution 
DAY] Tot Is 
NSB 
Std 
0 
Std 0.2 0.5 1 2 5 10 20 50 100 QC Sample 
Assay 
- 500 500 480 450 400 480 450 400 480 450 400 500 500 buffer 
Std - 100 - 20 50 100 20 50 100 20 50 100 - - 
Anti- 
- - 100 100 100 100 100 100 100 100 100 100 100 100 sera 
Label 400 400 400 400 400 400 400 400 400 400 400 400 400 400 
Vortex mix all tubes and incubate for 72 hours at 4 °C 
DAY 4 Tot 
als 
NSB 
Std 
0 
Std 0.2 0.5 1 2 s 10 20 50 100 QC sample 
Anti- 
rabbit - 100 100 100 100 100 100 100 100 100 100 100 100 100 
Sac-Cel 
Vortex mix all tubes and incubate for 30 min at room temperature. Add 1 ml RO water. 
Centrifuge at 1100 for 30 min irate and count the pellet as , p av 
Table 2.6 CCK radioimmunoassay protocol. 
Laboratory inter-assay coefficients of variation for low and high quality 
control samples, used at the beginning and end of each assay, were reported to be 
10.6 and 18.2 % respectively (Long, 2000) 
2.2.3.5.5 Preparation of charcoal stripped serum 
Charcoal stripped serum in used for plasma hormone radio immunoassays in 
the standard curve. It is pooled plasma that has been stripped of small proteins and 
peptide hormones, and is added in order to mimic the serum in the samples. Agarose 
coated charcoal was previously prepared by mixing 150 g Norit PN. 5 charcoal with 
500 ml distilled water and leaving to settle. The water was decanted and this process 
was repeated until the water was clear. This de-fines the charcoal (removal of fine 
dust-like particles). The charcoal was left to dry overnight. 25 g agarose was 
dissolved in 500 ml distilled water and heated to 70 °C. 100 g of the de-fined charcoal 
was mixed with the agarose and cooled to 50 °C. The solution was poured into I litre 
acetone and stirred before filtering. The charcoal filtrate was dried overnight. 
Fasted blood is collected from 3 to 5 volunteers (to accumulate 500 ml or 
more) and the blood is left standing in Kilner jars at room temperature for 2-3 hours 
in order to obtain a clot. The blood is then stored at 4 °C overnight. The next day, 
serum is decanted from the blood clot and pooled. The prepared charcoal is added to 
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the pooled serum at 25 g per 200 ml of plasma and the resulting slurry is left to mix 
overnight at 4 °C. The slurry is then centrifuged at 6500 g(av) for 60 minutes. The 
supernatant is removed and filtered. A 0.25 ml aliquot of the filtered serum is 
centrifuged at 13,000 g(av) and checked for remaining fines of charcoal. The filtering 
process is repeated until no charcoal fines remain. Charcoal stripped serum is stored 
in aliquots of 10 ml at -20 °C. 
2.2.3.5.6 Quality controls 
Pooled plasma obtained from several volunteers who donated blood was used 
for quality controls for GIP, GLP-1, insulin and CCK radio immunoassays. Volunteers 
either gave blood after an overnight fast or 45 to 60 minutes following a high fat, high 
carbohydrate meal (3 assorted doughnuts) to produce the low and high quality 
controls (QCs). Plasma QCs for plasma paracetamol analysis on the Cobas Mira were 
from the blood of a fasted volunteer who had consumed 1.5 g paracetamol 45 minutes 
earlier. All QCs were stored at -20 °C in 1 ml aliquots. 
2.2.3.5.7 Iodination 
125I-GIP and 125I-GLP-1 were produced at the University of Surrey using the 
same method for both peptides. 3g of Sephadex G-15 was left overnight in 15 nil of 
0.1 M sodium acetate pH 5.0 at room temperature. On the day of the iodination the 
swollen Sephadex was poured into a plastic chromatography column (35 micron 
filter) with a yellow pipette tip and a length of 1 mm PVC tubing attached. 15 ml of 
protein elution buffer (0.5 % HSA and 5000 KIU/ml aprotinin in 50 ml of 0.1 M 
sodium acetate pH 5.0) was allowed to drip through the column. 
5 Fig of GIP or 3 µg of GLP- 1 (7-36) amide had previously been weighed out 
on the microbalance, and then dissolved in 10 µl of 0.4 M phosphate buffer. The 
column, peptide and other equipment were transferred to the hot lab where the 1251 
sodium iodide (10 µl containing 37 MBq) was added to the peptide. 10 µl of 
chloramine T solution (7.5 mg in 5 ml 0.4 M phosphate buffer pH 7.4) was added to 
the radiolabel and peptide, and the reagents were mixed with the displacement pipette 
tip for 15 seconds. 20 pl of sodium metabisulphite solution (10 mg in 5 ml 0.4 M 
phosphate buffer pH 7.4) was immediately added to stop the reaction. 200 µl of 
protein elution buffer was added to the iodinated peptide, and then the whole solution 
was transferred to the top of the Sephadex column. The labelled peptide solution was 
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allowed to drip through, while protein elution buffer was gradually added to the top 
of the column, and the drips were collected into LP4 tubes. Ten drips were counted 
per fraction, and a 10 µl aliquot of each fraction was counted on the gamma counter 
to produce an elution profile with two peaks. The fractions of the first peak were kept 
as they contained the iodinated peptide. The second peak was the free iodine. The 
chosen fraction (usually the highest or the one after) was aliquoted into 20 µl aliquots 
in LP3 tubes containing 100 pl of 10 % HSA, and the aliquots were frozen and stored 
at -20 °C. See figure 2.4 for an example of an elution profile. 
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Figure 2.4 Elution profile of a GLP-1 iodination (counts per minute in 10 µl of 
fraction). 
2.2.3.5.8 Affinity purification of GIP and GLP-1 
The label was added on day 2 of the GIP and GLP-1 radioinnnunoassays, and 
affinity purification was carried out immediately beforehand. Designated GIP and 
GLP-1 affinity columns had been prepared previously and were stored in bicarbonate 
buffer at 4 °C. Both affinity purification columns contained a solid phase (silica 
beads) of rabbit anti-GLP-1 or anti-GIP antibodies. 
The bicarbonate buffer was allowed to drain out of the clamped column. The 
column was washed with 10 ml 0.0825M HC1(passed through under pressure). Then 
20 ml of GIP/GLP-1 assay diluent (1: 10 stock buffer + HSA and aprotinin) was 
allowed to drip through to equilibrate the column. The GIP/GLP-1 radiolabel was 
reconstituted with 3 ml assay diluent and layered on the stoppered column, which was 
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then capped and roller-mixed for 30 minutes. The column was then un-stoppered and 
the assay diluent was left to drain out. The column was washed with 20 ml RO water 
to remove more free iodine in addition to that removed on the day of iodination. 5 ml 
of 0.0825M HCl was gradually added to the column and the drips containing the 
iodinated peptide were collected in a5 ml glass vial that had previously been rinsed 
in assay diluent. An aliquot of the eluted label was then counted and the dilution 
calculated to add approximately 5000 cpm/100 µl to each assay tube. The column 
was further washed with 10 ml water and 10 ml bicarbonate buffer, and then stored in 
bicarbonate buffer at 4 °C. 
2.2.4 Statistical Analysis 
Food intake was analysed using one factor repeated measures ANOVA using 
a statistical package for the PC (STATISTICA for Windows, Statsoft, Inc. (1997) 
Tulsa, OK, USA). This software was also applied for the analysis of subjective 
appetite responses and plasma hormone and metabolite data using two-way analysis 
of variance with repeated measures (ANOVA). Two-way, repeated measures 
ANOVA on x-b values (x minus baseline value) or two-way, repeated measures 
ANCOVA (analysis of covariance), with baseline values designated as covariates, 
were carried out where the baseline data were very variable. For example, these 
analyses were used where there was high inter- and intra-individual variation in VAS 
ratings, variable baseline ratings in the case of plasma amino acid data (see section 
2.2.3.3.6), or where sample sizes were small. Paired t-tests were used where 
appropriate. Pearsons correlation coefficient was used to test the association between 
two sets of data; Spearman rank order correlation was used if the data was not 
normally distributed. Spearman rank order correlation is a non-parametric test that 
calculates the relationship between two sets of data by determining the number of 
concordant ranking pairs minus the number of disconcordant ranking pairs. 
Modifications and additional statistical procedures are described in the methods 
sections for each chapter. 
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2.3 Reproducibility of satiety methodology: the measurement of food 
intake using ad libitum test meals and visual analogue scales 
for the subjective assessment of appetite. 
2.3.1 Aims 
The purpose of this study was to investigate the reproducibility of the 
methodology used in the current research to measure eating behaviour. Subjects were 
given identical preloads under the same conditions on three separate occasions in 
order to assess variation in food intake and the reproducibility of the visual analogue 
scales. 
2.3.2 Subjects 
Eighteen healthy volunteers (10 male, 8 female) aged between 20 and 28 
years were recruited from the University. The volunteers were all non-dieting, normal 
weight, non-smoking, and had no special dietary requirements (although two 
vegetarians were included) or eating habits. The volunteers were also screened using 
the DEBQ (van Strien et al., 1986). Only those men and women scoring less than 3.0 
overall were asked to participate. To ensure that the subjects liked the foods provided 
but did not eat excessively, they were asked to complete a questionnaire that rated 
food choices and excluded foods that they did not like (appendix IV). The subject's 
second choice for each food category was provided in the ad libitum test meal. 
Finally, all volunteers signed a consent form that stated they had read the Information 
for Volunteers sheet and agreed to the conditions of the study. The subjects were told 
that the study was investigating mood and food choice. The study protocol was 
approved by the local ethics committee. 
2.3.3 Study protocol 
A single-blind, within-subjects, repeated measures design was used for the 
experiment, with each subject serving as his or her own control. Each subject was 
required to attend the Clinical Investigation Unit at the University of Surrey on 3 
occasions - each occasion for an identical liquid milkshake-type meal, the 
composition of which remained unknown to all but the investigators. 
On the day of a study, subjects ate their breakfast (which they were required 
to keep consistent on each study day), after which they were required to drink only 
water and eat only what was provided for them on the study. They came to the 
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Clinical Investigation Unit between 1200 and 1300 h for a set lunch. This was to 
ensure that they were at a standardised level of hunger/satiety when they arrived for 
the study in the evening. Lunch was a commercially available pasta based ready-meal 
(the same type was consumed each study day) providing 1456-1644 kJ, 14.5-20.9 g 
protein, 11.0-13.5 g carbohydrate, and 4.3-6.4 g fat (mean 1623 kJ, 17.5 g protein, 
12.3 g carbohydrate, 5.0 g fat). The subjects had been instructed to eat a light evening 
meal the day before and their customary (cereal-based) breakfast, and also to avoid 
strenuous exercise and alcohol from 2000 h the day before until the study. On the day 
of the study they were required to drink only water and eat only what was provided 
for them from breakfast onwards. 
The subjects arrived at the Unit between 1715 and 1730 h and completed their 
first VAS ratings (appendix V). They then consumed the milkshake-type meal 
preload and then sat quietly together watching light television programmes. They 
filled out further VAS ratings 5,20,40, and 55 min after the preload, and were 
separated after 60 min to eat the buffet-style ad libitum test meal (see appendix 111). 
The subjects were partitioned so that they could not see others eating, and they were 
instructed not to talk to each other in order to minimise external influences on their 
food intake. They were asked to eat as much as they liked until they felt comfortably 
full, and informed that if they would like more of the food on their tray they could 
take home the remainder. This was designed to prevent over-consumption beyond the 
state of comfortable fullness. Final VAS sheets and questionnaires were completed 
when they had finished eating. There were at least 7 days between sessions. 
2.3.4 Test meals 
An identical milkshake-type liquid meal was used on each study day as the 
preload. The subject was given a choice of strawberry or banana flavour, but this was 
kept consistent on each study day. The ingredients were blended with an electrical 
blender and made up to 450 ml with water (table 2.7): 
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Ingredient 
Double Cream 
Maltodextrin 
Nesquik 
Total energy 
Content 
46 g (22 g water, 22 g fat, 
<1 g protein, 1.2 g CHO, 
828 kJ) 
50 g (50 g CHO, 837 kJ) 
20g(20gCHO, 326kJ) 
1992 kJ 
Table 2.7 Composition of liquid preload used to test the reproducibility of 
satiety methodology 
2.3.5 Statistical analysis 
Tests of repeatability were performed on VAS ratings according to Bland and 
Altman (Bland & Altman, 1986) and Raben et al. (Raben et al., 1995). Thus 
coefficients of repeatability (CR), i. e. 2x standard deviation (2 SD), on the 
differences between meal I and 2, meal 2 and 3, and meal 1 and 3 were calculated for 
fasting values, mean scores over the 5 to 55 min range, and post-meal values. The CR 
is defined so that 95% of the difference is expected to be less than 2 SD (British 
Standards Institution, 1979). The coefficient of variation (CV) was also calculated: 
CV (%) = (SD/mean of three meals) x 100. Correlation coefficients were calculated 
on subjects' ratings between study sessions (r2). Lastly, the mean differences in VAS 
scores between sessions (between meal 1 and 2, meal 2 and 3, and meal I and 3) were 
tested by t-test for unpaired data assuming unequal variances for significant 
differences from zero (Bland and Altman, 1986) in order to check for bias. 
2.3.6 Results 
2.3.6.1 Energy and food intake 
Energy intakes are illustrated according to study session order (first, second 
and third occasion) below (figure 2.5). 
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Figure 2.5 Energy intake following repeated identical 1992 kJ liquid meal 
preloads on three separate test occasions (mean ± SEM, n= 18). Intake was lower 
during the third meal compared to both the first (p = 0.004) and second meals (p = 
0.01), but there was no difference between energy intake during the first and second 
study sessions. 
One factor repeated measures ANOVA showed a clear order effect for ad 
libitum test meal energy intake (p = 0.006) (see figure 2.5). Post hoc comparison of 
the means for energy intake indicated that subjects consumed significantly less food 
on the third study session compared to the first session (p <0.005) and the second 
session (p <0.05). 
One factor repeated measures ANOVA of the macronutrient data (figure 2.6) 
showed that the reduction in energy intake was distributed evenly, rather than a 
selection of one type of macronutrient, with significant differences in protein (p = 
0.002), carbohydrate (p = 0.006) and fat (p = 0.03). 
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Figure 2.6 Macronutrient intake following repeated identical 1992 kJ liquid 
meal preloads on three separate test occasions (mean ± SEM, n= 18). The post 
hoc Duncan test showed that intake was lower during the third meal compared to both 
the first (protein and CHO p=0.003, fat p=0.02) and second meals (protein p= 
0.003, CHO p=0.02, fat p=0.03), but there was no difference between intake during 
the first and second study sessions. 
Coefficients of variance (CVs) of energy intake for each subject were 
calculated as a measure of within-subject variance for energy intake. The mean CV in 
ad libitum test meal intake over the three study sessions was 13.9 %, ranging from 6.7 
% to 25.8 %, showing that subjects differed greatly in their ability to respond 
consistently to an identical preload. Further analysis of the distribution of within- 
subject CVs showed that 11 out of 18 of the subjects had inter-meal CVs between 6 
and 15 %. There were no significant differences between men and women in the 
magnitude of within-subject variability in energy intake (mean CVs 15.3 % men, 12.1 
% women), but the women had a smaller range of CVs (6.7-25.8 % men, 7.8-18.5 % 
women). 
2.3.6.2 Subjective appetite ratings 
The results for hunger, desire to eat and fullness are illustrated (see figures 
2.7,2.8 and 2.9). Repeated measures two-way ANOVA on hunger, change in hunger, 
desire to eat, change in desire to eat, fullness, and change in fullness showed no 
differences between study sessions (meal order), or meal order x time interactions. As 
expected, there was a highly significant time effect on all appetite scores, p <0.00001. 
It can be seen from the graphs that the profiles for hunger and desire to eat were very 
similar on each occasion, and that fullness ratings did not differ significantly. 
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Figure 2.7 VAS ratings (cm) for hunger following repeated identical 1992 kJ 
liquid meal preloads on three separate test occasions (mean ± SEM, n= 18). 
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Figure 2.8 VAS ratings (cm) for desire to eat following repeated identical 1992 
kJ liquid meal preloads on three separate test occasions (mean ± SEM, n= 18). 
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Figure 2.9 VAS ratings (cm) for fullness following repeated identical 1992 kJ 
liquid meal preloads on three separate test occasions (mean ± SEM, n= 18). 
See appendix IX for repeatability tables. Mean differences in ratings 
(including baseline, post-preload (1 hour means), and post-ad libitum test meal 
ratings) between meals (meal 2-1, meal 3-1, and meal 3-2) were not significantly 
different from zero using a t-test for unpaired data assuming unequal variances 
(Bland & Altman, 1986; Raben et al., 1995). The correlation coefficients (r2) over all 
baseline and post-preload VAS ratings ranged between 0.14 and 0.78, and the 
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majority were statistically significant. However, the statistical significance of these 
correlation coefficients dropped considerably following the ad libitum test meal 
(range r2 0.00 - 0.36). CVs (%) were calculated for each subject for their baseline, 
post-preload (1 hour means), and post-ad libitum test meal VAS ratings to see how 
their scores varied between study sessions (see figure 2.10). Baseline and post- 
preload fullness ratings appeared to be more variable than those for hunger and desire 
to eat. Post-ad libitum test meal scores were less variable for fullness ratings 
compared to hunger and desire to eat. 
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Fig 2.10 Mean within-subject CVs (%) on VAS ratings following repeated 
identical 1992 kJ liquid preloads (baseline, post-preload, and post-ad libitum test 
meal) for hunger, desire to eat (DTE) and fullness VAS ratings. Within-subject 
CVs (%) were increased for hunger and DTE ratings after the ad libitum test meal, 
compared to fullness, whereas CVs were increased for baseline fullness ratings and 
post-preload compared to hunger and DTE ratings. 
2.3.7 Discussion 
2.3.7.1 Food intake 
Administering an identical preload on three separate occasions led to a non- 
significant decrease in subsequent mean food intake on the second session, and a 
statistically significant reduction by the third session. 
The food intake results may reflect a sensory-specific satiety process. 
Sensory-specific satiety is a term usually used to describe a decrease in the 
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pleasantness of the food during the course of a meal, leading to the termination of 
eating. It is generally accepted that this process is a food-specific satiety, unrelated to 
post-prandial effects and entirely a result of sensory influences (Hetherington et al., 
1989). In the present study it seems likely that the sensory properties of the buffet- 
style test meal are having a psychological effect on appetitive response. The most 
obvious explanation for the decrease in intake is that the attractiveness and perceived 
pleasantness of the meal decreased on the second and third occasions, which could be 
termed "sensory apathy". Another explanation may be that the subjects knew they 
could leave the investigation unit once they had eaten, and the circumstances were no 
longer novel on the second and third study sessions, which may have led to them 
rushing the ad libitum test meal in order to leave the study earlier. 
The majority of subjects (11 out of 18) did not have very high inter-meal 
variability in food intake (<15 %). This suggests that it is the minority of subjects that 
may yield unreliable results in a study using an ad libitum food intake experimental 
design to measure the effect of a nutritional variable on appetite control. It is possible 
that this minority comprise individuals that slipped through the net during the 
screening process, i. e. they deviate from the "normal" eating behaviour pattern but 
this was not detected by the DEBQ, nor were they excluded by screening out 
smokers, dieters, and high-level exercisers. Consideration must be given to whether 
volunteers were truthful when these questions were asked. Since these individuals 
may always get through, despite efforts to exclude them by questionnaires and other 
screening tools, it further serves to emphasise the importance of large subject 
numbers and randomisation when carrying out this type of study. 
2.3.7.2 Visual analogue scales 
Subjective ratings of hunger, desire to eat and fullness showed no differences 
between the three study sessions. Our results agree with those of Raben et al. (1995) 
in that VAS scores may produce similar mean responses over time following a test 
meal (in our case a liquid preload) but the within-subject differences between the 
study sessions were large as shown by the coefficients of variance. The results serve 
to emphasise the large amount of variability in hunger and satiety, or at least 
perception of hunger and satiety, from day to day under seemingly identical 
environmental conditions, which is then added to by methodological variation. 
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Mean differences between study sessions were small, but the coefficients of 
repeatability showed that they were spread over a large range. 95 % of the difference 
is within 2 SD, denoted by the CR, and this ranged from 2.20 to 4.15 cm for fasting 
scores, 1.81 and 3.28 cm for post-preload scores, and 2.44 and 4.11 cm for post-ad 
libitum test meal scores. These are quite large CRs for a scale of 1 to 10 cm but they 
are comparable to those reported by Raben and colleagues (1995) (CRs of 2.9 to 5.2 
cm for fasting scores). A more recent study using the same statistical methods to 
assess the reproducibility of appetite scores reported slightly lower values (Flint et 
al., 2000). Flint and colleagues obtained CRs of 2.7 to 3.0 cm for fasting scores and 
1.6 to 2.0 cm for post-preload scores, but they only measured two repeated study 
sessions whereas three sessions were included in the present study. This is important 
as the upper level CRs obtained in the present study were mainly a result of 
comparison with the third session. They also used a much greater number of subjects 
(n = 55). Correlation coefficients of subjects' ratings between sessions were 
moderately high following the preload, and all statistically significant, although the 
association was not as close between the second and third session (average r2 of 0.4). 
Baseline correlations were fairly high. There were no significant correlations of 
subjects' ratings between sessions post-ad libitum test meal, except for desire to eat 
between the second and third sessions. This means that subjects who were scoring 
higher in one session after the ad libitum test meal, did not necessarily score higher in 
another session. Therefore, subjects were less consistent in their VAS ratings once 
they had consumed the ad libitum test meal. This may reflect the fact that they were 
not eating the same amount of food on each occasion, or that they enjoyed the meal 
less on consecutive occasions, or maybe they took less care over their scoring as it 
was the last thing they did before they left the study. 
An important pattern to emerge out of the VAS ratings results was observed 
from the coefficient of variance (CV %) figures. Within-subject variability over the 
three study sessions was higher for hunger and DTE, but lower for fullness, after the 
ad libitum test meal. Inversely, baseline and post-preload ratings were more variable 
for fullness and considerably less variable for hunger/DTE. This observation directs 
our attention to a design weakness in the VAS paradigm. It can be interpreted as a 
reflection of the fact that subjects can judge their subjective feelings of satiety more 
reliably and reproducibly when there is a stimulus to satiety (i. e. they have eaten a 
meal). Concomitantly, subjective feelings of hunger or DTE can be expressed more 
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reliably when the stomach is not full. Even after the liquid preload, hunger and DTE 
was less variable within subjects, so a "drink"-type meal does not suppress 
motivation to eat as much as a solid buffet-style meal does. There may be a case for 
changing the design of the scales to a continuum of `hungry'/`full', rather than the 
separate `not at all hungry'/`as hungry as I've ever felt' and `not at all full'/`as full as 
I've ever felt' models used in this thesis, and in many other publications. Although 
these concepts are treated as two different sensations for the purposes of the study of 
appetite, it may be that the human subjects used in these experiments exhibit an 
improved response when hunger and satiety are treated as two extremes of the same 
sensation. 
The present study further underlines the importance and complexity of the 
psychological effects of food and the influence of psychological state on food intake 
and appetite. The reduction in food intake over the three study sessions under 
identical conditions has serious implications for all experimental studies that measure 
satiety, and show that the measurement of the effect of any given physiological 
variable on satiety must minimise psychological "noise" so as not to overwhelm the 
physiological effects. It also suggests that any physiological effects on satiety would 
have to be extremely marked to be picked up above the psychological influences. The 
variability shown in baseline VAS ratings is of concern since there is no nutritional 
stimulus and so this should stand a better chance of reproducibility between sessions. 
However, this may be rectified during analysis by standardising post-preload scores 
(y) to baseline values (x), i. e. change from baseline (y-x). Z scores can also be used to 
transform the data so that the number of SD from the mean of subject ratings over the 
time points for each rating is analysed, which was recommended for the processing of 
VAS data when there is large variation (Rogers, informal communication). 
With hindsight, the food intake measurement in this experiment could have 
been improved by the measurement of ratings of pleasantness, palatability, and 
sensory properties of the ad libitum test meal by VAS scores. This would have shed 
light on the reasons behind the reductions in food intake. The importance of 
randomisation is underscored by these results. It is also important to use a large 
number of subjects when studying appetite. The inclusion of meal order as a 
covariant in repeated measures ANOVA calculations may be a way round the 
problem of reduced food intake with more than two repeated meals. Setting up a 
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familiarisation session with the ad libitum test meal and using VAS ratings may have 
removed the novelty factor and improved reproducibility scores. However, this may 
also carry the risk of accentuating the "sensory apathy" already mentioned which 
could lead to a worsening of reproducibility. Another improvement to the 
experimental protocol would have been if all the subjects had been informed that they 
would be required until a later, set time, which may have reduced the risk of the 
subjects rushing the test meal in order to leave earlier. These suggestions are, 
however, suitable improvements for future work on appetite and food intake. 
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Chapter 
Three 
Chapter 3 
THE EFFECT OF PHENYLALANINE ON APPETITE AND POSSIBLE 
PHYSIOLOGICAL MECHANISMS 
3.1 General introduction 
In studying the role of protein and amino acids in appetite regulation, it was 
initially decided to investigate the effect of a single amino acid, phenylalanine, on 
satiety mechanisms. 
Phenylalanine is an amino acid with an aromatic side chain (figure 3.1). It is 
one of the nutritionally essential amino acids, and of the total body phenylalanine 
content, a very small fraction is free in the plasma (Garlick & Reeds, 1993). 
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Figure 3.1. The molecular structure of a) phenylalanine and b) L-aspartyl-L- 
phenylalanine methyl ester (aspartame) 
Thirty years ago it was shown that duodenal perfusion with phenylalanine, 
unlike many other individual amino acids, increased CCK secretion compared to 
saline, although not to the same extent as a duodenal perfusion of a mixture of 
essential amino acids (Go et al., 1970). This observation was supported by findings 
that showed intestinal perfusion of phenylalanine led to a strong CCK secretory 
response in dogs (Meyer & Grossman, 1972). Gibbs and Smith had noted that CCK 
induced satiety responses in rats and monkeys, and went on to test the hypothesis that 
phenylalanine ingestion may therefore suppress food intake (Gibbs & Smith, 1977). 
As expected, L-phenylalanine preloads (lg/kg body weight) led to a strong and rapid 
suppression of food intake in rhesus monkeys. Phenylalanine was also found to delay 
gastric emptying in human beings (0.1 M in 600 cc water) (Byrne et al., 1977). 
Weight of food ingested was reduced in a separate human study on obese volunteers 
93 
where 8g of encapsulated amino acids (phenylalanine, valine, methionine, and 
tryptophan) were ingested half an hour before the meal (Butler et al., 1981). In 
addition, Muurahainen and colleagues (1988) reported that encapsulated 
phenylalanine (10g), consumed simultaneously with tomato soup, significantly 
reduced ad libitum food intake at a meal presented twenty min after the preload. 
Phenylalanine is widely ingested as the sweetener, aspartame (L-aspartyl-L- 
phenylalanine methyl ester). Aspartame is a high intensity, non-nutritive sweetener 
added to a large variety of foods but most commonly in low-calorie beverages and 
desserts, and as a tabletop sweetener added to tea or coffee. When aspartame enters 
the intestine following ingestion it can produce a number of possible combinations of 
metabolites. Enzymes may hydrolyse it to aspartate, phenylalanine and methanol, 
which are then absorbed into the circulation. Aspartame may also undergo esterase 
hydrolysis into aspartylphenylalanine and methanol in the intestinal lumen. This 
dipeptide is then absorbed and hydrolysed to the two constituent amino acids within 
the enterocyte. Aspartame is not thought to enter the blood stream (Pardridge, 1986). 
There have been a number of human studies carried out that show aspartame 
increases satiety (Birch et al., 1989; Rogers et al., 1990; 1991; 1995). Rogers and 
colleagues (1990) found that 234 mg of encapsulated aspartame plus 200 ml water 
significantly reduced energy intake one hour later by 732 kJ, whereas 234 mg of 
aspartame dissolved in 200 ml water and 2 placebo capsules containing cornflour 
only reduced energy intake by 205 kJ, a non-significant effect. The control preload 
was 200 ml water and 2 placebo capsules. A second experiment revealed that the 
aspartame dissolved in water led to a greater decrease in self-rated desire to eat and 
hunger, but it was the encapsulated aspartame that led to a significant reduction in 
food intake. Rogers et al. (Rogers et al., 1991) also investigated whether the amino 
acid constituents of aspartame, phenylalanine and aspartate, would have individual 
effects on food intake in an attempt to identify the source of aspartame's anorectic 
effects. Again, food intake was reduced at the meal one hour after the preload capsule 
containing 400 mg of aspartame, but neither the phenylalanine (200 mg), nor 
aspartate (200 mg) had any effect compared to the control (cornflour in a capsule). 
The anorectic effect could only be stimulated by aspartame ingested without tasting. 
Rogers and Blundell (Rogers & Blundell, 1992) could not produce a comparable 
reduction in food intake in rats when aspartame was injected intraperitoneally with 
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water, or administered by gavage. The authors explained this as the result of a species 
difference; an argument backed up by the fact that rats do not taste aspartame as 
sweet. Another study from the same laboratory discovered that the time interval 
between preload and test meal was important in whether food intake would be 
significantly reduced. In this case, there was a reduction after 60 min, but not after 30 
or 5 min (Rogers et al., 1995). 
There are also a few studies that do not support the assertion that aspartame 
reduces subsequent food intake on a short-term basis. Encapsulated phenylalanine 
had no effect on food intake, macronutrient selection and self-rated scores for appetite 
and mood in human volunteers in a study by Ryan-Harshman and colleagues (Ryan- 
Harshman et al., 1987). The same authors also carried out an experiment to test the 
effects of encapsulated aspartame at two large doses and another dose of 
phenylalanine on measures of appetite and again, there were no significant 
differences in food intake or subjective appetite scores. However, Rogers and 
Blundell presented a paper containing re-analysis of the raw data from the first 
experiment by Ryan-Harshman and colleagues (Rogers & Blundell, 1994). They 
pointed out that the placebo used was another amino acid, alanine, which may well 
also suppress food intake. The differences between 3 doses of phenylalanine (0.84, 
2.52 and 5.04 g), and 5.04 g alanine was marginally non-significant (p = 0.052) in 13 
subjects. A post hoc test showed that the main difference was between the highest and 
lowest doses of phenylalanine (p = 0.008), and there was even a trend towards 
suppressed food intake following alanine compared to the lowest dose of 
phenylalanine (p = 0.057). Therefore, not only was there a dose-dependent 
suppression of food intake by phenylalanine, but food intake following the lowest 
dose of phenylalanine (0.84 g) was probably closer to the true control level than 
alanine. Rogers and Blundell (1994) concluded that phenylalanine induced a dose- 
dependent suppression of food intake and alanine suppressed food intake in this 
instance. Similar conclusions were drawn from further inspection of the results from 
experiment two. 
Anderson et al. (Anderson et al., 1989) looked at the effects of aspartame on 
food intake on children but found different results. They carried out two experiments. 
The first compared aspartame plus carbohydrate with sodium cyclamate (amounts in 
equivalent sweetness to the aspartame) and alanine in amino acid equivalent amounts 
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in a fruit-flavoured drink. The second experiment compared aspartame with sucrose. 
Neither experiment produced any differences between conditions at the ad libitum 
test meal 90 min later (food intake and macronutrient selection), or subjective 
appetite ratings. However, it could be argued that 90 min was too long a delay 
between the preload and the test meal to detect the behavioural outcome from 
possible hormonal or direct effects triggered in the gut, and also that alanine was not 
an appropriate choice for a control. 
Twenty-four weeks of aspartame treatment (75 mg/kg body weight per day) 
had no effects on body weight in over one hundred human subjects (Leon et al., 
1989), but then previous experiments only showed that aspartame influenced short- 
term satiety. Rodin (1990) failed to show an effect of aspartame-sweetened lemonade 
compared with fructose-sweetened, glucose-sweetened lemonade or plain water on 
food intake 40 min later. Aspartame also had no effect on food intake one hour later 
in a study using diet soda as the vehicle (Black et al., 1990). These experiments used 
aspartame dissolved in a beverage, whereas Rogers and colleagues (1990,1991, 
1992,1995) had demonstrated an effect for encapsulated aspartame only. 
From these studies, it is difficult to form any clear idea of what is happening 
to appetite mechanisms following aspartame or phenylalanine ingestion. The 
conflicting results are likely to be the result of differences in experimental design, 
(age/sex, preload, dose administered, the ad libitum test meal, and time elapsed 
between the preload and test meal). There is sufficient evidence to suspect that 
aspartame, or phenylalanine alone, does have a satiety effect, and the following 
chapter aims to confirm or refute this assumption and to address possible 
physiological mechanisms. Since CCK and GLP-1 are widely believed to be 
important satiety peptides in human beings (Ballinger et al., 1995; Lieverse et al., 
1995; Flint et al., 1998; Gutzwiller et al., 1999), and CCK has already been shown to 
be secreted in response to large doses of phenylalanine (Ballinger & Clark, 1994), the 
involvement of these hormones will be investigated. Effects on gastric emptying rate, 
which is inhibited by these gut peptides and is intrinsically linked to satiety, will also 
be explored. 
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3.2 The effect of phenylalanine supplementation on food intake 
and subjective appetite ratings 
3.2.1 Aims and hypothesis 
This study tested the hypothesis that phenylalanine induces short-term satiety 
mechanisms in human subjects, and that there is a dose-response relationship between 
phenylalanine consumption and on both subjective ratings of appetite and subsequent 
short-term food intake. 
3.2.2 Subjects 
Nine healthy volunteers (4 male, 5 female) aged 22 to 30 years (mean 24, SD 
2.6 years) were recruited from students and staff at the University of Surrey. None of 
the volunteers accepted on to the study were dieting, had a BMI of >25 kg/m2, had 
special dietary requirements or unusual eating habits, were phenylketonurics, or took 
regular medication (except oral contraceptives or non-prescription analgesics). The 
volunteers were also screened using the Dutch Eating Behaviour Questionnaire (van 
Strien et al., 1986) shown in appendix II, which measures dietary restraint, externality 
and emotionality. Only those men and women scoring less than 3.0 overall (mean 
score = 2.4, SD = 0.3) were asked to participate. A 3-day food diary was completed 
prior to acceptance on the study in order to highlight any unusual dietary habits. 
To ensure that the subjects liked the foods provided but did not eat 
excessively, they were asked to complete a questionnaire that rated food choices and 
excluded foods that they did not like (appendix IV). The subject's second choice for 
each food category was provided in the ad libitum test meal. The subjects were also 
given empty capsules of the type used in the experiment in advance to make sure that 
they could swallow them without any difficulty. Finally, all volunteers signed a 
consent form at the beginning of their first session, which stated that they had read 
the Information for Volunteers sheet. The subjects were told that the study was 
investigating the effect of amino acids on mood and food choice, but they were not 
told explicitly what the capsules contained. The study protocol was approved by the 
local ethics committee. 
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3.2.3 General procedure 
A within-subjects, repeated measures single blind design was used for the 
experiment, with each subject serving as his or her own control. Every subject 
received each of the following: 5g phenylalanine, 2g phenylalanine, 400 mg 
phenylalanine and 5g cornflour (placebo) in random order. Each dose was 
administered in 10 opaque gelatine capsules; the intermediate doses were made up to 
5g with cornflour. The capsules were ingested with 300 ml of cool water (10-15 °C), 
followed by 200 nil of warm water (40-45 °C) (to facilitate the dissolving of the 
capsules). Each subject was required to attend the Clinical Investigation Unit at the 
University of Surrey on four occasions - each occasion for one treatment. 
The subjects had been instructed to eat a light evening meal and their normal 
(cereal-based) breakfast, and to avoid alcohol from 2000 h the evening before until 
the study. They were also to abstain from any heavy or vigorous exercise for 24 hours 
before the study. On the day of the study they were required to drink only water and 
eat only what was provided for them from breakfast onwards. Subjects were provided 
with their choice of standard pasta-based `ready-meal' for lunch (at between 1200 h 
and 1300 h), which was kept the same on each study day (mean 1623 kJ, 17.5 g 
protein, 12.3 g carbohydrate, 5.0 g fat). They were then free to go until the start of the 
study. Table 3.1 shows the study protocol. In addition to visual analogue scales 
(VAS) for hunger, desire to eat and fullness, subjects were also required to rate how 
well they felt (headache, stomachache, nausea, heart pounding, feeling flushed, faint, 
jittery, refreshed and light-headed) in order to monitor any side-effects of 
phenylalanine consumption. 
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Time Action Visual analogue scales (VAS) and food 
(h) preference checklist 
1730 Arrive at the investigation unit 
1755 V 
1800 Treatment (consumed capsules 
+ water) 
1815 V 
1835 N 
1855 d 
1900 Consume ad libitum buffet-style 
test meal. 
-1920 (after meal termination) 
Table 3.1 Study protocol for the investigation of the effect of phenylalanine 
supplementation on food intake and subjective appetite ratings. 
Whilst eating the ad libitum test meal, the subjects were partitioned in order to 
minimise social interaction and external influences on their eating behaviour. Final 
visual analogue scale (VAS) ratings (appendix V) and food preference checklists 
(appendix VI) were completed when the subjects finished eating. When the final 
ratings and questionnaires had been completed the subjects were free to go home. 
There were at least three days between sessions. 
3.2.4 Subjective measures of appetite 
Subjects rated their hunger, desire to eat, and fullness and completed food 
preference checklists as described in section 2.2.1.3. 
3.2.5 Treatment doses and meals 
Capsules: The gelatine capsules were filled with L-phenylalanine (Scientific 
Hospital Supplies) and/or cornflour, and weighed on a microbalance to ensure that 
each capsule contained 500 mg exactly. Ten capsules made up a5g dose. The 
kilojoule, carbohydrate and phenylalanine contents of each dose is shown in table 3.2. 
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Approximate Energy (kJ) Cornflour (g) Phenylalanine (g) 
Control 84 5 <0.001 
400 mg PA 84 4.6 0.4 
2g PA 84 32 
5g PA 84 05 
Table 3.2. Approximate energy, carbohydrate and phenylalanine content of each 
treatment. 
Ad libitum test meal: The self-selection meal consisted of a variety of 
palatable, cold, lunch-type foods - sandwiches with two types of fillings, salad items, 
full-fat fruit yoghurt, biscuits, and cake. See appendix III for a description of the 
foods used. All foods were weighed before being served and re-weighed after the 
subjects had eaten to record the amount consumed (g) of each food. A glass of water 
(300 ml) was provided with the meal. On average the total energy available from a 
tray of food was approximately 12,552 kJ. 
3.2.6 Results 
3.2.6.1 Energy and food intake 
Results show a trend towards reduced food intake following increasing doses 
of phenylalanine (see figure 3.2). One way repeated measures analysis of variance 
(ANOVA) comparing energy intake (kJ) during the ad libitum test meal across all 
four doses produced no statistically significant differences. Standardising energy 
intake for body weight (intake in kJ/weight in kg) did not produce any significant 
differences either. Comparing weight of food intake (g) across all doses by one way 
repeated measures ANOVA produced a difference that was not quite significant (p = 
0.066), as did weight of food intake standardised for body weight, p=0.061 (see 
figure 3.2). A paired t-test between energy intake following the control and 5g 
phenylalanine (PA) conditions showed that there was a significant difference in 
energy intake (p <0.05). 
One way, repeated measures ANOVA was also carried on energy intake at 
each study session to test for any order effects, since previous work had revealed that 
energy intake is reduced on the third study session with repeated identical preloads 
and ad libitum test meals (see section 2.3). There were no differences in energy intake 
between study sessions (p = 0.532) and mean intakes appeared similar for each 
session (4942,5276,4766 and 5021 kJ in the 1st, 2nd, 3rd and 4th study sessions 
respectively). 
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Control 400 mg 2g5g 
Dose 
Figure 3.2 The effect of phenylalanine dose (control, 400 mg, 2g or 5 g) on food 
intake (weight ingested (g) per kg body weight). Mean ± SEM, n=9, *p <0.05. 
Repeated measures ANOVA of protein intake (g) showed a significant 
treatment effect between the four doses, p <0.02. The same effect was found for 
protein intake standardised for body weight (see table 3.3), p <0.02. Post hoc analysis 
of protein intake (g) standardised for body weight revealed that the subjects 
consumed significantly less protein following 5g of phenylalanine compared to the 
control treatment (p <0.002), the 400 mg phenylalanine (p <0.02) and the 2g 
phenylalanine (p <0.05). No significant differences were found in fat or carbohydrate 
consumption when intake was analysed in terms of weight (g) or weight (g) 
standardised for body weight. 
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Treatment Energy Food intake Protein intake Fat intake (g) CHO intake (g) 
(phe) intake (kJ) (g) per (g) per kg/bw per kg/bw per kg/bw 
per kglbw kg/bw 
Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM 
Control 77 7 9.0 0.7 0.60 0.05 0.77 0.08 2.20 0.17 
400 mg 76 7 8.8 0.7 0.56 0.05 0.77 0.09 2.18 0.18 
2g 72 4 8.3 0.6 0.54 0.05 0.73 0.04 2.08 0.15 
5g 67 5 7.6 * 0.4 0.48** 0.04 0.66 0.05 1.91 0.15 
*Significantly different from control dose and 400 mg phenylalanine, p <0.05; ** 
significantly different from control dose, p <0.002. 
Table 3.3 Food intake by energy (kJ) and weight (g) per kg body weight (per 
kg/bw), and macronutrient intake by weight (g) per kg/bw following the control 
condition and increasing doses of phenylalanine (400 mg, 2 g, and 5 g). 
Ad libitum test meal intake was also analysed in terms of type of food 
consumed - savoury, sweet or condiments. Repeated measures ANOVA of intake of 
savoury foods in terms of weight (g) showed a main effect of dose that was just short 
of significance, p=0.061. Post-hoc analysis indicated that the savoury food intake 
after 5g of phenylalanine was significantly less than that after the control dose (p 
<0.02). There were no differences in intake of sweet foods or condiments, however. 
3.2.6.2 Subjective ratings of appetite 
The results showed no significant differences in subjective appetite ratings 
between doses. See figures 3.3,3.4 and 3.5. 
Two way, repeated measures ANOVA of the VAS scores for hunger, desire to 
eat, and fullness, and the change from baseline (x-b) for hunger, desire to eat and 
fullness, showed no significant main effects of dose. ANOVA of the raw data 
excluded the after meal ratings, as you would expect the subjects to eat to the same 
level on each occasion, and ANOVA of the change from baseline excluded the 
baseline ratings in addition. There was a significant main effect for time for the raw 
data for hunger (p <0.02), desire to eat (p <0.05), and fullness (p <0.05), and for the 
change from baseline (at t +15, +35 and +55 min) for hunger (p <0.005) and desire to 
eat (p <0.005). There were no dose x time interactions for hunger, desire to eat or 
fullness. 
Pearson Product Moment correlation analysis of the change in score at t +15 
min (t + 15 min minus baseline) with ad libitum test meal intake found that only the 
change in fullness correlated significantly with subsequent energy intake (r = -0.765, 
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p=0.016) and weight of food intake (r = -0.820, p=0.007) following treatment with 
5g phenylalanine. There were no correlations for hunger and desire to eat, or for any 
other dose treatment. 
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Figure 3.3 Hunger VAS ratings (cm) following consumption of encapsulated 
phenylalanine at doses of 400 mg, 2 g, or 5g compared to control. Mean ± SEM, 
n=9. There were no significant differences in hunger response. 
103 
+ Control 
" 400 mg 
2g 
-5 05 10 15 20 25 30 35 40 45 50 55 60 65 70 75 
Time (min) 
0 5g 
Figure 3.4 Desire to eat VAS ratings (cm) following consumption of 
encapsulated phenylalanine at doses of 400 mg, 2 g, or 5g compared to control. 
Mean f SEM, n=9. There were no significant differences in desire to eat. 
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Figure 3.5 Fullness VAS ratings (cm) following consumption of encapsulated 
phenylalanine at doses of 400 mg, 2 g, or 5g compared to control. Mean ± SEM, 
n=9. There were no significant differences in fullness response. 
Satiety quotients (SQs) were calculated for hunger, desire to eat and satiety 
ratings but one way repeated measures ANOVA revealed no significant differences 
between treatments (p = 0.246,0.684 and 0.838 respectively). There were no 
significant side effects resulting from phenylalanine consumption. 
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3.2.6.3 Food preference checklist 
Two way, repeated measures ANOVA on the change from baseline of the 
total number and total energy of all foods, protein foods, high fat foods, high 
carbohydrate foods, mixed carbohydrate/fat foods and low fat foods showed no main 
effect of dose on type of food selected, but there were consistent significant main 
effects for time (ANOVA oft +15, +35 and +55 min) for change in total energy and 
total number of foods. See figure 3.6. There was also a dose x time interaction for 
change from baseline (x-b) of carbohydrate food preference (p <0.05). Post-hoc 
analysis showed that this was due to a decrease in carbohydrate food selection after 2 
g of phenylalanine compared to an increase for the other 3 treatments, especially at t 
+55 min. 
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Figure 3.6 Number of food items selected from the food preference checklist 
following consumption of encapsulated phenylalanine at doses of 400 mg, 2 g, or 
5g compared to control. Mean ± SEM, n=9. There were no significant 
differences in the total number of food items selected. 
3.2.7 Discussion 
3.2.7.1 Food intake 
The results show that energy intake was not affected by phenylalanine 
supplementation in doses of up to 5g in young healthy adults. There was, however, a 
dose-related suppression of food intake in terms of food weight per kg body weight, 
which approached significance, and post hoc analysis revealed that intake after the 5 
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g phenylalanine dose was significantly lower compared to the control and 400 mg 
phenylalanine conditions. 
The data suggest that the bulk or volume of the food rather than the energy 
content was the major determinant of satiety and that phenylalanine may act by 
amplifying the short-term satiation process that occurs while the food is passing from 
the stomach to the duodenum. Furthermore, it is possible that phenylalanine may 
promote a delay in gastric emptying, therefore curtailing the volume of food that may 
be comfortably ingested. Phenylalanine may act on specific amino acid receptors in 
the duodenum that trigger a neural reflex to delay gastric emptying, possibly via a 
vago-vagal pathway as amino acid-specific afferent vagal receptors have been 
identified as being located superficially in the upper intestinal mucosa (Jeanningros, 
1982). One could also speculate that vagal afferent signals could trigger the 
stimulation of CCK release from the CCK-secreting cells in the upper small intestine, 
either through autonomic nervous transmission to the enteric nerve plexus or via a 
long neural reflex. There is some evidence that the phenylalanine may also be acting 
directly on CCK cells that border onto the small intestine lumenal wall to stimulate 
CCK secretion, possibly via a calcium channel opening mechanism (Liddle, 1997). 
There were no effects on subjective appetite ratings prior to the ad libitum test meal, 
and a gastric load is known to potentiate the inhibiting actions of CCK on gastric 
emptying. Therefore, these results support the theory that duodenal phenylalanine 
immediately triggered CCK secretion. It is hypothesised that circulating CCK acted 
on receptors on vagal afferent fibres sensitive to gastric distension during the test 
meal thereby amplifying their basal firing. This would increase the subsequent delay 
in gastric emptying (Schwartz et al., 1991). 
3.2.7.2 Macronutrient selection 
Protein intake (g) was significantly suppressed with increasing dose, with post 
hoc comparisons showing intake after the 5g dose to be significantly lower than 
intake after the other three conditions. Suppression of protein intake might be 
expected since 5g is a large amount of phenylalanine to ingest at once, with the daily 
estimated intake of these subjects averaging 2.3 g per day (from their food diaries). 
An excessive intake of protein can have adverse metabolic effects, especially if there 
is an imbalance in essential amino acids as in this case (Jackson, 1999), and so this 
may reflect a post-absorptive central mechanism to protect against amino acid 
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toxicity. The possible routes for central aminostatic regulation of protein intake are 
via amino acid sensors in the brain or by conversion to the neurotransmitter dopamine 
via tyrosine. However, the evidence for a significant increase in dopamine synthesis 
and release following administration of amino acid precursors is not convincing (see 
section 1.3.2). In addition, although a few studies have investigated the existence of 
amino acid sensors in the brain that may regulate food intake (Rogers & Leung, 1973; 
Anderson et al., 1994; Currie et al., 1995), the mechanistic evidence is sparse and 
therefore not conclusive as yet. 
There is another possible explanation. Since satiation is increased following 5 
g phenylalanine, the reduction in protein may be linked to a hedonistic decision by 
the subjects to reduce their selection of savoury foods, in order to leave more room 
for the highly palatable sweet/high fat foods. This is supported by the dose-related 
suppression in savoury items of food whereas the same relationship is not observed 
for sweet foods or condiments. The reduction in protein intake was not predicted by 
any reduction in high protein food selection in the pre-meal food preference checklist 
scores. A Pearson Product Moment correlation failed to show any correlation 
between food preference checklist selection of high protein foods over t +15, t +35 
and t +55 min, and actual protein intake (g/kg body weight) at the ad libitum test meal 
for any of the dose conditions. There was, however, a significant correlation between 
intake of savoury foods (g) after the 5g dose of phenylalanine and protein energy 
selection in the food preference checklists at t +55 min, (r = 0.692, p=0.039). More 
work is required to disentangle the role of food types versus macronutrients in satiety, 
but this is outside the scope of the present research. 
3.2.7.3 Subjective appetite 
Subjective feelings of hunger, desire to eat and fullness were unaffected by 
phenylalanine treatment. These results would therefore lend support to the hypothesis 
suggested by Rogers et al. (1995) for aspartame that phenylalanine is amplifying the 
satiating effect of food in the stomach and small intestine, and that phenylalanine 
treatment does not affect pre-meal feelings of hunger and satiety. Only the change in 
fullness immediately following capsule ingestion showed any correlation with food 
intake (per kg/bw) at the ad libitum test meal, which suggests that hunger and desire 
to eat may be under a different mechanism of control to fullness and that hunger and 
desire to eat may be poor predictors of subsequent intake. With hindsight, the 
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experimental protocol could have been improved by carrying on the VAS ratings 
beyond the ad libitum test meal, perhaps every hour until their next meal, so that any 
post-meal effects on satiety could have been discerned. 
3.7.2.4 Food preference checklists 
These results show that pre-meal food choices may be affected by increased 
doses of phenylalanine, with a dose-response suppression of selection of carbohydrate 
foods and low fat foods in terms of energy. When low fat food preference is 
standardised for the change from baseline, there are no significant effects for dose, 
time or a dose x time interaction at t +15, t +35 and t +55 min. It cannot be assumed, 
therefore, that treatment was affecting preference for low fat foods. The effect of 2g 
of phenylalanine on carbohydrate food preference (change from baseline) is difficult 
to explain, since the 5g phenylalanine treatment produced similar results to the 
control and 400 mg phenylalanine treatments. The greater risk of statistical type 1 
errors in a study of this size may explain this result. 
In conclusion, it has been demonstrated that there is a weak dose-dependent 
effect of phenylalanine on food intake, with a significant effect after 5g of 
phenylalanine. It is probable that the influence of this amino acid on food intake 
would have been more marked if there had been more subjects in the study. Since 
pre-ad libitum test meal subjective appetite scores were unaffected, phenylalanine 
may have reduced food intake by amplifying the satiating effect of the ad libitum test 
meal, possibly via CCK-mediated mechanisms. 
3.3 The effect of phenvlalanine supplementation on circulating 
metabolite and hormone status, gastric emptving and satiety 
3.3.1 Aims and hypothesis 
A large dose of phenylalanine has been shown to reduce subsequent food 
intake with an ad libitum test meal. It is hypothesised that the mechanisms for this 
satiety effect may involve an increase in the secretion of the satiety peptides, CCK or 
GLP-1, and possibly delayed gastric emptying. Potential effects on other hormones, 
GIP and insulin were investigated, and levels of plasma metabolites, glucose and 
amino acids, were measured. 
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3.3.2 Subiects 
Six lean healthy volunteers (4 females and 2 males) between 20 and 30 years 
were recruited from the University. The volunteers were all non-dieting, with no 
special dietary requirements or eating habits (as assessed by the completion of a three 
day food diary), and a BMI <25 kg/m2. They had no significant current or previous 
medical history (including phenylketonuria) and took no medication apart from the 
oral contraceptive pill. They were selected on the basis of their responses to the Dutch 
Eating Behaviour Questionnaire (van Strien et al., 1986) shown in appendix II, and 
their self-reported habitual protein intake and physical activity levels. Subjects were 
non-smokers and did not consume more than 20 units of alcohol per week. All 
subjects were interviewed and a venous blood sample taken for haematological and 
biochemical screening to confirm their suitability to participate in the study. The 
volunteers signed a consent form before they were accepted onto the study, which 
included a statement that they understood that they would be giving some blood as 
part of the study. Their GP was informed that their patient was going to participate in 
this study, and given the opportunity to notify as to any medical reason why their 
patient should not take part. 
To ensure that the subjects liked the foods provided but did not eat 
excessively, they were asked to complete a questionnaire to rate their food 
preferences and to exclude foods that they did not like (appendix IV). The subject's 
second choice for each food category was provided in the ad libitum test meal. The 
subjects were also given empty capsules of the type used in the experiment in 
advance to make sure that they could swallow them without any difficulty. The 
subjects were told that the study was to investigate the effects of phenylalanine on 
mood and food choice. The study protocol was approved by the local ethics 
committee. 
3.3.3 General procedure 
A within-subjects, repeated measures design was used for the experiment, 
with each subject serving as his or her own control. Subjects were asked to refrain 
from drinking alcohol the evening before. On the day of the study they were required 
to consume their normal breakfast, and not eat anything else until their standard 
lunch. Lunch was provided as a standard pasta dish that the subject has previously 
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indicated a liking for, and eaten between 1145 and 1230 h. For the rest of the day the 
subjects were required to eat or drink nothing except water until two hours before the 
study. 
Subjects arrived at the Clinical Investigation Unit at 1730 h (2 people per 
study day), and an intravenous cannula was inserted into an antecubital vein in the 
forearm under local anaesthetic. Blood samples were taken for the measurement of 
plasma amino acids, glucose, insulin, GLP-1, GIP and CCK according to the 
methodology detailed in section 2.2.3.1. Six electrodes were positioned over the 
stomach and lower back to measure gastric emptying by electrical impedance 
epigastrography (EIE). A baseline blood sample was taken, and the first VAS ratings 
(appendix V) completed by the subject. Although the main purpose of the study was 
to investigate changes in plasma hormones and metabolites and effects on gastric 
emptying, VAS ratings were completed during the study, as well as the measurement 
of food intake. Subjects lay in a semi-supine position on a bed and were instructed to 
stay as motionless as possible in order to obtain a steady EIE trace. Once a 
satisfactory ten minute baseline reading had been obtained for the EIE recordings, the 
subjects consumed 5g of encapsulated phenylalanine or placebo (cornflour) with 300 
ml of cool water (10-15 °C), followed by 150 ml of warm water (40-45 °C) in order to 
hasten the dissolution of the 10 gelatine capsules in the stomach. Further blood 
samples (15 ml) were taken at 15,25, and 35 min, and VAS ratings/food preference 
checklists were completed by the subjects at 10,20 and 30 min after the capsules. 40 
min after ingestion of the capsules the BE recordings were stopped and the ad 
libitum test meal was offered to the subject. An interval of 40 min was chosen 
because it was hypothesised that the phenylalanine-induced satiety mechanisms were 
short-term processes involving a direct effect of phenylalanine on intestinal receptors 
or lumenal gastrointestinal hormone-secreting cells. Since it was assumed that the 
capsules would dissolve within 30 min of ingestion, the optimal time for a short-term 
augmentation of satiety was theorised to be 40 min after phenylalanine ingestion. 
The subjects were screened off from the other participants and instructed to 
eat until they were comfortably full, and to the same level of fullness on both 
occasions. They were also told that they could take the remaining food home with 
them if they wished. The duration of the meal was noted. Immediately following the 
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termination of eating a last blood sample was obtained and the last set of subjective 
appetite questionnaires completed; then the volunteers were free to go. 
3.3.4 Treatments and meals 
Capsules. The 10 capsules were filled with 5g L-phenylalanine (Scientific 
Hospital Supplies) or 5g cornflour. It was decided to administer 5g phenylalanine as 
this was the amount previously shown to produce a clear satiety effect in human 
volunteers (see section 3.2.6.1). 
Ad libitum test meal: This was the same meal as described in section 3.2.5 
(appendix III). 
3.3.5 Subjective measures of appetite 
Subjects rated their hunger, desire to eat, and fullness as detailed in section 
2.2.1.3. 
3.3.6 Results 
3.3.6.1 Gastric emptying 
Gastric emptying rates were slower following treatment with phenylalanine 
compared to the control (see table 3.4). 
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Control (min) Phelalanine (min) 
F 9.2 11.1 
B 11.6 16.5 
D Missing 14.6 
E 9.1 15.5 
C 8.9 16.4 
A 10.5 12.4 
Mean 9.86 14.38* 
SEM 0.52 1.11 
Table 3.4 Gastric half-emptying times (T50s) following 5g of encapsulated 
phenylalanine or cornflour (control), *p <0.05. 
Results were analysed using a two-tailed paired t-test, and it was shown that 
the T50s following the phenylalanine treatment were significantly longer in duration 
than the control treatment (p = 0.017). 
3.3.6.2 Blood metabolite and hormone profiles 
3.3.6.2.1 Plasma glucose 
Plasma glucose concentrations were unaffected by phenylalanine treatment 
(figure 3.7). 
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Figure 3.7 Plasma glucose concentrations (mean ± SEM, n= 6) following either 5 
g phenylalanine or 5g cornflour (control). There were no significant differences in 
plasma glucose response. 
3.3.6.2.2 Plasmaphen, ylalanine 
Plasma levels of phenylalanine were measured in order to estimate maximum 
time taken for capsules to dissolve and their contents to reach the duodenum. Plasma 
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levels of phenylalanine started to increase 35 min after ingestion of the capsules. 
Furthermore, by the time the subjects had finished eating their ad libitum test meal, 
the increased plasma levels were approximately four times higher than the meal- 
induced increase following ingestion of the control. Mean plasma phenylalanine 
concentrations are shown for 5 subjects in figure 3.8. Two way, repeated measures 
ANOVA on the change from baseline (x-b) showed the difference in phenylalanine 
concentrations between treatments to be nearly significant overall (p = 0.056), and 
there was a significant treatment x time interaction (p <0.01) mostly due to the large 
difference in plasma phenylalanine levels after the test meal. A paired t-test between 
treatments at t +35 min showed a significant difference (p <0.05) due to increased 
concentrations after the phenylalanine treatment. 
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Figure 3.8 Plasma phenylalanine concentrations (mean ± SEM, n= 5) following 
either 5g phenylalanine or 5g cornflour (control). The difference in plasma 
phenylalanine levels were significant at t +35 min (paired t-test, p <0.05) and highly 
significant following the ad libitum test meal, resulting in a significant treatment x 
time interaction (p <0.05) over all time points (post hoc Duncan test shows a 
significant difference, p <0.005, after the test meal) and a near significant treatment x 
time interaction (p = 0.074) before the ad libitum test meal (post hoc Duncan test 
shows a significant difference, p <0.05, at t +35 min). 
3.3.6.2.3 Plasma tyrosine 
Since phenylalanine is a precursor for tyrosine synthesis, plasma tyrosine 
concentrations were analysed to discover whether a high dose of phenylalanine could 
significantly increase plasma tyrosine levels. Plasma levels of tyrosine started to 
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increase slightly 35 min after ingestion of the capsules. Following the ad libitum test 
meal, the increased mean plasma levels were approximately 1.6 times higher than the 
meal-induced increase following ingestion of the control. Mean plasma tyrosine 
concentrations are shown for 5 subjects in figure 3.9. Two way, repeated measures 
ANOVA on the change from baseline (x-b) showed the difference in tyrosine 
concentrations between treatments to be nearly significant overall (p = 0.063). There 
was a significant treatment x time interaction (p <0.01) due to the large difference in 
plasma tyrosine levels after the test meal. A paired t-test between treatments at t +35 
min showed that there were not yet any significant differences in plasma levels of 
tyrosine (p = 0.122), and that all the difference occurred following the ad libitum test 
meal. 
0.16 
0.14 
0.12 
0.1 
ý 
0.08 
ý--- 
.5 ° 0.06 
. 2: 1 
0.04 
0 
Preload 
0.02 
Ad libitum 
test areal 
ý: 
ý 
Phenylalanine 
Control 
-10 -5 05 10 15 20 25 30 35 40 45 50 55 
Time (minutes) 
Figure 3.9 Plasma tyrosine concentrations (mean ± SEM, n= 5) following either 
5g phenylalanine or 5g cornflour (control). The difference in plasma tyrosine 
change from baseline values were not significant at t +35 min but highly significant 
following the ad libitum test meal resulting in a treatment x time interaction (p 
<0.01). 
3.3.6.2.4 Plasma leucine 
Plasma leucine levels are shown in figure 3.10 to illustrate the response of 
other plasma amino acids that are not linked to phenylalanine intake. There was no 
difference in plasma levels of leucine between treatments. 
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Figure 3.10 Plasma leucine concentrations (mean ± SEM, n= 5) following either 
5g phenylalanine or 5g cornflour (control). There were no differences in plasma 
leucine concentrations between treatments. 
3.3.6.2.5 Plasma GIP 
There were no differences in plasma GIP concentrations before the ad libitum 
test meal, but the postprandial rise in GIP was clear for both treatments. The mean 
increase in plasma GIP concentrations following the ad libitum test meal (n = 5) was 
larger following the phenylalanine treatment but this was not statistically significant. 
See figure 3.11. 
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Figure 3.11 Plasma GIP concentrations (mean ± SEM, n= 6) following an 
encapsulated treatment of either 5g phenylalanine or 5g cornflour (control). 
There were no significant differences in plasma GIP response. 
3.3.6.2.6 Plasma GLP-1 
There were no differences in plasma GLP-1 concentrations before the ad 
libitum test meal was eaten; plasma GLP-1 levels increased markedly for both 
treatments following the meal (figure 3.12). 
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Figure 3.12 Plasma GLP-1 concentrations (mean ± SEM, n= 6) following an 
encapsulated treatment of either 5g phenylalanine or 5g cornflour (control). 
There were no significant differences in plasma GLP-1 response. 
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3.3.6.2.7 Plasma insulin 
Plasma insulin concentrations are illustrated in figure 3.13. There were no 
significant differences between the profiles following the treatment, but as expected 
there was an increase in plasma insulin following the ad libitum test meal. 
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Figure 3.13 Plasma insulin concentrations (mean ± SEM, n= 6) following an 
encapsulated treatment of either 5g phenylalanine or 5g cornflour (control). 
There were no significant differences in plasma insulin response. 
3.3.6.2.8 Plasma CCK 
Plasma CCK concentrations were higher following the phenylalanine 
treatment compared to control before the ad libitum test meal (see figure 3.14). Two 
way, repeated measures ANOVA showed that there were no overall significant 
differences in plasma CCK levels between treatments. However, there was a 
significant treatment x time interaction before the ad libitum test meal when baseline 
CCK concentrations were included as a covariate (ANCOVA, p <0.05), due to the 
cross-over in CCK response profiles There was also a significant treatment x time 
interaction immediately before (t +35 min) and after the ad libitum test meal when 
baseline CCK concentrations were included as a covariate (ANCOVA, p <0.05). 
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Figure 3.14 Plasma CCK concentrations (mean ± SEM, n= 6) following an 
encapsulated treatment of either 5g phenylalanine or 5g cornflour (control). 
There was a treatment x time interaction when comparing phenylalanine to control 
due to the opposing time-courses in plasma CCK levels before (p <0.05) and after the 
ad libitum test meal (p <0.05). 
3.3.6.3 Energy and food intake 
Energy and food intake was almost identical following phenylalanine or the 
control, and repeated measures ANOVA between the two treatments showed no 
significant differences. See table 3.5. In accord with this, there were no differences in 
protein, fat or carbohydrate intake in terms of weight in grams. 
Treatment Energy Food intake Protein Fat intake CHO intake 
-intake 
(kJ) intake (g) O (g) 
Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM 
Phenylalanine 4631 401 535 50 34 3.0 46 3.9 137 11.7 
Control 4577 395 510 50 33 2.8 46 4.3 134 11.0 
Table 3.5 Food intake by energy (kJ) and weight (g), and macronutrient intake 
by weight (g) following an encapsulated treatment of either 5g phenylalanine or 
5g cornflour (control). 
There were no significant differences in the duration of the ad libitum test 
meal between conditions. 
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3.3.6.4 Subjective ratings for appetite 
Two way, repeated measures ANOVA of the VAS ratings for hunger, desire 
to eat, and fullness, and the change from baseline (x-b) for hunger, desire to eat and 
fullness, showed no significant main effects of treatment. See figures 3.15,3.16 and 
3.17. 
10 Ad 1ibi& m test 
meal 
Zý 
0 
-5 05 10 15 20 25 30 35 40 45 50 55 
Time (min) 
Figure 3.15 Hunger VAS ratings (mean ± SEM, n= 6) following consumption of 
5g encapsulated phenylalanine or cornflour (control). There were no significant 
differences in hunger response. 
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Figure 3.16 Desire to eat VAS ratings (mean ± SEM, n= 6) following 
consumption of 5g encapsulated phenylalanine or cornflour (control). There 
were no significant differences in desire to eat. 
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Figure 3.17 Fullness VAS ratings (mean ± SEM, n= 6) following consumption of 
5g encapsulated phenylalanine or cornflour (control). There were no significant 
differences in fullness response. 
Satiety quotients (SQs) were calculated for hunger, desire to eat and satiety 
ratings but a two-tailed paired t-test revealed no significant differences between 
treatments (p = 0.211,0.276 and 0.560 respectively). 
3.3.7 Discussion 
Previous studies have shown phenylalanine reduces food intake and that it 
also induces a strong CCK secretory response (Meyer & Grossman, 1972; Gibbs & 
Smith, 1977; Owyang et al., 1986; Muurahainen et al., 1988; Ballinger & Clark, 
1994). The present study aimed to investigate the nature of the physiological response 
to phenylalanine consumption that may explain its effects on satiety, especially in 
regard to gastric emptying rate and the satiety peptides CCK and GLP- 1. 
Gastric emptying rate was clearly shown to be slower following treatment 
with phenylalanine compared to the control, as demonstrated by longer half-emptying 
times of a water load obtained by electrical impedance epigastrography. This supports 
a role for delayed gastric emptying in phenylalanine-induced satiety. 
The measurement of plasma phenylalanine concentrations was carried out as 
an indicator of the maximum time taken for the capsules to dissolve in the stomach 
and their contents to reach the intestine. Previous research has shown that the 
pharmacokinetic responses to aspartame capsules differ from those observed when 
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the substance is ingested in a solution (Stegink et al., 1987). Peak plasma 
phenylalanine concentrations were significantly higher and reached significantly 
earlier when 3g aspartame was consumed in a liquid rather than swallowed in 
capsules, which also increased plasma phenylalanine: LNAA (large neutral amino 
acid) ratios. As the initial divergence between plasma phenylalanine profiles over 
time in this study occurred at t +35 min, it can be safely assumed that the capsules 
had at least started to dissolve and that the intestinal mucosa was in direct contact 
with a significant quantity of dissolved phenylalanine. The relatively late appearance 
of plasma phenylalanine is probably due in part to a low solubility (2.965 g in 100 ml 
water), and also the fact that free amino acids are mainly absorbed in the ileum by 
specific amino acid transporters (Kutchai, 1998). The very large increase in plasma 
phenylalanine levels after the ad libitum test meal following treatment with 5g 
phenylalanine compared to 5g cornflour suggests the ingestion of the meal coincided 
with the time when the majority of the phenylalanine dose was absorbed. 
Oral ingestion of a relatively large dose of phenylalanine has a marked effect 
on plasma tyrosine concentrations. Tyrosine is synthesised from phenylalanine, and is 
a precursor in the brain for the catecholamine dopamine, which is involved in the 
regulation of food intake. Tyrosine transport into the brain involves the same large 
neutral amino acid carrier as tryptophan; therefore a tyrosine/large neutral amino 
acids (LNAA) supply-limited mechanism of dopamine synthesis may conceivably be 
involved in appetite regulation. Unfortunately the tyrosine/LNAA ratio could not be 
calculated here, since it was not possible to measure plasma levels of tryptophan 
successfully. Since plasma leucine was unchanged by phenylalanine supplementation 
it can be assumed that the plasma tyrosine/LNAA ratio was increased. However, as 
discussed in section 1.3.2, an enhanced entry of tyrosine into the brain cannot be 
taken to imply increased rates of tyrosine hydroxylation (forming intermediates for 
dopamine synthesis), and the duration of the study was rather short for such a 
process, in the unlikely event that it did take place, to make a difference to short-term 
appetite control. 
Phenylalanine treatment was shown to produce differing plasma CCK 
responses to the control but this was not a simple increased level following one 
treatment compared to the other. Following the control treatment, mean plasma CCK 
levels appeared to increase by 1 pmol/L at t +15 min, whereas they remained steady 
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following phenylalanine. However, this difference did not contribute to the 
significant treatment x time interaction shown for pre-meal values (2 way, repeated 
measures ANOVA with individual values expressed as change from baseline: x-b). In 
fact the difference between plasma CCK concentrations at t +35 min, where levels 
were increased following phenylalanine compared to control, were significant (p 
<0.05) after a post hoc Duncan test and the sole contributory factor to the treatment x 
time interaction. This difference coincides with the time point when plasma 
phenylalanine concentrations start to increase, supporting the hypothesis that 
phenylalanine ingestion increases CCK secretion. Since some phenylalanine was 
absorbed and CCK secretion was also increased by t +35 min, then it can be inferred 
that lumenal phenylalanine was interacting with intestinal receptors or CCK-secreting 
cells between t +25 and t +35 min. 
The difference between CCK levels after the ad libitum test meal, where 
plasma CCK is decreased following phenylalanine treatment, is less robust. A paired 
t-test on the post-meal values (x-b) was not significant (p = 0.145), nor on the raw 
data with either t +35 min or baseline values as covariates. Although this difference 
contributes significantly to the treatment x time interaction over all time points when 
2 way, repeated measures ANOVA (post hoc Duncan test, p <0.05) is carried out on 
the raw data or x-b data, the analysis only includes 5 subjects due to I missing post- 
meal time point. Therefore, the reliability of this result must be questioned. The 
individual data shows that 3 out of 5 subjects showed a decrease in plasma CCK 
concentrations after the meal following phenylalanine treatment. If this is a real 
effect, it could be speculated that the CCK-secreting cell becomes desensitised to the 
stimulation of food as a result of previous exposure to high doses of phenylalanine. 
Further studies would be required before this result could be confirmed. 
The results show that phenylalanine in relatively high doses has no effect on 
plasma levels of glucose, insulin, GIP or GLP-1, either during the fasting state or 
post-prandially. Amino acids to have relatively poor insulinaemic effects following 
ingestion, and there is nothing in the literature to suggest that phenylalanine may be a 
potent secretagogue for GIP or GLP- 1. 
In this study, no concurrent differences in satiety were observed, either in 
terms of food intake or subjective ratings for hunger, desire to eat and fullness. 
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However, this is not surprising since past studies have shown that inter- and intra- 
subject variation is large and in this investigation there were only six subjects. It is 
also possible that the physiological measurements may have been an important factor 
in obscuring any effect on satiety, since cannulation, observing the decanting of blood 
in the same room, and wearing electrodes on the stomach and lower back are hardly a 
natural setting for a meal. 
It can be concluded so far that the phenylalanine ingestion led to a delay in 
gastric emptying and an increase in CCK secretion. This provides support for a CCK- 
mediated mechanism for short-term phenylalanine-induced satiety. However, a direct 
causal relationship between phenylalanine-induced CCK secretion and CCK-induced 
satiety cannot be assumed. Failure to block satiety with CCK-A antagonists following 
an amino acid mixture (equivalent to the amino acid pattern of albumin) (Trigazis et 
al., 1997) or intraduodenal phenylalanine (Yox et al., 1992) in rats suggests that 
CCK-A receptors are responsive to CCK released by protein but not CCK released by 
amino acids in suppressing food intake. One possibility is that protein-stimulated 
CCK acts directly on vagal afferent CCK-A receptors to cause satiety, whereas amino 
acids may act indirectly to increase satiety by delaying gastric emptying thereby 
amplifying gastric distension sensations, since one of the major actions of CCK is in 
delaying gastric emptying. 
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3.4 The effect of alanine supplementation on food intake and 
subjective appetite ratings 
3.4.1 Aims and hypothesis 
Alanine has been used by previous researchers as a control treatment when 
investigating the influence of phenylalanine or aspartame on hunger and satiety 
(Ryan-Harshman et al., 1987; Anderson et al., 1989). However, Rogers & Blundell 
(Rogers & Blundell, 1994) have suggested that alanine itself may have an effect on 
appetite. On this basis it is hypothesised that alanine, administered as a preload, will 
enhance satiation at an ad libitum test meal compared to a control preload of 
cornflour. Subjective visual analogue scales (VAS) and food preference checklists 
will be used to detect any pre-meal changes in appetite. 
3.4.2 Subiects 
Twelve healthy volunteers (7 male, 5 female) aged 18 to 25 years (mean 21, 
SD 2.1 years) were recruited from students at the University of Surrey. BMI ranged 
from 20.5 to 28.5 kg/m2 (mean 23.5, SD 2.7 kg/m2). Volunteers accepted on to the 
study were non-smokers, non-dieting, had no special dietary requirements or unusual 
eating habits, and did not take regular medication (except oral contraceptives or non- 
prescription analgesics). The volunteers were also screened using the Dutch Eating 
Behaviour Questionnaire (van Strien et al., 1986) shown in appendix II, which 
measures dietary restraint, externality and emotionality. Only those men and women 
scoring less than 3.0 overall (mean score 2.4, SD 0.4) were asked to participate. A 3- 
day food diary was completed prior to acceptance on the study in order to highlight 
any unusual dietary habits. 
To ensure that the subjects liked the foods provided but did not eat 
excessively, they were asked to complete a questionnaire that rated food choices and 
excluded foods that they did not like (appendix IV). The subject's second choice for 
each food category was provided in the ad libitum test meal. The subjects were also 
given empty capsules of the type used in the experiment in advance to make sure that 
they could swallow them without any difficulty. Finally, all volunteers signed a 
consent form prior to the first study day that stated they had read the Information for 
Volunteers sheet. The subjects were told that the study was investigating the effect of 
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amino acids on mood and food choice, but they were not told explicitly what the 
capsules contained. The study protocol was approved by the local ethics committee. 
3.4.3 General procedure 
A within-subjects, repeated measures single blind design was used for the 
experiment, with each subject serving as his or her own control. Every subject 
received each of the following: 5g L-alanine (Scientific Hospital Supplies) and 5g 
cornflour (control) in random order. Each dose was administered in 10 opaque 
gelatine capsules, and the capsules were ingested with 400 ml of warm water to 
facilitate the dissolving of the capsules. Subjects were required to attend the Clinical 
Investigation Unit at the University of Surrey on two occasions - each occasion for 
one treatment (test or control). 
The subjects had been instructed to eat a light evening meal and their normal 
(cereal-based) breakfast, and to avoid alcohol from 2000 h the evening before until 
the study. They were also requested to abstain from any heavy or vigorous exercise 
for 24 hours before the study. On the day of the study they were required to drink 
only water and eat only what was provided for them from breakfast onwards. 
Subjects were instructed to come to the Clinical Investigation Unit at the same 
designated time on both occasions (between 1115 h and 1145 h). Table 3.6 shows the 
study protocol. 
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Time 
(min) 
Action Visual analogue scales (VAS) 
and food preference checklist 
-20 Arrive at the investigation unit 
-5  
0 Treatment (consumed capsules + water) 
+5  
+20  
+40  
+60 
Consume ad libitum buffet-style test 
meal. 
 
X75 (after meal termination) 
Table 3.6 Study protocol for the effect of alanine on food intake and subjective 
appetite ratings. 
Whilst eating the ad libitum test meal, the subjects were partitioned to 
minimise social interaction and external influences on eating behaviour. They were 
instructed to eat until they were comfortably full. Subjects could take leftover food 
home if they wished. VAS ratings were not used for well-being ratings (headache, 
stomchache nausea etc. ) as there was a risk that too many ratings might cause 
subjects to take less care over their appetite scores. Instead, subjects were asked if 
they felt well throughout the study period with the intention of noting any side effects 
of alanine consumption. Subjects noted the time of their next eating episode 
following the ad libitum meal. There was a one week interval between sessions. 
3.4.4 Subjective measures of appetite 
Subjects rated their hunger, desire to eat, and fullness and completed food 
preference checklists as described in section 2.2.1.3. 
3.4.5 Treatments and meals 
Capsules: The gelatine capsules were filled with L-alanine or cornflour, 
weighed on a microbalance to ensure that each capsule contained 500 mg exactly. 
Ten capsules made up a5g dose. 
Ad libitum test meal: This was the same meal as described in section 3.2.5 
(appendix III). 
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3.4.6 Results 
3.4.6.1 Energy and food intake 
Mean energy (kJ), food (g) and macronutrient (g) intakes at the ad libitum test 
meal following alanine and control treatments are shown in table 3.7. A paired, two- 
tailed t-test comparing energy, food and macronutrient intake showed no statistically 
significant differences. 
Treat- Energy Food intake Protein Fat intake CHO intake 
ment intake (kJ) (g) intake (g) (g) (g) 
Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM 
Alanine 4526 305 501.7 29.3 33.5 2.6 46.5 3.0 132.4 9.8 
Control 4205 408 463.8 36.5 31.6 3.2 42.8 4.5 123.3 11.8 
Table 3.7 Food intake by energy (kJ) and weight (g), and macronutrient intake 
by weight (g) following consumption of 5g encapsulated alanine or cornflour 
(control). 
There were no significant differences in the time intervals to the next eating 
episode following the ad libitum test meal between conditions, with the average inter- 
meal interval being 3h 17 min (SEM 37 min) and 4h 27 min (SEM 27 min) for 
alanine and the control respectively. 
3.4.6.2 Subjective ratings of appetite 
There was a slight early decrease in desire to eat and an early increase in 
fullness following alanine compared to the control. Two way, repeated measures 
ANOVA showed few significant overall main effects of treatment. Desire to eat was 
decreased at t +5 min following treatment with alanine (p <0.05) compared to control. 
This difference was not significant for hunger (p = 0.110). ANCOVA of fullness 
(with baseline values as covariate) showed a significant effect of treatment over t +5 
and t +20 min (p <0.05), with levels of fullness being greater following alanine 
compared to control. This suggests that alanine increased satiety immediately 
following ingestion of the capsules. See figures 3.18,3.19 and 3.20. 
127 
10 
Ad libin4m test 
meal 
8 
Prebad 
N 
I 
4$ 
2 
0 
05 10 15 20 25 30 35 40 45 50 55 60 65 70 75 
Tim (min) 
Alarir 
a Control 
Figure 3.18 Hunger VAS ratings (mean ± SEM, n= 12) following consumption 
of 5g encapsulated alanine or cornflour (control). There were no significant 
differences in hunger response. 
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Figure 3.19 Desire to eat VAS ratings (mean ± SEM, n= 12) following 
consumption of 5g encapsulated alanine or cornflour (control). Desire to eat (x-b 
values) was decreased at t +5 min following treatment with alanine (paired t-test, p 
<0.05) compared to control. 
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Figure 3.20 Fullness VAS ratings (mean ± SEM, n= 12) following consumption 
of 5g encapsulated alanine or cornflour (control). Fullness ratings (ANCOVA 
with baseline values as covariate) were significantly increased following alanine 
compared to control at time points t +5 and t +20 min (p <0.05). 
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Satiety quotients (SQs) were calculated for hunger, desire to eat and fullness 
ratings but a paired t-test revealed no significant differences between treatments (p = 
0.607,0.444 and 0.914 respectively). 
3.4.6.3 Food preference checklist 
Two way, repeated measures ANOVA on the total number of all foods, 
protein foods, high fat foods, and high carbohydrate foods were analysed. A 
significant main effect of treatment was found for total number of foods selected (x- 
b), with more foods being selected over all time points (including post-meal 
selections) following the control compared to alanine treatment (p <0.05). See figure 
3.21. The opposite relationship was found for number of high protein foods selected 
but this was not statistically significant (figure 3.22). There were no differences in 
number of high carbohydrate items selected between treatments (figure 3.23). A 
paired t-test at t +5 min revealed a near significant difference for number of high fat 
foods selected (x-b), as more items were selected following control compared to 
alanine treatment (p = 0.096). See figure 3.24. 
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Figure 3.21 Change in number of food items selected from the food preference 
checklist (mean ± SEM, n= 12) following consumption of encapsulated alanine 
compared to control. More food items (change from baseline values: x-b) were 
selected following the control treatment compared to alanine treatment (p <0.05). 
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Figure 3.22 Change in number of high-protein food items selected from the food 
preference checklist (mean ± SEM, n= 12) following consumption of 
encapsulated alanine compared to control. There were no significant differences 
between treatments. 
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Figure 3.23 Change in number of high-carbohydrate food items selected from 
the food preference checklist (mean ± SEM, n= 12) following consumption of 
encapsulated alanine compared to control. There were no significant differences 
between treatments. 
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Figure 3.24 Change in number of high-fat food items selected from the food 
preference checklist (mean ± SEM, n= 12) following consumption of 
encapsulated alanine compared to control. There were no significant differences 
between treatments, but a paired t-test at t +5 min revealed a near significant 
difference for number of high fat foods selected (x-b), (p = 0.096). 
Side effects such as nausea or headache were not reported by any subject 
following alanine consumption. 
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3.4.7 Discussion 
The aim of this study was to determine whether alanine could exert a similar 
suppressive influence on food intake to phenylalanine. This would clarify whether 
alanine is a suitable nutrient to use as a control treatment when investigating the 
satiating properties of other amino acids or aspartame, as used by previous 
researchers (Ryan-Harshman et al., 1987; Anderson et al., 1989). Various tools were 
used to measure appetite, including food intake assessment at an ad libitum test meal, 
VAS ratings of hunger, desire to eat and fullness, and food preference checklists. 
The food intake data showed that alanine had no effect on energy, weight of 
food or macronutrient intake at the ad libitum test meal 60 min later. These results are 
at odds with those reported by Rogers & Blundell (1994), when they reanalysed the 
negative data from a study on the effect of phenylalanine on food intake that used 
alanine as a control (Ryan-Harshman et al., 1987). Rogers & Blundell concluded that 
alanine suppressed food intake in that study, although less potently than 
phenylalanine. Based on this evidence, it is surprising that the hypothesis for the 
present study is not supported. In addition to this, there was no difference in the 
duration of the inter-meal interval following the ad libitum test meal. 
However, the lack of effect of alanine on food intake was not reflected by the 
subjective appetite measurements. Early appetite responses to the treatments appeared 
to be affected, with desire to eat reduced by alanine at t +5 min and fullness increased 
by alanine at t +5 and t +20 min. In addition to this, a significant main effect of 
treatment was uncovered for change from baseline in total number of food items 
selected from the food preference checklists; alanine ingestion resulted in fewer food 
items being selected overall. This suggests that, although food intake was unaffected, 
pre-meal subjective hunger and satiety were influenced by alanine ingestion. Ryan- 
Harshman et al. (1987) did not find any statistically significant treatment effects from 
their VAS data for hunger but this can be explained by the fact that they were filled 
out too infrequently, i. e. immediately before treatment, immediately before the ad 
libitum test meal, and after the ad libitum test meal. Alanine may influence appetite 
but this is likely to be through a different mechanism to phenylalanine. Although 
phenylalanine has no effects on pre-meal subjective appetite, it causes a dose- 
dependent reduction in food intake (Rogers & Blundell, 1994; see section 3.2), and it 
has been postulated that this may be because phenylalanine enhances the satiating 
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capacity of food. However, alanine reduced hunger and decreased fullness before the 
meal but did not affect food intake. Thus it can be theorised that the influence of 
alanine on motivation to eat is overruled by the presence of other nutrients in the 
gastrointestinal tract. 
3.5 The effect of aspartame and aspartame constituents on gastric 
emptying, plasma cholecystokinin and eluca8on-like peptide-1 
response 
3.5.1 Aims and hypothesis 
Aspartame has previously been found to increase satiety in human subjects 
(Leung et al., 1968). The hypothesis for this study is that aspartame affects satiety by 
potentiating CCK secretion in the presence of nutrients in the intestine, and 
consequently delaying gastric emptying. This study will determine whether aspartame 
has any such physiological effects. The possibility that aspartame may alter the 
secretion of other gut hormones will be examined. Whether the whole and the amino 
acid constituents, phenylalanine and aspartic acid, have the same effects when 
administered in equivalent amounts will also be explored. 
3.5.2 Subiects 
Six lean healthy volunteers (4 female and 2 male) were recruited from the 
University, aged 24 to 31 years (mean 27.7, SD 2.9 years). The volunteers were all 
non-dieting, with no special dietary requirements, and a BMI <25 kg/m2 (mean 20.1, 
SD 1.5 kg/m2). They had no significant current or previous medical history (including 
phenylketonuria) and took no medication apart from the oral contraceptive pill and 
occasional minor analgesics. They were selected on the basis of their responses to the 
Dutch Eating Behaviour Questionnaire (mean score 2.4, SD 0.2)(van Strien et al., 
1986) shown in appendix II, and their physical activity levels. Subjects did not 
consume more than 20 units of alcohol per week. 
All subjects were interviewed and a venous blood sample taken for 
haematological and biochemical screening to confirm their suitability to participate in 
the study. The volunteers signed a consent form before they were accepted onto the 
study, which included a statement that they understood that they would be donating 
some blood as part of the study. Their GP was informed of their participation in the 
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study, and was given the opportunity to notify the researcher of any reason why they 
should not take part. The study protocol was approved by the local ethics committee. 
3.5.3 General procedure 
A within-subjects, repeated measures design was used for the experiment, 
with each subject serving as his or her own control. Subjects were asked to refrain 
from consuming alcohol, caffeine and products containing aspartame or paracetamol 
the evening before, and until the study. On the day of the study they were required to 
consume nothing except water until 90 min before the study, and then no water until 
the study began. 
Subjects arrived at the Clinical Investigation Unit at the University of Surrey 
between 0730 h and 0900 h (two people per study day), and an intravenous cannula 
was inserted into an antecubital vein in the forearm under local anaesthetic by a 
qualified doctor or nurse. Blood samples were taken according to the methodology 
detailed in section 2.2.3.1. Six electrodes were positioned over the stomach and lower 
back to measure gastric emptying by EIE, as detailed in section 2.2.2.2. Once a 
satisfactory ten minute baseline reading had been obtained for the EIE recordings, the 
subjects consumed one capsule containing either the placebo, aspartame or aspartic 
acid + phenylalanine, together with 450 ml water containing 3 dissolved crushed 
paracetamol tablets (1.5 g paracetamol). Blood samples were taken for the 
measurement of plasma glucose, amino acids, CCK, GLP-1, GIP and insulin, and 
VAS sheets (appendix V) were completed according to the protocol shown in table 
3.8. Sixty min after ingestion of the capsule and water the EIE recordings were 
stopped and the subject was given the opportunity to move about. Immediately on 
their return the EIE recordings were restarted, and when a steady baseline had been 
attained (approximately 5 min later) a liquid test meal was offered to the subject. 
Another hour of blood samples and VAS questionnaires followed. 
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Table 3.8. Study protocol for the effect of aspartame and constituent amino 
acids on gastric emptying, plasma metabolite and hormone response and 
subjective appetite ratings. 
3.5.4 Treatments and meals 
Capsules: The capsules were filled with 400 mg aspartame (donated by 
NutraSweet Powder, Forum Products Ltd, Redhill) or 176 mg of L-aspartic acid + 
224 mg L-phenylalanine (Scientific Hospital Supplies, Liverpool) (the same amounts 
as 400 mg aspartame), or 400 mg cornflour (control), and they were weighed out on a 
microbalance. 
Test meals: A liquid test meal containing 1992 kJ was consumed by the 
subject on each of the 3 study days. The liquid test meal was mixed using an electric 
blender and was formulated using double cream, maltodextrin and strawberry- or 
banana-flavoured Nesquik and were made up to 450 ml in volume with water (see 
table 3.9). 
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Ingredient 
Double Cream 
Maltodextrin 
Nesquik 
Total energy 
Content 
46 g (22 g water, 22 g fat, 
<1 g protein, 1.2 g CHO, 
828 kJ) 
50g(50gCHO, 837 U) 
20 g (20 g CHO, 326 kJ) 
1992 kJ 
Table 3.9 Composition of liquid test meal used to test the physiological effects of 
ingesting aspartame or aspartame constituents (400 mg). 
3.5.5 Subjective measures of appetite 
Subjects rated their hunger, desire to eat, fullness, and thirst as detailed in 
section 2.2.1.3. 
3.5.6 Results 
3.5.6.1 Gastric emptying 
3.5.6.1.1 Electrical Impedance Epigastrography 
Figure 3.25 shows that gastric half-emptying times (T50s) following the liquid 
test meal were shorter following the constituent amino acids: 
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Figure 3.25 Mean gastric emptying T50s (± SEM, n= 6) following aspartame or 
its amino acid constituents compared to the control treatment. Gastric emptying 
times following the liquid test meal were significantly different between treatments 
(p <0.005), with shorter T50s following the constituent amino acids. 
Results were analysed using repeated measures ANOVA, and it was shown 
that there were no differences between the treatments following the water load but 
that they were significantly different following the liquid test meal (p = 0.002), with 
the post-hoc Duncan test showing that T50s were shorter following the amino acids 
compared to the control and aspartame. The aspartame and control gastric emptying 
times were very similar for five out of six of the subjects. 
The percentage volume emptied following each liquid load is illustrated in 
figure 3.26. Repeated measures two way ANOVA showed that there was a significant 
overall treatment effect (p <0.0005), and the post-hoc Duncan test showed that there 
was a greater percentage volume retained following the control compared to the 
aspartame (p <0.05) and amino acids (p <0.0005), and following the aspartame 
treatment compared to the amino acids (p <0.005). 
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Figure 3.26 Percentage volume of liquid test meal remaining in the stomach 
consumed one hour after ingestion of aspartame, constituent amino acids of 
aspartame or the control (mean ± SEM, n= 6). The rate of gastric emptying 
significantly decreased firstly with aspartame, and to a greater extent following the 
constituent amino acids. 
3.5.6.1.2 Paracetamol absorption 
Plasma paracetamol concentrations were measured for 60 min following 
ingestion of the treatment (aspartame, constituent amino acids or control), 1.5 g 
paracetamol and the water load (figure 3.27). Time until peak concentration (tmax), 
peak concentration (cmax) and area under the curve (AUC) were calculated for each 
subject's paracetamol results for the first sixty min until the liquid test meal. There 
were no significant differences between treatments. 
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Figure 3.27 Plasma paracetamol concentrations following consumption of 
aspartame or constituent amino acids compared to control (mean ± SEM, n= 6). 
There were no significant differences in plasma levels between treatments. 
The parameters of gastric emptying of the water load were as follows (table 3.10): 
Control Aspartame Phenylalanine + aspartic acid 
Mean SEM Mean SEM Mean SEM 
tmax (min) 30.0 7.8 27.5 4.6 32.5 7.2 
cmax (mmoUL) 0.19 0.02 0.17 0.01 0.18 0.02 
AUC mmol/L by min 7.47 0.94 7.69 0.66 7.69 0.94 
AUC tO tot +15 min 
mmo VL by min) 
1.85 0.50 1.67 0.28 1.52 0.44 
Table 3.10 Gastric emptying parameters for paracetamol absorption following 
consumption of aspartame or constituent amino acids compared to control. 
Mean (± SEM) n=6. Repeated measures ANOVA between the treatments show no 
significant differences. 
3.5.6.2 Blood metabolites and hormones 
3.5.6.2.1 Plasma lud cose 
Figure 3.28 shows plasma glucose concentrations. As expected, plasma 
glucose levels increased significantly following the liquid test meal, and ingesting 
aspartame or phenylalanine + aspartic acid had no effect on plasma glucose 
concentrations compared to baseline. Two way repeated measures ANOVA revealed 
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no significant differences in glucose response either before or after the liquid test 
meal. 
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Figure 3.28 Plasma glucose concentrations following consumption of aspartame 
or constituent amino acids compared to control (mean ± SEM, n= 6). There were 
no significant differences in plasma levels between treatments. 
3.5.6.2.2 Plasma phenylalanine 
Figure 3.29 shows plasma phenylalanine concentrations (n = 5). 
Phenylalanine levels increased following aspartame and constituent amino acids 
ingestion compared to the control. Two way, repeated measures ANOVA (values as 
change from baseline, x-b) revealed a main treatment effect (p <0.05) on plasma 
levels, with a post hoc Duncan test between treatments showing the greatest 
differences to lie between the constituent amino acids and control treatments (p 
<0.05), followed by aspartame compared to control (p = 0.06). If the plasma 
phenylalanine profiles are separated into pre-meal and post-meal levels, there was a 
main treatment effect before the liquid test meal that was marginally non-significant 
(p = 0.067), but this difference is more marked following the liquid test meal (p 
<0.05). Plasma phenylalanine levels appeared to increase more quickly following the 
aspartame compared to the phenylalanine + aspartic acid treatment. 
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Figure 3.29 Plasma phenylalanine concentrations (x-b) following consumption of 
aspartame or constituent amino acids compared to control (mean ± SEM, n= 5). 
There was a significant main effect of treatment on overall phenylalanine levels (p 
<0.05). Phenylalanine levels were significantly different from control following 
phenylalanine + aspartic acid (p <0.05), and aspartame (p <0.05) following the liquid 
test meal. 
>o E 
142 
3.5.6.2.3 Plasma aspartic acid 
Plasma aspartic acid concentrations (n = 5) are shown in figure 3.30. There 
were no significant main effects of treatment, time or treatment x time interactions on 
plasma aspartic acid levels. 
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Figure 3.30 Plasma aspartic acid concentrations (x-b) following consumption of 
aspartame or constituent amino acids compared to control (mean ± SEM, n= 5). 
There were no significant differences in plasma aspartic acid levels between 
treatments. 
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3.5.6.2.4 Plasma tyrosine 
Plasma tyrosine concentrations (n = 5) are shown in figure 3.31. There were no 
significant main effects of treatment, time or treatment x time interactions on plasma 
tyrosine levels. 
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Figure 3.31 Plasma tyrosine concentrations (x-b) following consumption of 
aspartame or constituent amino acids compared to control (mean ± SEM, n= 5). 
There were no significant differences in plasma tyrosine levels between treatments. 
3.5.6.2.5 Plasma CCK 
Plasma CCK concentrations are illustrated in figure 3.32. Plasma CCK 
remained at baseline levels following the treatment until the liquid test meal, when 
there was a rise in CCK levels following all treatments. There were no significant 
differences between CCK responses to treatment, nor were there any treatment x time 
interactions. 
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Figure 3.32 Plasma CCK concentrations following consumption of aspartame or 
constituent amino acids compared to control (mean ± SEM, n= 6). There were no 
overall, pre-meal or post-meal significant differences in plasma CCK levels between 
treatments. 
3.5.6.2.6 Plasma insulin 
Mean plasma insulin concentrations are shown in figure 3.33. There were no 
significant effects of treatment either before or after the liquid test meal on plasma 
insulin response. 
3.5.6.2.7 Plasma GIP 
Mean plasma GIP concentrations are shown in figure 3.34 There were no 
significant differences between treatments either before or after the liquid test meal. 
The plasma GIP value at 90 min appears to be reduced following the control pre- 
treatment compared to the aspartame and amino acids, although this difference is not 
statistically significant by repeated measures ANOVA at that time point (p = 0.19). 
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Figure 3.33 Plasma insulin concentrations following consumption of aspartame 
or constituent amino acids compared to control (mean f SEM, n= 6). There were 
no significant differences in plasma insulin levels between treatments. 
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Figure 3.34 Plasma GIP concentrations following consumption of aspartame or 
constituent amino acids compared to control (mean ± SEM, n= 6). There were no 
significant differences in plasma GIP levels between treatments. 
3.5.6.2.8 Plasma GLP-1 
Mean plasma GLP-l concentrations are shown in figure 3.35. The plasma 
GLP-1 response to the liquid test meal was higher following the control compared to 
the aspartame and the constituent amino acids. Results were analysed using repeated 
measures two-way ANCOVA (with baseline values as covariate), and it was shown 
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that there was a main treatment effect on plasma GLP-1 concentrations (p <0.05), 
with the post-hoc Duncan test showing this to be the product of lower GLP-1 
concentrations following the aspartame compared to control at t +75 and t +90 min (p 
<0.00005 and p <0.005 respectively), and amino acids at t +75 and t +90 mins (p 
<0.0001 and p <0.005 respectively). 
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Figure 3.35 Plasma GLP-1 concentrations following consumption of aspartame 
or constituent amino acids compared to control (mean ± SEM, n= 6). Significant 
differences were found between treatments overall (p <0.05). GLP-1 plasma 
concentrations were strongly suppressed following the liquid test meal due to prior 
ingestion of aspartame and phenylalanine + aspartic acid. 
3.5.6.3 Subjective ratings of appetite 
Desire to eat was suppressed following the liquid test meal as a result of 
treatment with the constituent amino acids. Figures 3.36,3.37 and 3.38 show hunger, 
desire to eat and fullness respectively following the aspartame and constituent amino 
acids. 
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Figure 3.36 Hunger VAS ratings (mean ± SEM, n= 6) following consumption of 
aspartame or constituent amino acids compared to control. There were no 
significant differences in hunger response. 
Hunger 
Although there appeared to be a trend for reduced hunger ratings following 
the constituent amino acids, two way repeated measures ANCOVA (with baseline as 
covariate) and ANOVA (x-b values) did not uncover any significant differences 
between treatments, either overall time points, pre-meal or post-meal. 
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Figure 3.37 Desire to eat VAS ratings (mean ± SEM, n= 6) following 
consumption of aspartame or constituent amino acids compared to control. 
Desire to eat was significantly suppressed following the liquid test meal as a result of 
prior ingestion of the constituent amino acids, phenylalanine + aspartic acid (p 
<0.05). 
Desire to eat 
Desire to eat was significantly reduced following the liquid test meal as a 
result of prior ingestion of the constituent amino acids. 
Two way repeated measures ANCOVA (with baseline as covariate) over the 
entire time course of desire to eat ratings revealed no main treatment effects but a 
treatment x time interaction (p <0.05). Repeating this procedure over the pre-meal 
ratings failed to produce any significant differences. There was a significant treatment 
effect on change in desire to eat from the pre-liquid test meal baseline (60 min) (p 
<0.05), due to the suppression of desire to eat following pre-treatment with the 
constituent amino acids, phenylalanine and aspartic acid. 
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Figure 3.38 Fullness VAS ratings (mean ± SEM, n= 6) following consumption of 
aspartame or constituent amino acids compared to control. There were no 
significant differences in fullness between treatments. 
Fullness 
There were no significant main treatment effects or treatment by time 
interactions for fullness ratings. 
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3.5.6.3.1 Correlations between desire to eat and plasma phenylalanine/ aic 
emptying times following the liquid test meal 
Figure 3.39 shows that the change in plasma phenylalanine at t +75 min (x-b) 
and the change in desire to eat were significantly correlated following the constituent 
amino acids (r = -0.9774, p=0.004). There were no significant associations between 
gastric half-emptying times (T50s) and change in desire to eat (t +70 -t +60 min). 
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Figure 3.39 The association between individual ratings of change in desire to eat 
(cm) following ingestion of the liquid test meal (t +70 -t +60 min) and change in 
plasma phenylalanine concentrations at t+ 75 min (mmol/L). There was a 
significant correlation between these parameters following the constituent amino 
acids (p <0.005), but the association was marginally non-significant following the 
aspartame treatment (p = 0.056). 
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3.5.7 Discussion 
The hypothesis for the present study was made up of three parts: 
A) aspartame increases CCK secretion, 
B) aspartame delays gastric emptying (via CCK), 
C) aspartame increases satiety at a meal by these two linked mechanisms. 
The results did not support any part of this hypothesis for the following reasons: 
A) CCK secretion was unaffected by ingestion of 400 mg aspartame or 
equivalent constituent amino acids (figure 3.32), 
B) gastric emptying times were slightly shorter following aspartame and 
markedly shorter by equivalent constituent amino acids (figures 3.25 and 
3.26), 
C) food intake at a meal was not measured but aspartame did not affect 
subjective hunger, desire to eat or fullness either before or after a liquid meal. 
However, subjective ratings of desire to eat post-meal were reduced by prior 
ingestion of the constituent amino acids (figures 3.36,3.37, and 3.38). 
Unexpected effects were also observed: 
A) GLP-1 secretion was attenuated following the test meal when encapsulated 
aspartame or its constituent amino acids are consumed 60 min earlier, 
B) the time course of plasma levels of phenylalanine differed between aspartame 
and the constituent amino acids. 
It was also demonstrated that ingestion of 400 mg aspartame or its constituent 
amino acids had no effects on gastric emptying of water before the ingestion of a 
fat/carbohydrate-containing liquid meal. In addition, there were no differences in 
plasma glucose, aspartic acid, tyrosine, insulin, or GIP following any treatment. 
The lack of effect of aspartame and the constituent amino acids on plasma 
CCK concentrations does not support the theory that aspartame induces satiety by 
potentiating the release of CCK in response to food (Rogers & Blundell, 1992). 
Previous work in human subjects showing the release of CCK in response to 
phenylalanine has involved much larger doses of up to 10 g (Ballinger & Clark, 1994; 
section 3.2). This is approximately 50 times the amount of phenylalanine used in this 
experiment and therefore it is not surprising that an increase in plasma CCK levels 
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was not demonstrated here. Rogers & Blundell had identified CCK as a likely 
mediator for phenylalanine- and aspartame-induced satiety because both CCK and 
aspartame require a gastric stimulus to reduce appetite - gastric loads amplify satiety 
produced by CCK infusions (Schwartz et at., 1991) and aspartame fails to affect pre- 
meal VAS ratings but strongly reduces food intake. Rogers & Blundell (1992) also 
highlighted that the C-terminal dipeptide of CCK (and gastrin) contains the amino 
acid sequence Asp-Phe. The possibility of aspartame acting as a kind of CCK 
receptor agonist, however, is remote due to the fact that aspartame is hydrolysed to 
aspartic acid and phenylalanine before it can enter the circulation and that C-terminal 
CCK fragments with a sequence less than 4 amino acids do not show significant 
activity at CCK receptors (Ranney et al., 1976; Rehfeld et al., 1980; Opperman, 
1984; Cherner et al., 1988). Aspartame may well induce an increase in CCK secretion 
at higher doses of 2-5 g, but not at the low levels of intake previously shown to 
reduce food intake (Rogers et al., 1990; Rogers et al., 1991). 
Since no impact was made on plasma CCK levels by 400 mg aspartame or 
constituent amino acids, it is not unexpected that gastric emptying was not delayed 
either. If CCK had been elevated, a slower gastric emptying rate would have been a 
likely outcome. However, the apparent acceleration in gastric emptying rate following 
the liquid meal, shown by % volume of meal retained in the stomach following 
aspartame and phenylalanine + aspartic acid, was not anticipated. This effect was 
stronger following the constituent amino acids, as shown by the lack of significance 
for the shorter T50s following aspartame. It is indicated by the data, therefore, that 
aspartame weakly accelerated gastric emptying, and the constituent amino acids were 
a stronger stimulus of emptying rate. 
The finding that gastric emptying is accelerated following the liquid test meal 
as a result of pre-treatment with aspartame or the constituent amino acids is open to 
criticism regarding the methodology. Gastric emptying in the second half of the 
experiment was measured by EIE alone, and the discovery that the half-emptying 
times obtained using this method are clearly shorter than physiologically possible for 
a 1992 kJ meal raises some important questions. Since this method measures 
electrical conductivity and thus impedance, then gastric secretions are a source of 
impedance error since they may increase the conductivity of gastric contents, 
reducing total impedance and apparent emptying times. A non-conductive meal such 
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as the fat/carbohydrate liquid meal used in the present study would appear to empty 
faster than the true rate of emptying. Does the apparent acceleration in gastric 
emptying rate following the aspartame and amino acids result from a stronger 
stimulation of gastric acid secretion? 
Administration of large amounts of mixed amino acids, phenylalanine, 
tryptophan and histidine strongly stimulates gastrin and gastric acid secretion as 
shown by many researchers (Elwin, 1974; Cieszkowski et al., 1975; Walsh et al., 
1975; Konturek et al., 1976; Richardson et al., 1976; Byrne et al., 1977; Konturek et 
al., 1978a; Taylor et al., 1982). The administration of phenylalanine in the present 
study did not seem to affect gastric acid secretion in the first hour, or if it did the 
effect was not strong enough to be reflected in the gastric impedance results. We 
know that gastric emptying was unaffected during this time from the paracetamol 
data. Plasma phenylalanine levels began to increase at t +15 min and were 
significantly raised by t +60 min following the constituent amino acids, indicating 
that ingested phenylalanine had been in contact with gastric and intestinal mucosa 
during the first hour but failed to increase gastric acid secretion by a significant 
enough amount to affect impedance results. The studies that had shown increased 
gastric acid secretion following oral or gastric infusion of amino acids used larger 
amounts than used in the present study, typically 10 g or more (Cieszkowski et al., 
1975; Walsh et al., 1975; Konturek et al., 1976; Richardson et al., 1976; Byrne et al., 
1977; Konturek et al., 1978a; Taylor et al., 1982). Therefore, it cannot be inferred 
from these publications that the small amounts of phenylalanine (224 mg) used in this 
study increased pre-meal gastric acid secretion, especially as there was no evidence 
from the impedance data to suggest this. 
It has previously been shown, however, that intravenous administration of 
amino acids can increase gastric acid secretion via a gastrin-independent mechanism 
(Konturek et al., 1978a; Konturek et al., 1978b). This raises the possibility that the 
absorbed plasma phenylalanine in the latter half of the experiment (60-120 min) may 
have been stimulating gastric acid secretion during the gastric emptying of the 
fat/carbohydrate liquid test meal. During this time, faster emptying rates were shown 
following the constituent amino acids (when larger increases in plasma phenylalanine 
were observed), and to a lesser extent following the aspartame. Do these apparent 
shorter emptying times represent an increase in acid secretion and therefore a 
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reduction in impedance, or are they really a reflection of accelerated emptying rates? 
The work of Konturek and colleagues was further supported by other researchers who 
used physiological plasma levels of the aromatic amino acids (McArthur et al., 1983; 
Lenz et al., 1988). McArthur and colleagues intravenously infused graded doses of 
phenylalanine and tryptophan at physiological plasma levels over 4 hours in human 
subjects. Intravenous L-phenylalanine (at 3.13 mmol/h, or 65 mg/h in 125 ml) 
stimulated gastric acid secretion to 39% of the response to pentagastrin (maximal acid 
response) independently of gastrin while plasma phenylalanine concentrations were 
only raised to 0.09 mmol/L from a baseline of 0.05 mmol/L. Plasma phenylalanine in 
the present study rose from a mean baseline of 0.07 mmol/L to a mean peak of 0.107 
mmol/L at t +60 min following the constituent amino acids treatment; this elevation 
in plasma phenylalanine is certainly of a scale comparable to those observed by 
McArthur et al. (1983), and therefore one which you would expect to stimulate 
gastric acid secretion if similar physiological responses were occurring. 
However, the present study differs from the McArthur study. A major 
difference, apart from the route of administration, is that the subjects in this study 
also consumed a fat/carbohydrate-containing liquid test meal at the time of peak 
plasma phenylalanine levels. The meal itself was neutral (pH 6.6) and the double 
cream would have had a buffering effect on the acidity of the stomach contents. 
Furthermore, research has shown that 20 g intraduodenal fat completely inhibits the 
gastric acid response to intravenous amino acids + glucose; moreover intravenous fat 
nearly completely inhibits it (Varner et al., 1980). The liquid test meal used in the 
present study contained 22 g fat. It was shown in another study that intravenous 
infusion of glucose to maintain hyperglycaemia (plasma glucose 15 mmol/L) also 
completely abolished the gastric acid response to intravenous amino acids infused at 
10 g/hour (Lam et al., 1995). Plasma glucose levels only peaked at a mean 
concentration between 7.7 and 9.2 mmol/L in the present study (t +120 min), but 
systemic concentrations may have been raised enough to contribute to an inhibitory 
effect on gastric acid secretion. Furthermore, a study that looked at intravenous amino 
acids infusion using a solution that imitated physiological postprandial amino acid 
patterns found that basal gastric acid secretion was barely increased; they concluded 
that the findings of McArthur et al. (1983) were probably physiologically irrelevant 
as there may have been an unknown potentiating effect of the infusion of 
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phenylalanine and tryptophan together without any other amino acids present 
(Schulte-Frohlinde et al., 1993). 
No measurements of gastric acid secretion were made in this study and 
therefore no firm conclusions can be drawn regarding the validity of these gastric 
emptying results. Gastric acid secretions were not detected by EIE during the first 
half of the study when the water load was emptied, and usually gastric distension 
prompts an increase in gastric acid secretion (Richardson et al., 1976). Possibly a 
large increase in gastric acid secretion is required to alter epigastric impedance and 
confound the gastric emptying results. If the post-prandial rise in plasma 
phenylalanine was likely to elicit a greater increase in gastric acid secretion above 
control levels following the liquid test meal, it is likely that this would have been 
completely inhibited by the entry of fat and carbohydrate into the duodenum and their 
consequent absorption. In considering the facts, it can be concluded that EIE gastric 
emptying times in this experiment are probably quantitatively inaccurate, but any 
differences identified are likely to represent genuine changes in gastric emptying 
rates. With hindsight it would have been preferable to use the paracetamol absorption 
method with the liquid test meal but it was not known whether there would be any 
effect on gastric emptying nor when these effects would occur. 
The reasons why phenylalanine and aspartic acid, and to a lesser extent 
aspartame, stimulated gastric emptying in this study are not obvious. Initially, these 
finding seem to contradict previous observations (see section 3.3) where ingestion of 
phenylalanine delayed gastric emptying. However, this study only used 224 mg 
phenylalanine + 176 mg aspartic acid unlike the previous study which used 5g 
phenylalanine (22 times more). It is likely that these greatly differing doses of 
phenylalanine provoked two different physiological responses. Another major 
difference is that the 5g phenylalanine delayed gastric emptying of a water load, 
whereas 224 mg phenylalanine + 176 mg aspartic acid did not affect of emptying of a 
water load but did accelerate gastric emptying of a fat/carbohydrate-containing load. 
The interaction of the nutrients with the intestine therefore, may have modified the 
response to the amino acids. The most obvious difference between these studies is the 
aspartic acid component. Although the majority of aspartic acid (>99 %) is consumed 
in energy metabolism pathways in the intestinal mucosa (Kutchai, 1998; Wu, 1998), a 
fact borne out by the failure to increase plasma aspartic acid concentrations at any 
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time following ingestion, it may have interacted with receptors or enteroendocrine 
cells in the lumen before absorption. However, there is little in the literature to 
suggest that aspartic acid has any effects on gastric emptying rates, apart from a study 
where aspartic acid relaxed guinea pig fundic muscle cells and this would inhibit 
emptying (Huizinga, 1980). It is an excitatory amino acid and when localised in nerve 
terminals in the CNS is classed as a neurotransmitter, but the relevance of this to 
lumenal aspartic acid is questionable. 
The reduction in desire to eat observed after the liquid test meal following 
prior ingestion of the capsule containing the constituent amino acids supports 
previous findings to a limited extent. The lack of effect of treatment following the 
water load on all three appetite variables (hunger, desire to eat and fullness) supports 
the original assertion that aspartame does not influence pre-meal motivation to eat 
(Rogers et al., 1995). However, the absence of any significant differences in hunger 
or fullness following the liquid test meal is difficult to explain. The change in hunger 
following the test meal is also reduced as a result of prior constituent amino acid 
ingestion, an observation that supports the desire to eat findings even though non- 
significant. The lack of effect on fullness may be just a weakness in the methodology. 
The fact that the meal was in liquid form may have reduced its satiating properties 
and therefore it proved difficult for the subjects to rate how full they felt without a 
strong satiety stimulus. 
The suppression of desire to eat following the constituent amino acids but not 
following the aspartame during the second part of the study is an ambiguous finding. 
However, the primary purpose of this study was to discover the endocrine and 
metabolic effects of small doses of aspartame and constituent amino acids, as the 
satiety effects had already been clearly demonstrated on a number of occasions 
(Rogers et al., 1990; 1991; 1995). The small subject number used in this study design 
was adequate to detect physiological changes but typically studies designed to 
determine appetite effects use a much larger number of subjects. The problem of 
sample size was exacerbated by the invasive nature of the protocol, with the 
electrodes and wires from the EIE equipment and the cannulation for blood samples 
possibly impinging on the ability of the subjects to judge their motivation to eat 
consistently. 
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The attenuation of GLP-1 secretion following aspartame and constituent 
amino acids after ingestion of the liquid test meal is an unexpected finding, since the 
GLP-1 response is reduced under the same conditions where food intake is usually 
suppressed (Rogers et al., 1990; 1991; 1995), and where post-prandial desire to eat is 
reduced. The reduction in desire to eat was only shown following the constituent 
amino acids, whereas the suppression of GLP-1 levels occurred following both the 
aspartame and the constituent amino acids. It thus appears that GLP-1 levels are not 
linked to the appetite responses to aspartame and constituent amino acids, and that the 
attenuation of GLP-1 secretion is a side effect of administration of these amino acids 
and dipeptides. 
Reduced GLP-1 secretion may have reduced the level of inhibition of gastric 
emptying, and indeed it has been shown that the gastric emptying rate of the liquid 
test meal is accelerated following the two treatments - markedly following the amino 
acids, and less so following the aspartame. Whether there is a cause and effect 
relationship between these observations or that they were simply a result of another 
unknown factor remains to be established. 
Plasma levels of phenylalanine, tyrosine and aspartic acid were measured in 
order to obtain some idea of how soon the amino acids were absorbed and whether 
there were any differences in plasma profiles between aspartame and the constituent 
amino acids. The results for plasma phenylalanine were interesting. Plasma 
phenylalanine following the control remained at basal levels until the liquid test meal, 
when concentrations dropped considerably. This was expected, as the carbohydrate in 
the liquid test meal would have induced insulin secretion, which would enhance 
amino acid uptake into the tissues. Following aspartame, plasma concentrations were 
already slightly increased by t +15 min (non-significant p=0.088, n= 5) and then 
remained at a fairly constant level until t +90 min, when concentrations began to 
decline. Following phenylalanine + aspartic acid, plasma levels of phenylalanine did 
not increase significantly until t +60 min (p <0.005, n_ 5), at which point the 
increase was rapid and very distinct. Concentrations remained elevated at t +75 min 
and then dropped to previous levels at t +90 min. These pharmacokinetic differences 
cannot be the result of the rate of capsule dissolution as conditions were identical for 
each treatment. Therefore, the aspartame must have dissolved or been absorbed in the 
intestine at a different rate to the constituent amino acids. Aspartame is relatively low 
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in solubility (-3 g in 100 ml water), and phenylalanine and aspartic acid have even an 
even lower combined solubility (2.965 g and 0.778 g in 100 ml water respectively), 
and therefore it is probable that aspartame was absorbed earlier and at a slower rate 
than the constituent amino acids. This probability is supported by the fact that the rate 
of absorption of di- and tripeptides across the small peptide membrane transport 
system in the brush border is faster than the rate of individual amino acid transport. In 
addition, most of the amino acids that are absorbed in the jejunum are transported in 
to the epithelial cells as di- and tripeptides. The majority of free amino acids are 
consequently absorbed in the ileum via specific amino acid transport systems 
(Kutchai, 1998). Therefore, the blunted increase in plasma phenylalanine 
concentrations following aspartame is probably due to low solubility and the time 
required for its methyl group to be hydrolysed by intestinal esterases to yield 
methanol and aspartylphenylalanine; the earlier appearance of higher concentrations 
of phenylalanine may be because the dipeptide aspartylphenylalanine was absorbed 
more rapidly than the free amino acids and a greater proportion of dipeptides are 
absorbed in the jejunum. Some of the aspartylphenylalanine dipeptide may have been 
further broken down to free amino acids before absorption. The comparatively late 
appearance of plasma phenylalanine following the constituent amino acids, although 
also relatively low in solubility, is probably due to the fact that free amino acids are 
mainly absorbed in the ileum. Plasma tyrosine was unaffected by the treatments, 
probably because the amount of phenylalanine consumed was not sufficient to 
increase tyrosine synthesis. 
The striking difference in plasma profiles of phenylalanine following the 
constituent amino acids compared to the aspartame reflects the pattern of gastric 
emptying. Aspartame produced a modest steady increase in plasma phenylalanine 
during the first half of the study and a weak acceleration in gastric emptying rate 
following the liquid test meal, whereas the constituent amino acids caused a sudden, 
relatively large peak in plasma phenylalanine and a stronger increase in gastric 
emptying rate following the liquid test meal. The magnitude and temporal association 
between these two physiological processes suggests that they may be directly linked, 
although the mechanism for this is unclear. Whether this is a direct inhibitory effect 
of the amino acids on humoral or neural reflexes that normally delay the rate of 
gastric emptying cannot be determined with any certainty from this study, but the 
observed reduction in GLP-1 levels may provide a clue. 
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It is postulated that the amino acids escaped absorption for far enough along 
the intestine to either directly inhibit the GLP-1-secreting L cells, or stimulate an 
intermediate paracrine factor or neural reflex that could inhibit GLP-l secretion. The 
bulk of the constituent amino acids were absorbed relatively late (t +60 and +75 min) 
compared to when the capsules must have dissolved in the stomach (t +15 min 
according to the initial absorption of aspartame) giving them time to travel a good 
distance down the intestine. The absorption of the aspartame began earlier but 
persisted for as long as the constituent amino acids absorption, which could account 
for the weaker stimulus for faster gastric emptying rate, as proportionally less of the 
aspartame was in contact with intestinal mucosa at the time of the liquid meal. The 
fact that gastric emptying of the water load was unaffected by the earlier absorption 
of the aspartame amino acids can therefore be explained by the involvement of GLP- 
1 secretion, which would not be stimulated until the liquid meal was ingested. 
Therefore the restriction of GLP-1 release following the meal by the lumenal amino 
acids attenuated the inhibitory influence of this peptide on the rate of gastric 
emptying of the meal. Possible mechanisms for the inhibition of GLP-1 secretion by 
direct or paracrine effect, or neural reflex on the L cells can only be speculated on 
here. 
It is doubtful whether the lower GLP-1 levels are wholly responsible for the 
faster rate of gastric emptying. GLP-l definitely delays gastric emptying and the 
decreased availability of this peptide probably did reduce the inhibition of gastric 
emptying in this case. However, there was probably another factor involved in 
addition to lower GLP-1 levels because aspartame and the constituent amino acids 
reduced GLP-1 secretion to the same extent, whereas the increase in gastric emptying 
rate was greater following the constituent amino acids compared to the aspartame. 
Therefore, in addition to the reduced delay in gastric emptying following aspartame 
and its constituent amino acids due to the attenuation of an inhibitory influence (GLP- 
1), a direct pathway for stimulation of gastric emptying by the individual constituent 
amino acids is proposed. Mechanisms are unknown but it could be hypothesised that 
circulatory phenylalanine was acting on chemoreceptors in the stomach which may 
have initiated stimulation of gastric motility either via local neural reflexes or via 
vagal afferents and efferents. 
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Although we have shown these physiological consequences of ingesting small 
amounts of aspartame and constituent amino acids, the question of how 
aspartame/constituent amino acids increase satiety remains. The mechanisms for 
aspartame-induced satiety are difficult to discuss in the context of this study since no 
differences in subjective appetite ratings were shown (although food intake may have 
been reduced as previously shown, had we measured this parameter). However, a 
significant reduction in desire to eat was shown following the constituent amino acids 
and consequently we can speculate on mechanisms based on the current findings. The 
increased rate of gastric emptying is unlikely to have reduced desire to eat since it is 
normally a delay in gastric emptying that causes fullness sensations due to distension 
of the stomach. The faster delivery of nutrients to the intestine and more rapid 
absorption may have reduced desire to eat but through what mechanism? The effects 
of CCK and GLP-1 on satiety have been ruled out in this study since CCK was 
unaffected and GLP-1 secretion was diminished. Faster absorption of phenylalanine 
after the constituent amino acids was not a result of faster gastric emptying since this 
occurred just before the liquid test meal. 
It is hypothesised therefore, that the reduction in desire to eat was a 
consequence of the differences in pharmacokinetics of phenylalanine absorption 
following the two treatments. Due to differing rates and sites of absorption, plasma 
phenylalanine appeared slowly and earlier following aspartame whereas there was a 
sudden relatively large rise in plasma levels following the constituent amino acids. It 
can be inferred from this that the peak in plasma phenylalanine at t +60 and t +75 min 
following the constituent amino acids reduced feelings of desire to eat at the same 
time as the meal was ingested through a postabsorptive mechanism. This hypothesis 
is supported by statistical correlations between various parameters, although these 
should be regarded with caution due to the small sample number. Whereas there were 
no significant associations between gastric half-emptying times (T50s) and change in 
desire to eat (t +70 -t +60 min), there was a highly significant correlation for the 
constituent amino acids between the change in plasma phenylalanine at t +75 min (x- 
b) and the change in desire to eat (r = -0.9774, p=0.004). This means that those 
subjects who had higher plasma phenylalanine concentrations (relative to baseline) 
after ingestion of the liquid test meal also had larger reductions in desire to eat. This 
relationship was marginally non-significant following the aspartame (r = -0.8681, p= 
0.056), suggesting that even though the VAS ratings did not pick up any reduction in 
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desire to eat following aspartame treatment, the relationship between increased 
plasma phenylalanine and motivation to eat might still exist. 
In conclusion, these results show that aspartame did not increase CCK 
secretion, nor did it delay gastric emptying. The different responses to phenylalanine 
in this study compared to the previous study in this chapter, "The effect of 
phenylalanine supplementation on circulating metabolite and hormone status, gastric 
emptying and satiety" (section 3.3), may be a reflection of a dose effect. Small 
amounts of amino acids may be distinct from large amounts (5 g or more) in their 
physiological consequences. The differing absorption rates of phenylalanine between 
treatments may therefore have caused the divergent ratings of desire to eat. A sudden 
rise in plasma phenylalanine, together with the ingestion of fat and carbohydrate, 
reduced subjective ratings of desire to eat. Free amino acids from the two treatments 
may have inhibited GLP-1 secretion in the jejunum and ileum, and these lower GLP- 
I levels contributed to the accelerated gastric emptying rates. Either lumenal aspartic 
acid or high concentrations of circulating phenylalanine may have also directly added 
to the faster gastric emptying of the liquid meal, in addition to the attenuated GLP-1 
response. GLP-1 levels had no effect on appetite in this study, which suggests it is not 
an important satiety peptide in this situation. Gastric emptying rates were also 
unimportant in appetite regulation under these circumstances. 
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Chapter 
Four 
Chapter 4 
A COMPARISON OF ELECTRICAL IMPEDANCE EPIGASTROGRAPHY 
WITH OTHER TECHNIQUES FOR THE MEASUREMENT OF GASTRIC 
EMPTYING 
4.1 General introduction 
Electrical impedance epigastrography (EIE), a non-invasive technique for 
measuring gastric emptying (Sutton & McClelland, 1983; Pickworth, 1984; Sutton et 
al., 1985; McClelland & Sutton, 1985), was used in the previous chapter to detect 
differences in gastric emptying rates following treatment with encapsulated 
phenylalanine and aspartame. EIE relies on the principle that the resistance 
(impedance) between electrodes placed on the stomach and lower back is increased 
by the ingestion of a non-conductive meal. This is recorded as epigastric impedance, 
which is assumed to decrease in proportion with the meal leaving the stomach. This 
method has been previously shown to compare well with the dye-dilution method 
(McClelland & Sutton, 1985) and scintigraphy (Sutton et al., 1985) when using a 
liquid test meal of orange squash. It was already suspected that gastric secretions 
might influence electrical impedance (Mangnall, 1989), but EIE was chosen to 
measure gastric emptying in the phenylalanine study (section 3.3) because a water 
load was used (which would not generate significant gastric secretion). An alternative 
method, paracetamol absorption, was also included in addition to EIE for the 
aspartame study (section 3.5), although this could not be used both before and after 
the liquid test meal. The main advantages of EIE were portability, reduced costs, ease 
of operation and its relatively non-invasive nature, unlike the majority of available 
methods for the measurement of gastric emptying. 
It was noted that the gastric half emptying times (T50) calculated for the 
fat/carbohydrate liquid test meal used in the aspartame study (section 3.5.6.1.1) were 
shorter than expected for a 1992 kJ load. The average T50 following the 1992 kJ 
liquid test meal (control treatment) was 25.2 min (SD 5.4), a value that is clearly too 
low when compared to those values in the literature. For half of the meal to be 
emptied by 25 min, the amount of energy delivered to the duodenum would have 
been 40 kJ/min, whereas other studies have found a fairly constant rate of 8-13 
U/min during the first hour of gastric emptying (Hunt et al., 1985; Carbonnel et al., 
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1994). It appeared that EIE was underestimating the time taken for nutrient- 
containing liquid meals to empty from the stomach, possibly due to interference from 
gastric secretions. Gastric secretions are highly conductive due to their ionic 
composition, and will reduce the impedance of the stomach contents, giving an 
erroneous rate of emptying. However, with regard to within-subject studies, where 
differences in repeated measures of gastric emptying rate in response to manipulated 
liquid meals were of interest, the quantitative capabilities of this method were less 
important than being able to discriminate between longer or shorter gastric emptying 
times. In other words, as long as the influence of gastric secretions on the change in 
impedance of the stomach contents was a minor influence on apparent emptying rates 
of different meals, then it could still be used as a tool in repeated measures nutritional 
studies. 
It was decided to compare the EIE method with other methods of measuring 
gastric emptying. Firstly, EIE was compared to scintigraphy (Department of Nuclear 
Medicine, Royal Surrey County Hospital), a "gold standard" for the measurement of 
gastric emptying but disadvantaged for routine use by the cost of equipment and the 
use of radioactive isotopes (Urbain & Charkes, 1995). Although scintigraphy is 
considered to be a "gold standard" method, it is not without its technical and 
interpretational difficulties. For example, the distal end of the duodenum sometimes 
loops up behind the stomach, potentially leading to an overestimation of the 
remaining volume in the stomach when calculating the counts from an image. On the 
whole though, the use of a dual-headed gamma camera and calculating the geometric 
mean of the anterior and posterior counts in the stomach eliminates many of the 
errors associated with scintigraphy (septal penetration and downscatter). Secondly, 
EIE was compared to two other indirect measurements of gastric emptying, the 
paracetamol absorption and 13C-octanoic acid absorption methods (see section 2.2.2 
for methodology overview). Both studies compared methods using liquid meals of 
differing fat composition and plasma concentrations of glucose, insulin and gut 
hormones were measured to see how they varied with gastric emptying rate. 
165 
4.2 Comparison of electrical impedance epieastroaraphy with the 
"gold standard" method, scintigraphy, using liquid test meals 
of differing energy content. 
4.2.1 Aims and hypothesis 
Although EIE seems to generate shortened T50s for liquid meals containing 
fat and carbohydrate, it was hypothesised that these would still correspond in rank to 
those obtained by scintigraphy. Three liquid test meals of differing composition were 
used to test the agreement between the two methods, and levels of blood hormones 
and metabolites were measured in order to relate these to the gastric emptying results. 
4.2.2 Subiects 
Six volunteers (2 female, 4 male) were recruited at the Royal Surrey County 
Hospital, Guildford. Only subjects that were over the age of 45 years were accepted 
on to the study due to the use of radioactivity for the scintigraphy measurements. 
Subjects were all in the normal weight range (mean BMI 22.1 kg/m2, SD 1.9). All 
subjects were free from any medical history that may affect gastrointestinal motility. 
Standard haematology and biochemistry screening was conducted at the RSCH to 
confirm suitability to participate in the study, and a preliminary gastric emptying test 
of a water load using the EIE equipment was carried out to ensure accurate placement 
of the electrodes and to check that a clear trace could be obtained. The study protocol 
was approved by the local ethics committee. Subjects were asked to consume a light 
evening meal and refrain from consuming alcohol and caffeine the evening before the 
study, and on the study day. On the day of the study, after an overnight fast, they 
were required to consume nothing except water for six hours before the study, and 
then no water until the study was due to start. 
4.2.3 General procedure 
The study design was a randomised single-blind cross-over. Subjects arrived 
at the Clinical Investigation Unit at the Royal Surrey County Hospital at 1515 h, 
whereupon an intravenous cannula was inserted into a forearm vein by a qualified 
doctor; they were then escorted to the Nuclear Medicine department. Blood samples 
were taken for the measurement of plasma glucose, insulin, GLP-1 and GIP 
according to the methodology detailed in section 2.2.3.1. The EIE electrodes were 
attached to the stomach and lower back, and a comfortable supine position was 
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established between the horizontal detectors of the dual-headed gamma camera. The 
gamma camera detectors were positioned over and under the subject, and a weak 
radioactive source (Co-57), held over the xiphisternum, was used to position the 
stomach centrally in the field of view. EIE recordings were carried out for 10 min to 
enable a stable baseline impedance measurement to be obtained. Blood samples (15 
nil) were also taken at t -10 min and t +0 min (just before the meal). At around 1600 
h (0 min) the subject ingested either the glucose meal or one of the two 
fat/carbohydrate liquid test meals containing the radioactive label (12MBq of 99mTc- 
DTPA) via a wide bore plastic tube, whilst still lying in a supine position. At this 
point the imaging was initiated on the gamma camera and lasted up to two hours. 
Continuous EIE measurements were recorded simultaneously. The geometric mean 
(anterior counts x posterior counts) 1/2 of both anterior and posterior views were 
determined to correct for changes in tissue attenuation. Blood samples were obtained 
at 15 minute intervals following the meal. A schematic diagram of the protocol is 
below. 
Time 
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+5 
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+120 
EIE Scintigraphy Blood Meal Samples 
ý 
I 
.a 
ý 
ý 
%00 
ý 
ý 
ý* 
* Measurements only taken at +120 min for the milkshakes 
Table 4.1 Outline of protocol for comparison of scintigraphy and EIE in the 
measurement of gastric emptying. 
Note: 
1. The first three study sessions (one individual's glucose and low fat test meals and 
another's glucose meal) positioned the subject in a semi-supine position rather 
than almost fully supine. The detectors had been aimed at an angle to the stomach 
and duodenum rather than parallel, and a parallel view facilitated a more 
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accurate detection of the counts left in the stomach by the gamma camera. The 
change in position may have led to an alteration in gastric emptying time, and, if 
so, a slower emptying rate would be expected supine compared to semi-supine. In 
addition, the first four study sessions (the same two individuals' glucose and low 
fat test meals) took place in the morning whereas the rest of the study sessions 
took place late afternoon. It is possible that this may have had a minor bearing on 
gastric motility. Nausea may also have an effect on gastric motility but this was 
not reported by any of the subjects. 
2. Due to technical difficulties whilst working in the Nuclear Medicine department 
of the Royal Surrey County Hospital, blood samples were not kept in ideal 
conditions following centrifugation. The internal temperature of the designated 
centrifuge was warm and there was no freezer available in the vicinity. GIP and 
GLP-1 contained in the plasma samples were in an advanced stage of 
degradation by the time the plasma was assayed, since these hormones are not 
stable unless stored on ice and frozen immediately after separation of the plasma. 
Consequently, plasma GIP and GLP-1 concentrations are not reported here due 
to doubts over the accuracy of the data. 
3. The constraints of time and money limited the study to 6 subjects. This sample size 
was clearly not ideal for a validation study such as this, especially when 
correlating gastric half-emptying times between the methods. For that reason, 
additional studies are required before the current results can be confirmed as 
definitive. 
4.2.4 Meals 
A different liquid test meal was ingested by the subject on each of the three 
occasions -a glucose meal, a low fat meal and a high fat meal. The glucose meal was 
450 ml in volume, with a 10 % concentration of glucose and an energy content of 753 
U. The fat/carbohydrate liquid test meals were formulated using double cream, 
maltodextrin and Nesquik and were also made up to 450 ml in volume with water 
(see table 4.2). The conductivity of the low and high fat test meals were 0.29 and 0.54 
milliSiemens/cm respectively. Therefore a very simple meal containing 10 % glucose 
(45 g) was tested between methods, and also two meals that contained the same 
amount of carbohydrate (70 g) but differing amounts of fat (4 g and 44 g): 
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Glucose test meal Low fat test meal Hi h fat test meal 
Double Cream - 8g (4g fat, 151 kJ) 92g (44g fat, 1657 kJ) 
Maltodextrin - 50g (50g CHO, 837 kJ) 50g (50g CHO, 837 kJ) 
Nesquik - 20g (326 kJ) 20g (326 kJ) 
(flavouring) 
Glucose 45 g - - 
Total energy 753 kJ 1314 kJ 2820 kJ 
(Fat: O% energy (Fat: 12 % energy (Fat: 59 % energy 
CHO: 100 % energy) CHO: 88 % energy) CHO: 41 % energy) 
Table 4.2. Composition of glucose, low and high fat liquid test meals used for the 
comparison of scintigraphy and EIE in the measurement of gastric emptying. 
4.2.5 Statistical analysis 
Results were analysed by one factor repeated measures ANOVA or two way 
repeated measures ANCOVA (with baseline values as covariates) for statistical 
differences as detailed in section 2.2.4. Incremental area under the curve was also 
employed to compare differences in plasma glucose or insulin responses between the 
low and high fat test meals by a two-tailed, paired t-test. Agreement between the 
gastric emptying methods was assessed by Spearman rank order correlation. 
4.2.6 Results 
4.2.6.1 Gastric emptying times 
4.2.6.1.1 Electrical Impedance E iQ gastrography (EIE) 
Repeated measures ANOVA showed that there were clear differences in 
gastric half-emptying times following the three different meals for EIE (n = 6, p= 
0.0001), with the Duncan post-hoc test revealing the differences to lie between 
glucose and high fat meals, and between low fat and high fat meals, but not between 
glucose and low fat meals. The average gastric emptying half times (T50s) using the 
ElE method are shown in figure 4.1. 
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Figure 4.1 Gastric half emptying times (T50s) obtained by the electrical 
impedance epigastrography method (mean ± SEM, n= 6). Gastric emptying times 
were significantly longer following the high fat test meal (2820 kJ) compared to the 
low fat test meal (1314 kJ) and the glucose test meal (753 kJ). This difference 
between meals was highly statistically significant (p <0.0005). 
4.2.6.1.2 Scintigraphy 
The geometric means for scintigraphy were also significantly different (n = 6, 
p=0.015) and the post-hoc test showed that the differences followed the same pattern 
as for EIE. Gastric half-emptying times were longer for the high fat milkshake, as 
expected. The average gastric emptying half times (T50s) using the scintigraphy 
method are shown in figure 4.2. 
  Glucose test meal 
  Low fat test meal 
  High fat test meal 
All subjects Supine subjects 
only 
Figure 4.2 Gastric half emptying times (T50s) obtained by the scintigraphy 
method (mean ± SEM, n= 6). Gastric emptying times were significantly longer 
following the high fat test meal (2820 kJ) compared to the low fat test meal (1314 kJ) 
and the glucose test meal (753 kJ). This difference between meals was statistically 
significant (p <0.05). 
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4.2.6.1.3 Comparison of the two methods 
Paired two tailed t-test between the EIE and scintigraphic T50s showed 
significant differences for the glucose meal (p <0.0005), low fat meal (p <0.000005) 
and high fat meal (p <0.05). The percentage volume of meal emptied from the 
stomach was also analysed by two-way repeated measures ANOVA for each meal 
over the first 60 min in order to ascertain whether the actual percentages were 
significantly different between methods. There was a significant main difference in 
gastric emptying methods for the glucose meal (p <0.05), the low fat meal (p 
<0.000005), and the high fat meal (p <0.0005), with the overall percentage emptied 
values being higher for EIE compared to scintigraphy. 
Using Spearman's rank correlation coefficients it was shown that there were 
no significant correlations within any of the meal types, although there was a trend 
towards significance for the correlation between EIE and scintigraphy half emptying 
times following the low fat test meal (Spearman r=0.771, p=0.072). Figure 4.3 
illustrates the relationship between the sets of EIE and scintigraphy data. 
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Figure 4.3 Scatterplot showing the association between gastric half emptying 
times (T50) from the two methods, EIE and scintigraphy, following each of the 
liquid test meals (glucose 753 kJ, low fat 1314 kJ, and high fat 2820 kJ). No 
significant associations between methods were shown by Spearman rank correlation. 
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Glucose meal: EIE Scintigraphy 
T50s T50s 
Mean 17.3 50.7 
Minimum 11.8 38 
Maximum 24.1 64 
SD 5.2 8.9 
Low fat test EIE Scintigraphy 
meal: T50s T50s 
Mean 20.2 61.2 
Minimum 13.2 48 
Maximum 30.1 75 
SD 7.1 9.9 
High fat test EIE Scintigraphy 
meal: T50s T50s 
Mean 29.3 160 
Minimum 21.2 86 
Maximum ý__ _. _..... _........ _.. _......... _.... 
35.1 330 
SD 93.9 
Table 4.3. Mean gastric half-emptying times and descriptive statistics following 
each of the liquid test meals (glucose 753 kJ, low fat 1314 kJ, and high fat 2820 
kJ). 
4.2.6.2 Plasma glucose and insulin 
Plasma glucose and insulin concentrations were measured simultaneously 
with gastric emptying for each meal. The low fat and high fat meals contained the 
same amount of carbohydrate but differing amounts of fat and so these were 
compared to see how these blood parameters changed with the addition of fat. Plasma 
levels of these substances were correlated with gastric emptying T50s as measured by 
EIE and scintigraphy following all three liquid test meals. 
4.2.6.2.1 Plasma lud 
The results for plasma glucose concentrations following the three meals are 
illustrated below (figure 4.4). Two way repeated measures ANCOVA between the 
two meals with a constant carbohydrate content (low and high fat test meals) showed 
that there were no meal-related significant differences over time between the meals, 
nor was there a meal x time interaction. 
Paired t-tests (2-tailed) for the incremental area under the curve (IAUC) 
revealed no significant differences between the low and high fat test meals, either 
overall, t+ 0-45 min or t+ 45-90 min. There were no significant correlations 
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between IAUC or tmax (time until peak concentration) for plasma glucose and gastric 
half emptying times. 
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Figure 4.4 Plasma glucose concentrations (mean ± SEM, n= 6) following each of 
the liquid test meals (glucose 753 kJ, low fat 1314 kJ, and high fat 2820 kJ). No 
significant differences were found between the low and high fat liquid test meals. 
4.2.6.2.2 Plasma insulin 
Plasma insulin concentrations are shown in figure 4.5. The two test meals 
(low and high fat) led to a significant main effect of treatment (p <0.05); the highest 
overall insulin levels followed the low fat milkshake. There was also a treatment x 
time interaction (p <0.005), with the post-hoc test revealing that the differences lay 
mainly between t+ 30 and 90 min. 
173 
soo------- F- 
45 Liquid test 
4 meal 
° 350 
300 
250 
200 
150 
ä 100 
50 
-* -- Glucose test meal 
  Low fat test meal 
A High fit test meal 
ý 
-10 0 10 20 30 40 50 60 70 80 90 100 110 120 
Tim (mm) 
Figure 4.5 Plasma insulin concentrations (mean ± SEM, n= 6) following each of 
the liquid test meals (glucose 753 kJ, low fat 1314 kJ, and high fat 2820 kJ). 
Plasma insulin levels were significantly higher following the low fat test meal 
compared to the high fat test meal (p <0.05). 
Paired t-tests (2-tailed) for the incremental area under the curve (IAUC) 
revealed a significant difference between the low and high fat test meals, t+ 0-45 min 
(p = 0.013). There were no significant correlations between IAUC or tmax (time until 
peak concentration) for plasma insulin and gastric half emptying times. 
4.2.7 Discussion 
The aim of this study was to compare EIE as a tool for measuring gastric 
emptying with the "gold-standard" scintigraphy. Both methods achieved statistical 
significance in the difference in gastric half-emptying times for the low and high fat 
test meals. However, the actual half-emptying times reported were very different (see 
table 4.3). It can be seen that the data ranges do not overlap between the two methods, 
and the ranges and standard deviations are much larger for the scintigraphic data - 
characteristics that become increasingly marked with increasing fat content of the 
meals. The longest gastric half-emptying time recorded by scintigraphy (high fat test 
meal) was nine times longer than the longest recorded by EIE. 
Scintigraphy is the accepted "gold standard" method for measuring gastric 
emptying (Urbain & Charkes, 1995), although it also has its interpretational 
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problems. It is therefore assumed that these scintigraphic T50s are accurate. This 
assumption is supported by a closer look at the emptying rates in terms of energy 
content. Studies employing both dye-dilution and scintigraphic methods have found 
gastric emptying rates of a liquid meal to be fairly constant at 8-13 kJ/min during the 
first hour of gastric emptying (Hunt et al., 1985; Carbonnel et al., 1994), with an 
average rate of 11.3 kJ/min over two hours for a 400 ml, 4.2 kJ/ml polycose liquid 
test meal (Hunt et al., 1985). Calculation of energy emptied per min from the 
scintigraphic T50s yields values of 7.4,10.7, and 8.8 kJ/min for the glucose, low fat 
and high fat test meals respectively. However, the corresponding values using the EIE 
T50s generates emptying rates of 21.8,32.5 and 48.1 kJ/min for glucose, low fat and 
high fat test meals respectively; these emptying rates are clearly nonsensical when 
compared to the scintigraphic emptying rates and the results obtained in previous 
studies (Hunt et al., 1985; Carbonnel et al., 1994). 
Although the actual half-emptying times obtained in the present work are 
extremely different, similarities in subject ranking order between the methods would 
uphold HE as a useful method where discerning differences in gastric emptying rates 
are a priority. Using a non-parametric correlation test, it is clear that there is no 
relationship between the gastric half-emptying times for the two methods within 
meal-type. It could be argued that this may be because the sample size is small, and 
the low fat milkshake did show a near significant correlation. There may have been a 
weak relationship between the two sets of data if the sample size had been larger, 
especially as a positive result had already been reported in one of the original papers 
for an orange squash drink (Sutton et al., 1985). It should be noted, however, that two 
out of six subjects in this paper had EIE gastric half-emptying times that were only 
two-thirds of that recorded by scintigraphy, and another subject had a scintigraphic 
emptying time that went beyond the duration of the gamma camera recording (Sutton 
et al., 1985). Based on the present results, the inescapable conclusion is that EIE is 
not an accurate method for measuring actual gastric emptying time compared to the 
"gold standard" scintigraphy. The large degree of variance that can be observed in the 
data produced by the so-called "gold standard" shows that this method is hardly ideal, 
but the smaller variance obtained by EIE may be an artifact of the apparent limitation 
of all gastric emptying times to below 35 min. 
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It may be that EIE and scintigraphy are simply not measuring the same 
physiological process. EIE is measuring the change in electrical impedance and this is 
assumed to be a direct reflection of the stomach contents emptying into the 
duodenum. It is suspected that the impedance recordings are also picking up changes 
in conductivity due to gastric secretions, especially with the introduction of fat into 
the meals. The high fat test meal may be reducing conductivity by buffering the 
gastric secretions and inhibiting further gastric secretions via enterogastrone 
feedback, e. g. CCK, GLP-1 (Lloyd et al., 1997), thereby increasing impedance and 
appearing to prolong gastric emptying time compared to the low fat test meal. This 
effect is presumed to be additive to the real gastric emptying differences occurring in 
terms of reduction in impedance, causing an apparently smaller T50. It is not known 
what proportion of the EIE T50s was a reflection of gastric emptying changes and 
what proportion was due to differences in gastric secretions. Another possible source 
of impedance error is the changing resistance on the surface of the skin where the 
electrode is attached due to sweating, although you would expect this type of error to 
be fairly consistent for each meal, unless there was a large change in room 
temperature from one occasion to another. 
The discrepancies in gastric emptying time between methods seem to be 
magnified by the increasing complexity of the meal, and so it would be useful to 
carry out the same comparison on six subjects simply with a water load. This has not 
yet been done due to financial restraints and difficulties in organising sessions on the 
gamma camera at the Royal Surrey County Hospital. In order to investigate the 
possibility of gastric and pancreatic secretions altering the impedance recordings via 
changes in conductivity, it has been suggested that a meal with the same conductivity 
as the basal stomach tissue and contents is administered, as then it could be assumed 
that any changes in impedance would be due to secretions in the gut. Preliminary 
investigations into a possible correction factor for the effects of gastric secretions on 
gastric emptying times have been produced by colleagues in the Department of 
Physics (Amaee et al., 1999). 
As expected, the addition of fat to a carbohydrate-constant meal (low fat and 
high fat test meals) significantly decreased plasma concentrations of insulin over the 
course of two hours, although plasma glucose levels were not significantly affected. 
Plasma glucose levels did at least appear to follow the same profile as plasma insulin 
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as illustrated by the charts, and there was a significant treatment by time interaction 
from t +45 to t +90 min (p <0.005) due to the late plasma glucose peak following the 
high fat test meal. The reduced plasma insulin and later plasma glucose peak 
following the high fat test meal are likely to be a result of a fat-induced slowing down 
of gastric emptying rate. 
In order to investigate the importance of gastric emptying in plasma levels of 
glucose and insulin the relationship between these parameters was analysed using 
non-parametric correlation techniques. Gastric emptying T50s from both methods 
were matched by rank order against time until peak concentration (tmax) and 
incremental area under the curve (IAUC) for the plasma constituents. In other words, 
do the subjects with longer gastric emptying times have higher or lower levels of 
insulin and glucose? Predictably, EIE T50s did not correlate with plasma glucose or 
insulin, as you might expect since this method was a poor evaluator of gastric 
emptying times. However, scintigraphic T50s showed no significant correlations 
either. 
In conclusion, the two methods for measuring gastric emptying, BE and 
scintigraphy, yield differing results for gastric emptying times and do not seem to 
relate to each other. Scintigraphy is costly, impractical and is a poor "gold standard", 
but it appears from these results that EIE may not be a valid alternative. 
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4.3 Comparison of electrical impedance epigastrography with 
paracetamol absorption and the 3C-octanoic acid breath test. 
using low and high fat liquid test meals. 
4.3.1 Aims and hypothesis 
EIE gastric emptying times have been shown to be artificially short and they 
failed to correspond in subject rank to those of scintigraphy. Although scintigraphy is 
regarded as the "gold standard" for gastric emptying, it is highly subject to error. It 
was hypothesised that EIE gastric emptying times may therefore relate to other 
indirect methods of measurement. The aim of this study was to compare EIE with two 
different methods for gastric emptying measurement, paracetamol absorption and the 
13C-octanoic acid breath test. The same two liquid test meals of differing fat content 
were used to test the agreement between the two methods, and levels of blood 
hormones and metabolites were measured in order to relate these to the gastric 
emptying results. 
4.3.2 Subiects 
Ten volunteers (9 females, 1 male), mean age 25 years (SD 2.2) were 
recruited for the study from students at the University of Surrey, Guildford. Subjects 
were in the normal weight range (mean BMI 20.6 kg/m2, SD 2.5). All subjects were 
free from any significant medical history and standard haematology and biochemistry 
screening was conducted at the RSCH to confirm suitability to participate in the 
study. A letter was sent to their GP to inform them about the study and to give their 
GP an opportunity to confirm their patient's suitability. Subjects were asked to refrain 
from consuming alcohol and caffeine the evening before the study, and on the study 
day. They were also requested to avoid taking any products containing paracetamol 
for forty-eight hours before the study. On the day of the study, after an overnight fast, 
they were required to consume nothing except water until one hour before the study, 
and then no water until the study was due to start. The study protocol was approved 
by the local ethics committee. 
4.3.3 General procedure 
Subjects were studied on two occasions (at least one week apart), one day for 
the low fat meal and one day for the high fat meal. The order of the meals was 
randomised. Subjects arrived singly at the Clinical Investigation Unit at the 
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University of Surrey at 0900 h, whereupon a qualified medical professional inserted 
an intravenous cannula into an antecubital vein under local anaesthetic. Blood 
samples were taken for the measurement of plasma glucose, insulin, GLP-1, GIP and 
CCK according to the methodology detailed in section 2.2.3.1. The six EIE electrodes 
were attached to the stomach and lower back, and the subjects found a comfortable 
semi-supine position on the bed. EIE recordings were carried out for 10-15 min to 
enable a stable baseline impedance measurement to be obtained. Baseline blood 
samples (15 ml) and breath samples were also taken at t-10 and t +0 min (just before 
the meal). 
Volume of CO2 production was determined by the use of a metabolic monitor 
(Deltatrac) and ventilated hood with a flow rate of 40 ml/min. The Deltatrac was 
switched on 1h before the study to warm up and calibrated for barometric pressure 
and gas using a standard gas mixture of 5% CO2 and 95 % 02. Breath samples were 
collected at intervals into gas-tight glass tubes with screw lids for the determination 
of 13C enrichment of the breath with an isotope ratio mass spectrometer at the 
Department of Biological and Nutritional Sciences, University of Newcastle (Dr 
Chris Seal). 13 C02 in the breath samples was expressed as atom percent excess (APE), 
i. e. the percentage of 13CO2 in the total CO2 above natural background of 13CO2. Five 
measurement sessions of CO2 production rate were carried out (one measurement per 
min) and the data (ml/min) was averaged over each session to give continuous values 
for the whole 4 h. APE and CO2 production in ml/min was entered into this formula 
to give pmoles of 13 CO2 in each time interval: 
CO2 (ml/min) x APE x 44.6` x time interval of breath samples (min) 
13 CO2 (µmol) was then summed over 4h to give a cumulative curve. Each 
cumulative time point was then expressed as a percentage of the initial dose to give a 
cumulative recovery curve. This was then fitted using the equations given in section 
2.2.2.3. 
Volunteers received a high or low fat liquid test meal at t +0 min, which 
contained 50 mg of 13C-labelled Na-octanoate and 1.5 g of paracetamol (3 x 500 mg 
Conversion factor from CO2 (ml) to CO2 (µmol). Imol gas occupies 22.414 L at STP therefore 1 pmol gas 
occupies 0.022414 ml. 1/0.022414 = 44.6. 
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tablets). Blood samples, EIE recordings and breath test samples were taken at 
intervals thereafter. A schematic diagram of the protocol is below. 
Timin 
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Table 4.4. Outline of protocol for comparison of EIE, paracetamol absorption 
and 13C-octanoic acid breath test in the measurement of gastric emptying. 
See section 2.2.3.1 for blood sampling protocol. 
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4.3.4 Meals 
Two different liquid test meals were ingested by the subject on each of the 
two occasions -a low fat meal and a high fat meal identical to those in the previous 
study. These were formulated using double cream, maltodextrin and Nesquik and 
were made up to 450 ml with water (see table 4.5) containing 1.5 g of paracetamol. 
Carbohydrate content was constant whereas fat content differed. The conductivity of 
the low and high fat test meals were 0.29 and 0.54 milliSiemens/cm respectively. 
Low fat test meal High fat test meal 
Double Cream 8g (4g fat, 151 kJ) 92g (44g fat, 1657 kJ) 
Maltodextrin 50g (50g CHO, 837 kJ) 50g (50g CHO, 837 U) 
Nesquik 20g (326 kJ) 20g (326 kJ) 
(flavouring) 
Total energy 1314 kJ 2820 kJ 
(Fat: 12 % energy (Fat: 59 % energy 
CHO: 88 % energy) CHO: 41 % energy) 
Table 4.5 Composition of low and high fat liquid test meals used for the 
comparison of EIE, paracetamol absorption and ' C-octanoic acid breath test in 
the measurement of gastric emptying. 
50 mg of 13C-labelled Na-octanoate was dissolved in the double cream in a 
measuring jug before the maltodextrin, Nesquik, and water (containing paracetamol - 
see below) was added, and the whole mixture was blended. 
Note: 
1. The first 4 subjects were administered soluble paracetamol in the milkshake. 
Soluble paracetamol was used because this was the method of choice used by 
previous authors (Maddern et al., 1985) and it was necessary to ensure that the 
paracetamol was evenly dispersed throughout the test meal. It was observed 
however, that the half emptying times recorded by the EIE equipment were 
unusually long (approximately 40 to 50 min for the high fat test meal instead of 
the more usual 30 min), and they did not differentiate between the low and high 
fat milkshakes. It was confirmed that this is not due to individual variation as two 
subjects were tested again with the same milkshake, omitting the paracetamol, 
and their half-emptying times were shorter and in the range that would be 
expected. It is unlikely that paracetamol was directly delaying gastric emptying as 
this was a well-established method used by many researchers in the past 
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(Heading et al., 1973; Maddern et al., 1985; Petring & Flachs, 1990; van Wyk et 
al., 1993; van Wyk et al., 1995). Additionally, one subject received soluble and 
non-soluble paracetamol on two separate occasions with the high fat liquid test 
meal, which gave very similar plasma paracetamol results for both conditions. 
This suggests that the different forms of paracetamol did not directly affect 
gastric emptying rate or the absorption kinetics of paracetamol in this individual. 
The most likely explanation was that the soluble paracetamol altered the 
conductive properties of the liquid test meal. Soluble paracetamol increased the 
conductivity of the low fat meal from 0.29 to 4.16 milliSiemens/cm and the high 
fat meal from 0.54 to 3.69 milliSiemens/cm. It was discovered from the 
manufacturers of this brand of soluble paracetamol (Sterwin Medicines, 
Guildford) that 47% of the tablet weight was sodium bicarbonate (for 
effervescence), and therefore a total of 4.026 g sodium bicarbonate was being 
added to the test meal (in 3 tablets of soluble paracetamol). Increased 
conductivity of the stomach contents would indeed be expected to decrease 
impedance from the outset and perhaps appear to artificially lengthen gastric 
emptying time. It was decided, therefore, to use tablets of paracetamol (without 
effervescence) for the remaining six subjects. These were crushed in a pestle and 
mortar, added to water and then blended in with the test meal ingredients using 
an electric hand whisk 
In summary, three subjects received low and high fat test meals with soluble 
paracetamol, one subject received two high fat test meals with soluble or crushed 
tablet form paracetamol, and six subjects (whose results are reported here) 
received low and high fat test meals with crushed non-effervescent paracetamol 
tablets. Two of the subjects that had received soluble paracetamol also underwent 
one more session (EIE alone) with a paracetamol free high fat test meal, to see 
what their gastric half-emptying times should have been. There were no reports of 
nausea during any study session. 
2. Unfortunately one subject's impedance trace (n =6 non-effervescent paracetamol 
tablets group) for the high fat test meal had to be excluded because the trace 
contained numerous movement artifacts and the data was uninterpretable. 
3. Plasma CCK concentrations were analysed from t +0 to t +120 min rather than 
from t -10 to t +240 min due to a shortage of antiserum. 
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4. Although 10 subjects were used in the study, the problems encountered using EIE 
with soluble paracetamol resulted in a smaller sample size of 6 subjects. As for 
the last study, this sample size was not ideal when calculating correlations. 
Again, additional studies are required before the current results can be confirmed 
as definitive. 
4.3.5 Statistical analysis 
Results were analysed by two-tailed paired t-test or two way repeated 
measures ANCOVA for statistical differences as detailed in section 2.2.4. Time until 
peak concentration (tmax) and incremental area under the curve (IAUC) were also 
employed to compare differences in plasma hormone or metabolite response between 
low and high fat test meals. Plasma paracetamol response was expressed as tmax, 
peak concentration (cmax) and (IAUC). EIE and 13C-octanoic acid gastric emptying 
parameters were expressed as gastric half emptying times (T50). Agreement between 
gastric emptying methods was assessed by Spearman rank order correlation. 
4.3.6 Results 
4.3.6.1 Gastric emptying times 
4.3.6.1.1 Electrical impedance a iý agstrography (EIE) 
The average gastric emptying half times (T50s) using the EIE method are 
illustrated in figure 4.6. A two-tailed, paired t-test showed that the longer T50s 
following the high fat liquid meal were significantly different to the low fat test meal 
T50s (n = 6, p <0.05). 
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Figure 4.6 Gastric half emptying times (T50s) obtained by the electrical 
impedance epigastrography method (mean ± SEM). Gastric emptying times (in 
the non effervescent paracetamol group) were significantly longer following the high 
fat test meal (2820 kJ) compared to the low fat test meal (1314 kJ) (p <0.05). The 
chart also illustrates the misleading EIE T50s obtained following the addition of 
soluble paracetamol rather than non-effervescent tablets to the liquid test meal (n = 
3), and the shorter, more typical EIE T50s for two of these subjects when a 
paracetamol-free high fat liquid test meal was ingested. 
4.3.6.1.2 13C-octanoic acid breath test 
The breath test T50s were significantly different between test meals for the 
whole sample group (n = 9, p <0.005) and for the smaller sub-group of subjects that 
could be measured by EIE (n = 6, p <0.05). Gastric emptying times were longer 
following the high fat test meal, as illustrated in figure 4.7. 
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Figure 4.7 Gastric half emptying times (T50s) obtained by the 13C-octanoic acid 
breath test method (mean ± SEM). Gastric emptying times were significantly 
longer following the high fat test meal (2820 kJ) compared to the low fat test meal 
(1314 kJ) (in all subjects, p <0.005, and in the non-effervescent paracetamol sub- 
group, p <0.05). 
Figure 4.8 shows the mean cumulative 13C percentage dose recovery 
following the low and high fat test meals. 
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Figure 4.8 Cumulative 13C(C02) recovery as a percentage of dose administered 
following low (1314 kJ) and high fat (2820 kJ) liquid test meals (mean ± SEM, n 
9). 
4.3.6.1.3 Paracetamol absorption test 
Paracetamol concentrations in the plasma following the two liquid test meals 
are shown in figure 4.9. No significant differences were found between meals for 
mean plasma paracetamol levels over 4 hours (p = 0.099), but there was a highly 
significant meal by time interaction (p = 0.000005). 
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Figure 4.9 Plasma paracetamol concentrations (mmoVL) following low fat (1314 
kJ) and high fat (2820 kJ) liquid test meals (mean ± SEM, n= 6). There was a 
highly significant meal by time interaction (p <0.00001). 
Time to reach peak plasma paracetamol concentrations (tmax) and 
incremental area under the curve (IAUC) , 0-120 min, were significantly different 
between test meals (see figure 4.10). Peak concentrations (cmax) were not 
significantly different between test meals (see table 4.6). 
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Figure 4.10 Plasma paracetamol gastric emptying parameters, tmax (min) and 
incremental AUC, 0-120 min (mmolIL by time (min)), following low fat (1314 
kJ) and high fat (2820 kJ) liquid test meals (mean ± SEM). Results are given for 
all subjects (n = 9) and subjects who took non-effervescent paracetamol tablets only 
(n = 6). *p <0.05, ** p <0.01. Tmax was significantly longer for the whole group 
and the sub-group following the high fat test meal. Incremental AUC, 0-120 min was 
significantly larger in the sub-group that took non-effervescent paracetamol tablets 
only. 
C 
Mean (SEM) 
max 
(mmol/L) Non-effervescent tablets only 
Total (n = 9) 
(n = 6) 
Low fat test 0.108 (0.010) 0.097 (0.009) 
meal 
High fat test 0.127 (0.013) 0.113 (0.011) 
meal 
Table 4.6 Plasma paracetamol gastric emptying parameter, cmax (mmolL), 
following low fat (1314 kJ) and high fat (2820 kJ) liquid test meals (mean ± 
SEM). Results are given for all subjects (n = 9) and subjects who took non- 
effervescent paracetamol tablets only (n = 6). There were no significant differences 
in cmax following the test meals. 
4 . 
3.6.1.4 Comparison of the three methods 
4.3.6.1.4.1 EIE and paracetamol absorption test 
EIE and the paracetamol absorption test produce different gastric emptying 
parameters and so they are not directly comparable by a paired t-test. Gastric 
emptying parameters from the paracetamol absorption method (tmax, IAUC 0-60 min 
and IAUC 0-120 min) and EIE T50s were plotted against each other and the 
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Spearman's rank correlation was computed. There were no significant correlations 
between methods. See figure 4.11. 
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Figure 4.11 Plasma paracetamol gastric emptying parameters, tmax (min), 
IAUC 0-120 min (mmol/L by time) and IAUC 0-60 min (mmol/L by time), 
plotted against EIE T50s (min) following low fat (1314 kJ) and high fat (2820 
kJ) liquid test meals. Spearman rank order correlation between methods for each 
meal produced no significant associations. 
4.3.6.1.4.2 EIE and 13C-octanoic acid breath test 
Two-tailed, paired t-tests between EIE and breath test T50s revealed that 
gastric emptying times were significantly different for these methods (low fat p 
<0.001, high fat p <0.0005), with the breath test T50s being very much longer than 
the EIE T50s. EIE and breath test T50s were plotted against each other to assess the 
strength of their association (see figure 4.12) and the Spearman rank correlation was 
computed. No significant correlations were found between the two methods (r = 
0.486, p=0.329 low fat milkshake; r=0.700, p=0.188 high fat milkshake). 
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Figure 4.12 13C octanoic acid breath test T50s (min) plotted against EIE T50s 
(min) following low fat (1314 kJ) and high fat (2820 kJ) liquid test meals. 
Spearman rank order correlation between methods for each meal produced no 
significant associations. 
4.3.6.1.4.3 Paracetamol absorption and 13C-octanoic acid breath tests 
Gastric emptying parameters from the paracetamol absorption method (tmax, 
IAUC 0-60 min and IAUC 0-120 min) and 13C-octanoic acid breath test T50s were 
plotted against each other, and the Spearman's rank correlation was computed. There 
were no significant correlations between methods. See figure 4.13. 
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Figure 4.13 Plasma paracetamol parameters of gastric emptying, tmax (min), 
IAUC 0-120 min (mmol/L by time) and IAUC 0-60 min (mmol/L by time), 
plotted against 13C-octanoic acid breath test T50s (min) following low fat (1314 
kJ) and high fat (2820 kJ) liquid test meals. Spearman rank order correlation 
between methods for each meal produced no significant associations. 
4.3.6.1.4.4 Discriminatory power of the gastric emptying parameters between the low 
and high fat liquid test meals 
The difference between the low fat and high fat results for each gastric 
emptying parameter (GET) was calculated for each subject, and this was converted to 
a coefficient (%) of difference in order to standardise the large variation between the 
different methods: 
Difference coefficient ((low fat GET - high fat GET)/average (low fat GET, 
high fat GET)) x 100 
The largest difference coefficients within the subgroup of 6 subjects were 
produced by the paracetamol tmax method (mean -108.1 %, SEM 22.3), and the 
smallest by the breath test T50s (mean -26.6 %, SEM 9.4). Figure 4.14 illustrates the 
discriminatory power of each method for the whole group (n = 9) and the non- 
effervescent paracetamol tablet sub-group (n = 6). Paracetamol IAUC, 0-120 min, 
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also showed a greater level of discrimination between the meals compared to the 
breath test and EIE T50s. 
Gastric emptying parameters 
HE T50 Breath test T50 Paracetamol tmax 
Figure 4.14 The magnitude of the differences in gastric emptying times between 
the low and high fat test meals by each of the three different methods (± SEM), 
EIE T50,13C-octanoic acid breath test T50 and paracetamol tmax (min). The 
difference coefficient is ((low fat GET - high fat GET)/average (low fat GET, high 
fat GET)) x 100 (%). Coefficients are given for the whole group (n = 9) and for the 
subjects that consumed the non-effervescent paracetamol tablets only (n = 6). 
4.3.6.2 Plasma metabolites and hormones 
4.3.6.2.1 Plasma lud cose 
The results for plasma glucose concentrations following the low and high fat 
meals are illustrated below (figure 4.15). Two way repeated measures ANCOVA 
between the low and high fat test meals showed that there were no meal-related 
significant differences over time between the meals, but there was there a significant 
meal x time interaction (p <0.00005). 
Plasma glucose IAUC (0-120 min), cmax and tmax were correlated by 
Spearman rank order correlation with gastric emptying parameters (n =6 due to 
missing data). There was a significant positive correlation between glucose IAUC (0- 
120 min) and paracetamol IAUC (0-120 min) (Spearman r=0.943, p <0.005) 
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following the high fat test meal, but there were no significant relationships between 
plasma glucose and gastric emptying parameters following the low fat test meal. 
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Figure 4.15 Plasma glucose concentrations (meant SEM, n= 9) following 
differing liquid test meals (low fat 1314 kJ and high fat 2820 kJ). There was a 
highly significant treatment x time interaction between test meals (p <0.00005). 
4.3.6.2.2 Plasma insulin 
The results for plasma insulin concentrations following the low and high fat 
meals are illustrated below (figure 4.16). Two way repeated measures ANCOVA 
between the low and high fat test meals showed that there was a significant main 
effect of meal on overall plasma insulin levels (p <0.05). 
Plasma insulin IAUC (0-120 min), cmax and tmax were correlated by 
Spearman rank order correlation with gastric emptying parameters (n =6 due to 
missing data). There were no significant relationships between plasma insulin and 
gastric emptying parameters following either meal. 
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Figure 4.16 Plasma insulin concentrations (meant SEM, n= 9) following 
differing liquid test meals (low fat 1314 kJ and high fat 2820 kJ). There was a 
significant treatment effect between test meals (p <0.05). 
4.3.6.2.3 Plasma GIP 
The results for plasma GIP concentrations following the low and high fat 
meals are illustrated below (figure 4.17). Two way repeated measures ANCOVA 
between the low and high fat test meals showed that there was a significant main 
effect of meal on overall plasma GIP levels (p <0.05). 
Plasma GIP IAUC (0-120 min), cmax and tmax were correlated by Spearman 
rank order correlation with gastric emptying parameters (n =6 due to missing data). 
There was a significant positive correlation between GIP cmax and EIE T50s 
(Spearman r=0.900, p <0.05), and between GIP tmax and breath test T50s 
(Spearman r=0.899, p <0.05) following the high fat test meal. There were no 
significant correlations following the low fat test meal. 
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Figure 4.17 Plasma GIP concentrations (meant SEM, n= 9) following differing 
liquid test meals (low fat 1314 kJ and high fat 2820 kJ). There was a significant 
treatment effect between test meals (p <0.05). 
4.3.6.2.4 Plasma GLP-1 
The results for plasma GLP-1 concentrations following the low and high fat 
meals are illustrated below (figure 4.18). Two way repeated measures ANCOVA 
between the low and high fat test meals showed that there was no significant main 
effect of meal on overall plasma GLP-1 levels. However, from t +60 to t +240 min 
there was a significant meal by time interaction (p <0.05). 
Plasma GLP-1 IAUC (0-120 min), cmax and tmax were correlated by 
Spearman rank order correlation with gastric emptying parameters (n =6 due to 
missing data). There were significant correlations between GLP-1 cmax and 
paracetamol IAUC (0-120 min) (Spearman r=0.886, p <0.05) following the low fat 
test meal. There were also significant correlations following the high fat test meal 
between GLP-1 tmax and EIE T50s (Spearman r=0.975, p <0.005) and breath test 
T50s (Spearman r=0.897, p <0.05). 
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Figure 4.18 Plasma GLP-1 concentrations (meant SEM, n= 9) following 
differing liquid test meals (low fat 1314 kJ and high fat 2820 kJ). There was a 
significant treatment by time interaction from t +60 to t +240 min (p <0.05). 
4.3.6.2.5 Plasma CCK 
The results for plasma CCK concentrations (t +0 to t +120 min only) 
following the low and high fat meals are illustrated below (figure 4.19). Two way 
repeated measures ANCOVA between the low and high fat test meals showed that 
there was a significant main effect of meal on overall plasma CCK levels (p <0.05). 
Plasma CCK IAUC (0-120 min), cmax and tmax were correlated by 
Spearman rank order correlation with gastric emptying parameters (n =6 due to 
missing data). The only gastric emptying parameter to significantly correlate with 
CCK was the breath test T50, which had a negative relationship with CCK cmax 
following the low fat test meal (Spearman r= -0.826, p <0.05). 
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Figure 4.19 Plasma CCK concentrations (mean± SEM, n= 9) following differing 
liquid test meals (low fat 1314 kJ and high fat 2820 kJ). There was a significant 
main effect of meal on overall plasma CCK levels (p <0.05). 
4.3.7 Discussion 
The aim of this study was to compare three methods of measuring gastric 
emptying, two of which relied on the relationship between absorption of a substrate 
and gastric emptying rate, and the other employing the change in electrical impedance 
that occurs when a non-conductive meal enters and leaves the stomach. 
Using the same low and high fat liquid test meals as in the previous study 
(section 4.2), it was shown that EIE T50s, breath test T50s and paracetamol 
parameters tmax and IAUC 0-120 min were all significantly different between the 
two meals. Therefore, in a research setting, where the object of the study was to 
discern differences in the gastric emptying rate of a liquid meal, all the methods 
tested would apparently be adequate. However, the three methods differed in their 
discriminatory power in assessing the difference between low and high fat meals. A 
difference coefficient was used to assess the discriminatory power of the methods. 
This showed that the paracetamol absorption method was the best discriminator and 
that the breath test T50s showed the least difference. EIE T50s were closer to breath 
T50s than paracetamol tmax in their discriminatory power between meals. When the 
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paracetamol tmax means are compared to the scintigraphy T50 means obtained in the 
previous study for identical test meals (see section 4.2.6.1.2), it is striking how 
similar they seem (low fat: scintigraphy T50 61 min, SEM 4, paracetamol tmax (n = 
6) 63 min, SEM 25; high fat: scintigraphy T50 160 min, SEM 38, paracetamol tmax 
(n = 6) 175 min, SEM 17). Scintigraphic T50s from the previous study (section 
4.2.6.1.2) also showed a similar magnitude of discrimination between the test meals 
(scintigraphy -75.8 %, SEM 17.9; paracetamol tmax (n = 6) -76.9 %, SEM 23). 
Although this is a comparison across two different studies and therefore different 
subjects, the test meal composition was identical. Thus the similarities between the 
values obtained by scintigraphy and paracetamol tmax suggest that the latter method 
could be investigated as a cheaper, safer method of estimating the T50s that would be 
obtained if the "gold standard" was used. Heading et al. (1973) found a significant 
relationship between scintigraphic T50s and peak plasma paracetamol concentrations 
(r = -0.77, p <0.005), as did Maddern et al. (1985) for plasma paracetamol tmax (r = 
0.62, p <0.05), both following liquid meals. Therefore, there is some reason to believe 
that paracetamol absorption (tmax) was quantitatively the better method in this study, 
despite the fact that the values of the other methods, EIE and 13C-octanoic acid breath 
test, were expressed as gastric half emptying times, whereas tmax is merely the time 
until peak concentration. 
Again, ME T50s were artificially short, with mean values of 21 min (low fat) 
and 28 min (high fat) leading to expected average emptying rates of 32 (low fat) and 
50 kJ/min (high fat) over the whole emptying period; emptying rates that are not 
physiologically plausible, repeating the findings of previous studies using this method 
(see sections 3.5.7 and 4.2.7). Breath test T50s (208 min, SEM 26, and 272 min, SEM 
33, for low and high fat meals respectively, n= 6) produce expected emptying rates 
of 3.2 and 5.2 kJ/min respectively. These emptying rates appear rather slow and so 
whilst EIE is underestimating gastric emptying times, the 
13C-octanoic acid breath 
test may be over-estimating emptying times. As already discussed, the reasons for the 
underestimated EIE T50s may involve the increasing conductivity of the stomach 
contents during the emptying phase, possibly the result of gastric secretions. 
The explanations for overestimated breath test T50s can be ascertained from 
published debates in 13C-octanoic acid breath test papers. The original experiment by 
Ghoos et al. (Ghoos et al., 1993) involved a 1046 kJ meal containing scrambled egg, 
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2 slices of white bread, 5g margarine and 150 ml water. The egg yolk had already 
been spiked with the labelled octanoic acid sodium salt and baked separately. The 
mean T50 was 72 min, a great deal shorter than the gastric half emptying times 
obtained in the present work, even if you take the low energy content into account, 
with an average estimated emptying rate of 7 kJ/min. These authors had shown that 
the gastric emptying rate is the main rate-limiting step for appearance of 13C enriched 
CO2 in the breath. However, the breath test T50s reported in the present work include 
the amount of time taken for the 13C-sodium octanoate to be absorbed, metabolised 
and excreted from the body's CO2 pool. Ghoos et al. (1993) argued that this delay is 
constant between and within individuals. When the closely related breath test T50s 
and scintigraphy T50s were regressed against each other, the regression line 
intersected with the y axis at 66 min rather than the origin, and this value of 66 min 
was subtracted from breath test T50 results (obtained from the mathematical formula 
used here) as an estimate of scintigraphic T50s. This value of 66 min was said to 
correspond to the T50 for absorption and oxidation of octanoic acid after 
intraduodenal intubation (62 min). 
The values reported in the present study can actually be considered as being 
half processing times (Delbende et al., 2000). The subtraction of 66 min cannot be 
applied to the data reported in this thesis as a different type of test meal was used and 
half the amount of 13C-octanoic acid was added to the meal. To apply the same 
correction factor to these results would necessitate a validation study against 
scintigraphy for the low and high fat liquid test meals. However, just out of interest, 
the correction factor of 66 min would yield T50s of 142 and 206 min for the low and 
high fat meals respectively, and estimated average emptying rates over the 4h would 
be 5 and 7 kJ/min respectively. These rates correspond more closely to those obtained 
in the literature (Ghoos et al., 1993; Maes et al., 1996). As pointed out in the original 
paper however (Ghoos et al., 1993), it was shown that the preparation methods of the 
separately baked and spiked egg yolk ensured good retention of the tracer, whereas it 
is not known whether separation of fat and aqueous phases occurred in the high fat 
liquid meal of the current experiment, or how this would have affected appearance 
rates of enriched CO2. 
Choi et al. (Choi et al., 1997) repeated the methods of Ghoos et al. (1993) to 
test their hypothesis that a uniform correction factor could be applied across 
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individuals and within repeated measures on an individual. Although they did find 
good repeatability within individuals, equal to that obtained using scintigraphy, they 
found that the duration of the collection period (4,5 or 6 h) introduced large 
variability, and that the T50s did not correlate with scintigraphic T50s, and so they 
argued that a correction factor of -66 min for breath test T50s was not valid. They 
asserted that the inter-individual variations in absorption and oxidation were large and 
that a sampling period of 6h with more frequent sampling was crucial for accurate 
gastric emptying breath test T50s. These conclusions were disputed by Perri et al. 
(Perri et al., 1998), who repeated the experiment again and showed a good correlation 
between scintigraphic and breath test T50s (r = 0.74, p=0.00003), with the 
regression line intercepting the y axis at 61 min (very close to the original 66 min). 
Their whole study (with a greater number of subjects, n= 88) was reported in a recent 
paper (Delbende et al., 2000), where the same significant correlation remained and 
the cross-section between the y axis and the regression line was at 67 min, I min 
more than the value obtained by Ghoos et al. (1993). Objections to Choi and 
colleagues' point of view were also raised by Maes et al. (Maes et al., 1998), who 
thought that longer collection periods improved curve fitting but did not greatly affect 
the T50 in normal subjects, which according to the mathematical formula depends on 
the instantaneous slope and shape of the curve, not the total amount of 13CO2 
recovered in the breath. They said that scintigraphy also benefits from more frequent 
sampling time points, and they maintained that the time taken for absorption, 
metabolism and excretion was extremely constant. 
A fairly constant level of 13C02 in baseline breath samples is important, since 
the increase above baseline in 13C enrichment is determined to calculate percentage 
dose recovered. Therefore, a similar diet the day before each study (so that 13C-rich 
foods are not consumed before one study and not the other) and a stable metabolic 
rate (i. e. strict control over levels of physical activity before and during the study) is 
of the utmost importance in carrying out 13C-substrate breath test studies. Both of 
these controls were observed in carrying out the present study thus it is assumed that 
excretion rate was not underestimated, especially as CO2 production rates were 
measured directly, as suggested by Amarri and colleagues (Amarri et al., 1998), 
rather than estimated using body surface area and a value of 5 mmol/m2 per min as 
previous investigators had done (Ghoos et al., 1993; Maes et al., 1995; Maes et al., 
1996; Choi et al., 1997). Also, a frequent rate of breath sampling was included in the 
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experimental protocol, increasing the accuracy of the curve fitting and achieving 
correlation coefficients >0.95 between the raw data and fitted data (mean r=0.997). 
It is likely that the results obtained by the 13C-octanoic acid breath test method 
are precise, but not accurate due to the absence of a validated correction factor for the 
liquid test meals used in this study. Perhaps using high energy liquid test meals 
required the longer sampling time of 6h suggested by Choi et al. (1997), especially 
since many individuals' cumulative curves had not yet reached 50 % percentage dose 
recovered by the 4h time point following the high fat test meal. The weak 
discriminatory power between low and high fat liquid meals compared to the 
paracetamol absorption test may have been a result of the long gastric emptying times 
(due to increased energy and fat content), and perhaps the breath test method is more 
suited to reduced energy loads with shorter T50s that fall within the 4 h. Regarding 
the present work, the subject of volunteer compliance is pertinent here as it is unlikely 
that they would have been willing to remain motionless for 6 hours. 
When the three gastric emptying methods were correlated against each other 
for each meal using non-parametric methods it was found that none of the tests 
significantly correlated against any of the other tests. This is probably partly due to 
small sample size as often the actual R values were moderately high. Fairly strong 
associations were found between paracetamol IAUC (0 to 60 min) and BE T50 
(Spearman r= -0.71) and paracetamol IAUC (0 to 120 min) and breath T50 
(Spearman r= -0.77) following the low fat meal, and between breath test T50 and 
HE T50 following the high fat meal (Spearman r=0.70). It is difficult to discuss the 
significance of these findings with a sample size of 6 subjects, but it appears that 
there may have been a trend for the breath test and paracetamol parameters to agree 
following the low fat meal. 
Unlike the previous experiment (section 4.2.6.2.1) using identical meals, 
plasma glucose levels were significantly different over time, as shown by a 
significant treatment by time interaction (p <0.00005). This is due to the fact that the 
sampling time of the present study was twice as long as the previous one. If the same 
time interval is taken (2 h) then no significant differences are found as before. As in 
the previous study, plasma insulin concentrations were significantly decreased 
following the high fat test meal compared to the low fat test meal, and the plasma 
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glucose and insulin levels followed a similar profile. The increased plasma insulin 
concentrations and earlier mean glucose peak following the low fat test meal 
compared to the high fat test meal are likely to be due to the faster gastric emptying 
rate of the low fat meal. In support of this it can be observed from figure 4.9 that the 
time course of plasma paracetamol concentrations were reflected by the plasma 
glucose and insulin profiles. 
Plasma GIP concentrations were significantly increased following the high fat 
test meal compared to the low fat during the whole 4h sampling time. There was also 
a significant treatment by time interaction in plasma GLP-1 response, with higher 
levels of GLP-1 following the high fat meal. The results for plasma GIP and GLP-1 
agree with those previously reported for low and high fat meals (Long, 2000). Plasma 
CCK concentrations were significantly increased following the high fat meal 
compared to the low fat meal, an effect that is well known and agrees with earlier 
findings (Hopman et al., 1985; Liddle et al., 1985; Drewe et al., 1992). It can also be 
noted that the plasma CCK response following the high fat test meal was biphasic, 
with the second mean peak occurring in parallel to the plasma GIP mean peak. It 
could be hypothesised that the initial peak (which occurred in parallel to the low fat 
test meal peak) was mainly gastric distension-induced, with the second peak a 
consequence of increasing intestinal fat load, which is why it emerges simultaneously 
with peak plasma GIP concentrations, levels of which closely reflect rate of fat 
absorption (Koop et al., 1990). 
A number of correlations were found between plasma hormones and gastric 
emptying parameters. Slower BE gastric emptying of the high fat test meal was 
associated with higher GIP peaks and longer times to reach peak GLP-1 
concentrations. Longer breath test T50s for the high fat test meal were associated 
with extended times to reach peak GLP-1 and GIP concentrations, and faster breath 
test emptying of the low fat test meal was associated with increased peak CCK 
concentrations. Increased paracetamol concentrations were associated with increased 
levels of plasma glucose following the high fat test meal, and with increased levels of 
GLP-1 following the low fat test meal. None of the gastric emptying parameters 
correlated with plasma insulin concentrations. 
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The relationship between longer gastric emptying times and an extended time 
to reach peak GIP and GLP-l concentrations, and between delayed gastric emptying 
and decreased CCK levels following the low fat meal, suggests that gastric emptying 
rate determines the secretion rate of these hormones. Although a greater amount of fat 
ingestion will delay gastric emptying and increase hormone secretion, there is 
variability between individuals in their gastric emptying times and so those 
individuals who empty more slowly for a given test meal will also show a longer time 
to reach peak plasma concentrations compared to those who empty the meal at a 
faster rate. Interestingly, although insulin IAUC (0 to 120 min) correlated with 
glucose IAUC (0-120 min) following the high fat meal there were no correlations 
between parameters of insulin secretion and parameters of incretin secretion for either 
test meal, and thus it appears that differing insulin profiles were directly influenced 
by circulating levels of absorbed glucose rather than the incretins, GIP and GLP- 1. 
In conclusion, EIE T50s are quantitatively inadequate for clinical and research 
use, but in terms of ranking order with other methods and with plasma glucose and 
hormone parameters, the EIE methodology performed better than it did in the 
previous study. This may be explained by the fact that the physicists who operated the 
equipment had improved their techniques for positioning the electrodes to obtain a 
stronger deflection with the ingestion of the meal. The breath test method was a poor 
discriminator between meals and may have been hampered by the choice of test meal. 
However, it correlated well with paracetamol parameters following the low fat meal 
(when breath T50s were shorter). The best method, both quantitatively (although 
tmax is not equal to T50) and in terms of discriminating power between low and high 
fat test meals seemed to be the paracetamol absorption method, especially tmax. 
Paracetamol IAUC correlated well with other methods and with plasma glucose and 
hormonal parameters. The paracetamol absorption method is fairly invasive since it 
involves taking blood, but could be the easiest and least expensive method for 
measuring the emptying rate of liquid test meals in a research setting, especially 
where blood samples are frequently taken for the measurement of other variables 
anyway. It is also safe compared to scintigraphy, as ionising radiation is not involved, 
and is suitable for studies where subjects may be overweight or obese (a limiting 
factor for EIE) or where it is not practical to remain still for long periods (a limiting 
factor for EIE and 13C-octanoic acid breath test). 
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Chapter Five 
Chapter 5 
THE EFFECT OF CASEIN AND WHEY PROTEIN ON APPETITE AND 
PHYSIOLOGICAL MECHANISMS 
5.1 Introduction 
It is a well-established fact that protein is more satiating, kilojoule for 
kilojoule, than carbohydrate or fat (Booth et al., 1970; De Castro, 1987; Barkeling et 
al., 1990; Hill & Blundell, 1990; Johnstone et al., 1996; Vandewater & Vickers, 
1996; Stubbs et al., 1996; Porrini et al., 1997; Latner & Schwartz, 1999). However, 
there is some evidence that different protein sources may differ in their satiating 
capacity, as it was shown that satiety was greater after a meal of fish compared to a 
beef or chicken meal (Uhe et al., 1992). Little is yet known how this may happen and 
not all observers report differences. Lang and colleagues (Lang et al., 1998) tested 
satiety and food intake using 6 different protein sources, but there were no differences 
in 8-hour satiety ratings or 24-hour food intake. A subsequent study, using smaller 
quantities of protein (casein, gelatin, and soy protein), showed a slight difference in 
hunger, although it was confirmed that varying the protein type in a mixed meal had 
no effect on 24 hour food intake (Lang et al., 1999). 
Of interest in this chapter is the concept of "fast" and "slow" proteins 
introduced by Boirie et al. (Boirie et al., 1997) to describe the differences between 
whey and casein in their digestion and absorption. They showed that casein, which 
coagulates in the stomach due to precipitation by gastric acid, had a slower rate of 
absorption and exerted less of an increase in plasma amino acids compared with the 
non-coagulating whey protein. Acidification of casein in the stomach creates a curd, 
thereby delaying the gastric emptying of this protein and also causing a resistance to 
digestion by pepsin (Billeaud et al., 1990; Miller et al., 1990). On the basis of 
Melinkoff's original aminostatic concept relating plasma amino acids to satiety 
(Melinkoff et al., 1956), whey as a "fast" protein, might be expected to be more 
satiating than casein . 
When ingested as liquid test meals, whey reduced short-term 
food intake to a greater extent than casein (Long et al., 2000), (see figure 5.1), 
suggesting that any positive influence on satiety mediated by the longer stomach 
retention time of casein was overwhelmed by the postprandial metabolic responses. 
205 
6000 , 
Figure 5.1 Ad libitum test meal energy intakes (n 16) 90 min after isoenergetic 
liquid preloads containing 48 g casein or whey protein (1674 and 1695 kJ 
respectively). Maltodextrin and double cream were added, giving a final % energy 
ratio of 50: 25: 25 for protein: CHO: fat. Values are means with their standard errors 
represented by vertical bars. Mean energy intakes were significantly different, (paired 
two-tailed t-test; p=0.034, ). (From Long et al., 2000). 
This implies that large rises in post-prandial plasma amino acid levels have a 
strong effect on short-term appetite responses, but that measurement of satiety over a 
longer period (Lang et al., 1999) may not detect the influence of postprandial amino 
acid kinetics. The importance of plasma amino acid levels over time following a meal 
requires further investigation. 
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5.2 Investigation into the effect of casein and whey protein on 
circulating metabolite and hormone status. gastric emptying 
and subjective appetite ratings 
5.2.1 Aims and hypothesis 
Previous work carried out by Samantha Long at the University of Surrey 
showed that a whey protein liquid meal reduced food intake to a greater extent than 
the same meal containing casein (Long et al., 2000). It is hypothesised that these 
different milk proteins, administered as a liquid preload, exert differing effects on 
short-term metabolite and hormonal responses before and after a standard meal. 
Since, whey protein is more satiating than casein protein, the elevation of satiety gut 
peptides GLP-1 and CCK might be expected. A randomised within-subject 
experimental design was used to examine the metabolic responses and pancreatic/gut 
hormone profiles following casein or whey liquid test meals. 
5.2.2 Subiects 
Nine lean healthy volunteers (8 female and 1 male) were recruited from the 
University, mean age 25 years (range 22 - 30). The volunteers were all non-dieting, 
with no special dietary requirements, and a BMI <25 kg/m2 (mean 22.6, SD 1.5 
kg/m2). They had no significant current or previous medical history and took no 
medication apart from the oral contraceptives. Volunteers who consumed more than 
20 units of alcohol per week or consumed more than 20% of their energy intake as 
protein were excluded (as assessed by a7 day food diary), as were smokers and 
heavy exercisers/athletes. All volunteers completed the Dutch Eating Behaviour 
Questionnaire (van Strien et al., 1986) as shown in appendix II, and those whose 
mean score was >3.0 were excluded (mean score 2.4, SD 0.5). Prospective subjects 
were interviewed and gave written consent to participate in the study, including a 
statement that they understood that they would be giving some blood as part of the 
study. A venous blood sample was taken for haematological and biochemical 
screening (full blood count, liver and renal function) to confirm their suitability to 
participate in the study. A letter was sent to their GP to inform them about the study, 
and to give their GP an opportunity to confirm their patient's suitability. The study 
protocol was approved by the local ethics committee. 
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5.2.3 General procedure 
Subjects were studied on two occasions (at least 3 days apart), one day for the 
whey protein meal and one day for the casein protein meal. They were instructed to 
avoid alcohol and high protein meals the evening before, and until the study. It was 
also requested that they withhold from taking any paracetamol tablets or paracetamol- 
containing products for the previous 24 hours. On the day of the study they consumed 
a standard high carbohydrate cereal and skimmed milk breakfast (delivered to the 
volunteer in advance) before 0800 hours, and then consumed nothing except water 
until 60 min before the study, and then no water until the study. 
Subjects arrived at the Clinical Investigation Unit at the University of Surrey 
at 1100 h (2 to 4 people per study day), and an intravenous cannula was inserted into 
an antecubital vein in the forearm under local anaesthetic by a qualified doctor or 
nurse. Blood samples were taken for the measurement of plasma amino acids, 
glucose, insulin, GLP-1, GIP and CCK according to the methodology detailed in 
section 2.2.3.1. Baseline blood samples were taken and the initial visual analogue 
scale (VAS) ratings (appendix V) of hunger, desire to eat and fullness were 
completed by the subject (-10 and 0 minute time points). The subject consumed a 
liquid test meal containing either 50% of the energy content as whey or casein protein 
(see table 5.1). The liquid test meal was presented in a black opaque beaker with a lid 
and was drunk through a straw so that any difference in the appearance of the 
preloads was not visible to the subject. The milkshake also contained 1.5 g of 
dissolved paracetamol (three crushed paracetamol tablets) in order to measure gastric 
emptying. Blood samples were taken at intervals for 90 min before the standard lunch 
was provided. VAS ratings were completed by subjects immediately before each 
blood sample was taken. Subjects were required to consume all the food provided at 
the standard lunch. The standard lunch contained sandwiches, yoghurt and cake, and 
the amount of energy provided was standardised to the subject's body weight (42 kJ 
per kg body weight). Two further VAS ratings and blood samples were taken 
following the standard lunch. 
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Time Blood VAS Treatment 
(min) sample 
-10 to v 
0 v v Consume casein or whey liquid test meal 
+1.5 g paracetamol 
+5 v 
+15 v v 
+25 v 
+35 v v 
+45 v v 
+60 v v 
+75 v 
+90 v v Consume standard lunch (42 kJ/kg body 
weight) 
+120 v v 
+180 v v 
Table 5.1 Study protocol for the effect of casein and whey liquid test meals on 
plasma metabolite and hormone response, gastric emptying and subjective 
appetite ratings. 
5.2.4 Meals 
Isoenergetic, high protein liquid test meals containing 1674/1695 kJ were 
consumed by the subject each study day. The milkshake meal was formulated using 
commercially available whey or casein protein formulas (see appendix XI for amino 
acid composition), double cream, and maltodextrin, so that protein provided 50 % of 
the energy, fat 25 % and carbohydrate 25 %, plus 1.5 g paracetamol (3 x 500 mg 
paracetamol tablets). They were made up to 450 ml with water (see table 5.2): 
High casein liquid test meal High whey liquid test meal 
Protein powder 
Double Cream 
Maltodextrin 
57 g (48 g protein, 858 kJ) 
23 g (11 g fat, 414 kJ) 
24 (24 CHO, 402 kJ) 
63 g (48 g protein, 1021 kJ) 
19 g (9 g fat, 339 kJ) 
20 (20 CHO, 335 kJ) 
Total energy 1674 kJ 1695 kJ 
Table 5.2 Comnnsitinn of hauid test meals used to test the effect of different 
protein types, casein and whey, on plasma metabolite and hormonal response. 
The standard cold lunch was calculated to supply each subject with 42 kJ/kg 
body weight, with each component of the meal making up the same proportion of 
total energy intake for each individual. This was calculated using a Microsoft Excel 
worksheet linked to other worksheets containing nutritional compositions of the foods 
(appendix X). The meal was based on the subjects' food choices (obtained during 
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recruitment): turkey or ham sandwich, lettuce, almond or lemon cake, and "thick and 
creamy" yoghurt. 
5.2.5 Subjective measures of appetite 
Subjects rated their hunger, desire to eat, and fullness as detailed in section 
2.2.1.3. Results were analysed by two way repeated measures ANCOVA as raw data 
with baseline values as covariate. The t -10 and t +0 min values were expressed as a 
mean and designated as covariate (or t +90 min when analysing post-standard lunch 
scores). 
5.2.6 Results 
5.2.6.1 Gastric emptying 
Plasma paracetamol concentrations following the casein and whey liquid test 
meals are shown in figure 5.2. 
Two-way repeated measures ANOVA on plasma paracetamol concentrations 
showed that there was no overall treatment effect, but there was a treatment x time 
effect (p <0.05), significant at t +35 min according to the post hoc Duncan test. This 
reflects the cross over where plasma paracetamol concentrations following the casein 
showed a greater increase compared to the whey until t +60 min, at which point 
concentrations levelled off and then dropped below whey levels. 
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Figure 5.2 Plasma paracetamol concentrations (mean ±SEM, n= 9) following 
isoenergetic 1700 kJ liquid test meals containing either casein or whey protein 
(50 % energy). There were no significant differences in plasma levels between 
treatments but there was a treatment x time interaction (p <0.05). 
Time until peak concentration (tmax), peak concentration (cmax) and area 
under the curve (AUC) were calculated for each subject's paracetamol results for the 
first 90 min until the standard lunch. There were no significant differences. The mean 
results were as follows (table 5.3): 
Casein Whey 
(SEM) (SEM) 
tmax (min) 56.7 (9.17) 73.3 (8.82) 
Cmax (mmolIL) 0.08 (0.01) 0.08 (0.01) 
Incremental AUC 0-90 min (mmol/L by 4.25 (0.34) 4.03 (0.53) 
min) 
Table 5.3 Mean gastric emptying parameters for paracetamol absorption 
following isoenergetic 1700 kJ liquid test meals containing 50 % energy either 
casein or whey protein, t +0 -t +90 min (before the standard lunch). Mean f 
SEM, n=9. Paired t-test between the conditions showed no significant differences. 
5.2.6.2 Blood metabolite and hormone profiles 
5.2.6.2.1 Plasma lud cose 
Plasma glucose concentrations are shown in figure 5.3. Ingesting both the 
high casein and high whey liquid test meal led to a slight rise in plasma glucose 
concentrations but there were no differences between treatments. 
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Figure 5.3 Plasma glucose concentrations (mean ±SEM, n= 9) following 
isoenergetic -1700 kJ liquid test meals containing either casein or whey protein 
(50 % energy). There were no significant differences in plasma levels between 
treatments. 
5.2.6.2.2 Plasma amino acids 
Plasma amino acid concentrations were analysed as change from baseline 
values (x-b) by two way repeated measures ANOVA. 
Total plasma amino acids, expressed as change from baseline (x-b), are shown 
in figure 5.4. Two way repeated measures ANOVA revealed no overall significant 
differences in total plasma amino acid levels between liquid test meals (p = 0.158), 
although there was a significant treatment x time interaction (p = 0.005). Two way 
repeated measures ANOVA on post-standard lunch values (t +90 to t +180 min) 
revealed a nearly significant increase in total plasma amino acids concentrations 
following the whey test meal (p = 0.051). 
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Figure 5.4 Change in mean total plasma amino acids (x-b mmol/L, ± SEM) 
following isoenergetic 1700 kJ liquid test meals containing either casein or 
whey protein (50 % energy). There was a significant treatment x time interaction (p 
= 0.005) due to increasing concentrations during the 2nd and 3rd hours following the 
whey liquid test meal compared to the casein. 
Results for individual amino acids (x-b averaged over 180 min, derived from 
two way repeated ANOVA calculations) are shown in table 5.4. 
Standard lunch 
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Amino acid 
(mmol/L) 
Casein test meal 
(mean x-b, 0-180 
min) 
Whey test meal 
(mean x -b, 0-180 
min) 
Main treatment 
effect 
(p value) 
Treatment 
x time 
interaction 
(p value) 
Aspartic acid (asp) 0.004 0.009 <0.005 <0.05 
Glutamic acid (glu) 0.014 0.029 <0.05 <0.05 
Glycine (1) 0.035 0.027 NS NS 
Threonine (thr) 0.070 0.119 <0.05 <0.00005 
Alanine (ala) 0.113 0.140 NS NS 
Arginine (arg) 0.050 0.053 NS <0.05 
Proline (pro) 0.211 0.126 <0.005 <0.005 
Tyrosine (tyr) 0.053 0.043 NS <0.05 
Valine (val) 0.166 0.207 NS (p = 0.082) <0.001 
Methionine (met) 0.036 0.037 NS <0.01 
Isoleucine (ile) 0.090 0.164 <0.005 <0.00005 
Leucine (leu) 0.160 0.244 <0.001 <0.0000001 
Phenylalanine (phe) 0.040 0.033 NS NS 
Table 5.4 Mean plasma amino acid values (mmol/L) over t +0 to t +180 min 
expressed as change from baseline (x-b), derived from two-way repeated 
measures ANOVA, following isoenergetic -1700 kJ liquid test meals containing 
50 % energy either casein or whey protein. NS: non-significant. Plasma 
concentrations were significantly increased overall following the whey liquid test 
meal for asp, glu, thr, ile, and leu. Plasma concentrations were significantly increased 
following the casein liquid test meal for pro. There were no differences for gly, ala, 
arg, tyr, val, met and phe. There were significant treatment x time interactions due to 
higher concentrations following whey in the 2°d and 3rd hours for asp, glu, thr, arg, 
val, met, He, and leu. There were significant treatment x time interactions due to 
higher concentrations following casein in the I" hour for tyrosine. There was a 
significant treatment x time interaction for proline due to higher concentrations 
following casein throughout the whole study. 
The branched chain amino acids (valine, isoleucine and leucine) and threonine 
were among those amino acids that showed the uppermost statistical significance in 
their differences in postprandial plasma profiles between the two test meals. See 
figure 5.5. 
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Figure 5.5 Change in mean total plasma branched chain amino acids (x-b 
mmol/L, ± SEM) following isoenergetic 1700 kJ liquid test meals containing 
either casein or whey protein (50 % energy). Valine, isoleucine and leucinc plasma 
profiles were all clearly divergent with high levels of statistical significance 
following the two test meals. 
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5.2.6.2.3 Plasma GIP 
Plasma GIP concentrations are illustrated in figure 5.6. 
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Figure 5.6 Plasma GIP concentrations (mean ±SEM, n= 9) following 
isoenergetic 1700 kJ liquid test meals containing either casein or whey protein 
(50 % energy). Plasma GIP concentrations were significantly higher following the 
whey test meal compared to the casein (p <0.005). 
Two way repeated measures ANCOVA on the raw data, t +0 - 180 min, 
showed that overall plasma GIP concentrations were significantly higher following 
the whey liquid test meal (p = 0.001). There was also a significant treatment x time 
effect (p = 0.020), which reflected the divergence in plasma GIP levels after the +25 
min time point. 
5.2.6.2.4 Plasma GLP-1 
Plasma GLP-1 concentrations are illustrated in figure 5.7. Two way repeated 
measures ANCOVA on the raw data, t +0 - 180 min, did not produce any significant 
differences (p = 0.191). However, when values were calculated as change from 
baseline (x-b), significant differences were shown between the casein and whey liquid 
test meals t +0 - 90 min (p = 0.041). Analysis of plasma GLP-1 concentrations 
following the standard lunch was carried out as change from pre-lunch baseline 
(change from +90 min), and a significant treatment x time effect was shown (p = 
0.004), due to the large increase in GLP-1 levels at +120 min following the whey 
compared to the casein. 
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Figure 5.7 Plasma GLP-1 concentrations (mean ±SEM, n= 9) following 
isoenergetic -1700 kJ liquid test meals containing either casein or whey protein 
(50 % energy). Plasma GLP-1 concentrations (x-b) were slightly increased following 
the whey test meal compared to the casein but this difference was not quite 
significant (p = 0.057). 
5.2.6.2.5 Plasma Insulin 
Plasma insulin concentrations are illustrated in figure 5.8. There were no 
significant differences in plasma insulin concentrations following casein or whey 
liquid preloads. 
5.2.6.2.6 Plasma CCK 
Plasma CCK concentrations are illustrated in figure 5.9. Two way repeated 
measures ANCOVA on the raw data, 0-180 min, showed that overall plasma CCK 
concentrations were significantly higher following the whey liquid test meal (p = 
0.017). 
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Figure 5.8 Plasma insulin concentrations (mean ±SEM, n= 9) following 
isoenergetic -1700 kJ liquid test meals containing either casein or whey protein 
(50 % energy). Plasma insulin concentrations were not significantly different. 
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Figure 5.9 Plasma CCK concentrations (mean dSEM, n= 9) following 
isoenergetic 1700 kJ liquid test meals containing either casein or whey protein 
(50 % energy). Plasma CCK concentrations were significantly increased following 
the whey test meal (p <0.05). 
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5.2.6.3 Subjective ratings of appetite 
Desire to eat and hunger was reduced by whey protein compared to casein 
following the standard lunch, and fullness was increased by whey compared to casein 
for the duration of the 3 h. Hunger, desire to eat and fullness after the casein and 
whey liquid test meals are shown (figures 5.10,5.11 and 5.12 respectively). 
Two way repeated measures ANCOVA of the hunger ratings showed that 
there were no overall or pre-standard lunch treatment effects. However, there was a 
trend towards a treatment effect following the standard lunch (p = 0.061), taking t 
+90 min as covariate. Desire to eat ratings were also significantly different following 
the standard lunch (p = 0.020). Two way repeated measures ANCOVA of fullness 
ratings showed that there was a significant treatment effect on fullness t +0 to t+ 180 
min (p = 0.037) and t +90 to t +180 min (p = 0.031), and a trend towards increased 
fullness from t +0 to t +90 min (p = 0.070). 
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Figure 5.10 VAS ratings (cm) for hunger (mean ± SEM, n= 9) following 
isoenergetic -1700 kJ liquid test meals containing either casein or whey protein 
(50 % energy). The whey liquid test meal reduced hunger to a greater extent 
following the standard lunch compared to the casein liquid test meal. This effect was 
marginally non-significant (p = 0.06). 
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Figure 5.11 VAS ratings (cm) for desire to eat (mean ± SEM, n= 9) following 
isoenergetic 1700 kJ liquid test meals containing either casein or whey protein 
(50 % energy). The whey liquid test meal reduced desire to eat to a greater extent 
following the standard lunch compared to the casein liquid test meal (p <0.05). 
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Figure 5.12 VAS ratings (cm) for fullness (mean ± SEM, n= 9) following 
isoenergetic 1700 kJ liquid test meals containing either casein or whey protein 
(50 % energy). The whey liquid test meal increased overall fullness to a greater 
extent compared to the casein liquid test meal (p <0.05). 
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5.2.7 Discussion 
The main interest that lay behind this investigation was the evidence for and 
against the differing satiating capacity of various protein sources (Uhe et al., 1992; 
Lang et al., 1998; 1999). Boirie et al. (1997) had previously introduced the concept of 
"fast" and "slow" proteins to describe the differences between whey and casein in 
their digestion and absorption. Casein, as a coagulating protein, had a slower rate of 
absorption and exerted less of an increase in plasma amino acids compared with 
whey, which does not coagulate. Based on the aminostatic theory that a larger rise in 
plasma amino acids would increase satiety, a study by Long and colleagues (2000) at 
the University of Surrey found that whey was more satiating than casein. The purpose 
of this study was to identify the physiological processes behind these differences in 
satiating capacity, specifically the endocrine and metabolic processes. 
Firstly, the demonstration of different gastric emptying rates was attempted 
using the paracetamol absorption method. The results showed that paracetamol 
absorption was faster following the casein until t +35 min but then levelled out for the 
remainder of the study period. Whey, on the other hand, continued to produce an 
increase in plasma paracetamol concentrations, overtaking casein concentrations at 75 
min and reaching a mean peak at 120 min. The initially faster absorption of 
paracetamol following the casein probably represented the solubilised paracetamol in 
the liquid compartment of the meal, as the casein protein had precipitated into curds 
in the stomach. The removal of the protein compartment (through forming solidified 
curds) of the liquid meal might have accelerated initial liquid gastric emptying 
compared to the whey liquid meal, which presumably contained evenly dispersed 
lipid, carbohydrate and protein throughout each unit volume of the meal emptied. The 
comparatively greater proportion of protein and fat reaching the duodenum following 
the whey meal would have induced a greater inhibition of initial gastric emptying. 
Therefore, the differing intragastric properties of the two test meals might have 
altered the pharmacokinetics of paracetamol absorption. Casein resulted in an initial 
faster gastric emptying rate followed by a plateau in plasma levels due to slower 
emptying of the solid casein curds. Whey, on the other hand resulted in a steady, 
initially more linear emptying rate which resulted in a higher mean plasma 
paracetamol peak and then a decline. 
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Therefore the paracetamol absorption method is unsuitable for calculating 
established gastric emptying parameters such as tmax, cmax and AUC with these 
meals because the casein meal effectively changes from a liquid meal to a solid/liquid 
meal through precipitation in the stomach. The pharmacokinetics of paracetamol 
absorption can, however, still be used to illustrate the differing gastrointestinal effects 
of the two protein sources, proven by the significant treatment by time interaction 
produced by repeated measures, two-factor analysis of variance (p <0.05). 
Despite the obviously differing gastrointestinal absorption rates occurring in 
some components of the meal, plasma glucose concentrations were remarkably 
similar following both liquid test meals. Neither plasma insulin and glucose responses 
were significantly different following the two meals, in contrast to previous findings 
for different protein types (Hubbard et al., 1989; Gannon et al., 1988; Lang et al., 
1999). However, plasma insulin concentrations followed a similar pattern to plasma 
paracetamol concentrations, with plasma insulin levels appearing higher until t +60 
min following the casein liquid test meal, and then decreasing below whey levels 
after t +60 min. To some extent this was similar to plasma glucose concentrations, 
with plasma glucose response appearing slightly higher following the casein meal up 
until 60 min. Plasma glucose, insulin and paracetamol all followed time courses that 
were very similar to each other, and that were very different from the time courses 
taken by plasma gastrointestinal hormones. 
Just under half of the plasma amino acids measured (5 out of 13) had an 
overall greater plasma response to the whey meal, whereas the rest showed no 
significant difference from t +0 to t+ 180 min. The only exception was proline, which 
significantly increased following the casein meal. A further 3 amino acids were 
significantly increased in the plasma from t +60 to t +180 min following whey 
(making a total of 8 out of 13). Examination of the plasma amino acid profiles of the 
whey and casein protein formulas (appendix XI) reveals that the largest differences in 
composition (g per 100g) between the two products are in arginine, methionine, 
phenylalanine, proline and tyrosine, where these amino acids are increased by more 
than 50 % in the casein formula. Three of these amino acids, phenylalanine, tyrosine 
and proline are among the five amino acids that were not increased in the plasma after 
whey, and all in fact show an increase in levels during the first hour following the 
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casein. Arginine and methionine were still increased following whey from t +60 to t 
+180 min, despite their larger relative content in the casein test meal. 
Analysis of plasma total amino acids confirmed that the majority of amino 
acids were increased in the plasma following the whey liquid test meal relative to the 
casein liquid test meal, but that the difference was mainly apparent after the first hour. 
Individual amino acids varied widely in the size of this divergence in plasma levels; 
the branched chain amino acids (valine, isoleucine and leucine) and threonine showed 
the most marked differences. Phenylalanine, whose effects on satiety are reported 
more than any other amino acid, showed no significant differences in plasma levels 
following the two test meals, probably due to the greater amount in the casein 
formula. Tryptophan is another amino acid that has been frequently linked with 
appetite regulation, but unfortunately tryptophan concentrations could not be 
analysed using this methodology. 
If the whey protein component of the test meal was emptied from the stomach 
more rapidly than the casein protein component, we can hypothesise that the protein- 
induced CCK response will be larger following the whey test meal. This indeed 
appears to be the case although the degree to which the higher plasma CCK 
concentrations are a result of the fat component or the protein component of the whey 
meal remains unknown. If it is assumed that the mixture emptied into the duodenum 
for the duration of the pre-standard lunch study period (90 min) contained a greater 
proportion of protein per ml following the whey meal compared to the casein, then it 
is likely that the higher CCK levels in the plasma were due to the greater secretory 
effect of hydrolysed whey protein. However, the greater GIP response following the 
whey, usually regarded as a marker for fat absorption, suggests that a greater 
proportion of fat was being emptied and absorbed as well, certainly from t +35 min 
until t +90 min. The increase in plasma GLP-1 levels following the whey meal 
supports this assumption, and also provides an additional mechanism for the greater 
satiating properties of whey compared to casein according to the current literature 
supporting GLP-1 as an important satiety peptide (Gutzwiller et al., 1999; Flint et al., 
1998). 
The visual analogue scales for subjective measurement of hunger, desire to eat 
and fullness supported previous work in that whey appeared to reduce hunger and 
223 
desire to eat following the standard lunch, and increase overall fullness compared to 
casein. Clear differences can be discerned between the responses to the two liquid test 
meals and the present findings confirm that due to the differing nutrient availability, 
endocrine responses and metabolic kinetics of these two protein sources, satiety is 
greater following the faster-absorbed whey protein compared to casein. The greater 
satiating capacity of whey may be a result of CCK- and GLP-1- mediated satiety 
mechanisms as well as the large increase in plasma amino acid concentrations; indeed 
the latter process may well be insufficient to induce such a marked satiety response 
following mixed meals without the additional support of the gut peptides that are 
involved in appetite regulation. 
The results are consistent with previous findings that casein and whey liquid 
test meals emptied from the stomach at different rates. The whey meal emptied 
homogeneously at a steady rate, whereas the casein meal emptied in a biphasic 
manner due to its transformation to a solid/liquid meal, with the liquid component 
emptying earlier. The metabolite and hormonal profiles provide a clue to the contents 
of these components. Carbohydrate emptied at a uniform rate with the liquid 
component of the casein meal, since there were no significant differences in plasma 
insulin or glucose between meals. The divergent profiles of plasma CCK and GIP 
(and to a lesser extent GLP-1) following t +25 min suggest that fat, as well as protein, 
emptied more slowly after the casein meal. This may have been a result of 
incorporation of fat into the casein curds or possibly a generally stronger inhibition of 
gastric emptying through a neural reflex response to the retention of solid matter in 
the fundus. 
In conclusion, it was shown that the different protein types, casein and whey, 
exert differing effects on plasma amino acid, GIP, GLP-1 and CCK responses before 
and after a standard meal. It is difficult to attribute the greater satiety response to a 
whey meal to the large increase in plasma amino acid concentrations exclusively, 
since the increase in satiety-gut hormones (CCK and GLP-1) that resulted from the 
difference in gastric emptying may have contributed to the reduction in food intake 
observed in the previous experiment (Long et al., 2000). In reality, it is difficult to 
separate these hormonal and metabolite responses since they will always occur 
together in a natural context, and their influences on satiety probably complement 
each other. 
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Chapter Six 
Chapter 6 
GENERAL DISCUSSION 
The three strands of experimental work described in the preceding chapters 
were carried out with the purpose of uncovering the short-term physiological 
mechanisms behind the protein-related regulation of appetite. The methodology used 
in order to do this was investigated in terms of the repeatability of tools used to 
measure appetite, and also the accuracy of the technique chosen to measure gastric 
emptying. An individual amino acid that had previously been implicated in the 
induction of satiety, phenylalanine, was investigated in terms of its effect on appetite, 
gastrointestinal hormones, metabolites and gastric emptying, administered both as a 
large dose, and also as a small dose as part of aspartame. Finally, two protein types 
were investigated as part of a mixed macronutrient liquid test meal in terms of their 
effect on plasma levels of amino acids, gastrointestinal and pancreatic hormones, and 
gastric emptying, and how these variables related to appetite response. The relevance 
and importance of these results will be discussed in the following chapter. 
6.1 Methodology 
6.1.1 The measurement of appetite 
Preloads and ad libitum test meal intakes have frequently been used to 
measure food intake following the manipulation of macronutrients or energy, but the 
reproducibility of food intake measurement has not, to the author's knowledge, so far 
been addressed. In the work described in this thesis, energy intake at the ad libitum 
buffet-style meal on repeated occasions was reduced on the third study session, 
despite the fact that the liquid preload and experimental conditions were identical on 
each study day. This raises an important issue for studies using ad libitum food intake 
as a measure of changes in appetite, and underlines the considerable influence of 
cognitive processes on eating behaviour. The value of randomisation, use of 
psychological screening tools such as the DEBQ, minimisation of external and 
emotional influences, and uniformity in experimental conditions (environmental 
setting, presentation of the meal, time of day etc. ) is highlighted by this work. In the 
context of this thesis, there was only one study carried out that measured food intake 
on more than two occasions: "The effect of phenylalanine supplementation on food 
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intake and subjective appetite ratings" (see section 3.2). The results were organised in 
terms of study session number order and analysed by repeated measures ANOVA, but 
mean food intake was equal across each study session thus the reduction in food 
intake observed with phenylalanine intake was not confounded by a meal order effect, 
although the strength of the phenylalanine-induced satiety may have been dissipated 
by a repeated meals effect. The ad libitum buffet-style meal is limited as a method for 
measuring appetite changes for the reason that it will discern very large effects but 
more subtle changes in food intake may be masked by the "sensory apathy" that 
occurs with repeated identical meals. Therefore, it is suggested that studies aiming to 
discern small changes in food intake following a certain treatment limit the number of 
study sessions to two, if possible, and leave at least a week "wash-out" period 
between study sessions. 
This "sensory apathy" effect on food intake with repeated identical meals is a 
symptom of the fact that laboratory food intake research by definition is a poor model 
for free-living eating patterns. The very fact that researchers want to isolate one 
variable and measure its effect on food intake means that all the other factors that 
normally influence food intake are removed, and this distorts the true eating response 
to the variable of interest. The problems associated with laboratory measurement of 
food intake have recently been reviewed by de Castro (De Castro, 2000). This author 
points out that the cost of food, the lack of external restraints such as a work schedule 
on the timing and duration of a meal, the emphasis on lunch-time meals during the 
week rather than evening-time meals and weekends (when many people consume the 
majority of the day's energy intake), prior beliefs and predetermined ideas about 
foods, and social facilitation are all factors that increase or decrease food intake and 
are removed in the laboratory. The removal of these influences can lead to the over- 
emphasis of the importance of a variable of interest, especially as appetite studies 
typically last for a few hours only. For example, palatability appears to be a major 
influence on food intake from laboratory studies whereas in fact free-living people 
rarely select foods low in palatability and so the influence of palatability on overall 
food intake is relatively small (de Castro, 2000). In the context of the present research 
work, free-living people would rarely sit down to a meal far larger than they could 
possibly eat as they do with the ad libitum buffet-style meal. Thus, the methodology 
removes one important real-life mechanism for the control of food intake - the 
perceived wastefulness and gluttony normally implicit in this kind of eating 
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behaviour. Further thought should be applied to designing a method for the 
measurement of food intake that simulates eating patterns in real-life, but that keeps 
constant but does not remove the other influences on food intake (reduces "noise"), in 
order that the true significance of any nutritional variable can be judged. This would 
present an extremely challenging and lengthy task for any researcher in the field of 
appetite. 
Visual analogue scales are important tools for the measurement of appetite, 
not just as a proxy for the measurement of food intake, but often in detecting changes 
in motivation to eat that are not reflected by food intake, as demonstrated by the 
results reported in this thesis for alanine treatment (see section 3.4) and in the work of 
other research groups (Gielkens et al., 1999; Lang et al., 1999). They are, however, 
highly dependent on the individual's interpretation of bodily sensations and strongly 
influenced by cognitive factors. Visual analogue scales and their reproducibility were 
also investigated simultaneously with food intake following the same three repeated 
identical liquid preloads and ad libitum buffet-style meal. Although no significant 
differences were found between mean scores for hunger, desire to eat and fullness on 
each occasion, this does not adequately show the reproducibility of VAS ratings. The 
statistical methods of Bland and Altman (1986), as used by Raben et al. (Raben et al., 
1995) in their study of the reproducibility of VAS ratings on two occasions, were 
applied to the results obtained here. Raben and colleagues found reasonably large 
repeatability coefficients (CR) in their study, and the CRs reported in this thesis were 
of a similar magnitude. Subsequently smaller CRs were reported in a more recent 
study by the same group (Flint et al., 2000), but the measurements were only repeated 
on two occasions, and the upper level CRs obtained in the present study were mainly 
a result of comparison with the third session. 
The relatively poor reproducibility of VAS ratings on repeated study days 
with identical preloads limits the usefulness of this methodological tool for the 
detection of more subtle changes in appetite. Although it has been shown in this 
thesis (see sections 3.4,3.5 and 5.2) and in many other research papers (Silverstone & 
Stunkard, 1968; Hill & Blundell, 1990; Flint et al., 1998; Kahler et al., 1999) that the 
subjective measurement of appetite using VAS ratings can be used successfully to 
detect changes in response to pharmacological and nutritional variables, the risk of 
missing small changes in motivation to eat is great. VAS measurements require care 
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when interpreting the results and when analysing statistically. Different people tend 
to used the scales in different ways - some may regard the extreme ends of the scale 
as, for instance, `as hungry as I've ever felt' in any day, and mark their scales at the 
ends more often. Others may regard the ends of the scale as `as hungry as I've ever 
felt' in their lifetime, and mark their scales around the middle. It is very important 
that the subjects are informed what is expected of them, i. e. that the ends of the line 
are extreme feelings, to mark the extent of their feelings according to that exact 
moment, and to emphasise the importance of these scales to subjects or they may 
succumb to tedium and take less care over the accuracy of their marks on the line. 
The simultaneous use of food preference checklists can occasionally reflect 
motivation to eat more robustly than VAS ratings, possibly because it presents the 
individual with a way of thinking about their appetite sensations in real terms, i. e. 
how many of these foods do you feel like eating? Some people will respond with 
more accuracy to one method more than another and perhaps the best way of 
detecting appetite changes is by spreading the net wide and using VAS ratings, food 
preference checklists and ad libitum food intake simultaneously. Bearing this in mind, 
it can be concluded that VAS ratings show relatively poor reproducibility in the 
measurement of appetite but can be a useful accessory to other within-subject, 
repeated measurements of food intake; the method is sensitive to variables that have 
potent effects on motivation to eat (those sufficient to override cognitive and learned 
influences on eating behaviour). The high risk of type H errors should be considered 
within some experimental paradigms when using VAS ratings. 
Power calculations were made based on the data according to the method of 
Gore & Altman (1982) using a nomogram. Appendix XII shows the results. The 
number of subjects needed to detect a 10 % difference in fasting VAS scores in a 
repeated measures design with a power of 0.8 would be between 25 to 34. These 
numbers are slightly higher for the post-preload mean (27 to 45) and a good deal 
lower for the post-ad libitum test meal values (11 to 25). The number of subjects 
required to detect a 10 % difference (418 kJ) in ad libitum test meal intake with a 
power of 0.8 would be 73; however, only 32 subjects would be needed for a 15 % 
difference in intake. These sample sizes seem quite large compared to the numbers 
used in the appetite studies here (section 3.2, n=9; section 3.4, n= 12). However, our 
sample sizes are comparable to those used in the literature. The power calculations 
carried out by Flint et al. (2000) on pooled data (n = 55) showed that 32 subjects were 
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needed to test all VAS appetite parameters, with a power of 0.8 and using a paired 
design -a figure that is not that far from the subject number of 45 calculated here. 
Running 32 to 45 subjects in an experimental study involving an ad libitum test meal 
would be expensive, and investigators must balance the risk of type I and II errors 
against the cost of running that many subjects. If the variable of interest is expected to 
have a large effect on appetite then fewer subjects (10 - 20) could be used, and it 
must be considered whether the variable is of any relevance to appetite regulation if 
the effect is expected to be small. Nevertheless, stringent statistical procedures for 
appetite studies are extremely important as the results of studies that use small sample 
sizes may be misleading, or at the very least need to be regarded with caution. 
6.1.2 The measurement of gastric emptying 
Gastric emptying was measured by EIE (a technique developed and conducted 
by colleagues in the Department of Physics at the University of Surrey) during two of 
the studies described in this thesis (sections 3.3 and 3.5), not including the 
comparative methodological studies. The validity of the EIE technique was called 
into doubt when abnormally short half emptying times compared to those reported in 
the scientific literature were obtained for the liquid test meal used in the aspartame 
study (section 3.5). EIE was compared with the "gold standard" scintigraphy in the 
first comparative study, and then with the paracetamol absorption test and the 13C- 
octanoic acid breath test in the second comparative study. EIE and scintigraphy 
yielded differing results for gastric emptying times, and they related poorly to each 
other in terms of rank order. Ranking order and agreement in values remained poor 
between LIE and the paracetamol absorption and 13C-octanoic acid breath tests. The 
second comparative study showed that slower gastric emptying rates of the high fat 
test meal, as measured by EIE, were associated with longer times to reach peak 
plasma GIP and GLP-I concentrations; however, the EIE/scintigraphy study found no 
such relationships for BE and metabolites. 
The fact that EIE discerned differences in gastric emptying rate of a water 
load following 5g phenylalanine, and in the gastric emptying rate of a liquid test 
meal following aspartame or the constituent amino acids, suggests that it could 
reliably detect a slower or faster gastric emptying rate. However, it was realised that 
the gastric emptying values were shorter than expected, and that the validity of this 
method was not sound as originally thought (McClelland & Sutton, 1985; Sutton et 
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al., 1985). The reason for the abnormally short gastric emptying times is the 
premature return to baseline. This is thought to be due to gastric acid secretions 
increasing the conductivity of the stomach contents, thereby reducing the magnitude 
of the difference in conductivity between the stomach tissue and the stomach contents 
(a non-conductive meal). Since the differences obtained in ME T50s are mainly a 
result of the initial trajectory of the reduction in impedance before this is truncated by 
the postprandial flattening of the trace due to the increased conductivity of the 
stomach contents, the proportion of the value that is determined by gastric acid 
secretion can be assumed to be minor but enough to prevent a correlation with other 
methods of gastric emptying. The problems associated with using EIE do not lend 
support for its future use in nutritional or clinical studies, but for the purpose of the 
work detailed in section 3.3 and 3.5, this method adequately detected differences in 
gastric emptying rates despite yielding erroneous values. 
6.2 Phenylalanine and appetite 
The objectives behind this line of enquiry included the exploration of the 
physiological mechanisms behind the reduction in satiety following aspartame 
ingestion previously demonstrated by Peter Rogers and colleagues. To recap, it had 
been shown that aspartame (but not phenylalanine or aspartic acid alone) ingested 
without tasting reduced food intake whereas aspartame dissolved in water had no 
effects (Rogers et al., 1990; 1991). In addition, aspartame reduced food intake when 
the interval between capsule and ad libitum test meal was one hour, but not with 
intervals of 5 and 30 min (Rogers et al., 1995). The authors had speculated that the 
physiological mechanism might involve the augmentation of CCK secretion in 
response to nutrients, since phenylalanine in large doses had previously been shown 
to induce CCK secretion (Ballinger & Clark, 1994; section 3.3) and also due to the 
fact that aspartame did not affect pre-meal subjective ratings of appetite. The main 
aims in the present research work was to discover if CCK or GLP-1 were involved, 
since GLP-1 is another gastrointestinal hormone involved in satiety, and whether this 
involved a modification of gastric emptying. 
Large doses of phenylalanine (5 g) reduced food intake but did not influence 
pre-meal subjective ratings of appetite. There was a discernible dose-dependent effect 
on food intake (weight of food) but smaller doses did not cause a significant effect. 
The same large dose of phenylalanine increased pre-meal plasma CCK concentrations 
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and also overall plasma levels of tyrosine. It was also shown that alanine, used by 
previous authors as a control when testing the effect of phenylalanine on appetite 
(Ryan-Harshman et al., 1987), did not affect food intake but did reduce hunger and 
increase fullness before the ad libitum buffet-style meal. It appears that whilst large 
doses of phenylalanine did not influence appetite when there were no other nutrients 
in the gastrointestinal tract, the treatment did amplify the satiating effect of food; in 
contrast, the equivalent dose of alanine did increase pre-meal satiety but this was 
obscured by the satiating effect of a meal. More complicated results were unearthed 
when this line of enquiry was extended to small doses of aspartame, which had 
previously been shown to potently reduce food intake (Rogers et al., 1990; Rogers et 
al., 1991). Aspartame did not increase CCK concentrations in the plasma, but both its 
constituent amino acids, and to a lesser extent aspartame itself, accelerated gastric 
emptying rates. Subjective ratings of desire to eat were reduced following a standard 
liquid test meal (one hour after the constituent amino acids treatment), and this was 
associated with larger plasma peaks in plasma phenylalanine. Plasma GLP-1 
secretion was suppressed by aspartame and the constituent amino acids. Although the 
reasons for this effect are not clear from the present results, the lower GLP-1 levels 
may partially account for the acceleration in gastric emptying rate, since one of the 
main functions of GLP-1 is the inhibition of gastric emptying. 
Since reduced levels of GLP-1 did not decrease subjective satiety in this study 
and, plasma CCK concentrations were unaffected, it can be concluded that these 
gastrointestinal hormones are not involved in the reduction in food intake previously 
observed one hour after ingestion of encapsulated aspartame. The increase in gastric 
emptying rate following the standard liquid test meal with aspartame and constituent 
amino acids treatment is probably not relevant to satiety mechanisms either. The lack 
of effect of aspartame on post-meal subjective ratings of appetite is puzzling and does 
not support the findings of Rogers and colleagues (1990; 1991; 1995), since you 
would expect post-meal subjective ratings of appetite to reflect food intake. However, 
this may be because VAS results probably reflect a mainly cognitive, motivational 
aspect of appetite plus post-absorptive metabolic satiety signals, whereas food intake 
is a combination of responses to feelings of distension, the elusive post-absorptive 
metabolic satiety signals, as well as cognitive influences. The most direct satiety 
message during a meal is when the stomach begins to get full, and most people will 
stop eating before this sensation becomes uncomfortable unless the food is highly 
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palatable and is eaten infrequently. Since the meal was a standard liquid test meal of 
medium energy content (1992 Id), maybe the increased fullness sensations 
experienced with solid, higher energy ad libitum test meals (Rogers et al., 1990; 
1991; 1995) were not triggered by the liquid, medium energy test meal used in the 
present work (Hulshof et al., 1993). The aspartame was amplifying the satiating 
effect of food in Rogers and colleagues' studies, possibly through increasing 
distension-induced nervous transmissions to the brain, which could not take hold with 
a standard liquid meal, perhaps because most of the liquid meal is held in the antrum 
and emptied rapidly rather than stored in the fundus before liquefaction (Collins et 
al., 1991; Urbain & Charkes, 1995). The fact that reductions in subjective desire to 
eat ratings were observed in the present study suggests that the constituent amino 
acids affected appetite via other mechanisms, reflected by the widely differing plasma 
phenylalanine profiles following aspartame and the constituent amino acids. The time 
point where the greatest reduction in desire to eat occurred coincided with the peak 
plasma phenylalanine concentrations and the ingestion of the standard liquid test 
meal. Whereas, plasma phenylalanine concentrations following the aspartame stayed 
moderately elevated throughout the study, there was no increase in concentrations 
then a sudden peak following the constituent amino acids. This occurred due to 
differences in intestinal absorption for dipeptides and individual amino acids as 
already discussed (section 3.5). In summary, the contrast in appetite results following 
encapsulated aspartame compared to Rogers and colleagues' studies can be attributed 
to the use of a smaller standard liquid test meal rather than a large ad libitum solid 
test meal, i. e. lack of a strong stimulus for gastric distension. The additional finding 
that constituent amino acids reduced desire to eat following a standard liquid test 
meal is probably related to the absorption of individual amino acids in the distal small 
intestine (ileum) and the sudden plasma phenylalanine peak that coincided with the 
ingestion of the meal, i. e. post-absorptive signals. 
Therefore, if it is hypothesised that aspartame may have previously increased 
satiety by enhancing distension-induced neural signals in the presence of a substantial 
gastric stimulus, but not with the involvement of gastrointestinal hormones CCK and 
GLP-l, nor gastric emptying, what is the relevance of this to free-living human 
beings? Previous findings that encapsulated aspartame does not reduce food intake 
when ingested up to 30 min before a meal (Rogers et al., 1995), and only when 
ingested without tasting (Rogers et al., 1990), suggest that the likelihood of aspartame 
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ingestion affecting anyone's normal eating behaviour is remote. In theory there are 
still possibilities for the therapeutic treatment of overweight, but the reduction in 
energy intake involved might not be effective in cases of obesity (- 730 U at the ad 
libitum test meal (Rogers et al., 1990)), and the obtrusive and obsessive nature of this 
intervention in eating behaviour would not be regarded by experts in the field as 
conducive to re-educating the patient towards normal healthy meal patterns. 
If it is hypothesised that the constituent amino acids of aspartame, 
phenylalanine and aspartic acid, reduced desire to eat in this study by large increases 
in plasma phenylalanine concentrations, this is of more interest with regard to the 
original aminostatic theory discussed in section 1.1.4.1. It suggests that an increase in 
plasma phenylalanine concentrations can reduce motivation to eat independently from 
pre-absorptive factors such as the satiety gut peptides, CCK and GLP-1, and 
distension satiety signals (this can be assumed since gastric emptying was 
accelerated, which would reduce intragastric pressure). If the kinetics of post-prandial 
increases in plasma amino acids can affect motivation to eat, this suggests that there 
is an aminostatic sensor either in the periphery or the central nervous system that 
transmits satiety signals to the appetite centres in the brain. Since peak phenylalanine 
concentrations were still in the normal postprandial range following the constituent 
amino acids treatment containing 224 mg phenylalanine (mean 0.107 mmol/L, SEM 
± 0.021 at t+60 min), this suggests that the amino static sensor is very sensitive to 
small imbalances in plasma amino acid profiles. The satiety response observed in the 
earlier studies, where food intake was reduced in response to a5g dose of 
phenylalanine, clearly represented a separate mechanism involving delayed gastric 
emptying and increased CCK production. This cannot be regarded as a physiological 
response, as the likelihood of any individual ingesting 5g of phenylalanine, 
especially with no other amino acids to balance this, is extremely slight. 
In conclusion, it is hypothesised that the relevance of phenylalanine ingestion 
to normal everyday appetite regulation is minor. Previous findings that phenylalanine 
increases satiety via the increased secretion of CCK did not apply to physiological 
phenylalanine intakes. Physiological levels of phenylalanine intake affected satiety by 
reducing motivation to eat immediately after ingestion of a nutrient-containing liquid 
test meal, but this was probably because there was a sudden imbalance of amino acids 
in the plasma over a short time period (i. e. a high phenylalanine/total remaining 
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amino acids ratio). The only instance where this might occur in real life is by 
ingestion of "diet" drinks sweetened with aspartame while in the fasted state, 
followed by the consumption of a protein-free meal. However, it has been shown in 
the present work that plasma phenylalanine concentrations following aspartame were 
constant and elevations were slight due to differences in absorption of the dipeptide 
compared to free phenylalanine. 
6.3 Physiological mechanisms behind the differing satiating effects 
of two proteins, casein and whey 
The phenylalanine chapter established that small physiological imbalances in 
plasma amino acid concentrations could influence motivation to eat, but that in 
practice this was unlikely to occur in free-living human beings. The main aims of the 
casein and whey chapter (section 5.2) were to investigate the physiological 
mechanisms behind the different satiating properties of the two milk proteins, and the 
importance of the biokinetics of plasma amino acids following different types of 
whole protein sources was of particular interest. Was the increased satiating capacity 
of whey protein due to the larger increases in plasma amino acids that would result 
from the faster gastric emptying rate compared to casein protein? The results showed 
that there was a divergence in plasma amino acid levels after the first hour of the 
study, with total plasma levels increased relative to casein following the whey test 
meal. We were unable to prove that the differences in the time course of plasma 
amino acids were wholly responsibly for the differences in satiety, since plasma 
levels of the satiety gut peptides, GLP-1 and CCK, were also higher following the 
whey protein meal. This requires further studies with a modified protocol to 
investigate the importance of postprandial amino acid levels in the short-term satiety 
response. Carbohydrate-free and fat-free test meals, which would simplify the gut- 
mediated hormonal response, would be highly unpalatable, unrepresentative of a 
normal mixed meal, and would not remove the influence of differing protein-induced 
CCK secretion on satiety. The other alternative would be to separate the components 
of a mixed meal to eradicate the gut-mediated, gastric emptying-linked response, i. e. 
a liquid test meal of fat and carbohydrate could be ingested simultaneously with 
intravenous or intraduodenal infusion of an amino acid mixture simulating a normal 
protein source, for example beef. If the amino acid mixture was infused at different 
rates, replicating the plasma profiles seen when the casein and whey liquid test meals 
235 
have been consumed, then any differences in satiety responses could be examined 
against a background of hopefully constant gut peptide secretion. 
Of course, plasma amino acids profiles are not independent from gut-mediated 
mechanisms during the course of digestion and absorption of a normal-mixed meal. 
In addition, casein is the only protein to exhibit this property of precipitating in 
stomach acid to form curds and thereby delay gastric emptying, and therefore is 
limited as a model for appetite responses to normal protein-containing meals. In a 
normal meal, there is often a variable quantity of vegetable and cereal fibre which 
will affect gastric emptying and absorption rates of amino acids, as well as the 
differing digestibility properties of different protein sources (meats, dairy, egg 
albumin, Quorn (Burley et al., 1993)). The fat and carbohydrate content of a meal 
will affect gastric emptying rate through the negative feedback of gut hormones, 
thereby influencing the absorption rate of amino acids. It is only when we try and 
unravel all these physiological responses to food to discover the importance of one 
particular mechanism, such as the aminostatic control of food intake, that the extent 
to which all of these processes are inextricably linked can be truly understood. 
6.4 Concluding remarks 
This thesis has addressed the short-term physiological mechanisms behind 
amino acid-induced satiety in human beings. The effect of a single amino acid, 
phenylalanine, on short-term satiety and gastrointestinal responses has been 
investigated. It is concluded from these studies that phenylalanine does lead to an 
increase in satiety, but this may be a result of two different physiological mechanisms 
depending on whether consumed as a large dose (pre-absorptive gastrointestinal 
response) or a small dose (post-prandial increases in plasma phenylalanine 
concentrations). The suppressive effect of aspartame on food intake is not a result of 
CCK or GLP-1 response, nor is it due to delayed gastric emptying, but it has been 
hypothesised here that perhaps the dipeptide methyl ester stimulates sensory nerve 
endings in the intestine that enhance the sensations of gastric distension. The direct 
stimulation of sensory nerve terminals near the lumen of the GI tract is an important 
area of research for protein/amino acid-induced satiety. A greater understanding of 
these neuronal signals is essential if we are not going to remain ignorant of the 
mechanisms for the short-term regulation of appetite. The investigation into the 
physiological mechanisms behind the differing satiating properties of casein and 
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whey has shown that the difference in gastric emptying rates of meals incorporating 
these proteins result in distinct responses for a range of gastrointestinal hormones, in 
addition to a large rises in plasma amino acid concentrations following the whey 
compared to the casein meal. The research shows that short-term changes in appetite 
as a result of protein intake may involve acute increases in postprandial plasma amino 
acid profiles. These post-prandial changes are not exclusive of pre-absorptive satiety 
mechanisms such as gastric distension, delayed gastric emptying, and increased 
secretion of satiety gut peptides in their influence on food intake and subjective 
appetite. 
6.5 Recommendations for future work 
The work that has been carried out for this thesis has yielded some interesting 
results, but has raised many more questions than it was able to answer. These 
questions may form the basis of future research, and hypotheses for further studies 
are suggested below. 
1) Aspartame reduces food intake but does not increase pre-meal subjective 
ratings of appetite. Since this has been shown to be independent of an increase 
in plasma CCK levels, it is hypothesised that aspartame may act directly on 
gastrointestinal afferent nerve terminals to enhance the stimulation of 
distension-induced feelings of fullness. Further physiological studies in animals 
(not the rat since there may be a species difference in responses to aspartame 
(Rogers & Blundell, 1992)), possibly using the techniques of Jeanningros 
(1982), are needed to test whether specific vagal afferent neurons in the stomach 
and intestine respond to perfusion with aspartame. 
2) The short-term satiety response to large doses of phenylalanine (5 g) involves 
increased secretion of CCK and delayed gastric emptying. Using the same dose 
of phenylalanine compared to a control dose (cornflour), but ingested 
simultaneously with a fat/carbohydrate preload would determine its effects on 
satiety when consumed as part of a meal. Measurement of plasma CCK and 
gastric emptying rate would establish whether phenylalanine affects these 
variables additionally to the fat-induced effects, or whether a fat-induced delay 
in gastric emptying and increase in CCK secretion would overwhelm any 
phenylalanine-induced effects. 
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3) Intraduodenal and intravenous infusion of an amino acid mixture simulating 
the profile of a commonly ingested food protein, e. g. beef, should be carried out 
in human subjects to determine the importance of postprandial flux in 
circulatory amino acids in appetite regulation. The mixture would be infused at 
physiological concentrations but at different rates (slow and steady versus rapid 
and acute) over 3-4 hours, and subjective appetite ratings and ad libitum food 
intake would be measured during that time. This would clarify whether the 
kinetics of post-absorptive changes in plasma amino acids are directly related to 
satiety or whether they are just a consequence of pre-absorptive changes in 
gastric emptying and hormonal response. 
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Appendi40 ces 
APPENDIX I SUMMARY OF THE METHODS AVAILABLE TO MEASURE 
GASTRIC EMPTYING RATES IN HUMAN SUBJECTS 
Method Details References 
C-octanoic C-octanoic acid is a carbon-labelled medium chain fatty acn which undergoes rape ( oos el W., 
acid breath absorption in the duodenum and oxidation in the liver. 13CO2 excretion in the breath over 1993; Maes et al., 
test time was found to closely reflect gastric emptying rate, the main rate-limiting step. 13C 1994; Macs et al., 
enrichment is measured by an isotope ratio mass spectrometer and results are expressed as 1995; Man er at. 
% recovery of administered dose. It is preferable to measure CO2 production 1996; Choi of al., 
simultaneously rather than use an estimate based on body surface area. Based on the 1997; Swart & van 
assumption that the octanoic acid is digested, absorbed, metabolised and excreted at the den Berg, 1998; 
same rate between individuals and within individuals with repeated measures. Non- Delbende or at, 
invasive. 2000) 
Applied Non-invasive, less portable than EIE. 16 electrodes are placed in a circular array around the (Avill eta ., 
1997; 
potential trunk. An alternating current of 5mA at 50kHz is passed between pairs of adjacent Mangnall. 1989) 
tomography electrodes and the potential difference between the remaining 13 adjacent electrode pairs 
are measured. Gastric emptying profiles are obtained by circling the image of the stomach 
and calculating the change in resistivity with ingestion of a liquid meal. Reduces problem 
with movement artifacts seen for EIE. Compares well with scintigraphy and dye dilution 
techniques. 
Dye dilution Uncomfortable and invasive. A nasogastric tube is passed into the empty stomas which a (George. 1, 
then washed out, and the test meal, labelled with phenol red, is administered. Samples are Backers er al., 
removed from the stomach at intervals and the volume of food remaining in the stomach 1992; Maughan & 
and volume of gastric secretions is measured using the concentration of phenol red. The Leiper. 1996). 
sample is then returned to the stomach until the next sampling int. 
- - Electrical stoiis Non-invasive, portable. 6 electrodes are placed Zli and lower back. An (Pickworth. ; 
impedance alternating current of 4mA at 100kHz is passed through one set of electrodes and the McClelland & 
epigastro- impedance is recorded by the remaining 4. Half-emptying time is calculated from the peak Sutton, 1985; 
graphy (EIE) of the initial impedance deflection to the half way point where the trace returns to baseline. Sutton of al.. 1985; 
Non-conductive liquid meals used. Subject remains very still due to movement artifacts. Boston. 1995; 
M 1.1989) 
Magnetic Non-invasive, but expensive. Can be used to measure gastric emptying. gastric motility ( zer es , 
resonance visualise the stomach in 3D. Consume a non-toxic meal containing gadolinium 1992; Lehmann et 
imaging tetraazacyclododecane tetraacetic acid (Gd-DOTA). Transaxial slices (10mm wide) taken al., 1996; Schwizer 
(MRI) over the upper abdomen every 15 min to measure emptying. Total volume of gastric et al., 1996; 
contents at each time point calculated by summing the gastric volumes of all slices of each Schwizer er al.. 
sequence, and calculated according to signal intensity. Avoids errors of overlap seen in 1997) 
scintigraphy. Disadvantages: have to hold breath in expiration during transaxial scans to 
reduce movement artefacts. 
Paracetamol Paracetamol is quickly ibs-m bed fiorn the um and this was found to relate to gastric ( ing et ., 
absorption emptying. 1.5g of soluble paracetamol is administered orally, and the appearance of 1973; Maddern or 
paracetamol in the blood plasma is used to measure the rate of emptying of a liquid meal. al.. 1985; Petring 
Liquid meals only. The area under the curve, time until peak plasma concentrations, and & Flachs, 1990; 
value of peak plasma concentrations are used as indictors of gastric emptying. van Wyk et al., 
1993; van Wyk or 
al., 1995). 
Scintigraphy Considered to be the "gold standard". Use a gamma camera (often anterior and (Harvey et ., 
posterior detectors) to show the passage of a radiolabelled meal through the stomach and 1970; Heading er 
into the duodenum, and to produce scintigraphic images of the counts per minute. % al., 1971; Meyer el 
retention of meal can be calculated from the number of counts in the defined region of al., 1976; Tothill es 
interest (the full stomach at completion of ingestion). Can be used for solid and liquid al., 1978; Meyer et 
meals. Expensive, equipment in demand, involves radioactivity so repeated studies limited. at, 1983; Donovan 
Subject to correction for radioactive decay, downscatter for dual isotope studies and septal & Harding, 1986; 
penetration, intestinal overlap, and movement of the meal towards the camera (need to use Urbain & Charkes, 
the geometric mean). 1995; Harding & 
N i, 1998). 
Ultrasono- Non-invasive. Uses an ultrasound instrument gastric emptying on videotape, ( el at. 
graphy Can measure solid-liquid and liquid meal emptying. Gastric emptying time calculated by 1993; Cucchiara et 
measuring the cross-section of the gastric antrum corresponding to the sagittal plane al., 1995; Okamoto 
passing through the superior mesenteric vein (reference point) (time for the antral area to et al.. 1997) 
return to baseline). Compares well with scintigraphy. 
291 
APPENDIX II THE DUTCH EATING BEHAVIOUR QUESTIONNAIRE 
Subject number Date 
Please answer each question by circling the most appropriate alternative. 
1) If you have put on weight, do you cat less than you usually do? 
Never Seldom Sometimes Often Very often Not relevant 
2) Do you have a desire to eat when you are irritated? 
Never Seldom sometimes often Very often Not relevant 
3) If food tastes good to you, do you eat more than usual? 
Never Seldom Sometimes Often Very often 
4) Do you try to eat less at mealtimes than you would like to eat? 
Never Seldom Sometimes Often Very often 
5) Do you have a desire to eat when you have nothing to do? 
Never Seldom Sometimes Often Very often Not relevant 
6) Do you have a desire to eat when you are depressed or discouraged? 
Never Seldom Sometimes Often Very often Not relevant 
7) If food looks and smells good, do you eat more than usual? 
Never Seldom Sometimes Often Very often 
8) How often do you refuse food or drink offered because you are concerned aboutyour weight? 
Never Seldom Sometimes Often Very often 
9) Do you have a desire to eat when you are lonely? 
Never Seldom Sometimes Often Very often Not relevant 
10) If you smell something delicious, do you have a desire to eat it? 
Never Seldom Sometimes Often Very often 
11) Do you watch exactly what you eat? 
Never Seldom Sometimes Often Very often 
12) Do you have a desire to eat when someone lets you down? 
Never Seldom Sometimes Often Very often Not relevant 
13) If you have something delicious to eat, do you cat it straight away? 
Never Seldom Sometimes Often Very often 
14) Do you deliberately eat foods that are slimming? 
Never Seldom Sometimes Often Very often 
15) Do you have a desire to eat when you are cress? 
Never Seldom Sometimes Often Very often 
16) Do you have a desire to eat when you are expecting something umpleaaant to happen? 
Never Seldom Sometimes Often Very often 
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17) If you walk past the baker, do you have a desire to buy something delicious? 
Never Seldom Sometimes Often Very often 
18) When you have eaten too much, do you eat less than usual the following daYs7 
Never Seldom Sometimes Often Very often Not relevant 
19) Do you have a desire to eat when you are anxious, worried or-tense? 
Never Seldom Sometimes Often Very often 
20) If You walk past a snack bar or cafE do you have a desire to buy something_delicious? 
Never Seldom Sometimes Often Very often 
21) Do you deliberately eat less in order not to become heavier? 
Never Seldom Sometimes Often Very often 
22) Do You have a desire to eat when thins arc going sgainstyaýor when things have gone wrong? 
Never Seldom Sometimes Often Very often 
23) If see others eating, do you also have a desire to tat? 
Never Seldom Sometimes Often Very often 
24) How often do you try not to eat between meals because you are watching your weight? 
Never Seldom Sometimes Often Very often 
25) Do you have a desire to eat when you are frightened? 
Never Seldom Sometimes Often Very often Not relevant 
26) Can you resist eating delicious foods? 
Never Seldom Sometimes Often Very often 
27) How often in the evening do you try not to eat because you are watching yourwoijn? 
Never Seldom Sometimes Often Very often 
28) Do you have a desire to eat when you are disappointed? 
Never Seldom Sometimes Often Very often Not relevant 
29) Do you eat more than usual when you see others eating? 
Never Seldom Sometimes Often Very often 
30) Do you take your weight into account when you eat? 
Never Seldom Sometimes Often Very often 
31) Do you have a desire to eat when you are emotionally upset? 
Never Seldom Sometimes Often Very often Not relevant 
32) When preparing a meal are you inclined to eat something? 
Never Seldom Sometimes Often Very often 
33) Do you have a desire to eat when you are bored or restless? 
Never Seldom Sometimes Often Very often 
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APPENDIX III 
Food 
Turkey sandwiches 
OR 
AD LIBITUM TEST MEAL COMPOSITION 
Amount Energy acronu nta (g pert food) 
served (g) density (kJ/g) io at 
298 10 0.10 0.32 0.09 
Ham sandwiches 298 
OR 
Cheese sandwiches 285 
OR 
Tuna sandwiches' 310 
11 
13 
10 
Potato crisps 26 23 
Sweet biscuits2 96 15-16 
Cakes 107-140 17 
"Thick and creamy" 200 4 
fruit yoghurt 
Lettuce 50 <1 
Cucumber 84 <1 
Tomato 75 <1 
Mayonnaise3 30 
English mustard -8 
0.10 0.31 
0.12 0.32 
0.09 
0.16 
0.13 0.30 0.07 
0.06 0.46 0.38 
0.04-0.06 0.44-0.49 0.16-0.20 
0.03-0.07 0.50-0.58 0.13-0.20 
0.03 0.16 0.03 
0.01 0.02 0.00 
0.01 0.02 0.00 
0.01 0.03 0.00 
0.01 0.79 0.01 
0.08 0.08 0.22 
' Subjects had a choice of two kinds of sandwich. 
2 Subjects had a choice of type of biscuit, cake, and yoghurt. 
3 Mayonnaise and English mustard were offered in jars with the rest of the food. The jars were weighed before and after the 
meal. 
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APPENDIX IV LUNCH AND AD LIBITUM TEST MEAL PREFERENCE 
QUESTIONNAIRE 
ID number Date 
Standard lunch 
Time 
As part of this study a standard lunch is provided in the Clinical investigation Unit kitchen which you can come 
and eat at some time between 11.30 am and 1 pm. There is a choice of three lunches. Please tick whichever you 
prefer or cross out what you will not eat: 
Chicken pasta bake 
Cheese, pasta and tomato paste bake 
Tagiitet i carbonara 
Jelly 
Ad libitum test meal 
Please rank these sandwich fillings from I to 4 in terms of preference (with I being the one you most prefer and 
crossing out any you definitely do not like): 
Turkey 
Tuna 
Cheese 
Ham 
------------------- 
------------------- 
------------------- 
------------------- 
Please cross out any salad items that you do not like: 
Lettuce 
Cucumber 
Tomato 
Do you like ready salted crisps? If not please indicate which flavour you prefer. 
Please rank these biscuits in terms of preference and cross out any you do not like: 
Lincoln 
Tesco All Butter 
Tesco Almond Shortie 
Tesco All Butter Fruit 
Rich Tea 
------------------- 
------------------- 
------------------- 
------------------- 
------------------- 
Please rank which yoghurt flavours you prefer or cross out what you do not like: 
Morello Cherry 
Strawberry 
Brazil pineapple 
Williams pear 
White peach 
------------------- 
------------------- 
------------------- 
------------------- 
------------------- 
Please rank which cakes you prefer or cross out what you do not like: 
Almond slice 
Lemon slice 
Mini rolls 
Thank you. 
------------------- 
------------------- 
------------------- 
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APPENDIX V VISUAL ANALOGUE SCALES (VAS) USED TO MEASURE 
SUBJECTIVE APPETITE 
ID number Date Time 
Answer the questions by placing a vertical mark through the line for each question. Mark the 
lines according to how you feel at this moment. Regard the ends of the lines as indicating the 
most extreme sensations you have ever felt. 
How hungry do you feel? 
Not at all hungry Extremely hungry 
How strong is your desire to eat? 
Not at all strong Extremely strong 
How full do you feel? 
Not at all full Extremely full 
How thirsty do you feel? 
Not at all thirsty Extremely thirsty 
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APPENDIX VI FOOD PREFERENCE CHECKLIST 
ID number Date Time 
Please indicate which of the food items below you would like to eat at this moment. Do this by placing a cross on the line 
next to the item or items. Consider each item in turn and independently from the other items - you are not being asked to 
construct a menu form these foods. What we are interested in is. if you were presented with the item, would you like to eat 
it now. Therefore, you might mark some of the itemm none of them or all of them. 
A medium sized roast chicken breast 
A currant bun 
A small pancake (sweet) 
A medium sized peach 
A small packet of roasted, salted peanuts 
A large grilled cod fillet (no batter) 
A large tomato 
A small baked potato 
A small slice of rich cheesecake 
A small slice of apple pie 
A small gammon steak 
A medium portion of boiled rice 
A slice of melon 
A plain omelette (2 eggs) 
Fruit yoghurt (thick and creamy type, 150 g pot) 
A large bread roll 
A large portion of prawns 
A medium chunk of cheddar cheese 
A medium sized apple 
A plain croissant 
A large portion of tuna (canned in brine) 
A medium sized bowl of cornflakes with semi-skimmed milk and sugar 
A small cream-filled chocolate eclair 
A large raw carrot (peeled) 
A cheese scone 
Two slices of salami 
Grilled, lean beef rump steak (Soz) 
A green salad (no dressing) 
A large banana 
Three grilled fish fingers (coated in breadcrumbs) 
Other(s) 
--------------------------------------------------------------------------- 
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APPENDIX VII DERIVA TISA TION PROCEDURE FOR PLASMA AMINO 
ACID ANAL YSIS USING WATERS PICO-TAG SYSTEM 
FOR THE HPLC 
Solutions to be made up: 
A. Drying solution 
200 µl Methanol 
200 µl Sodium acetate (1 M) 
100 µ1 Triethylamine (TEA) 
B. Derivatising agent (with PITC) 
20 µl PITC 
140 µl Methanol 
20 µl TEA 
20 µl Water 
PROCEDURE: 
1. Vacuum dry sample/standard (20 µl) using the Pico-Tag work station 
2. Add drying solution (10 µl), vortex and vacuum dry again 
3. Coupling step: derivatise by adding derivatising agent (20 µl), vortex, leave 
for 10 min at room temperature and vacuum dry again 
4. Add methanol (10 pl), vortex and dry thoroughly 
5. Reconstitute in 100 µl eluent A (70 mM sodium acetate trihydrate, pH 6.45 + 
2.5 % acetonitrile) and inject 20 µl. 
NB. Allow PITC to come to room temperature before opening to prevent 
condensation. 
TEA should be blanketed with nitrogen gas and stored in the refrigerator for a 
maximum of 3 months. 
298 
APPENDIX VIII EXAMPLE OF A STANDARD AND PLASMA AMINO ACID SAMPLE 
CHROMA TOGRAPH USING WA TERS PICO-TAG METHODOLOGY FOR 
THE HPL C 
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APPENDIX IX REPEATABILITY OF APPETITE VAS RATINGS WITH 
REPEATED IDENTICAL LIQUID TEST MEALS 
BASELINE 1 and 2 study session 1 and 3 study session 2 and 3 study session 
Mean difference 
(CR) 
R2 Mean difference 
(CR) 
R2 Mean difference 
(CR) 
R' 
Hunger (cm) 0.28 (2.55) 0.42 0.25 (3.90) 0.39" -0.03 (3.02) 0.17 
Desire to eat (cm) 0.16 (2.20) 0.60" 0.28 (4.15) 0.24' 0.12 (3.76) 0.14 
Fullness (cm) -0.69 (3.50) 0.23* -0.52 (3.84) 0.39" 0.18 (3.23) 0.28* 
Differences in baseline VAS ratings following repeated identical 1992 Kj liquid preloads 
on three occasions. CR: coefficient of repeatability =2a SD of mean differences. *p 
<0.05, **p <0.01. 
MEAN 0-60 min 1 and 2 study session 1 and 3' study session 2 and 3 study session 
Mean difference 
(CR) 
R2 Mean difference 
(CR) 
R2 Mean difference (CR) R2 
Hunger (cm) 0.01 (2.29) 0.64** -0.02 (3.11) 0.62** -0.04 (2.41) 0.38** 
Desire to eat (cm) 0.02 (1.81) 0.78** 0.02 (3.28) 0.56** -0.00 (2.80) 0.42** 
Fullness (cm) 0.05 (2.25) 0.68** 0.33 (3.05) 0.65** 0.29 (2.45) 0.40** 
Differences in post-preload VAS ratings following repeated identical 1992 kJ preloads 
on three occasions. CR: coefficient of repeatability =2z SD of mean differences. *p 
<0.05, **p <0.01. 
POST AD LIBITUM- 1 and 2 study session 1 and 3 study session 2 and 3 study session 
TEST MEAL Mean difference 
(CR) 
R2 Mean difference 
(CR) 
R2 Mean di ce (CR) R2 
Hunger (cm) 0.02 (3.32) 0.00 0.24 (2.48) 0.01 0.22 (2.44) 0.18 
Desire to eat (cm) 0.40 (3.32) 0.00 0.41 (2.10) 0.00 0.01 (2.53) 0.36** 
Fniiness (cm) -0.54 (2.92) 0.04 -0.43 (3.61) 0.00 0.11 (4.11) 0.00 
Differences in average post-ad libitum test meal VAS ratings following repeated 
identical 1992 kJ preloads on three occasions. CR: coefficient of repeatability =2x SD 
of mean differences. **p <0.01. 
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APPENDIX X EXAMPLE OF MICROSOFT EXCEL WORKSHEET USED 
TO CALCULATE STANDARD LUNCH PORTIONS TO 
PROVIDE 42 KJ PER KG BODY WEIGHT 
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APPENDIX XI COMPOSITION OF WHEY AND CASEIN PROTEIN 
LIQUID TEST MEALS 
Per 100g of formula WHEY CASEIN 
Energy (kJ) 1727 1498 
Protein (g) 76.2 85.0 
Carbohydrate (g) 8.73 1.2 
Fat (g) 4.76 1.5 
Amino acids (g) 
Alanine 4.8 3.1 
Arginine 2.3 3.8 
Aspartic acid 10.2 7.3 
Cysteine 1.2 0.4 
Glutamic acid 17.2 22.3 
Glycine 2.0 1.9 
Histidine 1.6 3.2 
Isoleucine 8.4 5.8 
Leucine 10.5 10.1 
Lysine 9.1 8.3 
Methionine 1.6 3.0 
Phenylalanine 3.1 5.4 
Proline 6.1 10.5 
Serine 5.2 6.3 
Threonine 6.2 4.6 
Tryptophan 2.1 1.4 
Tyrosine 2.4 5.8 
Valine 6.0 7.4 
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APPENDIXXII POWER CALCULATIONS USING THE DATA FROM THE 
REPEATABILITY STUDY FOR AD LIBITUM FOOD 
INTAKE AND VAS RATINGS 
Detectable 
difference 
Fasting Post-preload (1 h 
mean) 
Post-ad libitum test 
meal 
(mm): 10 15 10 15 10 15 
Hunger 34 14 27 12 13 <8 
Desire to eat 25 11 43 18 11 <8 
Fullness 33 14 45 19 25 11 
Power calculations for visual analogue scales (VAS). Number of subjects needed to show 
the detectable difference of appetite scores with a power of 0.8 (p <0.05) using a repeated 
measures design. Calculations based on data from Chapter 2, "Reproducibility of satiety 
methodology: the measurement of food intake using ad libitum test meals and visual analogue 
scales for the subjective assessment of appetite" (section 2.3), n= 18. 
Detectable 418 628 837 difference (kJ): 
Energy intake 73 32 18 
Power calculations for energy intake at an ad libitum test meal. Number of subjects 
needed to show the detectable difference of energy intake with a power of 0.8 (p <0.05) using 
a repeated measures design. Calculations based on data from Chapter 2, "Reproducibility of 
satiety methodology: the measurement of food intake using ad libitum test meals and visual 
analogue scales for the subjective assessment of appetite" (section 2.3), n= 18. 
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